Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells

ABSTRACT

This invention relates, e.g., to a method for expanding mammalian acinar cells, comprising culturing the cells in a cell culture system comprising a cell culture medium and a cell attachment surface, under conditions wherein the acinar cells undergo a 3-4 fold expansion together with transdifferentiation into a modified cell phenotype (IP cells) showing characteristics of acinar cells and liver cells. The invention also relates to a method for transforming these IP cells to insulin-producing cells in vitro, comprising culturing the cells in a novel, defined medium. Also disclosed are suitable culture media for performing these methods, isolated cells having the phenotype of IP cells and/or produced by these methods, and kits for performing the methods.

This application claims the benefit of provisional application 60/384,000, filed May 28, 2002, which disclosure is incorporated by reference in its entirety herein.

BACKGROUND OF THE INVENTION

1. Field of the Invention

The invention relates to compositions and methods whereby, e.g. human pancreatic acinar cells are cultured under conditions that support expansion and transdifferentiation into glandular epithelial cells and subsequently into insulin-producing cells.

2. Background Information

The potential benefits of taking insulin-producing cells from organ donors and transplanting them into insulin-dependent, Type I diabetic patients is clear. In the Edmonton clinical trials, many patients have lived free from the delivery of exogenous insulin for approximately 2 years after being transplanted with intact islets from organ donor sources. However, current technology requires two organ donor pancreata to generate a sufficient number of islets (about 1 million islets, comprised of about 1,000 cells each) to transplant into one diabetic patient for cellular therapy. Thus, there has been emphasis in the diabetes field to identify new sources of insulin-producing cells for transplantation. Many avenues are being explored, including expansion of islets after harvest and before transplantation and the generation of new islets from stem-like cells derived from the bone marrow, or from precursor cells located in the pancreas. The challenges presented by these approaches are related to maintenance of function of islets over long periods of culture, and of the relative rarity of stem-like cells that can be harnessed for insulin production from the bone marrow and pancreas. The ductular precursor stem-like cells derived from the pancreas are reported to be more efficient than bone-marrow derived cells at differentiation into insulin-producing cells, and this may reflect their site of origin (i.e., pancreas) where they are certainly exposed to many differentiation signals related to the pancreatic microenvironment. The most abundant cell type in the pancreas is the acinar cell, which comprises about 85% of the pancreas. The acinar cells serve to produce and secrete digestive enzymes and, like islet cells, arise during development from the ductular cell compartment.

There have been reports that acinar cells, when cultivated in vitro, especially under conditions of stress, can undergo a ‘transdifferentiation’ into a cell type that resembles ductular cells, as determined by expression of CK19, CK7, and carbonic anhydrase (all reputed by the authors to be markers of duct cells) (Kerr-Conte, 1996; WO 02/29010 A2), Hall et al., 1992). Furthermore, Bouwens et al. (1998) have shown in vivo, in a model of pancreatic duct ligation, that acinar cells in the ligated portion of the pancreas undergo transdifferentiation into cells with a ductular phenotype. Further work has suggested that insulin-producing cells can be produced upon further differentiation of the duct cells in the ligated portion of the pancreas. The acinar cells are also reported to be of limited survivability in primary culture, with some culture conditions leading to loss of at least 50% of cells within a week. While primary duct cells have been demonstrated in vitro to convert into insulin-producing cells under some culture conditions (e.g. Bonner Weir, 2000, U.S. Pat. No. 6,011,647), there are no reports of cells that arose from acinar cells in vitro differentiating further to produce islet-like cells.

Prior to the development of the present system, primary pancreatic acinar cells were expanded without differentiation into insulin-producing cells, either in serum-containing medium (undesirable both because of the risk and the uncertainty associated with the use of serum), or in complex serum free media formulations. Likewise, primary pancreatic acinar cells have been transdifferentiated into insulin-producing cells without expansion, producing cells with an insulin-producing phenotype in small numbers. Furthermore, it has not been previously possible to obtain insulin-producing cells in good numbers using acinar cells as starting material.

Thus, there is a need for a simple cell culture system and method for rapidly generating large numbers of cells that can further differentiate into, e.g., insulin-producing cells, through expansion and differentiation of the abundant pancreatic acinar cells. Further, there is a need for a cell culture system and method for culturing and transforming such cells into insulin-producing cells. One cell culture system and related method disclosed herein allows a simple, one-step approach that generates expanded cultures that contain at least 80% intermediate progenitor cells that can give rise to insulin-producing cells. A second cell culture system and related method allows the further culturing of these intermediate progenitor cells or other glandular epithelial cells to obtain insulin-producing cells. Both IP cells and insulin-producing cells will be useful for cell-based therapies for the treatment of diseases such as diabetes.

SUMMARY OF THE INVENTION

The present invention provides compositions and methods whereby, e.g., acinar cells can be cultivated successfully in vitro, undergoing a 3-4 fold increase in cell number over time, and giving rise to a cell population that co-expresses acinar and ductal markers early during the culture (2-3 days ex vivo), then ultimately (e.g., about 7-8 days ex vivo) acquires a modified phenotype characterized by expression of some acinar-associated genes, as well as some liver-associated genes. The genes expressed by these modified cells at about 7-8 days ex vivo include, e.g., ductular cytokeratins (CK7, CK8, CK18 and CK19), hepatic nuclear factor 1 (HNF1), alpha-1 antitrypsin, pi-glutathione s transferase (pi-GST), liver-specific (basic helix-loop-helix (bHLH) transcription factor, Thy-1, CCAAT/enhancer-binding protein (C/EBP)-alpha and C/EBP-beta. These cells exhibit little if any expression of the pancreas-associated genes carbonic anhydrase, cystic fibrosis transmembrane conductance regulator (CFTR), elastase and amylase. By “little if any” expression of a gene is meant herein that gene expression is generally undetectable under conventional methods, such as the hybridization and immunocytochemical methods described herein, but expression may be detected by extraordinarily sensitive methods, such as PCR-based analysis. This type of modified cell is referred to herein as an intermediate progenitor (“IP”) cell. The expanded/transdifferentiated acinar cells (IP cells) can be produced using a general serum-containing media, or, in a preferred method, can be produced without serum on a surface comprising one or more extracellular matrix molecules (ECMs) in the presence of one or more soluble active factors. ECMs can be presented in 2 dimensional or 3 dimensional culture systems in the presence of soluble active factors.

The IP cells generated from these cultures are expected to be useful directly in certain medical applications. For example, there is evidence that such cells may under certain conditions become functioning insulin-producing cells when implanted in diabetic patients. The cells can also be used for drug discovery and toxicity studies.

In addition, according to a further aspect of the invention, the IP cells can be cultivated further, in a serum-free medium composed of any standard serum-free base medium (DMEM:HamsF12, for example) with BSA and combinations of factors, including ECMs, small molecules, and growth factors. After 5-10 days of culture, the IP cells undergo additional steps of differentiation, culminating in the formation of cell aggregates that express pro-insulin and C-peptide. Challenge of these cultures with a high-glucose medium causes release of insulin and C-peptide into the medium, indicating the production in these cultures of functional islet-like cells.

Thus, in a first aspect, the present invention provides a cell culture system comprising a superior cell attachment surface that also stimulates cellular expansion, and a simple culture medium including effective amounts of one or more soluble active factors, or serum (e.g. fetal bovine serum), added to a base medium composition. The cell culture system will be particularly useful for primary culture of mammalian epithelial cells, particularly human epithelial cells. In a preferred embodiment the cell culture system is used for the expansion and transdifferentiation of primary acinar cells, especially human pancreatic acinar cells.

The cell attachment surface for this cell culture system is any surface to which the cells can attach and expand, including both 2 dimensional (e.g. plates, flasks, roller bottles, petri dishes, wells etc.) and 3 dimensional (e.g. scaffold) environments. Preferably the surface comprises at least one type of ECM, or a peptide fragment thereof. Cells may, in some circumstances, detach from these surfaces and form self-supporting aggregates. Suitable fragments include peptides consisting of a sequence of three of more amino acid residues that are identical to any portion of the amino acid sequence of the ECM. Such fragments can be easily made and tested by means known to those of skill in the art. Most preferably the surface is a layer of collagen I. Many other surfaces known in the art are also suitable, such as Collagen VI, Collagen IV, Vitronectin, or Fibronectin. Collagen I is preferred due to ease and cost.

The base medium to which the soluble active factors are added may be any cell culture medium appropriate for growth and differentiation of epithelial cells. These include, but are not limited to, DMEM, Hams F12, MEM, M-199 and RPMI. The general requirements for such culture media and many suitable examples are known to those of skill in the art. To this base medium is added either serum (such as fetal bovine serum), or a stabilizing protein such as bovine serum albumin (ISA) along with effective amounts of soluble active factors. The medium is preferably serum-free.

Soluble active factors for the expansion and transdifferentiation of primary pancreatic acinar cells into IP cells include growth factors such as HGF receptor activators and EGF receptor activators. Preferred soluble active factors include one or more of EGF and Transforming Growth Factor-α, IGF1, HGF, betacellulin, prolactin and gastrin 1. HGF, EGF and/or Transforming Growth Factor-α are particularly preferred. Also preferred is the combination of IGF1 and betacellulin.

In one particularly preferred embodiment, the base medium contains a 1:1 mixture of DMEM and Hams F12. The base medium is completed with the addition of glutamine to a final concentration of ˜4 mM, insulin (˜0.1-10 μg/ml, preferably ˜0.01 mg/ml), transferrin (˜0.5-10 μg/ml, preferably ˜0.0055 mg/ml), selenium (˜0.25-5.0 ng/ml, preferably ˜0.0067 μg/ml of sodium selenite), and Epidermal Growth Factor (EGF) (˜1-20 ng/ml, preferably ˜10 ng/ml); this medium is hereafter referred to as pancreatic cell medium, or PCM. To this base medium formulation, up to ˜20% Fetal Bovine Serum (or other serum), preferably between ˜10-˜15% fetal bovine serum, most preferably about 10% or up to about 15% fetal bovine serum) may be added, or, to create a serum-free culture environment, the following components are added in place of serum: heat-inactivated bovine serum albumin (0.1-2%), Hepatocyte growth factor (HGF) (1-20 ng/ml), and/or Transforming Growth Factor Alpha (TGFα)(1-10 ng/ml). In addition, the medium may contain Betacellulin (0.5-20 ng/ml), Gastrin 1 (0.05-10 ng/ml), Prolactin (1.0-10 ng/ml), and/or IGF-1 (5-100 ng/ml). In particular formulations, greater or lesser amounts of these components may be added in order to achieve a formulation that is effective in supporting the expansion and transdifferentiation of the cells. Persons of skill in the art will appreciate that determining effective amounts of the components will require no more than routine experimentation.

By the use of this attachment surface and medium, the expansion and transdifferentiation of primary pancreatic cells with the desired phenotype is simplified greatly.

In a particularly preferred embodiment, the cell culture system is a combination of collagen I coated tissue culture surface (presented in a 2 dimensional or 3 dimensional form) and a serum-free medium containing BSA, insulin, transferrin, selenium, Hepatocyte growth factor (HGF), Epidermal Growth Factor (EGF) and Transforming Growth Factor Alpha (TGFA).

The cell culture system enables superior attachment in vitro of primary pancreatic epithelial cells for adherent culture compared to prior methods, while creating a cellular environment that promotes expansion of the epithelial component of primary pancreatic cultures with concomitant transdifferentiation of the acinar cells present in the starting material into IP cells, while minimizing emergence of undesired fibroblasts. Advantages of this culture system are ease of construction, few components needed, and that all components are readily available and easily used in the required manner.

The components of this aspect of the invention may be conveniently packaged in the form of a kit. The kit may include, for example, 1) a cell culture medium such as DMEM: 2) a serum-free medium supplement containing BSA, insulin, transferrin, selenium, HGF, EGF and TGFA, in suitable amounts to yield the concentrations noted above in the completed medium; and 3) at least one collagen I coated substrate, such as a vessel for tissue culture (e.g., dish(es) with at least one collagen-1 coated tissue culture surface), or collagen-1 coated inserts for use in culture dishes or other laboratory ware. The kit may also optionally include a tissue culture dish or other cell culture accessories and additional reagents that may be required to carry out epithelial cell culture and differentiation.

Culture systems consisting of scaffolds, collagen coated flasks or other vessels and serum-free base medium may be packaged along with the soluble active factors as a separate vial that would be added to the culture medium just prior to use. The active factor combination can be added to a variety of base media to accomplish the same end, e.g., growth and differentiation of primary pancreatic acinar cells in vitro. Such culture systems should also be useful for other cell types, particularly glandular epithelial cells derived from other organs and tissues, including those from liver, pancreas, intestine, prostate, and breast.

The collagen I surface provides superior cell attachment (thereby increasing the number of cells that adhere during initial culture and thus enhancing culture efficiency), while the collagen I and the combination of soluble active factors (e.g., HGF, TGFA and EGF) promote continued proliferation of cells over time, leading to an increase in cell number above what has been previously reported for primary pancreatic acinar cells. Furthermore, the expansion of the acinar cells is accompanied by a transdifferentiation in the majority of cells to an IP phenotype, which is potentially a therapeutically useful cell phenotype for the treatment of diseases such as diabetes. This likely occurs due to convergence of the intracellular signaling pathways associated with collagen I, HGF, TGFA and EGF, creating a synergistic response.

The cell culture system of the present invention has unexpected advantages over systems previously in use. Collagen I, IV, VI, Vitronectin and Fibronectin were expected to enhance cell attachment. However, other extracellular matrix molecules that yielded equivalent attachment of cells during the initial 18 hours of culture did not promote consistent growth of the cells over time in the serum-free medium containing HGF/EGF/TGFA. The most efficient and cost-effective method of achieving cell expansion AND differentiation into IP cells is to utilize a collagen-I surface and a medium containing reduced serum (preferably less than 20%, more preferably less than 15%, 10%, or 5%, most preferably 2%).

Another aspect of the invention is a method for culturing mammalian epithelial cells comprising adding said cells to the cell culture system described above, and maintaining them at suitable temperature and atmospheric conditions. By “mammalian epithelial cell” is meant any cell of a tissue or organ with an epithelial cell phenotype, defined by the presence of expression of cytokeratins and often through the presence of markers that suggest a tissue-specific function (i.e., epithelial cells of the skin make keratin, epithelial cells of the intestine make mucin, epithelial cells of the prostate make PSA). In a preferred embodiment, the cells are primary pancreatic cells, particularly human pancreatic cells. Suitable temperature for mammalian cells is usually in the range of about 37° C., but may be varied somewhat according to cell type. The atmosphere can be ordinary air, or other specialized mixtures of gasses suitable for maintaining cells, as will be familiar to persons of skill in the art. Expansion of pancreatic acinar cells can be maximized by decreasing the oxygen tension in the culture atmosphere to less than 21%, while transdifferentiation to IP cells can be enhanced by increasing oxygen tension to greater than 5%. A preferred range of oxygen tension is between about 5% and about 21%.

In a second aspect, the invention also provides methods and compositions for transforming glandular epithelial cells that have acquired expression of markers characteristic of an intermediate progenitor (IP) phenotype as described above into insulin-producing cells. By “glandular epithelial cell” is meant an epithelial cell that is a component of a gland. Glands are tissues that have a specific function related to secretion of key molecules—most organs in the body have glandular function (liver, intestine, pancreas, prostate, breast, pituitary, adrenal, kidney) whereby they produce and release hormones, digestive enzymes, or other life-essential fluids. Glandular epithelial cells from endoderm-derived organs (e.g., liver, intestine, pancreas) share many characteristics, including the ability to express many of the same genes. Particularly preferred are glandular epithelial cells from pancreas, for example acinar cells. As used herein, the terms “express” and “expression” generally refer to nucleic acids (e.g., mRNAs) or to protein gene products that are detectable by standard immunocytochemical methods.

In this aspect, the invention provides a second cell culture system comprising a cell attachment surface and a culture medium that supports and promotes the transformation of glandular epithelial cells into insulin-producing cells. The cell attachment surface is similar to and may be identical to the attachment surface for expanding primary pancreatic acinar cells. It may be presented in the form of a flat surface coated on a vessel or in the form of a scaffold or other surface adapted for cell culture. It can be comprised of, or coated with, any composition that is capable of maintaining cells or supporting cell growth. In a preferred embodiment, it comprises at least one ECM, such as Collagen I, Collagen VI, Collagen IV, Vitronectin or Fibronectin. In a particularly preferred embodiment, the cell attachment surface is Collagen-I.

In this aspect, the invention provides a further culture medium comprising at least one differentiation promoting factor (“DPF”) that promotes the transformation of glandular epithelial cells into insulin producing cells. The DPFs for the transformation of glandular epithelial cells into insulin producing cells can be one or more of Activin A, acidic FGF, basic FGF, C-Natriuretic Peptide (CNP), Calcitonin Gene Related Peptide, Cholera Toxin B Subunit, Dexamethasone, Gastrin-Releasing Peptide, Glucagon-like Peptide-1 (GLP-1), Glucose, IGF1, IGF2, Insulin, Laminin, LIF, Met-Enkephalin, PDGFAA+PDGFBB, Prolactin, Sonic Hedgehog, Substance P, TGF-alpha, Trolox (alpha-tocopherol derivative), or VEGF. Preferred concentrations in culture medium of each of these 23 DPFs are listed in Table 1. Although in some cases one DPF is sufficient, preferably two or more factors are used. As many as all 23 of the factors may be used. TABLE 1 Concentration Substance (micrograms/mL) Activin A (human, recombinant) 0.0005 CGRP alpha, (Calcitonin Gene Related Peptide, rat) 0.1905 C natriuretic peptide) (human, porcine, rat: frag 32-53) 0.10985 (CNP) Cholera Toxin B Subunit, recombinant 0.0125 DEXamethasone (9 alpha-fluoro-16alpha- 0.002 methylprednisolone)(hydrocortisone analogue) FGF acidic (aFGF = FGF1), Recombinant Human 0.0025 GLP-1 (7-36) amide, human (Glucagon-Like Peptide 0.033 1) Glucose (base should be I0ow; 0.9 ug/ml) 1.08 Insulin, human (low [ ] in base media 1 ug/ml) 9.5 LIF, human (leukemia inhibitory factor, human) 0.0025 PDGF AA + PDGF BB MIX 0.005 TGF alpha 0.001 Prolactin (human, recombinant)(a plasma growth 0.0012 hormone) Trolox (soluable Vitamin E) (C14H18O4) 0.625 GRP (Gastrin Releasing Peptide, Human) 0.143 IGF-1, recombinant human 0.0025 IGF-2, recombinant human 0.0025 Laminin 2.25 Met-Enkephalin (tyr-gly-glyl-phe-met) 0.003 Sonic Hedgehog (mouse, recombinant) 0.025 Substance P (full length) (H1875 is frag 1-4) 5 FGFb (=FGF2), human Recombinant 0.0025 VEGF 0.0025

In a preferred embodiment of this aspect of the invention, the culture medium comprises at least one (or as many as all 10) of the following differentiation promoting DPFs:.C-Natriuretic Peptide (CNP), Calcitonin Gene Related Peptide, Cholera Toxin B Subunit, Dexamethasone, Gastrin-Releasing Peptide, Laminin, Met-Enkephalin, PDGFAA+PDGFBB, Sonic Hedgehog, and Substance P.

In a preferred embodiment, the culture medium that promotes the transformation of glandular epithelial cells into insulin producing cells consists of a 1:1 mixture of DMEM and Hams F12 plus the components listed in Table 2. This medium is sometimes referred to herein as “Media or Medium G9.” TABLE 2 Concentration Factor Substance (Final) ug/ml 1 ANP Atrial Natriuretic 0.1530 Peptide, Rat (28 amino acids) 2 CCK-8-frag-amide CCK8, Fragment 26-33 0.0250 Amide (Cholecystokinin) (Asp-Tyr(SO3H)-Met- Gly-Trp-Met-Asp-Phe- NH2) 3 Caerulin sulfate Caerulein (Pyr-Gln- 0.0300 Asp-Tyr(SO3H)-Thr- Gly-Trp-Met-Asp-Phe- NH2 4 Cholera Toxin-B Cholera Toxin B 0.0125 Subunit, recombinant 5 Dex DEXamethasone (9 0.0020 alpha-fluoro-16alpha- methylprednisolone) (hydrocortisone analogue) 6 FGF-7 FGF7 (KGF) 0.0025 7 GLP-1 GLP-1 (7-36) amide, 0.0330 human (Glucagon-Like Peptide 1) 8 GRP GRP (Gastrin 0.1430 Releasing Peptide, Human) 9 Gastrin-1 Gastrin I Human 0.0000 10 Glucose Glucose (base should 1.0800 be I0ow; 0.9 ug/ml) 11 HGF Hepatocyte Growth 0.0025 Factor (HGF) recombinant 12 IGF-1 IGF-1, recombinant 0.0025 human 13 IGF-2 IGF-2, recombinant 0.0025 human 14 Insulin Insulin (low [ ] in base 9.5000 media 1 ug/ml) 15 Leu-Enkephalin Leu-Enkepthalin (tyr- 0.0030 gly-gly-phe-leu) 16 Nicotinamide Nicotinamide 610.0000 17 PTHRP-frag-1-34 pT II RP (Parathyroid 0.2060 Hormone Related Peptide (1-34), human) 18 Progesterone Progesterone 0.0030 19 Prolactin Prolactin (human, 0.0012 recombinant)(a plasma growth hormone) 20 Retinol acetate Retinoic Acid (Vitamin 0.0250 A) 21 SHH Sonic Hedgehog 0.0250 (mouse, recombinant) 22 Sodium selenite Selenium (Selenous 0.0250 Acid, Na salt) 23 Soybean trypsin inhibitor Trypsin Inhibitor, 0.5000 soybean (type I-S) 24 TGF-beta sRII TGF beta sRII (soluable 0.0050 receptor type 2) 25 Transferrin transferrin 2.7500 26 Trolox Trolox (soluable 0.6250 Vitamin E) (C14H18O4) 27 VIP Vasoactive Intestinal 0.0665 Peptide (VIP), human 28 aFGF FGF acidic 0.0025 (aFGF = FGF1), Recombinant Human 29 bFGF FGFb (=FGF2), human 0.0025 Recombinant 30 n-Butyric acid n Butyric Acid, Sodium 4.5400 Salt

The components of this aspect of the invention may also be conveniently packaged in the form of a kit. The kit may include, for example, 1) a cell culture medium such as DMEM, Hams F12, or a combination thereof; 2) a serum-free medium supplement containing: BSA and the DPFs Activin A, acidic FGF, basic FGF, C-Natriuretic Peptide (CNP), Calcitonin Gene Related Peptide, Cholera Toxin B Subunit, Dexamethasone, Gastrin-Releasing Peptide, Glucagon-like Peptide-1 (GLP-1), Glucose, IGF1, IGF2, Insulin, Laminin, LIF, Met-Enkephalin, PDGFAA+PDGFBB, Prolactin, Sonic Hedgehog, Substance P, TGF-alpha, Trolox (alpha-tocopherol derivative), or VEGF, or two or more of these components in combination, in suitable amounts to yield the concentrations noted in Table 1 in the completed medium; and 3) tissue culture dish(es) with at least one collagen-1 coated tissue culture surface (or collagen-1 coated inserts for use in culture dishes or other laboratory ware). The kit may also optionally include a tissue culture dish and/or other cell culture accessories and additional reagents that may be required to carry out epithelial cell culture and differentiation. In other embodiments, the kit may contain any of the media or media components discussed herein.

Culture systems consisting of scaffolds, collagen coated flasks or other vessels and serum-free base medium may be packaged along with the DPF(s) as a separate vial that would be added to the culture medium just prior to use. The DPF combination can be added to a variety of base media to accomplish the same end, e.g., growth and differentiation of primary pancreatic acinar cells in vitro. Such culture systems may also be useful for other cell types, particularly other epithelial cells derived from glandular tissues, including those from liver, pancreas, intestine, prostate, and breast.

The invention also provides a method for converting glandular epithelial cells into insulin-producing cells comprising culturing the glandular epithelial cells in the cell culture system described above. The method may further comprise removing the culture medium from the cell culture, re-feeding the cell culture with a serum-free medium with glucose, and measuring proinsulin production C-peptide production, or insulin release.

Furthermore, the invention provides an isolated population of insulin-producing cells containing cytoplasmic granules with immunodetectable proinsulin, insulin, and/or c-peptide that is derived from a population of cells of which a subset of cells expressed at least one marker associated with IP cells (e.g., expressed some acinar-associated genes, as well as some liver-associated genes, including, e.g., ductular cytokeratins (CK7, CK8, CK18 and CK19), HNF1, alpha-1 antitrypsin, pi-glutathione s transferase (pi-GST), liver-specific bHLH transcription factor, Thy-1, C/EBP-alpha and C/EBP-beta, and expressed little if any of the pancreas-associated genes carbonic anhydrase, cystic fibrosis transmembrane conductance regulator (CFTR), elastase and amylase).

By an “isolated” cell or population of cells is meant herein that the cell or cell population is removed from its original environment (e.g., the natural environment if it is naturally occurring), and isolated or separated from at least one other component with which it is naturally associated. For example, a naturally-occurring cell present in its natural living host is not isolated, but the same cell, separated from some or all of the coexisting materials in the natural system, is isolated. Such cell or cell populations could be part of a cell culture or cell population, and still be isolated in that such culture or population is not part of its natural environment.

In one preferred embodiment, the insulin-producing cells are derived from glandular epithelial cells obtained from mammalian pancreas, such as primary acinar cells.

The data disclosed in the examples below are generated from freshly isolated human pancreatic cells. The expansion of primary human pancreatic cells in these conditions produces cultures with a mixed epithelial IP phenotype, suitable for in vitro studies of IP cells for a variety of purposes, and suitable for transplantation in vivo for cell therapy for the treatment of diseases such as diabetes. The IP cells generated by these methods may also be useful in the study of pancreatic cell biology, as normal controls in the study of pancreatic epithelial cancers, and to test the effects of drugs/compounds on normal pancreatic epithelial cells (ductal or acinar). Furthermore, the cells may be further cultured to yield insulin-producing cells as demonstrated below.

BRIEF DESCRIPTION OF THE DRAWINGS

FIGS. 1A-D show microscopic images after treatment of starting material with antibodies to amylase (FIG. 1A), insulin (FIG. 1B), and CK19 (FIG. 1C) and the composition of the cell pellet of freshly isolated primary human pancreatic cells (FIG. 1D).

FIG. 2 shows growth curves constructed from primary human pancreatic cultures grown in commercial medium (with serum) or in the described pancreatic cell medium (PCM) with serum.

FIG. 3 shows a comparison of cell expansion in the base medium composition described vs. base medium+soluble growth factors (serum-free formula) vs. base medium+fetal bovine serum.

FIGS. 4A-B shows the effect of different culture surfaces on total cell number (FIG. 4A) and cell phenotype (FIG. 4B) after expansion.

FIGS. 5A-B show a comparison of cell phenotype after expansion in serum-containing (5A) and serum-free (5B) medium containing all soluble active factors.

FIG. 6 shows high power images of cell cultures expanded in various conditions, including serum-free base media supplemented with 3 soluble active factors, HGF, EGF & TGFA. Note epithelial morphology.

FIG. 7 shows a demonstration of growth of IP cells on ECM-coated surfaces as determined by metabolic activity assay over time. Note superior growth when Collagen I surface is combined with the media formulation described herein, yielding results superior to the combination of Matrigel and commercial media with serum.

FIG. 8A (upper left) shows expression of amylase by acinar cells after two days of culture (red staining), FIG. 8B (lower left) shows expression of CK19 (green staining), FIG. 8C (right) shows an overlay of the two images, showing co-expression (yellow) in a large proportion of cells.

FIG. 9 shows changing phenotype of primary acinar cells in culture over 5 days. Amylase is red, CK19 is green. Note appearance of yellow (amylase+CK19) on Day 2 and 3.

FIGS. 10A and 10B show primary human pancreatic cells that were expanded in serum-containing medium on Collagen I coated surface. Images were analyzed to determine total cells (FIG. 10A, blue nuclei) and total positive cells (FIG. 10B, blue nuclei surrounded by green staining for CK19).

FIG. 11 shows light microscopic (200×) appearance of pancreatic acinar cells cultured on a collagen I surface with all DPFs (Activin A, 0.5 ng/ml; acidic FGF, 2.5 ng/ml; basic FGF, C-Natriuretic Peptide (CNP), 0.11 μg/ml; Calcitonin Gene Related Peptide, 0.19 μg/ml; Cholera Toxin B Subunit, 12.5 ng/ml; Dexamethasone, 0.002 μg/ml; Gastrin-Releasing Peptide, 0.143 μg/ml; Glucagon-like Peptide-1 (GLP-1), 0.033 μg/ml; Glucose, 1.08 μg/ml; IGF1, 0.0025 μg/ml; IGF2, 0.0025 μg/ml; Insulin, 9.5 μg/ml; Laminin, 2.25 μg/ml; LIF, 0.0025 μg/ml; Met-Enkephalin, 0.0030 μg/ml; PDGFAA+PDGFBB (0.0050 μg/ml: 0.0025 μg/ml of PDGFAA+0.0025 μg/ml PDGFBB); Prolactin, 0.0012 μg/ml; Sonic Hedgehog, 0.025 μg/ml; Substance P, 5.0 μg/ml; TGF-alpha, 0.0010 μg/ml; Trolox (alpha-tocopherol derivative), 0.625 μg/ml; and VEGF, 0.0025 μg/ml).

FIG. 12A (top right panel) shows immunocytochemical analysis with CK19 antibodies (green).

FIG. 12B (lower right panel) shows immunocytochemical analysis with C-peptide antibodies (red).

FIG. 12C (left panel) shows an overlay image demonstrating the colocalization of CK19 and C-peptide (orange). Blue portions are DAPI stained nuclei.

FIG. 13A shows insulin release upon glucose challenge in IP cells that have not been detached and relocated (subcultured) during the growth and differentiation process.

FIG. 13B shows insulin release upon glucose challenge in IP cells that have been subcultured according to Example 10.

FIG. 13C shows C-peptide release upon glucose challenge in IP cells that have not been subcultured according to Example 10.

FIG. 14 shows the Isulin/DNA ratio in subcultured and nonsubcultured cells that are treated with Combinations 1, 2 and 3 of DFP media, as described in Example 11.

FIG. 15 shows insulin release in response to base level glucose (5 mm) and a glucose challenge (22 mm) over 10 days of culture in PCM and DPF media, as described in Example 13.

FIG. 15A shows insulin release in response to base level glucose (5 mm) and a glucose challenge (22 mm) over 14 days of culture in PCM and DMG9 media, as detailed in Example 14.

FIG. 16 is a graphical representation of the characteristics of the 17 classes of genes shown in Table 6, as indicated in the last column of the Table, as detailed in Example 14.

DETAILED DESCRIPTION OF THE INVENTION

In describing preferred embodiments of the present invention, specific terminology is employed for the sake of clarity. However, the invention is not intended to be limited to the specific terminology so selected. It is to be understood that each specific element includes all technical equivalents, which operate in a similar manner to accomplish a similar purpose. Each reference cited here is incorporated by reference as if each were individually incorporated by reference.

The following abbreviations are used:

-   BSA: bovine serum albumin -   BMP Bone Morphogenetic Protein -   bHLH: basic helix loop helix -   DMEM: Dulbecco's Modified Eagle's Medium -   TGF β1: Transforming Growth Factor β1 -   ECM: extracellular matrix molecules; naturally occurring proteins     produced by cells of a tissue that provide structural support as     well as a source of cellular signals related to adhesion. Examples     are collagen, vitronectin, fibronectin, laminin. -   EGF: Epidermal Growth Factor -   Hams F12: Ham's Nutrient Mixture F12 -   HGF: Hepatocyte growth factor -   HNF-1: Hepatic nuclear factor 1 -   IGF1: Insulin-like growth factor 1 -   IGF-II: Insulin-like growth factor 2 -   IP cells: Intermediate progenitor cells derived from an epithelial     cell, such as, e.g., a pancreatic acinar cell or a liver cell,     wherein the derived cells express some acinar-associated genes, as     well as some liver-associated genes, including, e.g., cytokeratins     (CK7, CK8, CK18 and CK19), HNF1, alpha-1 antitrypsin, pi-glutathione     s transferase (pi-GST), liver-specific bHLH transcription factor,     Thy-1, C/EBP-alpha and C/EBP-beta, and express little if any of the     pancreas-associated genes carbonic anhydrase, cystic fibrosis     transmembrane conductance regulator (CFTR), elastase and amylase). -   PDGF-A: Platelet derived growth factor alpha -   PDGF-B: Platelet derived growth factor beta -   TGFA, TGF-α: Transforming Growth Factor α

As used herein, the term “culture system” is intended to mean a system for growing and/or differentiating cells in culture, which comprises a cell attachment surface, preferably one that also stimulates cellular expansion, and a culture medium, which includes effective amounts of one or more factors, or serum (e.g. fetal bovine serum), added to a base medium composition.

When referring to active soluble factors and DPFs herein, “effective amount” means an amount that either alone or in combination with other included factors is effective in promoting either expansion and differentiation into IP cells, or into insulin-producing cells, as applicable.

EXAMPLES

I. Expansion and Transdifferentiation of Primary Acinar Cells into Glandular Epithelial Cells (Culture Phase I)

Materials and Methods:

Starting Material: Primary human pancreatic acinar cells are collected as waste from standard COBE gradient preparation of islet cells for transplantation (Lake et al., 1989). After density gradient centrifugation, the islets are present as a layer between 1.063 density and 1.10 density, and the remaining cells are collected as the pellet that sediments to the bottom of the gradient based on density. Approximately 48 hours after collection of the cells at the transplant center are received by the inventors in non-tissue-culture treated polystyrene flasks and are suspended in RPMI+10% fetal calf serum at a density of approximately 2.0 million cells/ml. Cell number and viability is assessed by trypan blue exclusion and enumeration on a hemacytometer by light microscopic observation.

Phenotypic Evaluation of Starting Material. A preparation of starting material was formalin fixed and paraffin-embedded as a cell pellet about 24 hours after initial harvest of the pancreatic cells. Paraffin sections were prepared, placed on slides, and subjected to immunocytochemical analysis with antibodies to insulin (Biogenex, San Ramon, Calif.), CK19 (Biogenex), and Amylase (Biogenex). A minimum of (3) sections per sample were assessed with each marker. All antibody staining was carried out according to the manufacturer's suggestion with pre-diluted commercial antibodies. For CK19, a 3 minute treatment with pepsin enzyme (Biogenex) preceded the blocking step for the purpose of antigen retrieval. Briefly, the sections were rehydrated through graded ethanols, followed by a 15 minute incubation in phosphate buffered saline (PBS) without calcium and magnesium. Protein Blocker (Biogenex) was added for 30 minutes prior to addition of primary antibodies. After (3) 5-minute washes, biotinylated secondary antibody (Biogenex) was added at a 1:100 dilution and sections were incubated for 30 minutes at room temperature. After (3) 5-minute washes, Alexa488 or Alexa-596-conjugated StreptAvidin (Molecular Probes, Eugene, Oreg.) was added for fluorescent visualization. For each slide, a minimum of (3) 200× images were captured using a Nikon fluorescent microscope fitted with a SPOT camera (Diagnostic Systems, Inc., Webster, Tex.). The images were assessed quantitatively using image analysis software (MetaMorph/Universal Imaging Corporation, Downington, Pa.) to determine relative fraction of insulin-positive, CK19+, and amylase+ cells. Insulin+ cells are the beta cells of the islets, CK19+ cells are the primary ductal cells, and amylase+ cells are the acinar cells (see Example 1).

Example 1 Characterization of Cell Culture Conditions

A. Serum-Free Medium

Freshly isolated primary human pancreatic cells were collected as a pellet from a COBE cell separator, fixed in formalin, paraffin-embedded, sectioned, and analyzed with antibodies to amylase, CK19, and Insulin. Images (FIGS. 1A and 1B) were collected on a Universal Imaging System (Universal Imaging Corporation) and analyzed with MetaMorph Software. This cell pellet (FIG. 1C) was comprised of 1.0% insulin+ cells (beta cells of the islet), 5.8% CK19+ cells (primary ductal cells), and 93.2% amylase+ and unlabeled (acinar cells and other cell types).

Primary human pancreatic cells were then seeded at 10⁴ or 10⁵ cells/cm² onto tissue culture treated polystyrene in either DMEM commercial medium plus 10% fetal bovine serum or in PCM plus 10% fetal bovine serum. Replicate cultures were harvested at 3 day intervals via trypsinization and live cells (as determined by trypan blue exclusion) and enumerated on a hemocytometer. The results (shown in FIG. 2) demonstrate that the (serum-containing) medium formulation described herein is superior to commercial media formulation for growth and maintenance of primary pancreatic cells. FIG. 3 compares the results of expanding the cells for 6 days in base medium, base medium plus all of the soluble active factors [HGF, ˜1-˜20 ng/ml, preferably ˜5.0 ng/ml; TGFA, ˜1-˜10 ng/ ml, preferably ˜2 ng/ml; Betacellulin, ˜0.5-˜20 ng/ml, preferably ˜10 ng/ml; Gastrin 1, ˜0.05-˜10 ng/ml, preferably ˜0.06 ng/ml; Prolactin, ˜1.0-˜10 ng/ml, preferably ˜2.4 ng/ml; and IGF1, ˜5-˜100 ng/ml, preferably ˜5 ng/ml)] and base medium plus 10% serum. The serum-free media formulation meets/exceeds expansion provided by media+serum.

The cell expansion experiment was repeated essentially as above, except that the base medium was supplemented with only three of the soluble active factors: TGF, HGF, and EGF. FIG. 6D compares the results of expanding the cells in the various media; FIGS. 6A, 6B and 6C show high power images of the cell cultures expanded under the various media conditions.

B. ECM Surfaces

The attachment of primary human pancreatic cells was evaluated by counting the number of attached cells vs. the number of cells initially seeded on a panel of ECM surfaces comprised of Collagen I (1 μg/cm²), Fibronectin (3 μg/cm²), Laminin (2 μg/cm²), Vitronectin (1 μg/cm²), Matrigel (1 μg/cm²), Human ECM (1 μg/cm²), or Poly-D -Lysine (3 μg/cm²). In one condition, a mixture of Collagen IV, Laminin, and Fibronectin was utilized. ECMs were placed into solution at the above concentrations and allowed to coat tissue culture-treated polystyrene surfaces according to manufacturer's suggestions of 1 hour at room temp. Excess ECM solution was then removed and surfaces were rinsed twice in water. Just before seeding cells, the water was aspirated, then cells were seeded onto the ECM surface at a density of 1×10⁵ cells/cm² in growth medium (PCM) composed of DMEM:HamsF12 mixture (1:1) with 4 mM glutamine, 1×ITS supplement (GIBCO 51500-056), 10% Fetal Calf Serum (Inactivated, Qualified, GIBC 26140-079), and 10 ng/ml Epidermal Growth Factor (EGF) (BD 4001). Cells were seeded onto tissue-culture polystyrene surface as a control. After 18 hours, unattached cells were washed away and remaining attached cells were re-fed with PCM and allowed to grow for 7 days prior to evaluation. Cultures were fixed in 10% formalin and subjected to immunocytochemistry with antibodies for CK19 and Amylase as described previously to determine phenotypic composition. Cells were counterstained with DAPI fluorescent blue nuclear stain to visualize individual cell nuclei for cell counting. The metabolic activity of cells subjected to the various conditions was determined by an MTS assay. Viable cells were measured using the MTS assay (Promega CellTiter 96 Aqueous One Solution Cell Proliferation Assay), a colorimetric method for determining the number of viable cells in proliferation or cytotoxicity. The results of this analysis are shown in FIG. 7.

Example 2 Further Studies with ECM Surfaces and Various Media Components

Primary pancreatic cells, composed of >90% non-islet/non-duct cells, were plated onto various coated surfaces at a density of 28,900 cells/well (10⁵ cells/cm²). Unattached cells were washed off after 18 hours, and cultures were re-fed and allowed to grow for 8 days. Cultures were fixed in formalin (10%) and subjected to phenotypic analysis with antibodies to CK19 and Amylase. The results are shown in FIG. 4A-B. While Collagens I, IV, Laminin, Fibronectin, and Matrigel provide a suitable surface for cell attachment and expansion, maintenance of acinar (amylase+) phenotype along with the presence of an increased proportion of cells with a glandular epithelial phenotype (CK19+) was superior on Collagen I. More than 50% of cells analyzed expressed amylase and more than 50% of cells analyzed expressed CK19, suggesting that a subpopulation of cells in these experimental conditions express both markers.

Tissue culture-treated polystyrene culture surfaces were coated with Collagen I as described above. Tissue culture medium (PCM) was prepared as described above. In some cases, serum was replaced with Fraction V BSA (99% pure, heat inactivated, Sigma), along with combinations of soluble growth factors, including IGF1, IGF2, betacellulin, HGF, EGF, and TGF-alpha. Optimal seeding density is between 10⁴ and 10⁵ cells/cm², as demonstrated in Example 3. Cells were seeded onto collagen-coated flasks (150 cm²) at 1.5×10⁶ cells/flask in PCM. After an ˜18 hr attachment period, unattached cells were washed away with gentle aspiration/rinse, followed by re-feeding with fresh medium. Cultures were monitored over time by metabolic assay (MT) and by trypsinization and cell counting, to establish cell number (see example 3). Cell phenotype at the end of the culture period was assessed as follows: small-scale cultures were set up simultaneously in 96-well plates. At the end of the culture phase, monolayer cells were fixed in 10% formalin for a minimum of 1 hour. After formalin was removed and monolayers were rinsed, cultures were subjected to immunocytochemistry as described in previous section for CK19, amylase, insulin, and vimentin (a marker of fibroblasts). The relative fraction of CK19+ cells was determined by quantitative image analysis as described above (see Example 4). After formalin was removed and monolayers were rinsed, cultures were subjected to immunocytochemistry as described in previous section for CK19 and vimentin (a marker of fibroblasts). Cells were also stained with amylase antibodies, but did not produce positive results due to release of digestive enzymes, such as amylase, by the cells over time in culture. The relative fraction of CK19+ cells was determined by quantitative image analysis as described above (see example 4). Acquisition of ductal markers by acinar cells was verified by demonstrating concomitant expression of CK19 and amylase in cell subpopulations during days 2-3 of culture (see example 5). For these experiments, CK19 primary antibodies were reacted with formalin-fixed cell cultures, followed by visualization with Alexa488-conjugated Goat anti-mouse IgG (Molecular Probes). Then, cells were subjected to a blocking step (Protein Blocker, BioGenex), followed by application of the second primary antibody (anti-amylase). Visualization of the amylase was accomplished by application of Alexa594-conjugated Goat Anti-Mouse IgG. Images were collected as described above. At the end of a 7-day culture period in the conditions described herein, between 65-90% of the cells in the culture express CK19, while less than 20% express vimentin (see example 6). Variations in the relative proportion of CK19+ cells probably reflect heterogeneity due to age, gender, and other unique characteristics of individual patients.

Example 3 Density of Cell Seeding

Primary pancreatic cells were seeded at (3) densities on tissue-culture treated polystyrene dishes (60 mm) and fed with PCM. Light microcopic observations were made daily. At the 24-hour timepoint, dishes were sacrificed and stained with trypan blue to assess viability. The results are shown in Table 3. TABLE 3 Seeding After 3 days Density At 24 Hours: At 48 Hours: Growth: 10⁴ cells/cm² Most cells attached, Mitotic Figures present Epithelial trypan blue negative (light microscopy) monolayer (live) forming 10⁵ cells/cm² Most cells attached, Mitotic Figures present Epithelial trypan blue negative (light microscopy) monolayer (live) forming 10⁶ cells/cm² Some cells attached, Few Mitotic Figures Cells are most are trypan blue present (light detached; positive (dead) microscopy) some fibroblasts present

Example 4

Cells were grown on a Collagen I surface, at 37° C. in 21% oxygen, in PCM medium or in base medium with 2% BSA, 2 ng/ml TGF-α, 10 ng/ml EGF, and 10 ng/ml HGF. After 7 days, cultures were fixed in 10% formalin and subjected to immunocytochemical analysis with fluorescent detection, followed by automated image collection and analysis. The results are shown in FIGS. 5A and 5B. Fibroblast (vimentin+) fraction, glandular epithelial cell fraction (CK19+), and fraction of unlabeled cells (Other) are similar after expansion. This suggests that replacement of serum with the serum-free medium maintains fraction of CK19+ cells without overgrowth of fibroblasts as compared to cells grown in serum-containing media.

Example 5

Primary pancreatic acinar cells were cultured for several days in a 1:1 ratio of DMEM and HamsF12, with 10% fetal bovine serum, 0.01 mg/ml insulin, 0.005 mg/ml transferrin, 0.0067 μg/ml sodium selenite, 10 ng/ml EGF, 4 mmol/liter glutamine and antibiotics. After 2 days of culture (4 days ex vivo), expression of amylase by the acinar cells is still strong (FIG. 8A, upper left panel, red staining) as determined by immunocytochemistry. Expression of CK19 is also apparent (FIG. 8B, lower left panel, green staining). Overlay of the two images (FIG. 8C) demonstrates clear co-expression of amylase and CK19 in a large proportion of the cells, indicating that an intermediate cell exists from active conversion of amylase+ acinar cells to an amylase+/CK19+ mixed acinar/ductal phenotype (AD cells). Daily evaluation of cultures (FIG. 9) demonstrated that onset of CK19 expression begins around Day 2 of culture and by Day 5 cultures have lost most immunodetectable amylase expression and CK19 expression is prevalent.

Example 6

After 7 days of growth in PCM/Collagen I surface, cells were fixed, stained with antibodies to CK19, and counterstained with nuclear DAPI. Total cell number was evaluated by automated image analysis (FIG. 10A left panel, blue-stained cell nuclei), while CK19+ cells were counted (FIG. 10B, right panel, green-stained cell cytoplasm). Of 378 total cells, 342 were immunopositive for CK19 (90%). After approximately 7 days of culture using conditions described herein, the acinar cells have concrete ductular characteristics, now referred to as IP cells. For most primary human cultures, more than 80% of cells in the culture after about 7 days express markers such as CK19 that are associated with ductular cells from a variety of tissues.

Example 7 Gene Expression Analysis of 7-Day Cultures (IP Cells)

Two independent IP cell cultures were subjected to Clontech 8K Atlas Gene Array analysis. IP cells were obtained by culturing primary acinar cells in a cell culture system comprising PCM and a Collagen I surface. Monolayer cultures were rinsed 2× with PBS, then detached from the flasks with 0.25% trypsin. Cells were pelleted by centrifugation at 1,200 RPM for 3 minutes in a swinging bucket centrifuge. Cell pellets were resuspended and washed 2× in PBS before a final centrifugation at 1,200 RPM for 3 minutes as described above. The supernatant was discarded and gently aspirated to remove as much liquid as possible from the cell pellet, which was then quick-frozen in a dry-ice/ethanol bath and stored at −80° C. until transfer to BD Clontech where gene expression analysis was performed, using conventional techniques.

Labelled P-33 cDNA probes were prepared from the 30 μg of total RNA from each sample by first enriching for poly A+RNA using a streptavidin-magnetic bead separation method that is part of the Atlas Pure Total RNA Labeling system. The labeled probes from each sample were hybridized with the plastic human 8K gene arrays for about 16 hours, the arrays were washed and imaged according to the Atlas array protocols. The Atlas image 2.7 software was used to align array images with the array grid template and to exclude false background signals or false signals due to strong signal bleedover. The transcript signals were then extracted from these aligned arrays using the Atlas Image 2.7 software and further statistical analysis of the changes in gene expression were performed.

In general, mRNA transcription was assayed, by hybridization to suitable oligonucleotide probes. In a few cases, e.g., for CK19 and amylase, the protein expression product was measured, using conventional methods of immunohistochemistry. A summary of the expression by these cell populations of a selected set of genes is presented in Table 4. Table 4 contains a list of genes expressed in IP cells and a comparison of expression patterns in primary acinar cells and primary ductal cells. Gene products identified as “+” were expressed; those identified as “++” were strongly expressed. Gene products designated ® are found in regenerating pancreas. TABLE 4 Primary Acinar Gene IP Cells Primary Ductal Cells Cells Aquaporin 1 + ++(mRNA)/+(protein) 0 Aquaporin 5 ++ +(mRNA)/−(protein) Aquaporin 8 + − + Insulin Receptor Substrate-2 + ++ ® Protein Kinase B (AKT) 0 + + Calpain (mu) ++ − ++ CFTR (Cystic Fibrosis 0 0 0 Transmembrane Conductance Regulator) Claudin 2 nd ++ − Claudin 3 + + + Claudin 4 + + + Claudin 5 nd − ++ Carbonic Anhydrase II 0 0 0 Inositol 1,4,5 triphosphate ++ − ++ Rc, Type 3 MUC-1 + ++ + MUC-6 ++ + Cytokeratin 7 ++ ++ − Cytokeratin 8 ++ + Cytokeratin 18 + + Cytokeratin 19 + ++ − alpha v integrin 0 + alpha 3 integrin ++ n/a beta 3 integrin 0 + beta 4 integrin + n/a beta 5 integrin 0 + fibronectin 0 + collagen IV + + vitronectin 0 + ® MMP2 0 Trace MMP9 + Trace TIMP1 ++ Trace TGF-alpha Trace ++ ® Gastrin 0 ++ ® ICAM-1 0 0 ICAM-2 0 0 ICAM-3 0 0 Pancreatitis Associated ++ + ® Trace Protein (PAP) Reg-1 + 0 Trace pyrimidinergic receptor P2Y + + Syndecan + +(low) Trace Glutathione S Transferase- + + − pi II. Transformation of Glandular Epithelial Cells into Insulin Producing Cells—Generating Insulin-Producing Cells by Differentiation of IP Cultures (Culture Phase II)

IP cultures can be utilized to generate insulin-producing cells by placing the cells in a second phase of culture that includes a surface, such as Collagen I, that promotes attachment of the IP cells combined with a defined medium formula that lacks serum but contains combinations of the following differentiation promoting factors: Activin A, acidic FGF, basic FGF, C-Natriuretic Peptide (CNP), Calcitonin Gene Related Peptide, Cholera Toxin B Subunit, Dexamethasone, Gastrin-Releasing Peptide, Glucagon-like Peptide-1 (GLP-1), Glucose, IGF1, IGF2, Insulin, Laminin, LIF, Met-Enkephalin, PDGFAA+PDGFBB, Prolactin, Sonic Hedgehog, Substance P, TGF-alpha, Trolox (alpha-tocopherol derivative), and VEGF. In the following examples, the base medium is composed of a 1:1 mixture of HamsF12 and DMEM with antibiotics and 0.2% Bovine Serum Albumin (Fraction V, heat inactivated 99% pure). In one example (Combination 1), the base medium contained Cholera Toxin B, Dexamethasone, GRP, GLP-1, Glucose, IGF-1, IGF-2, Insulin, Prolactin, Sonic Hedgehog, Trolox, aFGF, and bFGF. In another example (Combination 2), the base medium contained Activin A, CGRP-alpha, CNP, Glucose, GLP-1, IGF-2, Insulin, LIF, Met-Enkephalin, Prolactin, Sonic Hedgehog, aFGF, and vEGF. In a third example (Combination 3), the base medium contains Activin A, CGRP-alpha, Cholera Toxin B, Dexamethasone, Glucose, GLP-1, Insulin, LIF, Laminin, Met-Enkephalin, PDGFAA/BB, Sonic Hedgehog, Substance P, TGF-alpha, aFGF, and VEGF. The concentrations of these media supplements are listed in Table 1.

AD cells were placed into culture by either: 1) trypsinizing the cells from the surface on which they were generated, and redistribution onto a fresh attachment-promoting surface at a density of ˜5×10⁴ cells/cm², or 2) removing the medium, washing 2× in PBS to remove traces of old medium, and cultures re-fed with the new medium (described above) containing differentiation promoting factors. Cells are cultured for a period of 4-10 days at 37° C. and 21% oxygen. On Day 5, half of the medium is removed and replaced with an equal volume of fresh medium containing differentiation promoting factors.

Phenotypic Analysis of IP Cells After Differentiation Culture.

Morphological assessment of IP cells cultured in differentiation conditions described above was captured by light microscopy (see Example 8, below). The cellular phenotype of the cells comprising these cultures was assessed by immunocytochemistry as described above using monoclonal antibodies to vimentin, pro-insulin, C-peptide, MUC-1, and CK19 (See Example 10, below). Briefly, cultures were fixed with 10% formalin for 1 hour at room temperature, then washed with PBS and subjected to immunocytochemical protocol. (See Example 9, below).

Functional Analysis of IP Cells After Differentiation Culture.

The ability of the aggregated cell clusters to release insulin and C-peptide was assessed by subjecting the cultured cells to a glucose challenge as follows. Cells that had been cultured in differentiation medium for 7-10 days were washed 3× in PBS, then re-fed with either 1) base medium (described above) with 5 mM Glucose, or 2) base medium with 22 mM glucose. After 18 hours, the cell-conditioned medium was collected and subjected to ELISA analysis for insulin and C-peptide release (Diagnostic Systems Laboratories (DSL)). ELISAs were conducted using the standard range assay procedure according to manufacturer's specifications. Plates were incubated on a shaker during the assay and results were read in a Tecan spectrophotometric plate reader. Total ng of insulin or C-peptide per well were calculated for each media condition, for both 5 mM glucose media and 22 mM glucose media (See Example 10).

Example 8

Pancreatic acinar cells were cultured in Base Medium+ITS+Serum (10%) for 1 week, then trypsinized (treated with 0.25% Trypsin without EDTA for 10 minutes at 37° C.) and transferred to a fresh collagen-1 coated surface and placed in a medium containing all 23 DFPs listed. Over a period of 3-5 days, the cells readily formed three-dimensional pod-like structures, clearly observable by light microscopy (FIG. 11). Some larger pods detached from the culture surface after about 4-6 days in culture, and remained viable, as determined by trypan blue exclusion. The pod-like structures were hypothesized to be aggregations of insulin-producing cells, and subjected to further analysis as described below.

Example 9

Pod-like structures, generated the same manner as described in the previous example, were fixed in 10% formalin and subjected to immunocytochemical analysis first with CK19 monoclonal antibodies, then with C-peptide monoclonal antibodies, as described above. FIG. 12A shows a group of cells (DAPI stained nuclei are blue), some of which are immunopositive for CK19 (green staining). FIG. 12B shows the same group of cells, many of which are positive for C-Peptide, which is produced when the proinsulin molecule synthesized within the cell is cleaved to yield mature insulin; the C-peptide stained cells are red, with a typical granular staining of the cytoplasm. FIG. 12C shows a higher power overlay image, demonstrating colocalization of CK19 and C-peptide in a small subset of cells. Co-stained cells appear yellow-orange on the overlay image.

Example 10

Cells cultured in base medium (negative control), or in Combinations 1, 2 and 3 of the differentiation promoting media, were evaluated for their ability to release insulin and C-peptide into the culture medium. In addition, we assessed whether increasing concentrations of glucose led to the release of a greater quantity of insulin and C-peptide, indicating an islet-like functionality. First, the cells were cultured for 1 week in base medium+EGF(10 ng/ml)+ITS+10% fetal bovine serum (PCM). Then, cells were either subjected to a wash and medium change (non-subcultured), or to a wash, trypsinization/detachment, reseeding, and medium change. Replicate cultures were re-fed with either base medium (serum-free), fresh PCM, or one of the three combinations of differentiation promoting media (all serum-free). After 10 days, differentiation media were removed, cultures were washed 3× with PBS, then re-fed with serum-free base medium containing either 5 mM glucose or 22 mM glucose (final concentration). After 18 hours, the conditioned media were collected and subjected to ELISA analysis with antibodies to either Insulin or C-Peptide (DSL laboratories). FIGS. 13A, 13B and 13C, respectively, show insulin release by nonsubcultured cells, and insulin release and C-peptide release in response to glucose challenge. Since some of the cultures contain insulin, and cells can take insulin up from the medium, production of C-peptide is an important confirmation that the cells are synthesizing insulin de novo from the synthesis and processing of proinsulin. Furthermore, the production of insulin and C-peptide is increased in most cases with increasing glucose concentration, suggesting an islet-like function of cells within these cultures. Note that little insulin or C-peptide is produced in the base medium that contains no DPFs.

Example 11

Both the quantity of insulin and the quantity of DNA were measured in IP cells subjected to differentiation culture with or without enzymatic detachment and subculturing. Cultures were carried out precisely as described in the previous paragraph. DNA was measured utilizing a standard Picogreen assay (Molecular Probes), while insulin was measured by ELISA assay. Total ng of Insulin was divided by total μg of DNA in the sample, thus providing the insulin:DNA ratio value, in order to calculate a ratio of the quantity of insulin present vs. the number of cells present (reflected by DNA content). The results are shown in FIG. 14. In each of the differentiation media combinations, the insulin:DNA ratio is increased compared to base medium, suggesting that more insulin is produced on a per cell basis in the presence of DPFs than when cultured without them. Furthermore, the insulin:DNA ratio is increased slightly in some conditions upon glucose challenge (22 mM glucose vs. 5 mM), suggesting that the cells respond to glucose by releasing a greater quantity of insulin.

Example 12

Insulin-producing cells obtained by the preceding method were subjected to gene expression analysis as described above. Table 5 contains a list of the highest expressed genes, their position on the Clontech atlas 8K gene array, and relative expression of these genes (after normalization). Table 5 is attached hereto as Appendix 1.

Example 13

Primary human pancreatic cells were seeded at 0.5×10⁵ cells/cm² in PCM on a collagen-1 surface and grown for 7 days. Insulin was measured at Days 1, 7, and 10 as follows: Growth medium was removed, wells were washed 3× in phosphate buffered saline. After a pre-incubation for 1 hour at 37 C in base medium without insulin, with 5 mM glucose, media was removed and replaced with either 1) base medium (without insulin) with 5 mM glucose, or 2) base medium (without insulin) with 22 mM glucose. Insulin was measured in cell-conditioned media after 18 hours at 37° C. After 7 days of culture, PCM medium was replaced with either 1) fresh PCM, 2) serum-free base medium, 3) serum free base medium with all 23 differentiating factors, 4) serum-free combination 1, or 5) serum-free combination 2. The results are shown in FIG. 15. After 3 days exposure to the differentiating factors, increased insulin release is noted in presence of differentiating factors. The results on Day 1 argue against the presence of a significant number of insulin-producing cells in the starting material demonstrating the de novo generation of insulin-producing cells from acinar cells in the primary culture. It can be seen in the Figure that at the end of 10 days, insulin release in response to a glucose challenge is much greater in the DFP media than in the PCM or base medium, verifying the stimulatory effect that the DFPs exert on transformation of glandular epithelial cells into insulin-producing cells.

Example 14

Human pancreatic acinar cells were cultured on a collagen I surface in PCM from Day 1 to Day 7, thus generating a culture of IP cells at Day 7. On Day 7, the IP cells were washed and the PCM medium was replaced with the G09 differentiation medium containing the 30 factors listed in Table 2. At each time point (Days 1, 7, 10 and 14), insulin release was measured by washing the cultures three times with PBS, then challenging the cultures with a 1:1 mixture of DMEM and HAMs F12 containing either 5 mM or 22 mM glucose. After 18 hours of exposure to the glucose, supernatants were collected and insulin measured by ELISA. The results are shown in FIG. 15 a.

III. Expression Studies at Several Time Points of Primary Human Acinar Cells that are Expanded, Allowed to Differentiate into IP Cells and then Allowed to Differentiate Further into Insulin-Producing Cells

Example 15

Three independent samples of primary human pancreatic acinar cells were seeded and expanded described above. From Day 0 to Day 8, cells were on collagen I surface, seeded at 10⁴ cells/cm², in PCM. On Day 8, the medium was changed from PCM to the medium with the active factors shown in Table 2. Cells were fed twice with G09 (50% of medium replaced) between days 8 and 16. The cells remained on the surface throughout the culture process. Cultures were harvested at 3 days after the initial plating (actively trans-differentiating acinar cells), 8 days after plating (IP cells) and 16 days after plating (putative insulin producing cells) and subjected to gene expression analysis, as described in Example 7. mRNA expression data were obtained with 12K microarrays from Clonetech.

Briefly, growth medium was removed from the culture flasks and cells were lysed in trizol LS (Invitrogen) chaotrope/phenol reagent for about 2 minutes by pipetting the lysis solution over the cell layer. Three ml of RNAse free water was added per 9 ml of lysis solution in an Oak Ridge Cetrifuge tube. 2.4 ml chloroform was then added and the solution vigorously vortexed for 1 minute. The aqueous and organic phases were then separated by cetrifugation at 4° C. and the upper aqueous phase containing RNA was removed to a clean PET tube. The RNA was precipitated by isopropanol precipitation, washed with 70% ethanol and redissolved in 200 μl of RNAse free water. A chaotrope lysis reagent was immediately added to the RNA and it was further purified using a Qiagen spin column method with a DNAse digestion step. The purified RNA was finally eluted in 80 μl RNAse free water and stored at −80° C.

Labelled P-33 cDNA probes were prepared from the 30 μg of total RNA from each sample by first enriching for poly A+RNA using a streptavidin-magnetic bead separation method that is part of the Atlas Pure Total RNA Labeeling system. The labeled probes from each sample were hybridized with the plastic human 12 K gene arrays for about 16 hours, the arrays were washed and imaged according to the Atlas array protocols. The Atlas image 2.7 software was used to alighn array images with the array grid template and to exclude false background signals or false signals due to strong signal bleedover. The transcript signals were then extracted from these aligned arrays using the Atlas Image 2.7 software and further statistical analysis of the changes in gene expression were performed.

The raw expression data were analyzed as follows: (1) We filtered out genes that were not expressed at any of the 3 conditions/time points; (2) We normalized all of the microarrays against each other to remove differences from array-to-array and the effects of variability in sample processing, hybridization, etc.; (3) We identified genes which showed a statistically significant difference among the conditions/time points; and (4) We clustered the genes based on their temporal patterns in a way that is consistent with the design of the study and the changes in phenotype.

Table 6 shows expression data for the genes that were identified by the above analysis. This Table is attached hereto as Appendix 2. These identified genes were expressed at high levels at both Day 3 and Day 8, or their expression increased substantially between Day 3 and Day 8. The Table also shows the expression levels of these genes at Day 16, and the mean expression for all three condition/time points. The Table also shows the ratios of expression at various times: “I to A” is the ratio of expression of putative insulin-producing cells (Day 16) to acinar (Day 8) cells; “Int to A” is the ratio of IP cells (Day 8) cells to acinar cells (Day 3).

The data shown in Table 6 were further analyzed by clustering them into one of 17 “classes,” whose features are summarized on the Table. A graphical representation of the characteristics of these 17 classes in presented in FIG. 16.

The data from the Day 8 time points in Table 6 were also grouped with regard to whether the genes expressed at Day 8 in these cells belong to the classes of genes expressed normally in (1) liver and pancreas; (2) pancreas-associated genes; (3) liver-associated genes; or (4) progenitor-associated genes. The results are shown in Table 7. TABLE 7 BDT Intermediate Cells Pancreatic Pattern of Sample 1 Sample 2 Sample 3 Hepatic Pattern of Expression Expression Genes Expressed in Liver and Pancreas CK18 + + + hepatic lineage acinar cells CK8 + + + hepatic lineage acinar cells CK19 + + + bile duct duct cells CK7 + + + bile duct duct cells HNF1 + + + liver tc factor in beta cells α-1 antitrypsin ++ ++ ++ produced in differentiated hepatocytes yes Notch-1 − − Trace involved in differentiation of cells into developing pancreatic hepatic lineage epithelium α-fetoprotein − − − developing hepatocytes and hepatic developing pancreatic progenitors ducts Notch-3 Trace Trace Trace involved in differentiation of cells into pancreatic mesenchyme hepatic lineage and endothelium Notch-4 Trace Trace Trace- involved in differentiation of cells into pancreatic mesenchyme hepatic lineage and endothelium Jagged-2 + + + involved in differentiation of cells into yes hepatic lineage pi-glutathione s transferase + + ++ developing liver duct cells and centroacinar (pi-GST) cells γ-glutamyl transferase − − − developing bile duct acinar cells Pancreas-Associated Genes carbonic anhydrase − − Trace no duct cells CF transmemb conductance − − Trace no duct cells regulator elastase − − − no acinar cells amylase − − − no acinar cells insulin + Trace Trace no islet somatostatin Trace Trace Trace no islet Pancreatic Polypeptide + + Trace no islet Glucagon − − − no islet Liver-Associated Genes Sialyltransferase-6 − − − produced in differentiated hepatocytes no Liver-specific bHLH + + + liver-specific Tc factor no transcrip factor Thy-1 + + + hepatic oval cell marker no Glucose-6-phosphatase − − Trace hepatic lineage, progenitors and adult No Glutamine synthetase − − Trace hepatocyte No Carbamoyl phosphate − − − hepatocyte no synthetase-1 Dipeptidylpaptidase IV − − − hepatocyte no C/EBP-α ++ ++ + liver-specific Tc factor *turned on and upregul during hepatization of pancreas (copper-deficient diet) C/EBP-beta ++ ++ ++ liver-specific Tc factor *turned on and upregul during hepatization of pancreas (copper-deficient diet) Progenitor Cell-Associated Genes Sample 1 Sample 2 Sample 3 Tissue Musashi-1 − − − Intestine Nestin − − − Pancreas/Neuronal CD34 − − − Hematopoietic Thy-1 − − − Hepatic progenitors BMP-2 − − − Neuronal BMPRclA − − Trace Mesenchyme c-kit − − − Liver/Pancreas/Neuronal chromogranin A Trace Trace Trace Neuroendocrine/Liver/Intestine PDX-1 − − + Pancreas

As can be seen, at Day 8 IP cells no longer expressed genes consistent with pancreatic acinar cells, nor did they express a complement of genes specific for pancreatic ductular cells. The IP cells expressed low levels of some markers associated with pancreatic islets, including insulin, somatostatin and pancreatic polypeptide, suggesting that at least some cells in the population are competent to express endocrine genes of the pancreatic islets.

Surprisingly, the IP cells also expressed several liver-specific transcription factors (e.g., C/EBP alpha, C-EBP-beta) and other markers of mature and developing liver, including low levels of Thy-1, a marker associated with hepatic “oval” stem cells. This suggests that the differentiating cells were not moving simply from pancreatic acinar to pancreatic ductal, but had developed into a cell with both hepatic and pancreatic characteristics, while not fitting into any single gene expression profile of one of these cell types. The cells generated in this example resemble the cells that emerge from the pancreas of rodents that are fed a copper-deficient diet. (See, e.g. Rao et al., 1988). The pancreas of such animals goes through an acute phase of pancreatitis followed by “hepatization” of liver (which means cells that begin to express hepatic genes rather than pancreatic genes). Liver-like cells have also been reported in human fetal pancreas (Tsanadis et al., 1995) Isolated cells generated by the methods of the present invention (e.g., by propagating primary acinar cells or other types of endodermal cells or progenitor cells by the methods of the invention) are to be distinguished from naturally occurring cells that may have some of the characteristics of IP cells, such as oval cells or cells isolated from the pancreas of a rodent on a copper-deficient diet.

Cells having the characteristics of these IP cells may be useful for, e.g., therapeutic approaches in the treatment of diabetes. Furthermore, although the cells in this example were derived from pancreas, other epithelial tissues, or perhaps even any endoderm-derived tissue, may provide additional sources of cells that can be differentiated into cells having a similar phenotype. Suitable tissue types include, e.g., liver or intestine. These IP cells express genes associated with pancreas, liver, intestine and neuronal tissues. For example, they express mucin, CK19 and CK7, which are common markers associated with duct cells in the pancreas, liver and intestine. Thus, the gene expression pattern seen in these IP cells may serve as a predictive measure for cells derived from each of these tissues for the purpose of generating insulin-producing cells. Furthermore, IP cells may, under appropriate conditions, give rise, not only to pancreatic islet cells, but also to hepatocytes or any endoderm-derived tissue.

The disclosures of the following references, cited above in part, relate to the present invention:

-   WO 02/29010 A2 (Kerr-Conte); -   Bonner-Weir, S. et al., Proc. Natl. Acad. Sci. USA 97: 7999-8004     (2000), -   Bouwens, L., Microsc. Res. Tech. 43: 332-6 (1998), -   Bowens, L. et al. Diabetologia 41:629-33 (1998); -   Gmyr, V. et al., Diabetes 49:1671-80 (2000); -   Gmyr, V. et al. Cell Transplant 10:109-21 (2001), -   Gmyr, V. et al. Diabetes 49:1671-80 (2000), -   Hall, P. A. et al., J. Pathol. 166: 97-103 (1992); -   Kerr-Conte, J. et al., Diabetes 45:1108-14 (1996); -   Kerr-Conte, J. et al., Transplant Proc 27:3268 (1985); -   Pattou F. et al., Bull. Acad. Natl. Med. 184:1887-99 (2000); -   Rao, M S et al Biochem Biophys Res Comm. 156:131-6 (1988); -   Rooman, Ilse et al., Diabetes 51: 686-90 (2002); -   Rooman, I, et al. Diabetologia 43:907-14 (2000); -   Rooman, I. et al., Gastroenterology 121: 940-9 (2001); -   Trivedi, N. et al. Endocrinology 142:2115-22 (2001); -   Tsanadis, G. et al. Histol. Histopathol. 10:1-10 (1995); -   Wang, R. N. et al., Diabetologia 38:1405-11(1995); -   U.S. Pat. No. 6,011,647 (Ammon Peck).

The embodiments illustrated and discussed in the present specification are intended only to teach those skilled in the art the best way known to the inventors to make and use the invention, and should not be considered as limiting the scope of the present invention. The exemplified embodiments of the invention may be modified or varied, and elements added or omitted, without departing from the invention, as appreciated by those skilled in the art in light of the above teachings. It is therefore to be understood that, within the scope of the claims and their equivalents, the invention may be practiced otherwise than as specifically described.

The entire disclosure of all applications, patents and publications, cited above and in the figures are hereby incorporated in their entirety by reference. Position on Relative Expression, Relative Expression, GENE Atlas 8K Array Sample 1 Sample 2 aquaporin 5 7547 4539 4550 actin, beta 3952 3598 3442 actin, beta 8176 3047 3747 growth hormone secretagogue receptor 6846 2092 1710 profilin 1 448 1580 1246 special AT-rich sequence binding protein 1 3035 1437 886 (binds to nuclear matrix/scaffold- associating DNA's) cardiac-specific homeo box 2050 1395 2850 CCAAT/enhancer binding protein (C/EBP), 1588 1374 1671 beta RAS guanyl releasing protein 2 (calcium 8262 1263 1616 and DAG-regulated) cartilage paired-class homeoprotein 1 6677 1166 1241 paired-like homeodomain transcription 6805 1113 756 factor 1 transcription factor 21 7621 1063 801 CD3E antigen, epsilon polypeptide (TiT3 8054 994 1113 complex) CD151 antigen 5613 935 808 ATPase, Ca++ transporting, plasma 7940 919 876 membrane 2 ficolin (collagen/fibrinogen domain- 824 901 829 containing) 3 (Hakata antigen) inositol polyphosphate phosphatase-like 1 5989 832 425 protein tyrosine phosphatase, receptor 8367 806 810 type, S integrin, alpha 3 (antigen CD49C, alpha 3 1743 758 647 subunit of VLA-3 receptor) syntaxin 1A (brain) 6851 743 658 parathymosin 7135 725 852 thymosin, beta 10 7436 709 1617 midkine (neurite growth-promoting factor 2) 2470 682 802 arylsulfatase A 3147 678 3084 calbindin 2, (29 kD, calretinin) 7000 676 786 serine (or cysteine) proteinase inhibitor, 5214 668 678 clade A (alpha-1 antiproteinase, antitrypsin), member 1 retinal G protein coupled receptor 7972 653 696 myosin regulatory light chain 2, smooth 2499 638 561 muscle isoform butyrate response factor 1 (EGF-response 7325 630 646 factor 1) type I transmembrane receptor (seizure- 7583 589 394 related protein) type I transmembrane receptor (seizure- 7583 589 394 related protein) procollagen C-endopeptidase enhancer 3593 576 713 mitogen-activating protein kinase kinase 7069 558 571 kinase kinase 2 protease, serine, 1 (trypsin 1) 6323 558 656 pancreatitis-associated protein 4576 536 2177 angiotensin receptor 1B 4093 516 491 stratifin 6489 503 581 keratin 17 7903 500 364 somatostatin receptor 3 6872 432 433 myosin-binding protein H 4692 428 96 ephrin-A5 4202 411 381 RAP1, GTPase activating protein 1 1965 407 263 chymotrypsinogen B1 6604 405 830 ankyrin-like with transmembrane domains 1 3577 395 431 Misshapen/NIK-related kinase 2439 391 341 bone morphogenetic protein 6 4492 381 308 spllcing factor proline/glutamine rich 713 375 662 (polypyrimidine tract-binding protein- associated) claudin 12 2720 370 378 matrix metalloproteinase 23A 7491 368 138 neurogranin (protein kinase C substrate, 4465 366 335 RC3) dopamine receptor D2 1649 362 234 cardiotrophin 1 5283 359 507 CCAAT/enhancer binding protein (C/EBP), 7237 359 645 alpha paired box gene 9 5206 335 201 protein tyrosine phosphatase, receptor 8235 331 250 type, N keratin 8 7215 327 449 claudin 7 280 325 173 trophinin associated protein (tastin) 462 323 360 neuronal thread protein 8356 322 366 basic helix-loop-helix domain containing, 6734 318 215 class B, 2 annexin A2 4467 290 226 cathepsin D (lysosomal aspartyl protease) 7370 289 600 Bicaudal D (Drosophila) homolog 1 6822 284 217 lectin, galactoside-binding, soluble, 1 7331 280 310 (galectin 1) keratin 7 7171 278 481 glyceraldehyde-3-phosphate 3953 278 307 dehydrogenase aquaporin 6, kidney specific 7591 277 258 TNF receptor-associated factor 1 6037 269 270 Rho GDP dissociation inhibitor (GDI) alpha 5565 267 321 calcium channel, voltage-dependent, 3142 260 207 gamma subunit 4 glutamate receptor, ionotropic, kainate 1 4776 244 296 CCR4-NOT transcription complex, subunit 4 983 244 428 filamin A, alpha (actin-binding protein-280) 3457 241 233 peanut (Drosophila)-like 1 711 233 310 enhancer of rudimentary (Drosophila) 5921 231 405 homolog endothelin converting enzyme 1 7835 229 197

rotocadherin 17 2483 223 208

quaporin 8 7679 217 145

ynapsin I 4871 216 164

ubulin, alpha, brain-specific 2827 212 345

D44 antigen (homing function and Indian 7848 207 141

lood group system)

erebral cavernous malformations 1 2731 205 116

sulin-like 3 (Leydig cell) 666 202 365

denylate cyclase activating polypeptide 1 4489 200 74 pituitary)

airless (mouse) homolog 5185 196 36

sulin 4427 190 44

ranulin 928 184 201

ranulin 928 184 201

arly growth response 1 2111 178 136

yclin-dependent kinase inhibitor 1A (p21, 7852 175 108

ip1)

tem cell growth factor; lymphocyte 1606 174 152

ecreted C-type lectin

D4 antigen (p55) 5608 172 143

CTAIRE protein kinase 1 6334 161 78

ho GTPase activating protein 6 1035 160 220 G protein-coupled receptor 37 (endothelin 6318 158 35

eceptor type B-like)

yndecan 4 (amphiglycan, ryudocan) 3154 157 147

CTAIRE protein kinase 3 8050 155 159

mpty spiracles (Drosophila) homolog 2 2084 150 207

ransglutaminase 1 (K polypeptide 6674 150 101

pidermal type I, protein-glutamine-gamma- glutamyltransferase) potassium voltage-gated channel, 1335 147 62 subfamily G, member 2 aldehyde dehydrogenase 4 (glutamate 5985 147 207 gamma-semialdehyde dehydrogenase; pyrroline-5-carboxylate dehydrogenase) E1A binding protein p300 1433 144 197 LIM homeobox transcription factor 1, beta 8211 143 89 eukaryotic translation elongation factor 2 4536 134 150 mitogen-activated protein kinase kinase 5462 129 92 kinase 10 PPAR(gamma) angiopoietin related protein 3074 129 56 homeo box A5 7037 128 87 CD63 antigen (melanoma 1 antigen) 7769 124 91 nuclear receptor coactivator 3 4181 119 84 CD68 antigen 443 118 256 transmembrane 4 superfamily member 7 1571 117 29 pancreatic polypeptide 2735 116 136 endothelin type b receptor-like protein 2 6656 114 74 neurogenin 1 5772 113 91 insulin receptor substrate 2 6016 110 130 glutamate receptor, ionotropic, N-methyl D- 4702 109 58 asparate-associated protein 1 (glutamate binding) neurotrophin 5 (neurotrophin 4/5) 8259 108 89 pyrimidinergic receptor P2Y, G-protein 3857 105 65 coupled, 6 empty spiracles (Drosophila) homolog 1 2040 103 87 chromobox homolog 2 (Drosophila Pc 2832 101 139 class) heart and neural crest derivatives 2146 92 129 expressed 1 transglutaminase 2 (C polypeptide, protein- 7731 92 74 glutamine-gamma-glutamyltransferase) enolase 1, (alpha) 1389 92 205 thyroid transcription factor 1 4519 89 60 keratin 19 5923 88 223 Deleted in split-hand/split-foot 1 region 3641 87 104 glutathione peroxidase 4 (phospholipid 1874 84 72 hydroperoxidase) aristaless (Drosophila) homeobox 1783 81 103 GATA-binding protein 4 659 80 110 transcription factor 1, hepatic; LF-B1, 712 80 136 hepatic nuclear factor (HNF1), albumin proximal factor heat shock transcription factor 1 6708 79 57 liver-specific bHLH-Zip transcription factor 765 77 188 liver-specific bHLH-Zip transcription factor 765 77 188 eukaryotic translation initiation factor 3, 6280 76 94 subunit 4 (delta, 44 kD) eukaryotic translation initiation factor 3, 6280 76 94 subunit 4 (delta, 44 kD) gamma-aminobutyric acid (GABA) A 3720 70 178 receptor, alpha 6 retinoic acid receptor, gamma 5191 70 109 homeo box D9 1776 69 34 MAD1 (mitotic arrest deficient, yeast, 1946 63 38 homolog)-like 1 homeo box A4 7177 57 103 Thy-1 cell surface antigen 559 57 87 talin 603 53 84 bone morphogenetic protein receptor, type 332 53 45 II (serine/threonine kinase) hepatocyte nuclear factor 3, alpha 72 52 60 ryanodine receptor 2 (cardiac) 5244 47 40 signal transducer and activator of 3661 40 35 transcription 6, interleukin-4 induced

Appendix 2: TABLE 6 SwissProt Spot geneName day3 day8 day16 allMean ratioItoA rationIntto/ classID classsName P04270 E19ab2 actin; alpha; cardiac muscle 1198.174 760 5955.077 2637.676 2.31E+00 −8.57E−01 7 Equal A/Int; Up Islets O95996 N17ab2 adenomatous polyposis coli like 2708.542 5180 7594.139 5161.464 1.49E+00 9.36E−01 7 Equal A/Int; Up Islets Q14697 G02ef8 alpha glucosidase II alpha subun

306.0691 350 775.3358 477.9123 1.34E+00 1.92E−91 7 Equal A/Int; Up Islets P14209 G23ab7 antigen identified by monoclonal 389.822 507 1238.43 711.8924 1.67E+00 3.80E−01 7 Equal A/Int; Up Islets P30530 G14ef5 AXL receptor tyrosine kinase 314.4639 288 634.5658 412.2115 1.01E+00 −1.29E−01 7 Equal A/Int; Up Islets O43770 I23ab3 B-cell CLL/lymphoma 7C 700.573 1050 1504.52 1085.931 1.10E+00 5.87E−01 7 Equal A/Int; Up Islets O43852 P08ab3 calumenin 801.582 1290 4720.807 2269.921 2.56E+00 6.84E−01 7 Equal A/Int; Up Islets O75718 O24cd6 cartilage associated protien 430.4432 256 1090.59 592.2327 1.34E+00 −7.52E−01 7 Equal A/Int; Up Islets Q9Y3C0 G14ef2 CGI-116 protein 181.0293 301 416.7246 229.7237 1.20E+00 7.36E−01 7 Equal A/Int; Up Islets P78369 G09cd6 claudin 10 1176.087 742 2598.595 1505.471 1.14E+00 −6.65E−01 7 Equal A/Int; Up Islets P08572 P08ef6 collagen; type IV; alpha 2 1130.23 1350 4684.425 2389.488 2.05E+00 2.60E−01 7 Equal A/Int; Up Islets P11802 B05ef5 cyclin-dependent kinase 4 914.1579 978 2342.994 1411.839 1.36E+00 9.79E−02 7 Equal A/Int; Up Islets Q16555 O07ab4 dihydropyrimidinase-like 2 114.6165 164 921.1473 399.8267 3.01E+00 5.14E−01 7 Equal A/Int; Up Islets P33316 H23ab5 dUTP pyrophosphatase 177.2032 238 541.5382 318.7836 1.61E+00 4.23E−01 7 Equal A/Int; Up Islets P07992 K20ef6 excision repair cross-complemen

362.031 415 907.7933 561.6388 1.33E+00 1.97E−01 7 Equal A/Int; Up Islets O75636 B14cd3 ficolin (collagen/librinogen doma

1081.127 1010 4327.606 2139.448 2.00E+00 −9.87E−02 7 Equal A/Int; Up Islets Q9UBA6 B19ef4 G8 protein 379.6842 578 1489.206 812.6378 2.01E+00 6.41E−01 7 Equal A/Int; Up Islets Q9Y5P5 P08ef7 GDP-mannose pyrophosphoryta

171.1216 198 414.0862 261.0679 1.27E+00 2.10E−01 7 Equal A/Int; Up Islets O75293 E02ef7 growth arrest and DNA-damage-

194.3626 203 386.6833 261.3841 9.92E−01 6.35E−02 7 Equal A/Int; Up Islets P50152 C05ab6 guanine nucleotide binding prote

204.743 150 497.3097 283.8702 1.28E+00 −4.53E−01 7 Equal A/Int; Up Islets Q9NX09 C05gh3 HIF-1 responsive RTP801 348.8574 253 1032.929 545.0822 1.57E+00 −4.61E−01 7 Equal A/Int; Up Islets P05204 J22ab7 high-mobility group (nonhistone

2067.865 1120 6059.895 3082.818 1.55E+00 −8.84E−01 7 Equal A/Int; Up Islets Q9P0P2 C17ef3 homolog of yeast MOG1 325.8407 378 682.7568 462.1583 1.07E+00 2.14E−01 7 Equal A/Int; Up Islets Q9NWF8 L15gh2 hypothetical protein FLJ10055 172.167 241 374.3 262.6222 1.12E+00 4.88E−01 7 Equal A/Int; Up Islets Q9NWV4 B17gh2 hypothetical protein FLJ20580 221.4432 280 483.5381 328.2481 1.13E+00 3.37E−01 7 Equal A/Int; Up Islets Q9P0S8 A21ef3 hypothetical protein HSPC195 153.824 165 330.9111 216.4274 1.11E+00 9.72E−01 7 Equal A/Int; Up Islets Q9BWS9 P04gh5 hypothetical protein MGC3234 196.9154 161 427.2066 261.7132 1.12E+00 −2.90E−01 7 Equal A/Int; Up Islets Q9BSK0 K21gh8 hypothetical protein MGC4415 156.4692 117 684.3425 319.1224 2.13E+00 −4.25E−01 7 Equal A/Int; Up Islets Q9Y6M1 P09cd6 IGF-II mRNA-binding protein 2 135.2566 153 408.5101 232.2937 1.59E+00 1.79E−01 7 Equal A/Int; Up Islets Q9NQX7 H02gh7 Integral membrane protein 3 478.2728 481 1102.244 687.2575 1.20E+00 8.97E−03 7 Equal A/Int; Up Islets P08648 E23ef7 Integrin; alpha 5 (fibronectin rece

183.4629 124 478.7266 262.0713 1.38E+00 −5.65E−01 7 Equal A/Int; Up Islets O00410 J24ab6 karyopherin (importin) beta 3 326.6874 196 629.7656 384.2402 9.47E−01 −7.35E−01 7 Equal A/Int; Up Islets P07195 N16ab6 lactate dehydrogenase B 1003.971 1200 5593.079 2599.05 2.48E+00 2.57E−01 7 Equal A/Int; Up Islets P09382 N22ab6 lactin; galactoside-binding; solub 19170.52 35400 78086.75 44205.77 2.03E+00 8.83E−01 7 Equal A/Int; Up Islets O75427 P20ab6 leucine-rich repeat protein; neur

174.9605 231 543.3883 316.5457 1.63E+00 4.03E−01 7 Equal A/Int; Up Islets Q16553 A15ab7 lymphocyte antigen 6 complex; I

425.8933 494 938.4504 619.3701 1.14E+00 2.13E−01 7 Equal A/Int; Up Islets O75900 O05cd4 matrix metalloproteinase 23A 381.2184 297 851.7221 510.1038 1.16E+00 −3.58E−01 7 Equal A/Int; Up Islets Q9UNF1 H16ef7 melanoma antigen; family D; 2 193.8125 219 659.9701 357.6132 1.77E+00 1.77E−01 7 Equal A/Int; Up Islets P13995 J16cd6 methylene tetrahydrofolate dehy

321.4878 226 759.6021 435.6746 1.24E+00 −5.09E−01 7 Equal A/Int; Up Islets O00265 G19cd8 microtubule-associated protein;

189.7616 234 377.5576 267.156 9.93E−01 3.03E−01 7 Equal A/Int; Up Islets P27361 B13ef5 mitogen-activated protein kinase 358.0872 382 720.3119 486.849 1.01E+00 9.38E−02 7 Equal A/Int; Up Islets P24844 E18cd6 myosin; light polypeptide 9; regul 5480.451 7380 22518.95 11793.09 2.04E+00 4.29E−01 7 Equal A/Int; Up Islets Q9NVD4 J10gh2 N-acetylneuraminic acid phosph

153.4762 167 390.6642 237.1908 1.35E+00 1.26E−01 7 Equal A/Int; Up Islets Q9Y617 N22ef8 phosphoserine aminotransferase 169.9503 250 1238.851 553.0005 2.87E+00 5.58E−01 7 Equal A/Int; Up Islets O95356 A11gh7 pituitary tumor-transforming 3 237.2126 192 2276.181 901.8229 3.26E+00 −3.05E−01 7 Equal A/Int; Up Islets Q9Y5X6 G04cd6 plasma glutamate carboxypeptid

169.6268 142 366.6202 226.0168 1.11E+00 −2.58E−01 7 Equal A/Int; Up Islets Q15113 G20ab8 procollagen C-endopeptidase en

497.3967 402 2628.947 1176.046 2.40E+00 −3.08E−01 7 Equal A/Int; Up Islets O15460 D20cd4 procollagen-proline; 2-oxoglutar

262.1395 433 756.4003 483.9569 1.53E+00 7.25E−01 7 Equal A/Int; Up Islets O43556 I19gh1 sarcoglycan; epsilon 172.7191 215 349.304 245.5263 1.02E+00 3.13E−01 7 Equal A/Int; Up Islets P50454 M17ab6 serine (or cysteine) proteinase in 339.1762 612 4091.161 1680.942 3.59E+00 8.53E−01 7 Equal A/Int; Up Islets Q92853 A23cd8 similar to vaccinia virus HindIII K

444.062 553 997.4551 664.6951 1.17E+00 3.15E−01 7 Equal A/Int; Up Islets Q16658 P20cd1 singned-like (fascin homolog; sea 262.7872 479 1472.155 738.014 2.49E+00 8.66E−01 7 Equal A/Int; Up Islets Q9Y4Y8 E18cd7 Sm protein F 257.2026 278 548.9705 361.3772 1.09E+00 1.12E−01 7 Equal A/Int; Up Islets Q9BVH9 D18gh7 thioredoxin related protein 522.0262 481 1903.964 968.9954 1.87E+00 −1.18E−01 7 Equal A/Int; Up Islets Q9HBB0 L08gh8 Thy-1 co-transcribed 327.3502 374 1110.527 603.8101 1.76E+00 1.90E−01 7 Equal A/Int; Up Islets P01033 P09ef7 tissue inhibitor of metalloproteins 1236.457 1500 13029.41 5256.861 3.40E+00 2.83E−01 7 Equal A/Int; Up Islets Q15582 L20ef6 transforming growth factor; beta-

1221.083 2060 8540.86 3939.09 2.81E+00 7.51E−01 7 Equal A/Int; Up Islets Q01995 M07cd2 transgelln 3307.821 3880 18534.27 8573.074 2.49E+00 2.29E−01 7 Equal A/Int; Up Islets Q13641 B05ab2 trophoblast glycoprotein 479.6488 426 1399.786 768.6158 1.55E+00 −1.70E−01 7 Equal A/Int; Up Islets P06468 G08cd2 tropomyosin 2 (beta) 339.2292 589 13203.05 4710.469 5.28E+00 7.96E−01 7 Equal A/Int; Up Islets P51784 M21cd4 ubiquilin specific protease 11 158.0478 194 491.1246 280.9819 1.64E+00 2.94E−01 7 Equal A/Int; Up Islets P03996 E17ab2 actin; alpha 2; smooth muscle; a

412.1187 1940 41801.34 14717.63 6.66E+00 2.23E+00 9 Increasing A/Int/I P08123 P02ef6 collagen; type I; alpha 2 186.5666 576 14565.36 5109.251 6.29E+00 1.63E+00 9 Increasing A/Int/I P24821 A05ef7 hexabrachion (tenascin C; cytota 355.495 918 2371.983 1215.165 2.74E+00 1.37E+00 9 Increasing A/Int/I Q9NVA2 F13gh3 hypothetical protein FLJ10849 374.1496 861 3471.789 1568.848 3.21E+00 1.20E+00 9 Increasing A/Int/I P40261 M09cd1 nicotinamide N-methyltransferase 1060.579 2310 5683.533 3016.993 2.42E+00 1.12E+00 9 Increasing A/Int/I Q15063 C01ef7 osteoblast specific factor 2 (fascl

276.634 795 8328.222 3133.301 4.91E+00 1.52E+00 9 Increasing A/Int/I P09486 A09ef7 secreted protein; acidic; cysteine 404.2839 2760 63837.2 22333.48 7.30E+00 2.77E+00 9 Increasing A/Int/I P35625 K20ef5 tissue inhibitor of metalloprotein

216.254 619 10078.17 3637.823 5.54E+00 1.52E+00 9 Increasing A/Int/I Q9H2L5 G06gh8 AD037 protein 361.2297 681 158.8121 400.4602 −1.19E+00 9.15E+00 19 Int> (A; I) P15121 C18ab2 aldo-keto reductase family 1; me

2342.744 5380 2337.052 3354.494 −3.51E−03 1.20E+00 19 Int> (A; I) P08582 B14ef5 antigen p97 (melanoma associat

299.1375 595 80.80392 324.9781 −1.89E+00 9.92E+00 19 Int> (A; I) P20292 E06ab2 arachidonate 5-lipoxygenase-act 100.0016 687 203.2911 330.0345 1.02E+00 2.78E+00 19 Int> (A; I) O15342 A13ab3 ATPase; H+ transporting; lysoso

6063.171 16500 6160.831 9572.914 2.31E−02 1.44E+00 19 Int> (A; I) Q9BXJ0 H18gh6 C1q and tumor necrosis factor re

180.2978 350 154.1441 228.0109 −2.26E−01 9.55E−00 19 Int> (A; I) Q9NRJ3 P09gh4 CC chemokine CCL28 250.0021 1830 763.2866 948.0274 1.61E+00 2.87E+00 19 Int> (A; I) P05305 F17ab5 endothelin 1 866.4561 1810 403.431 1026.992 −1.10E+00 1.06E+00 19 Int> (A; I) P09341 A04ab6 GRO1 oncogene (melanoma gro

933.2938 4770 1006.711 2236.622 1.09E−01 2.35E+00 19 Int> (A; I) Q92730 O14ef4 GTP-binding protein 653.8575 2760 542.7528 1318.381 −2.69E−01 2.08E+00 19 Int> (A; I) Q9H5K0 L10gh5 hypothetical protein FLJ23360 151.2029 296 130.3196 192.6442 −2.14E−01 9.71E−01 19 Int> (A; I)

540.0362 1180 233.0055 650.8277 −1.21E+00 1.13E+00 19 Int> (A; I) P42701 A06ef7 Interleukin 12 receptor; beta 1 1227.347 22100 1333.521 8128.994 1.20E−01 4.17E+00 19 Int> (A; I) P09237 J15ef1 matrix metalloproteinase 7 (matri 9598.545 87300 19849.69 38905.32 1.05E+00 3.18E+00 19 Int> (A; I) P16860 O13ab8 natriurelic peptide precursor B 4340.214 12900 1260.906 6171.6 −1.78E+00 1.57E+00 19 Int> (A; I) P21359 L16ab7 neurofibromin 1 (neurofibromato

132.483 292 155.0822 193.3208 2.27E−01 1.14E+00 19 Int> (A; I) P02775 B07ef7 pro-platelet basic protein (Includ

33.98656 1400 265.2119 567.1992 2.96E+00 5.37E+00 19 Int> (A; I) Q9UDQ9 J22gh4 SBBI26 protein 121.5886 1080 238.8624 479.5908 9.74E−01 3.15E+00 19 Int> (A; I) O75635 P14cd3 serine (or cysteine) proteinase In 232.6336 3890 326.2581 1483.169 4.88E−01 4.08E+00 19 Int> (A; I) P02735 A11cd3 serum amyloid A1 496.9578 17400 957.6141 6295.724 9.46E−01 5.13E+00 19 Int> (A; I) O60635 F10cd5 tetraspan 1 321.8888 843 177.6479 447.5729 −8.58E−01 1.39E+00 19 Int> (A; I) P50591 C09cd4 tumor necrosis factor (ligand) su

536.7773 1550 476.2305 854.3061 −1.73E−01 1.53E+00 19 Int> (A; I) Q03169 I10ef7 tumor necrosis factor; alpha-indu 366.7502 1260 326.6536 650.583 −1.67E−01 1.78E+00 19 Int> (A; I) Q9C075 N11ef8 type I Intermediate filament cytok 848.9829 4200 401.4854 1818.182 −1.08E+00 2.31E+00 19 Int> (A; I) P02248 A01cd3 ubiquitin C 155.6735 892 62.04595 369.9913 −1.33E+00 2.52E+00 19 Int> (A; I) O95497 A15cd5 vanin 1 309.1556 1840 510.7208 887.0948 7.24E−01 2.57E+00 19 Int> (A; I) Q14202 B15cd5 zinc finger protein 261 199.6246 1040 247.9161 496.3668 3.13E−01 2.38E+00 19 Int> (A; I) P15514 M02ef7 amphiregulin (schwannoma-deri

103.1419 405 65.66067 191.2981 −6.52E−01 1.97E+00 18 Off A/I; On Int Q9BZL9 I21gh8 B aggressive lymphoma gene 126.3951 211 84.56927 140.8098 −5.80E−01 7.42E−01 18 Off A/I; On Int P30991 D14ef5 chemokine (C—X—C motif); recept

64.37115 260 120.2328 148.3131 9.01E−01 2.02E+00 18 Off A/I; On Int P29400 H13ab3 collagen; type IV; alpha 5 (Alport 53.50943 374 141.1609 189.6904 1.40E+00 2.81E+00 18 Off A/I; On Int Q9UK22 H22cd7 F-box only protein 2 87.59822 217 120.3781 141.6466 4.59E−01 1.31E+00 18 Off A/I; On Int Q16769 O15cd8 glutaminyl-peptide cyclotransfera 89.90252 195 113.0683 132.7502 3.31E−01 1.12E+00 18 Off A/I; On Int P02261 M06gh6 H2A histone family; member I 65.46028 263 126.664 151.868 9.52E−01 2.01E+00 18 Off A/I; On Int P20769 D03ef1 immunoglobulin heavy constant

101.245 176 102.5687 126.7136 1.87E−02 8.00E−01 18 Off A/I; On Int P52945 I12ab6 insulin promoter factor 1; homeo

74.60504 351 86.42558 170.7555 2.12E−01 2.24E+00 18 Off A/I; On Int Q14496 F21cd6 interferon-Induced protein 44 99.27101 286 98.28057 161.3017 −1.45E−02 1.53E+00 18 Off A/I; On Int P01583 F15ef7 interleukin 1; alpha 103.386 375 66.6314 181.5566 −6.34E−01 1.86E+00 18 Off A/I; On Int P01584 F17ef7 interleukin 1; beta 116.7675 415 119.0156 216.8707 2.75E−02 1.83E+00 18 Off A/I; On Int Q9GZM1 I20gh7 NDRG family member 4 102.1328 348 101.569 183.8736 −7.99E−03 1.77E+00 18 Off A/I; On Int P25105 G15ef5 platelet-activating factor receptor 97.43121 358 80.47935 177.9689 −2.76E−01 1.87E+00 18 Off A/I; On Int P58294 O14gh8 prokineticin 1 precursor 79.98286 241 137.5167 152.9437 7.82E−01 1.59E+00 18 Off A/I; On Int P23471 A06ef6 protein tyrosine phosphatase; re

85.55935 346 93.65845 175.0253 1.30E−01 2.02E+00 18 Off A/I; On Int O88386 D10ef3 RAB10; member RAS oncogene 123.2003 399 68.13944 196.7342 −8.54E−01 1.69E+00 18 Off A/I; On Int P10826 I08gh6 retinoic acid receptor; beta 67.98871 241 120.9469 143.3844 8.31E−01 1.83E+00 18 Off A/I; On Int O95786 I24ef3 RNA helicase 112.9366 241 89.32396 147.8829 −3.38E−01 1.10E+00 18 Off A/I; On Int P02778 O10ef7 small Inducible cytokine subfamil

65.03395 418 86.09019 189.6022 4.05E−01 2.68E+00 18 Off A/I; On Int P80162 F14cd1 small inducible cytokine subfamil

54.00821 311 129.2839 164.6594 1.26E+00 2.52E+00 18 Off A/I; On Int P43005 N23ef5 solute carrier family 1 (neuronal/

99.30514 189 110.8119 133.1898 1.58E−01 9.32E−01 18 Off A/I; On Int P01375 O09ef6 tumor necrosis factor (TNF supe

138.6153 386 75.13436 200.0804 −8.84E−01 1.48E+00 18 Off A/I; On Int Q16890 G04cd2 tumor protein D52-like 1 103.5477 191 98.01862 130.885 −7.92E−02 8.84E−01 18 Off A/I; On Int Q9H949 K11gh5 WW45 protein 111.8812 218 79.54574 136.5769 −4.92E−01 9.64E−01 18 Off A/I; On Int Q9H4G4 O06gh5 17 kD fetal brain protein 88.61746 223 532.2979 281.2148 2.59E+00 1.33E+00 8 Off Acinar; Increasing Int/I Q14040 B15ef1 collagen; type VI; alpha 1 38.27203 209 4724.413 1657.194 6.95E+00 2.45E+00 8 Off Acinar; Increasing Int/I P12110 B17ef1 collagen; type VI; alpha 2 88.00282 164 3835.637 1362.487 5.45E+00 8.97E−01 8 Off Acinar; Increasing Int/I P02751 K15ef1 fibronectin 1 4.441352 152 4171.603 1442.812 9.88E+00 5.10E+00 8 Off Acinar; Increasing Int/I P14652 N23ab6 homeo box B2 62.71629 291 3571.974 1308.575 5.83E+00 2.21E+00 8 Off Acinar; Increasing Int/I P08476 D15ef7 inhibin; beta A (activin A; activin 64.38161 318 854.6532 412.2794 3.73E+00 2.30E+00 8 Off Acinar; Increasing Int/I P17936 D07ab6 Insulin-like growth factor binding 38.22268 349 1302.669 563.1937 5.09E+00 3.19E+00 8 Off Acinar; Increasing Int/I Q9Y4K0 P18ab6 lysyl oxidase-like 2 75.91549 260 2525.644 953.7036 5.06E+00 1.77E+00 8 Off Acinar; Increasing Int/I P03956 N05ef7 matrix metalloproteinase 1 (inter

106.2193 203 590.2622 299.8442 2.47E+00 9.53E−01 8 Off Acinar; Increasing Int/I P39900 N15ef7 matrix metalloproteinase 12 (ma

18.2367 381 1219.953 539.7471 6.06E+00 4.39E+00 8 Off Acinar; Increasing Int/I P55001 G09ab7 microfibrillar-associated protein 2 99.33548 526 3302.631 1309.293 5.06E+00 2.40E+00 8 Off Acinar; Increasing Int/I Q9NYR0 O07gh7 SH3-domain kinase binding prot

34.69271 197 656.4675 296.0285 4.24E+00 2.50E+00 8 Off Acinar; Increasing Int/I O43623 D06ef4 snail homolog 2 (Drosophila) 96.88079 292 3028.508 1139.155 4.97E+00 1.59E+00 8 Off Acinar; Increasing Int/I P09936 I13cd4 ubiquitin carboxyl-terminal ester

46.30052 219 1523.166 596.7714 4.98E+00 2.18E+00 8 Off Acinar; Increasing Int/I Q02952 J11ab2 A kinase (PRKA) anchor protein 103.9756 364 229.1446 232.3779 1.14E+00 1.81E+00 4 Off Acinar; On Int = I Q99541 I19ab2 adipose differentiation-related p

67.38509 182 146.1347 132.005 1.12E+00 1.44E+00 4 Off Acinar; On Int = I P54284 N17ab3 calcium channel; voltage-depend 106.3248 227 254.9633 195.985 1.26E+00 1.09E+00 4 Off Acinar; On Int = I Q13269 G14ab5 cAMP responsive element bindin 100.6639 193 217.7521 170.529 1.11E+00 9.40E−01 4 Off Acinar; On Int = I Q9NPF2 M02ef4 chondroitin 4-sulfotransferase 133.8375 192 303.01 209.7612 1.18E+00 5.24E−01 4 Off Acinar; On Int = I Q9H7A5 F12gh7 chromosome 20 open reading fra 98.71521 179 208.0134 161.8637 1.08E+00 8.58E−01 4 Off Acinar; On Int = I Q9H9Q2 L23gh5 COP9 constitutive photomorpho

86.57682 115 184.3088 128.7341 1.09E+00 4.14E−01 4 Off Acinar; On Int = I P42771 D17ef5 cyclin-dependent kinase Inhibitor 43.35217 471 355.7426 290.1928 3.04E+00 3.44E+00 4 Off Acinar; On Int = I Q14650 J20ef4 cytoplasmic FMR1 interacting pr

132.5759 272 321.6348 242.2271 1.28E+00 1.04E+00 4 Off Acinar; On Int = I Q96IK6 F14gh6 DKFZP434C245 protein 145.227 104 91.06477 113.265 −6.73E−01 −4.89E−01 4 Off Acinar; On Int = I P12034 D05ef7 fibroblast growth factor 5 60.2377 259 317.6018 212.2747 2.40E+00 2.10E+00 4 Off Acinar; On Int = I Q93079 M20gh6 H2B histone family; member J 144.6906 428 271.2983 281.3281 9.07E−01 1.56E+00 4 Off Acinar; On Int = I Q9P016 A10ef8 HSPC144 protein 123.4601 348 399.4935 290.4476 1.69E+00 1.50E+00 4 Off Acinar; On Int = I Q9HBI5 M09gh4 HT021 116.3605 276 309.5798 233.835 1.41E+00 1.24E+00 4 Off Acinar; On Int = I Q9BY45 O24gh8 HTPAP protein 78.49388 109 177.2043 121.5622 1.17E+00 4.74E−01 4 Off Acinar; On Int = I P08397 G18ab6 hydroxymethylbilane synthase 139.0857 188 260.8417 196.1361 9.07E−01 4.38E−01 4 Off Acinar; On Int = I Q9BUV0 M06gh4 hypothetical protein dJ465N24.2. 68.40543 152 167.5592 129.3473 1.29E+00 1.15E+00 4 Off Acinar; On Int = I Q9H9A2 N22gh6 hypothetical protein DKFZp762U 82.54725 110 169.5379 120.7311 1.04E+00 4.16E−01 4 Off Acinar; On Int = I Q9NUV6 P09gh3 hypothetical protein FLJ11113 87.43713 178 136.6771 134.1021 6.44E−01 1.03E+00 4 Off Acinar; On Int = I Q9NXF7 C20gh2 hypothetical protein FLJ20280 66.49705 143 170.7367 126.7851 1.36E+00 1.11E+00 4 Off Acinar; On Int = I Q9H6V0 M05gh5 hypothetical protein FLJ21839 116.3704 258 323.3964 232.5844 1.47E+00 1.15E+00 4 Off Acinar; On Int = I Q9BUW5 K21gh6 hypothetical protein MGC4707 80.31127 170 203.9516 151.3887 1.34E+00 1.08E+00 4 Off Acinar; On Int = I Q9H765 I15gh6 hypothetical protein MGC5540 106.3949 220 206.6405 177.6046 9.58E−01 1.05E+00 4 Off Acinar; On Int = I Q14157 N23gh1 KIAA0144 gene product 95.13957 147 147.7214 129.9305 6.35E−01 6.27E−01 4 Off Acinar; On Int = I Q9Y2D8 A07ef8 KIAA0923 protein 84.1225 237 206.8269 176.1358 1.30E+00 1.50E+00 4 Off Acinar; On Int = I Q9H6Z3 E24gh5 kinesin family member 13A 111.6382 206 238.8822 185.578 1.10E+00 8.85E−01 4 Off Acinar; On Int = I Q99748 J24ab8 neurturin 123.7486 150 246.4754 173.2957 9.94E−01 2.74E−01 4 Off Acinar; On Int = I Q9NVD7 D11gh3 parvin; alpha 82.67948 140 230.66 151.1753 1.48E+00 7.62E−01 4 Off Acinar; On Int = I Q43175 H

4 Off Acinar; On Int = I Q13636 K19cd7 RAB31; member RAS oncogene 76.36263 118 170.0352 121.5169 1.15E+00 6.30E−01 4 Off Acinar; On Int = I Q9UIC2 L10ef2 RNB6 80.78879 171 194.395 148.7422 1.27E+00 1.08E+00 4 Off Acinar; On Int = I Q9NVQ7 K12gh3 Sec61 alpha form 2 82.6036 143 162.0674 129.1434 9.72E−01 7.89E−01 4 Off Acinar; On Int = I O75368 J08cd1 SH3 domain binding glutamic acl 92.82513 212 196.8753 167.1823 1.08E+00 1.19E+00 4 Off Acinar; On Int = I O95863 N01cd2 snail homolog 1 (Drosophila) 76.58448 134 157.9807 122.817 1.04E+00 8.06E−01 4 Off Acinar; On Int = I Q9UL01 H01cd8 squamous cell carcinoma antige

86.70353 111 176.4557 124.5829 1.03E+00 3.51E−01 4 Off Acinar; On Int = I Q16226 N05cd6 thioredoxin interacting protein 111.1384 454 529.2322 364.6675 2.25E+00 2.03E+00 4 Off Acinar; On Int = I P07996 A11ef7 thrombospondin 1 79.00174 139 163.2593 127.0819 1.05E+00 8.15E−01 4 Off Acinar; On Int = I Q99081 F10ef6 transcription factor 12 (HTF4; he 112.2294 181 256.0348 182.9347 1.19E+00 6.86E−01 4 Off Acinar; On Int = I O95922 L06ef7 tubulin tyrosine ligase-like 1 73.12945 245 253.9213 190.8311 1.80E+00 1.75E+00 4 Off Acinar; On Int = I P15036 H18ef6 v-ets erythroblastosis virus E26

149.9259 114 83.55955 115.8531 −8.43E−01 −3.94E−01 4 Off Acinar; On Int = I O95337 D04ef8 weakly similar to glutathione per

69.55111 164 284.3593 172.7489 2.03E+00 1.24E+00 4 Off Acinar; On Int = I Q9H1B5 M18gh5 xylosyltransferase II 81.87715 106 174.2539 120.5878 1.09E+00 3.68E−01 4 Off Acinar; On Int = I P55263 K07ab2 adenosine kinase 891.6698 720 299.6337 637.198 −1.57E+00 −3.08E−01 15 On A/Int; Down I P51648 A22ab2 aldehyde dehydrogenase 3 famil 1955.203 1390 507.3786 1284.046 −1.95E+00 −4.93E−01 15 On A/Int; Down I P50995 I08ab2 annexin A11 4888.71 3870 1773.94 3511.843 −1.46E+00 −3.36E−01 15 On A/Int; Down I P12429 I14ab2 annexin A3 9711.235 10800 1720.452 7424.351 −2.50E+00 1.59E−01 15 On A/Int; Down I P05026 L22ab2 ATPase; Na+/K+ transporting; b

3965.733 5290 1976.367 3744.962 −1.00E+00 4.16E−01 15 On A/Int; Down I P00751 M07ab3 B-factor; properdin 2984.309 2460 1178.473 2206.568 −1.34E+00 −2.81E−01 15 On A/Int; Down I Q9HA23 E10gh6 calponin like transmembrane dor 480.5263 528 193.0456 400.5912 −1.32E+00 1.36E−01 15 On A/Int; Down I Q16170 M17ab3 carcinoembryonic antigen-relate

984.7628 1230 212.7712 807.5766 −2.21E+00 3.15E−01 15 On A/Int; Down I P25774 P07ab5 cathepsin S 857.9751 776 228.9093 620.9386 −1.91E+00 −1.45E−01 15 On A/Int; Down I P21926 J13ef7 CD9 antigen (p24) 2011.966 3500 833.332 2115.74 −1.27E+00 8.00E−01 15 On A/Int; Down I Q9H2A7 M19gh5 chemokine (C—X—C motif) ligand 1 650.7961 842 235.8205 576.1228 −1.46E+00 3.71E−01 15 On A/Int; Down I O14493 G21ab4 claudin 4 1919.128 2480 799.5104 1732.749 −1.26E+00 3.70E−01 15 On A/Int; Down I P12277 M06ab4 creatine kinase; brain 373.8119 617 193.0681 394.4895 −9.53E−01 7.22E−01 15 On A/Int; Down I Q9NYS7 E20ef4 CS box-containing WD protein 596.6891 384 211.1821 397.3278 −1.50E+00 −6.35E−01 15 On A/Int; Down I P53355 D09ab5 death-associated protein kinase 1325.243 1260 558.9756 1048.818 −1.25E+00 −7.03E−02 15 On A/Int; Down I O15205 D17cd6 diubiqultin 7363.301 14700 2196.358 8102.423 −1.75E+00 1.00E+00 15 On A/Int; Down I Q9UFZ2 C23ef8 DKFZP564K247 protein 1325.797 1060 313.5237 900.9109 −2.08E+00 −3.18E−01 15 On A/Int; Down I P28562 M22ab5 dual specificity phosphatase 1 2077.188 1680 754.9876 1502.864 −1.46E+00 −3.09E−01 15 On A/Int; Down I Q16690 B21ab4 dual specificity phosphatase 5 485.6475 305 155.0161 315.2743 −1.65E+00 −6.70E−01 15 On A/Int; Down I Q9UJW0 H10ef1 dynactin 4 (p62) 778.5079 662 335.9831 592.1023 −1.21E+00 −2.34E−01 15 On A/Int; Down I E13gh5 ectonucleotide pyrophosphatase 233.9728 378 183.3797 265.0097 −3.52E−01 6.91E−01 15 On A/Int; Down I P00533 A06ef5 epidermal growth factor receptor 263.2516 334 182.4044 259.7582 −5.29E−01 3.42E−01 15 On A/Int; Down I Q13113 J02cd5 epithelial protein up-regulated in 13324.19 15500 2641.961 10494.6 −2.33E+00 2.20E−01 15 On A/Int; Down I P28161 M09ab6 glutathione S-transferase M2 (m

1020.341 690 217.4433 642.7437 −2.23E+00 −5.63E−01 15 On A/Int; Down I Q03013 L06ab3 glutathione S-transferase M4 333.2767 465 210.8696 336.469 −6.60E−01 4.81E−01 15 On A/Int; Down I P52594 A18ab7 HIV-1 Rev binding protein 439.4544 468 252.8058 386.6697 −7.98E−01 9.00E−02 15 On A/Int; Down I Q9NWT9 D09gh2 hypothetical protein FLJ20607 1062.388 757 368.3558 729.2943 −1.53E+00 −4.89E−01 15 On A/Int; Down I Q9BZR4 L12gh7 hypothetical protein HT036 748.0681 844 160.1449 584.0643 −2.22E+00 1.74E−01 15 On A/Int; Down I Q9BW25 A19gh6 hypothetical protein MGC3101 315.4695 409 150.4768 291.8079 −1.07E+00 3.76E−01 15 On A/Int; Down I P16144 I16ab6 integrin; beta 4 490.7243 672 157.31 440.0464 −1.64E+00 4.54E−01 15 On A/Int; Down I P10145 O22ef7 interleukin 8 6902.736 13300 1783.339 7330.866 −1.95E+00 9.47E−01 15 On A/Int; Down I Q05084 G10ab7 islet cell autoantigen 1 (69 kD) 600.5671 588 209.1329 465.8994 −1.52E+00 −3.05E−02 15 On A/Int; Down I Q9Y484 E14cd7 JM5 protein 1335.218 2010 938.9827 1429.625 −5.08E−01 5.93E−01 15 On A/Int; Down I P14923 M23ef6 junction plakoglobin 1969.949 2610 912.3081 1831.613 −1.11E+00 4.07E−01 15 On A/Int; Down I P05783 N06ef6 keratin 8 17317.24 12500 2306.177 10707.79 −2.91E+00 −4.70E−01 15 On A/Int; Down I P08727 L06ab6 keratin 19 4025.258 2800 631.8404 2484.93 −2.67E+00 −5.25E−01 15 On A/Int; Down I P08729 N14ef6 keratin 7 11605.48 11100 1888.38 8203.912 −2.62E+00 −6.19E−02 15 On A/Int; Down I P05787 N16ef6 keratin 8 11031.01 7880 1694.024 6867.677 −2.70E+00 −4.86E−01 15 On A/Int; Down I O14782 H22ab6 kinesin family member 3C 366.3528 652 242.2822 420.177 −5.97E−01 8.31E−01 15 On A/Int; Down I O00515 D05ab7 ladinin 1 3562.632 2040 824.2377 2140.683 −2.11E+00 −8.08E−01 15 On A/Int; Down I P80188 D13ab7 lipocalin 2 (oncogene 24p3) 5234.435 9070 664.0466 4989.308 −2.98E+00 7.93E−01 15 On A/Int; Down I Q9UQ53 G02ef3 mannosyl (alpha-1; 3-)-glycoprot

1485.546 931 398.5069 938.2331 −1.90E+00 −6.75E−01 15 On A/Int; Down I P80294 D15gh6 metallothionein 1H 327.8489 366 208.8705 300.7815 −6.50E−01 1.57E−01 15 On A/Int; Down I O75394 M10cd5 mitochondrial ribosomal protein

441.6574 646 213.7295 433.794 −1.05E+00 5.49E−01 15 On A/Int; Down I Q9Y376 H18ef2 MO25 protein 860.3225 1410 550.0258 939.6431 −6.45E−01 7.11E−01 15 On A/Int; Down I P15941 H22ab7 mucin 1; transmembrane 2330.649 1250 487.1995 1357.116 −2.26E+00 −8.95E−01 15 On A/Int; Down I Q16301 H11cd4 myelin transcription factor 2 2433.02 2560 545.0513 1844.855 −2.16E+00 7.14E−02 15 On A/Int; Down I Q99836 M07ab7 myeloid differentiation primary re 1088.39 1110 413.4864 871.4196 −1.40E+00 3.15E−02 15 On A/Int; Down I P24001 H08cd4 natural killer cell transcript 4 49232.84 71300 13531.68 44684.13 −1.86E+00 5.34E−01 15 On A/Int; Down I Q9C002 O12gh8 normal mucosa of esophagus sp

8605.554 17700 4423.686 10242.28 −9.60E−1 1.04E+00 15 On A/Int; Down I P25963 A16ef1 nuclear factor of kappa light poly 938.908 1270 605.6116 937.0159 −6.33E−01 4.32E−01 15 On A/Int; Down I P00491 L18ab7 nucleoside phosphorylase 820.4015 500 250.4586 523.7383 −1.71E+00 −7.13E−01 15 On A/Int; Down I P49763 O20ef7 placental growth factor; vascular 5604.053 12600 1723.953 6646.258 −1.70E+00 1.17E+00 15 On A/Int; Down I Q9Y342 A13ef2 plasmolipin 942.5595 983 300.2833 742.036 −1.65E+00 6.10E−02 15 On A/Int; Down I P43490 H04cd5 pre-B-cell colony-enhancing fact

2261.72 1730 651.3251 1546.408 −1.80E+00 −3.90E−01 15 On A/Int; Down I Q99988 B23ef7 prostate differentiation factor 1470.061 2930 681.8854 1694.813 −1.11E+00 9.96E−01 15 On A/Int; Down I Q9UJY1 B05ef3 protein kinase H11 1836.927 2080 544.441 1485.828 −1.75E+00 1.77E−01 15 On A/Int; Down I Q9H1C7 O10gh8 putative nuclear protein ORF1-F

11454.74 14800 3062.014 9771.26 −1.90E+00 3.69E−01 15 On A/Int; Down I P51149 A21ef6 RAB7; member RAS oncogene f

3422.13 5250 2267.107 3646.784 −5.94E−01 6.18E−1 15 On A/Int; Down I P51151 J22cd4 RAB9A; member RAS oncogene 1882.687 1580 721.6194 1393.904 −1.38E+00 −2.55E−01 15 On A/Int; Down I P15153 C17ef6 ras-related C3 botulinum toxin s

383.0769 418 213.0301 338.0922 −8.47E−01 1.26E−01 15 On A/Int; Down I P52566 I19ef1 Rho GDP dissociation inhibitor (

986.1501 788 352.0789 708.6827 −1.49E+00 −3.24E−01 15 On A/Int; Down I P01011 I08ef7 serine (or cysteine) proteinase in 40450.89 43700 10172.44 31439.89 −1.99E+00 1.11E−01 15 On A/Int; Down I P05120 P07ef7 serine (or cysteine) proteinase in 24922.82 38200 2879.818 21999.69 −3.11E+00 6.16E−01 15 On A/Int; Down I O14508 M13ef6 STAT induced STAT inhibitor-2 1511.844 1490 420.453 1139.68 −1.85E+00 −2.42E−02 15 On A/Int; Down I Q9Y6N5 G13gh4 sulfide dehydrogenase like (yeas 823.7665 871 284.0637 659.5107 −1.54E+00 7.99E−02 15 On A/Int; Down I O00161 C23cd4 synaptosomal-associated protein 1077.833 1340 687.0432 1034.031 −6.50E−01 3.11E−01 15 On A/Int; Down I P31431 F24cd1 syndecan 4 (amphiglycan; ryudo

2109.871 3080 887.6687 2026.067 −1.25E+00 5.46E−01 15 On A/Int; Down I O15533 B16ef7 TAP binding protein (tapasin) 313.1585 424 162.3501 299.8834 −9.48E−01 4.38E−01 15 On A/Int; Down I P17

87 F11ef5

1 4

5.8787 288 157.6175 317.0491 −1.65E+00 −7.35E−01 15 On A/Int; Down I Q16149 B15cd1 transporter 1m; ATP-binding casse 862.1561 1100 480.8685 813.3307 −8.42E−01 3.47E−01 15 On A/Int; Down I Q9Y2A9 C22ef3 UDP-GlcNac:betaGal beta-1; 3-N 774.5506 436 153.9485 454.8446 −2.33E+00 −8.29E−01 15 On A/Int; Down I O60625 N10cd3 vesicle associated membrane p

2480.868 2680 584.39 1914.133 −2.09E+00 1.10E−01 15 On A/Int; Down I P07948 A21ab7 v-yes-1 Yamaguchi sarcoma vira 512.646 443 170.1742 375.1466 −1.59E+00 −2.12E−01 15 On A/Int; Down I Q9P2N4 M10gh4 a disintegrin-like and metalloprot 159.7274 227 72.96867 153.1495 −1.13E+00 5.06E−01 14 On A/Int; Off I P47895 C04ab2 aldehyde dehydrogenase 1 famil 1247.008 2370 146.6644 1254.954 −3.09E+00 9.27E−01 14 On A/Int; Off I P04233 G09ef1 CD74 antigen (invariant polypept 229.4566 174 86.99566 163.6002 −1.40E+00 −3.96E−01 14 On A/Int; Off I Q9NZ31 L12gh4 chromosome 20 open reading fra

345.4771 375 137.4415 285.9642 −1.33E+00 1.18E−01 14 On A/Int; Off I O96002 G07cd5 chromosome X open reading frar 401.521 375 130.7318 302.4558 −1.62E+00 −9.81E−02 14 On A/Int; Off I O94907 J15gh6 dickkopf homolog 1 (Xenopus la

150.3215 200 84.53571 145.044 −8.30E−01 4.14E−01 14 On A/Int; Off I Q92796 K06ef5 discs; large (Drosophila) homolo

161.9581 154 84.90819 133.5184 −9.32E−01 −7.56E−02 14 On A/Int; Off I Q13115 O17ab4 dual specificity phosphatase 4 533.5415 730 146.312 469.8392 −1.87E+00 4.52E−01 14 On A/Int; Off I P29317 F02ef5 EphA2 267.722 279 82.15254 209.5143 −1.70E+00 5.78E−02 14 On A/Int; Off I P29323 D10ef5 EphB2 269.1598 232 74.35018 191.9946 −1.86E+00 −2.11E−01 14 On A/Int; Off I Q9UKF9 H10cd7 ets homologous factor 603.0262 587 102.0333 430.6372 −2.56E+00 −3.92E−02 14 On A/Int; Off I Q9NPD3 P22gh2 exosome component Rrp41 273.527 300 49.72784 207.9117 −2.46E+00 1.36E−01 14 On A/Int; Off I O43524 G12ab4 forkhead box O3A 262.2734 169 102.6435 177.9385 −1.35E+00 −6.35E−01 14 On A/Int; Off I P21217 M16ab3 fucosyltransferase 3 (galactoside 189.3354 257 60.24803 168.8097 −1.65E+00 4.40E−01 14 On A/Int; Off I O75205 D24ef2 G protein-coupled receptor; famil 621.7284 382 90.93956 364.8596 −2.77E+00 −7.03E−01 14 On A/Int; Off I O75712 A03ef1 gap junction protein; beta 3; 31 k

235.3139 402 145.5466 260.8655 −6.93E−01 7.72E−01 14 On A/Int; Off I Q92908 D12ab4 GATA binding protein 6 293.117 199 93.59788 195.3976 −1.65E+00 −5.55E−01 14 On A/Int; Off I O95210 P05cd4 genethonin 1 331.9855 241 112.69 228.6851 −1.56E+00 −4.60E−01 14 On A/Int; Off I O95395 K21cd5 glucosaminyl (N-acetyl) transfera 297.4236 274 45.82301 205.5863 −2.70E+00 −1.21E−01 14 On A/Int; Off I P48506 F22ab5 glutamate-cysteine ligase; cataly 299.1944 243 134.9982 225.879 −1.15E+00 −2.97E−01 14 On A/Int; Off I Q9UI98 F08ef8 hqp0256 protein 357.587 336 106.803 266.8154 −1.74E+00 −8.96E−02 14 On A/Int; Off I Q9H6D8 D18gh5 hypothetical protein FLJ22362 542.6184 595 127.4299 421.5312 −2.09E+00 1.32E−01 14 On A/Int; Off I P05362 I02ab6 Intercellular adhesion molecule 1 411.0131 424 67.80016 301.0074 −2.60E+00 4.56E−02 14 On A/Int; Off I Q07627 J20gh7 keratin associated protein 1.1 288.3566 303 40.28571 210.3957 −2.84E+00 6.93E−02 14 On A/Int; Off I Q9BYQ7 D10gh8 keratin associated protein 4.10 493.4934 605 96.51137 398.2261 −2.35E+00 2.93E−01 14 On A/Int; Off I O75071 F15gh1 KIAA0494 gene product 240.2512 167 91.77931 166.3595 −1.39E+00 −5.24E−01 14 On A/Int; Off I Q9UPQ2 G22ef8 KIAA1100 protein 224.7248 349 135.6811 236.4102 −7.28E−01 6.34E−01 14 On A/Int; Off I O43896 H10cd6 kinesin family member 1C 159.6982 170 73.44924 134.4385 −1.12E+00 9.16E−02 14 On A/Int; Off I Q13887 L05ab5 Kruppel-like factor 5 (intestinal) 494.1259 376 97.43054 322.6178 −2.34E+00 −3.93E−01 14 On A/Int; Off I O00312 D22cd3 MAP kinase-interacting serine/th

147.9629 150 86.60695 128.2701 −7.73E−01 2.20E−02 14 On A/Int; Off I O15264 H07ab8 mitogen-activated protein kinase 213.7425 160 76.32069 150.0667 −1.49E+00 −4.17E−01 14 On A/Int; Off I Q9UHA4 P10gh1 mitogen-activated protein kinase 268.8101 244 72.50042 195.0133 −1.89E+00 −1.41E−01 14 On A/Int; Off I P21397 F23ef6 monoamine oxidase A 427.3495 480 30.42645 312.5207 −3.81E+00 1.67E−01 14 On A/Int; Off I P55196 N07ab7 myeloid/lymphoid or mixed-linea

164.9238 168 78.62952 137.1449 −1.07E+00 2.56E−02 14 On A/Int; Off I Q12965 I24ab7 myosin IE 212.4935 276 122.0015 203.3655 −8.01E−01 3.75E−01 14 On A/Int; Off I Q9HBW1 O10gh7 NAG14 protein 417.9837 396 86.84398 300.2834 −2.27E+00 −7.79E−02 14 On A/Int; Off I Q9H2W4 D20gh6 neural precursor cell expressed; 361.6431 483 75.41197 299.9778 −2.26E+00 3.56E−01 14 On A/Int; Off I Q9NRR3 O06gh4 non-kinase CDc42 effector protei 194.8075 327 117.0936 213.1256 −7.34E−01 7.49E−01 14 On A/Int; Off I P23511 M19ab8 nuclear transcription factor Y; al

239.2485 226 132.3351 199.2783 −8.54E−01 −8.06E−02 14 On A/Int; Off I Q99650 D14cd4 oncostatin M receptor 337.1614 233 141.0848 237.114 −1.26E+00 −5.33E−01 14 On A/Int; Off I P04085 O16ef7 platelet-derived growth factor alp

441.7554 463 124.4793 343.2015 −1.83E+01 6.89E−02 14 On A/Int; Off I Q13048 N06cd2 pregnancy specific beta-1-glycop

149.7737 203 84.53571 145.8869 −8.25E−01 4.41E−01 14 On A/Int; Off I P10586 E11ef6 protein lyrosine phosphatase; re

466.2876 405 136.6718 335.8682 −1.77E+00 −2.05E−01 14 On A/Int; Off I O95200 N22ab8 retinoic acid receptor responder

437.2899 315 72.62859 275.0752 −2.59E+00 −4.72E−01 14 On A/Int; Off I Q9NVX8 P17ef3 Rho GTPase activating protein 8 425.2848 479 109.2541 337.8544 −1.96E+00 1.72E−01 14 On A/Int; Off I Q15418 N14ef5 ribosomal protein S6 kinase; 90 k 299.528 361 78.38666 246.2347 −1.93E+00 2.68E−01 14 On A/Int; Off I Q15434 F10ab8 RNA binding motif; single strand

454.6438 328 145.2438 309.3377 −1.65E+00 −4.70E−01 14 On A/Int; Off I Q15437 O10cd6 Sec23 homolog B (S. cerevisiae) 281.2005 235 126.9582 214.4633 −1.15E+00 −2.58E−01 14 On A/Int; Off I O60679 D15ef5 serum-inducible kinase 202.0368 194 62.20916 152.8498 −1.70E+00 −5.63E−02 14 On A/Int; Off I Q12890 N06ef5 SFRS protein kinase 1 350.4057 278 113.0428 247.1823 −1.63E+00 −3.33E−01 14 On A/Int; Off I Q12971 L03cd6 sialyitransferase 247.3141 329 96.91002 224.3379 −1.35E+00 4.11E−01 14 On A/Int; Off I P78556 M02cd2 small inducible cytokine subfamil 308.0437 382 59.31325 249.7105 −2.38E+00 3.10E−01 14 On A/Int; Off I O75751 F14ef4 solute carrier family 22 (extraneu 164.6419 238 66.83593 156.4431 −1.30E+00 5.31E−01 14 On A/Int; Off I Q9UM01 D08cd4 solute carrier family 7 (cationic

201.657 260 55.89528 172.4611 −1.85E+00 3.66E−01 14 On A/Int; Off I Q9Y5X1 D10ef2 sorting nexin 9 219.1839 240 108.9101 189.2981 −1.01E+00 1.30E−01 14 On A/Int; Off I P08842 D19ab3 steroid sulfatase (microsomal); a 436.4255 414 136.2997 328.904 −1.68E+00 −7.62E−02 14 On A/Int; Off I O43760 G09cd5 synaptogyrin 2 391.0545 238 118.1167 249.1866 −1.73E+00 −7.14E−01 14 On A/Int; Off I O75674 N15cd5 target of myb1-like 1 (chicken) 276.5234 285 54.32353 205.2456 −2.35E+00 4.30E−02 14 On A/Int; Off I P01135 K04ef7 transforming growth factor; alpha 215.9023 160 59.63082 145.3108 −1.86E+00 −4.29E−01 14 On A/Int; Off I Q9NT70 K13gh3 transmembrane protein vezatin 365.9385 401 129.2607 298.7991 −1.50E+00 1.33E−01 14 On A/Int; Off I O60656 G13gh3 UDP glycosyltransferase 1 family 546.3937 438 27.51254 337.3961 −4.31E+00 −3.18E−01 14 On A/Int; Off I Q9NZ42 N18gh4 uncharacterized hematopoietic s

196.9377 213 115.2737 175.1842 −7.73E−01 1.15E−01 14 On A/Int; Off I O76080 E14cd4 zinc finger protein 216 314.9706 211 74.56541 200.0768 −2.08E+00 −5.80E−01 14 On A/Int; Off I Q13015 H11ab2 ALL1-fused gene from chromoso 329.6061 1730 1752.9 1272.138 2.41E+00 2.40E+00 6 On Acinar; Up Int = I P04083 I06ab2 annexin A1 1114.486 8240 8292.245 5883.787 2.90E+00 2.89E+00 6 On Acinar; Up Int = I O605962 B14ab2 Arg/Abi-interacting protein ArgBF 1576.114 3320 2017.836 2304.427 3.56E−01 1.07E+00 6 On Acinar; Up Int = I Q07814 E04ef6 BCL2-associated X protein 430.8903 862 1101.457 797.9572 1.35E+00 1.00E+00 6 On Acinar; Up Int = I Q14201 E17cd7 BTG family; member 3 197.8608 451 419.4378 355.9496 1.08E+00 1.19E+00 6 On Acinar; Up Int = I Q9NR00 J21gh4 chromosome 8 open reading fra

2766.931 7310 3283.111 4453.955 2.47E−01 1.40E+00 6 On Acinar; Up Int = I Q9BUW7 K19gh6 chromosome 9 open reading fra

228.4878 650 551.4272 476.5934 1.27E+00 1.51E+00 6 On Acinar; Up Int = I O95401 N04cd4 cofactor required for Sp1 transcri 186.3494 395 588.6133 390.063 1.66E+00 1.08E+00 6 On Acinar; Up Int = I Q00535 B09ef5 cyclin-dependent kinase 5 269.7495 476 432.1176 392.629 6.80E−01 8.19E−01 6 On Acinar; Up Int = I P21741 E17ab7 midkine (neurite growth-promotin 2991.463 15400 9802.658 9388.855 1.71E+00 2.36E+00 6 On Acinar; Up Int = I Q9Y291 J15ef2 mitochondrial ribosomal protein

177.4689 330 365.4484 290.8529 1.04E+00 8.93E−01 6 On Acinar; Up Int = I O75376 E17cd6 nuclear receptor co-repressor 1 375.3879 1270 727.3836 791.9381 9.54E−01 1.76E+00 6 On Acinar; Up Int = I P03973 N10cd1 secretory leukocyte protease inhi 592.855 2070 4153.51 2270.718 2.81E+00 1.80E+00 6 On Acinar; Up Int = I O15427 F06cd4 solute carrier family 16 (monocar 228.58 753 785.8975 589.0175 1.78E+00 1.72E+00 6 On Acinar; Up Int = I P16949 D11ab7 siathrnin 1/oncoprotein 18 728.2643 2630 1984.807 1781.654 1.45E+00 1.85E+00 6 On Acinar; Up Int = I Q9NZ86 J08gh3 uncharacterized bone marrow p

311.3754 945 536.938 597.7198 7.86E−01 1.60E+00 6 On Acinar; Up Int = I P50440 A09ab5 glycine amidinotransferase (L-ar

1737.906 395 261.2318 798.1958 −2.73E+00 −2.14E+00 20 Other P29622 A06cd1 serine (or cysteine) proteinase In

461.3518 189 264.9574 304.9848 −8.00E−01 −1.29E+00 20 Other O14646 C17ab4 chromodomain helicase DNA bin

867.7631 180 273.1703 440.3418 −1.67E+00 −2.27E+00 20 Other P48307 I10cd4 tissue factor pathway Inhibitor 2 920.3007 366 277.6619 521.385 −1.73E+00 −1.33E+00 20 Other Q15125 D08cd6 emopamil binding protein (sterol

897.4306 230 282.4317 470.0852 −1.67E+00 −1.96E+00 20 Other P19387 B13ab8 polymerase (RNA) II (DNA direct

196.4282 155 282.8549 211.5128 5.26E−01 −3.39E−01 20 Other Q9P0K7 H08gh6 retinoic acid induced 14 177.983 275 283.8007 245.4643 6.73E−01 6.26E−01 20 Other P30086 E04ab8 prostalic binding protein 634.2686 462 300.6211 465.627 −1.08E+00 −4.57E−01 20 Other Q13045 C06ab5 flightless I homolog (Drosophila) 622.7072 501 306.0777 476.5407 −1.02E+00 −3.14E−01 20 Other O95084 G10cd7 protease; serince; 23 1096.756 246 314.746 552.6166 −1.80E+00 −2.15E+00 20 Other P49770 L11ef4 eukaryotic translation Initiation fa

731.6826 547 329.7361 536.2071 −1.15E+00 −4.19E−01 20 Other Q13948 J02ef6 cut-like 1; CCAAT displacement

222.2758 349 330.5149 300.5112 5.72E−01 6.50E−01 20 Other Q30201 H05ab3 hemochromatosis 205.1607 291 339.4607 278.446 7.26E−01 5.03E−01 20 Other P52895 I16gh6 aido-keto reductase family 1; m

4001.572 263 339.7988 1534.634 −3.56E+00 −3.93E+00 20 Other Q9Y5N1 M24cd7 histamine receptor H3 526.5133 203 341.1301 356.7517 −6.26E−01 −1.38E+00 20 Other P43378 N23ab8 protein tyrosine phosphatase; no 1360.729 445 368.4734 724.8175 −1.88E+00 −1.61E+00 20 Other P35414 O11ab2 angiotensin receptor-like 1 620.7039 406 395.8948 474.2345 −6.49E−01 −6.12E−01 20 Other Q14802 K03cd1 FXYD domain-containing ion tra

2174.215 711 402.87 1096.127 −2.43E+00 −1.61E+00 20 Other Q9Y266 F16cd6 nuclear distribution gene C hom

745.3985 447 408.3037 533.6949 −8.68E−01 −7.37E−01 20 Other P30043 O21ab3 biliverdin reductase B (flavin red

877.6813 565 417.1383 620.0433 −1.07E+00 −6.35E−01 20 Other Q9NP73 L06gh3 uncharacterized hematopoietic s

804.2103 446 421.5183 557.2055 −9.32E−01 −8.51E−01 20 Other Q12972 D17ab8 protein phosphatase 1; regulator 251.1796 358 425.52 345.0523 7.61E−01 5.13E−01 20 Other Q9Y288 N21ef2 PTD009 protein 738.5086 424 436.6114 532.9995 −7.58E−01 −8.01E−01 20 Other Q02750 K02ef7 mitogen-activated protein kinase 810.206 508 441.4249 586.6635 −8.76E−01 −6.72E−01 20 Other P42226 G23cd2 signal transducer and activator O 892.6025 516 450.4229 619.5568 −9.87E−01 −7.92E−01 20 Other P31947 M07ef6 stratifin 2941.197 741 452.267 1378.205 −2.70E+00 −1.99E+00 20 Other P46597 J12ab2 acetylserotonin O-methyltransfer. 2225.944 437 466.9229 1043.272 −2.25E+00 −2.35E+00 20 Other O14745 J24cd4 solute carrier family 9 (sodium/h

1844.719 642 504.4269 997.106 −1.87E+00 −1.52E+00 20 Other Q9NS67 D24gh1 G protein-coupled receptor 27 1464.475 381 595.0192 813.4043 −1.30E+00 −1.94E+00 20 Other Q9UKL5 J07cd8 programmed cell death 6 interact 995.6375 886 605.9272 829.3129 −7.16E−01 −1.68E−01 20 Other Q9UQL3 B11ef2 liver-specific bHLH-Zip transcript 825.7324 1150 606.7901 860.8974 −4.44E−01 4.78E−01 20 Other Q9NZZ1 P18ef2 hypothetical protein HSPC138 397.5554 450 618.4035 488.5944 6.37E−01 1.78E−01 20 Other Q9Y3Q3 H03cd7 integral type I protein 526.2023 355 631.4284 504.2124 2.63E−01 −5.68E−01 20 Other Q9NSN3 C10gh4 similar to aspartate beta hydroxy 355.1305 273 667.4052 431.8528 9.10E−01 −3.79E−01 20 Other Q9Y5Z0 B12cd7 beta-site APP-cleaving enzyme 2 1469.687 960 680.3343 1036.811 −1.11E+00 −6.14E−01 20 Other C21gh7 H2B histone family; member B 511.589 855 733.4035 699.9713 5.20E−01 7.41E−01 20 Other O14713 M11cd5 integrin cytoplasmic domain-ass

446.3806 746 737.9643 643.5596 7.25E−01 7.42E−01 20 Other P46095 P11ab4 G protein-coupled receptor 6 2336.841 460 760.4217 1185.918 −1.62E+00 −2.34E+00 20 Other Q98V10 K07gh6 hypothetical protein MGC3136 1761.627 653 779.7338 1064.815 −1.18E+00 −1.43E+00 20 Other Q99653 O08cd7 calcium binding protein P22 1713.549 1430 793.2383 1313.03 −1.11E+00 −2.59E−01 20 Other P41584 P16gh1 polymerase (RNA) II (DNA direct 560.1066 892 821.9856 758.0427 5.53E−01 6.71E−01 20 Other P11940 E06ab8 poly(A) binding protein; cytoplas

1738.585 669 827.8343 1078.525 −1.07E+00 −1.38E+00 20 Other Q00341 G21ab6 high density lipoprotein binding

545.5844 444 866.5328 618.5713 6.67E−01 −2.99E−01 20 Other Q16795 K08ab7 NADH dehydrogenase (ubiquino

1582.872 1190 873.0478 1214.409 −8.58E−01 −4.15E−01 20 Other Q13082 E05ab7 microtubule-associated protein 4 1217.396 472 873.8683 854.4272 −4.78E−01 −1.37E+00 20 Other P36405 D16ab2 ADP-ribosytation factor-like 3 508.3031 547 939.7284 665.1099 8.87E−01 1.07E−01 20 Other Q9NXH2 C04gh2 hypothetical protein FLJ20254 515.6731 467 959.9781 647.4269 8.97E−01 −1.44E−01 20 Other Q9Y323 D21ef2 hypothetical protein HSPC177 838.9663 1630 976.2242 1148.545 2.19E−01 9.59E−01 20 Other P48059 I12ab7 LIM and senescent cell antigen-

560.9674 918 1003.945 827.7691 6.40E−01 7.11E−01 20 Other Q9P0M9 M02ef2 mitochondrial ribosomal protein

579.0083 936 1024.359 846.5801 8.23E−01 6.93E−01 20 Other Q13813 E07cd2 spectrin; alpha; non-erythrocytic 2261.592 886 1070.984 1406.107 −1.08E+00 −1.35E+00 20 Other Q9Y379 H07ef2 CGI-69 protein 2556.713 1900 1174.107 1877.939 −1.12E+00 −4.26E−01 20 Other Q13247 O13gh1 splicing factor; arginine/serine-ri

718.1614 1210 1194.951 1041.827 7.35E−01 7.55E−01 20 Other P14416 D03ef6 dopamine receptor D2 814.5351 745 1299.03 952.9439 6.73E−01 −1.28E−01 20 Other Q06323 A15ef7 proteasome (prosome; macropal

1491.803 2350 1386.719 1742.377 −1.05E−01 6.55E−01 20 Other Q9NR31 H17gh4 SAR1 protein 752.6343 886 1386.849 1008.646 8.82E−01 2.36E−01 20 Other P05451 C07cd3 regenerating islet-derived 1 alpha 75644.12 1690 1394.425 26243.72 −5.76E+00 −5.48E+00 20 Other P04075 C12ab2 aldolase A; fructose-bisphosphat 4534.199 1590 1470.967 2532.66 −1.62E+00 −1.51E+00 20 Other Q15904 A19ab3 ATPase; H+ transporting; lysoso

833.0193 1380 1471.799 1228.765 8.21E−01 7.30E−01 20 Other P15559 G24ef7 NAD(P)H dehydrogenase; quino

537.0892 303 1486.45 775.5735 1.47E+00 −8.25E−01 20 Other O00303 L20cd3 eukaryotic translation initiation fa

1234.805 636 1556.448 1145.377 3.23E−01 −9.68E−01 20 Other P56705 M01gh7 wingless-type MMTV integration 3589.752 1590 1635.805 2271.364 −1.13E+00 −1.18E+00 20 Other P39210 I04ef7 MpV17 transgene; murine homo

990.336 894 1723.06 1202.587 7.99E−01 −1.47E−01 20 Other Q9UKL9 N03ef4 aldo-keto reductase family 1; m

16311.31 2840 1896.102 7016.796 −3.10E+00 −2.52E+00 20 Other O43516 E12cd3 Wiskott-Aldrich syndrome protein 1162.511 1190 1976.246 1444.29 7.68E−01 3.51E−02 20 Other Q9Y470 D01ef7 stem cell growth factor; lymphoc

1346.693 1110 2049.542 1503.556 6.06E−01 −2.73E−01 20 Other P29312 H12cd4 lyrosine 3-monooxygenase/tryopt

5187.766 4710 2331.854 4076.247 −1.15E+00 −1.40E−01 20 Other Q9Y5R8 P24gh4 MUM2 protein 1596.032 1750 2568.113 1971.095 6.86E−01 1.32E−01 20 Other P17676 D01ab5 CCAAT/enhancer binding protein 6064.068 2880 2723.688 3890.676 −1.15E+00 −1.07E+00 20 Other O95362 F11gh6 differentially expressed in hemat

10407.52 2680 2912.158 5333.102 −1.84E+00 −1.96E+00 20 Other O60417 C11gh7 S100 calcium binding protein A1

6955.642 5690 3097.579 5248.939 −1.17E+00 −2.89E−01 20 Other P19623 E17cd2 spermidine synthase 1644.266 1020 3417.978 2027.643 1.06E+00 −6.88E−01 20 Other Q9P039 P02ef7 FXYD domain-containing ion tra

2410.08 2120 4486.029 3004.627 8.96E−01 −1.87E−01 20 Other Q9BUF5 F05gh8 tubulin beta-5 2252.623 1580 4730.755 2855.744 1.07E+00 −5.08E−01 20 Other P00995 C23cd2 serine protease inhibitor; Kazal

67989.21 11300 5416.175 28226.58 −3.65E+00 −2.59E+00 20 Other P11142 E22ef7 heat shock 70 kD protein 8 11154.99 7640 5433.843 8144.601 −1.04E+00 −5.08E−01 20 Other P10620 E16ef7 microsomal glutathione S-transfe 6706.736 2430 5571.411 4901.595 −2.68E−01 −1.47E+00 20 Other Q13347 N02cd3 eukaryotic translation initiation fa 19633.03 5210 5660.757 10168.91 −1.79E+00 −1.91E+00 20 Other P15880 B16cd1 ribosomal protein S2 4356.01 2060 5964.993 4127.437 4.54E−01 −1.08E+00 20 Other Q9HCU0 E24gh4 tumor endothelial marker 1 prec

3139.145 2600 7148.075 4295.784 1.19E+00 −2.72E−01 20 Other Q04941 O16ab8 proteolipid protein 2 (colonic epit 17951.73 11800 8567.736 12775.93 −1.07E+00 −6.04E−01 20 Other Q9UPI1 M14cd2 small nuclear ribonucleoprotein

4625.515 8280 8998.787 7300.387 9.60E−01 8.39E−01 20 Other P13987 B18ef7 CD59 antigen p18-20 (antigen id 17383.17 19200 10453.43 15673.38 −7.34E−01 1.42E−01 20 Other Q9UI09 L02gh4 13 kDa differentiation-associated 1754.698 1990 2889.148 2210.198 7.19E−01 1.79E−01 3 Unchanged High Q9Y6H1 E23ef2 16.7 Kd protein 5687.333 4050 5837.94 5191.628 3.77E−02 −4.90E−01 3 Unchanged High Q9P0U1 C07gh3 6.2 kd protein 2323.402 1990 3847.586 2721.439 7.28E−01 −2.21E−01 3 Unchanged High P80095 N10ab7 6-pyruvoyl-tetrahydropterin syn

3223.922 2620 1569.69 2241.592 −1.04E+00 −2.99E−01 3 Unchanged High Q92747 F04ab2 actin related protein ⅔ complex 4894.401 3990 3030.018 3972.89 −6.92E−01 −2.93E−01 3 Unchanged High O15144 F08ab2 actin related protein ⅔ complex 13976.76 21400 17206.31 17538.09 3.00E−01 6.17E−01 3 Unchanged High O15145 F10ab2 actin related protein ⅔ complex 3065.881 3190 1793.813 2683.638 −7.73E−01 5.78E−02 3 Unchanged High P02570 A01cd7 actin; beta 66304.81 45400 38777.92 50171.41 −7.74E−01 −5.45E−01 3 Unchanged High P02570 H12cd7 actin; beta 84949.74 42400 44598.66 50643.44 −5.42E−01 −6.16E−01 3 Unchanged High P02570 P12cd7 actin; beta 21347.36 12200 15408.61 16331.85 −4.70E−01 −8.03E−01 3 Unchanged High P02571 A06ab6 actin; gamma 1 69165.16 59100 65677.15 64643.45 −7.47E−02 −2.27E−01 3 Unchanged High P12814 E23ab2 actinin; alpha 1 2400.607 2160 2638.011 2400.844 1.36E−01 −1.50E−01 3 Unchanged High O43707 G05ab2 actinin; alpha 4 6999.138 3810 3499.234 4769.196 −1.00E+00 −8.78E−01 3 Unchanged High P53999 C05cd7 activated RNA polymerase II tran 4478.986 4320 6009.318 4936.98 4.24E−01 −5.13E−02 3 Unchanged High P18848 I03ef5 activating transcription factor 4 (t 7160.888 5420 7668.286 6749.873 9.88E−02 −4.02E−01 3 Unchanged High P53680 A07ef1 adaptor-related protein complex: 2255.235 2530 4102.633 2963.423 8.63E−01 1.67E−01 3 Unchanged High P29274 A18ef5 adenosine A2a receptor 1990.124 2960 2004.596 2318.367 1.05E−02 5.73E−01 3 Unchanged High P54819 A04ab2 adenylate kinase 2 2997.607 2520 2851.739 2788.3 −7.20E−02 −2.53E−01 3 Unchanged High Q01518 O18cd6 adenylyl cyclase-associated prot 6946.788 11000 7171.205 8362.375 4.59E−02 6.59E−01 3 Unchanged High P32889 C03ef6 ADP-ribosylation factor 1 6040.796 7220 7907.02 7058.851 3.88E−01 2.58E−01 3 Unchanged High P18085 P21ab2 ADP-ribosylation factor 4 4777.904 8880 8342.165 7331.81 8.04E−01 8.93E−01 3 Unchanged High P26437 B02ab2 ADP-ribosylation factor 5 3739.477 4430 3984.845 4052.262 9.17E−02 2.45E−01 3 Unchanged High Q9BZX4 L08gh6 AKAP-binding sperm protein rop

2345.455 2780 2500.118 2541.066 9.21E−02 2.44E−01 3 Unchanged High P11768 K01ab2 alchocol dehydrogenase 5 (class

2220.156 1990 2854.318 2354.247 3.62E−01 −1.59E−01 3 Unchanged High P05067 N03ef6 amyloid beta (A4) precursor prot

2846.85 4180 3918.595 3649.558 4.61E−01 5.55E−01 3 Unchanged High Q06481 K22ab2 amyloid beta (A4) precursor-like 2117.652 3230 2290.191 2546.598 1.13E−01 6.10E−01 3 Unchanged High P07355 I12ab2 annexin A2 74767.39 112000 97217.17 94734.13 3.79E−01 5.86E−01 3 Unchanged High P08758 I18ab2 annexin A5 4487.905 4270 7134.202 5295.976 6.69E−01 −7.32E−02 3 Unchanged High P55064 O08ab2 aquaporin 5 10851.57 14200 11650.24 12248.87 1.02E−01 3.93E−01 3 Unchanged High Q13520 O10ab2 aquaporin 6; kidney specific 2404.748 2350 2457.278 2404.397 3.12E−02 −3.25E−02 3 Unchanged High P32391 D19ab2 ARP3 actin-related protein 3 hon 4291.823 4280 3941.05 4171.013 −1.23E−01 −3.92E−03 3 Unchanged High O43776 E18ab7 asparaginyl-tRNA synthetase 2570.968 3010 2854.989 2811.634 1.51E−01 2.27E−01 3 Unchanged High P24539 N22ab2 ATP synthase; H+ transporting; r 2908.697 3800 3228.203 3312.717 1.50E−01 3.86E−01 3 Unchanged High P48201 P04ab2 ATP synthase; H+ transporting; r 5694.182 4370 4857.955 4974.135 −2.29E−01 −3.82E−01 3 Unchanged High P05496 N24ab2 ATP synthase; H+ transporting; r 2176.378 1760 2400.575 2112.628 1.41E−01 −3.06E−01 3 Unchanged High Q06055 P02ab2 ATP synthase; H+ transporting; r 5784.579 3530 7732.552 5682.609 4.19E−01 −7.12E−01 3 Unchanged High O75947 P14ab2 ATP synthase; H+ transporting; r 2668.028 2520 1881.974 2355.858 −5.04E−01 −8.37E−02 3 Unchanged High P56385 P06ab2 ATP synthase; H+ transporting; r 2682.798 2090 2616.726 2462.524 −3.60E−02 −3.62E−01 3 Unchanged High P56134 P10ab2 ATP synthase; H+ transporting; r 11587.91 17200 14181.18 14327.12 2.91E−01 5.71E−01 3 Unchanged High P18859 P08ab2 ATP synthase; H+ transporting; r 3879.939 4840 5176.585 4633.559 4.16E−01 3.20E−01 3 Unchanged High O75964 P16ab2 ATP synthase; H+ transporting; r 2021.591 2630 2009.026 2219.11 −8.99E−03 3.78E−01 3 Unchanged High P25705 N14ab2 ATP synthase; H+ transporting; r 3657.512 2410 2967.207 3009.915 −3.02E−01 −6.05E−01 3 Unchanged High P06578 N16ab2 ATP synthase; H+ transporting; r 4072.978 3280 2557.962 3305.047 −6.71E−01 −3.11E−01 3 Unchanged High P36542 N18ab2 ATP synthase; H+ transporting; r 2479.5 2030 2436.284 2313.989 −2.54E−02 −2.91E−01 3 Unchanged High P48047 P18ab2 ATP synthase; H+ transporting; r 4222.314 4100 3541.047 3955.838 −2.54E−01 −4.09E−02 3 Unchanged High Q01814 P01ef5 ATPase; Ca++ transporting; plas 3157.447 3180 3242.707 3193.535 3.84E−02 1.05E−02 3 Unchanged High Q99437 A11ab3 ATPase; H+ transporting; lysoso

2495.618 3870 2087.291 2817.803 −2.58E−01 6.33E−01 3 Unchanged High P36543 A09ab3 ATPase; H+ transporting; lysoso

1854.198 2920 1659.749 2145.908 −1.60E−01 6.57E−01 3 Unchanged High O75348 A15ab3 ATPase; H+ transporting; lysoso

2734.484 5660 2721.878 3704.42 −6.67E−03 1.05E+00 3 Unchanged High Q16864 A21ab3 ATPase; H+ transporting; lysoso

6452.29 15900 7960.234 10101.59 3.03E−01 1.30E+00 3 Unchanged High P27449 A05ab3 ATPase; H+ transporting; lysoso

17134.14 24300 13120.57 18185.04 −3.85E−01 5.04E−01 3 Unchanged High O00244 L14ab2 ATX1 antioxidant protein 1 homo 2833.957 3500 3977.547 3435.675 4.89E−01 3.03E−01 3 Unchanged High O14503 M18ab3 basic helix-loop-helix domain cor 4978.916 4280 3254.631 4169.761 −6.13E−01 −2.20E−01 3 Unchanged High O60238 L11ab5 BCL2/adenovirus E1B 19 kD inte

1473.428 2420 3224.141 2371.407 1.13E+00 7.14E−01 3 Unchanged High P30536 L21ab3 benzodiazapine receptor (periph

1997.929 2880 2326.211 2405.625 2.19E−01 5.34E−01 3 Unchanged High P01884 C23ab3 beta-2-microglobulin 64872 105000 36055.95 68478.91 −8.47E−01 6.88E−01 3 Unchanged High P22004 I13ab5 bone morphogenetic protein 6 5036.985 4710 3780.005 4509.317 −4.14E−01 −9.65E−02 3 Unchanged High O95415 B02ef3 brain protein

3 7498.734 11200 5348.84 8032.295 −4.87E−01 5.85E−01 3 Unchanged High O75531 K11ab3 Breakpoint cluster region protein 2541.789 2740 2924.826 2736.992 2.03E−01 1.11E−01 3 Unchanged High P02593 A10ab6 calmodulin 2 (phospharylase kin

1573.77 4130 4742.485 3482.215 1.59E+00 1.39E+00 3 Unchanged High P07384 O24ef1 calpain 1; (mu/l) large subunit 3429.132 3420 2390.011 3078.324 −5.21E−01 −5.61E−03 3 Unchanged High P27797 P05ab5 calreticulin 10259.42 9700 15437.35 11797.33 5.89E−01 −8.16E−02 3 Unchanged High N06gh8 CaM-KII inhibitory protein 20298.71 28200 21760.79 23425.99 1.00E−01 4.75E−01 3 Unchanged High P47756 N14ab4 capping protein (actin filament) n 4348.079 4450 5015.377 4604.9 2.06E−01 3.38E−02 3 Unchanged High P15086 H13ab5 carboxypeptidase B1 (tissue) 9766.062 27.1 26.97129 3273.378 −8.50E+00 −8.49E+00 3 Unchanged High P52952 D22ab5 cardiac-specific homeo box 2859.197 1740 2282.546 2292.94 −3.25E−01 −7.19E−01 3 Unchanged High P13862 M21ef1 casein kinase 2; beta polypeptid

3674.921 3840 3873.228 3795.282 7.58E−02 6.25E−02 3 Unchanged High O14675 I02ef6 CASP8 and FADD-like apoptosis 2622.586 2500 1151.661 2092.229 −1.19E+00 −6.77E−02 3 Unchanged High P35221 C17ef7 catenin (cadherin-associated pro 3813.516 4230 3300.738 3782.772 −2.08E−01 1.51E−01 3 Unchanged High P07858 E01ab5 cathepsin B 2480.797 3860 4485.422 3607.853 8.54E−01 6.37E−01 3 Unchanged High P48509 K16ab4 CD151 antigen 7267.56 13700 8768.731 9901.71 2.71E−01 9.11E−01 3 Unchanged High P25063 G22cd8 CD24 antigen (small cell lung ca

21319.27 18200 8278.973 15932.79 −1.36E+00 −2.28E−01 3 Unchanged High P16070 O21ef1 CD44 antigen (homing function a 16178.96 9640 5778.642 10533.43 −1.49E+00 −7.47E−01 3 Unchanged High P08962 O18ab4 CD63 antigen (melanoma 1 an

9354.914 11600 10016.29 10307.1 9.86E−02 3.04E−01 3 Unchanged High O14519 K04ef5 CDK2-associated protein 1 4231.191 4180 4763.013 4389.995 1.71E−01 −1.90E−02 3 Unchanged High P25763 A12ab6 cell division cycle 42 (GTP bindi

4588.819 2840 2852.186 3426.736 −6.86E−01 −6.93E−01 3 Unchanged High P49368 N17cd2 chaperonin containing TCP1; su

2356.627 2880 2222.361 2484.939 −8.46E−02 2.87E−01 3 Unchanged High P48643 H10ef4 chaperonin containing TCP1; su

2238.933 2330 1561.625 2042.12 −5.20E−01 5.49E−02 3 Unchanged High O00299 M19ab6 chloride intracellular channel 1 6811.55 7240 5727.121 6591.299 −2.50E−01 8.71E−02 3 Unchanged High Q9Y2Q7 N02cd8 chromosome 11 open reading fr

4087.361 3800 5946.259 4610.942 5.41E−01 −1.05E−01 3 Unchanged High P09496 F15ab5 clathrin; light polypeptide (Lca) 5758.632 9260 5849.641 6957.341 2.26E−02 6.86E−01 3 Unchanged High O95832 L04gh1 claudin 1 3046.376 2450 918.0838 2138.383 −1.73E+00 −3.14E−01 3 Unchanged High O95471 A13ef1 claudin 7 2888.819 3350 1520.977 2587.177 −9.25E−01 2.14E−01 3 Unchanged High Q9UII4 B14ef1 cyclin-E binding protein 1 26180.8 29800 39655.02 31877.4 5.99E−01 1.87E−01 3 Unchanged High P04080 G16ab3 cystatin B (stefin B) 4312.168 5420 2370.13 4034.272 −8.63E−01 3.30E−01 3 Unchanged High P21291 J01ab5 cysteine and glycine-rich protein 2478.366 1710 2135.86 2109.096 −2.15E−01 −5.33E−01 3 Unchanged High O00622 J15ef7 cysteine-rich; angiogenic inducer 2070.203 1620 2978.542 2224.339 5.25E−01 −3.50E−01 3 Unchanged High P13073 L19ab5 cytochrome c oxidase subunit IV 6219.628 8550 6571.848 7115.048 7.95E−02 4.60E−01 3 Unchanged High P12074 K13gh1 cytochrome c oxidase subunit VI

3253.24 5800 4244.557 4434.13 3.84E−01 8.35E−01 3 Unchanged High Q02221 E17ab6 cytochrome c oxidase subunit VI

2968.24 2820 4604.241 3464.904 6.33E−01 −7.28E−02 3 Unchanged High P14854 A20ab6 cytochrome c oxidase subunit VII 1991.91 2660 2380.795 2344.331 2.57E−01 4.17E−01 3 Unchanged High P09669 E12ab6 cytochrome c oxidase subunit VI

2580.598 2090 1927.002 2197.56 −4.21E−01 −3.08E−01 3 Unchanged High P14406 G02ab5 cytochrome c oxidase subunit VII 4846.713 4500 4245.478 4530.346 −1.91E−01 −1.07E−01 3 Unchanged High O14548 G23cd5 cytochrome c oxidase subunit VII 2182.954 2450 3040.586 2556.481 4.78E−01 1.64E−01 3 Unchanged High P24311 K17ab5 cytochrome c oxidase subunit VII 3224.558 5150 3601.752 4057.995 2.38E−01 6.75E−01 3 Unchanged High P15954 P04ab5 cytochrome c oxidase subunit VII 12335.74 12200 9883.688 11482.48 −3.20E−01 −1.27E−02 3 Unchanged High P10176 B10ab5 cytochrome c oxidase subunit VII 3019.162 1900 3329.281 2750.974 1.41E−01 −8.65E−01 3 Unchanged High O43293 K19ab4 death-associated protein kinase 2535.403 1850 2088.808 2157.783 −2.80E−01 −4.55E−01 3 Unchanged High P46966 G14ef6 defender against cell death 1 7921.682 11200 9546.896 9563.241 2.69E−01 5.02E−01 3 Unchanged High Q09753 G01ab6 defensin; beta 1 4071.982 7630 2153.638 4619.611 −9.19E−01 9.07E−01 3 Unchanged High P18282 F23ab2 destrin (actin depolymerizing fac

7729.126 7570 6083.408 7126.01 −3.45E−01 −3.09E−02 3 Unchanged High P07108 H04gh1 diazepam binding inhibitor (GAB, 2541.011 1730 2995.768 2422.578 2.38E−01 −5.54E−01 3 Unchanged High P31689 D18ab7 DnaJ (Hsp40) homolog; subfamil 2491.051 2930 1789.662 2402.398 −4.77E−01 2.32E−01 3 Unchanged High Q9Y5T4 I10cd8 DNAJ domain-containing 2324.933 2520 2397.896 2414.457 4.46E−02 1.17E−01 3 Unchanged High Q9Y463 G15cd5 dual-specificity tyrosine-(Y)-phos 8211.965 6870 5987.39 7023.599 −4.56E−01 −2.57E−01 3 Unchanged High Q9NP97 C02ef8 dynein light chain 2A 4080.949 4160 5365.928 4534.283 3.95E−01 2.63E−02 3 Unchanged High Q15701 L08cd3 dynein; cytoplasmic; light polype

4492.679 5800 4332.161 4875.685 −5.25E−02 3.69E−01 3 Unchanged High P78545 O16ab4 E74-like factor 3 (ets domain tra

3781.196 2780 1455.944 2673.744 −1.38E+00 −4.42E−01 3 Unchanged High O60869 A03cd4 endothelial differentiation-related 5515.692 5680 4090.527 5094.856 −4.31E−01 4.19E−02 3 Unchanged High Q14259 L06ab4 enhancer of rudimentary homolo

3593.608 3950 5175.131 4241.036 5.26E−01 1.38E−01 3 Unchanged High P06733 C16ab4 enolase 1; (alpha) 12539.97 7460 9955.024 9983.774 −3.33E−01 −7.50E−01 3 Unchanged High P22712 D11gh6 enolase 1; (alpha) 6900.857 4290 5016.695 5403.444 −4.60E−01 −6.85E−01 3 Unchanged High P04720 O07ab6 eukaryotic translation elongation 36222.34 23200 23485.94 27648.74 −6.25E−01 −6.40E−01 3 Unchanged High P26641 A10ab4 eukaryotic translation elongation 6863.565 6540 11607.61 8337.901 7.58E−01 −6.91E−02 3 Unchanged High P13639 I15ab5 eukaryotic translation elongation 4023.855 2310 3360.073 3231.325 −2.60E−01 −8.01E−01 3 Unchanged High O15372 L24cd3 eukaryotic translation initiation fa

2870.027 1930 2391.869 2398.394 −2.63E−01 −5.70E−01 3 Unchanged High O75821 L22cd3 eukaryotic translation initiation fa

3009.075 2670 3333.728 3005.577 1.48E−01 −1.70E−01 3 Unchanged High Q64252 L11ab6 eukaryotic translation initiation fa

2755.438 1540 2127.874 2141.68 −3.73E−01 −8.38E−01 3 Unchanged High O15371 L18cd3 eukaryotic translation initiation fa

4273.919 4030 3558.848 3954.373 −2.64E−01 −8.46E−02 3 Unchanged High P04765 A22ab4 eukaryotic translation initiation fa

7716.222 7170 6363.169 7083.99 −2.78E−01 −1.05E−01 3 Unchanged High Q14240 H13ab4 eukaryotic translation initiation fa

2091.816 2190 2519.322 2267.015 2.68E−01 6.61E−02 3 Unchanged High P10159 A18ab5 eukaryotic translation initiation fa

9023.244 5240 5651.752 6638.65 −6.75E−01 −7.84E−01 3 Unchanged High Q9NQT4 H05gh4 exosome component Rrp46 2098.514 2590 2304.48 2331.056 1.35E−01 3.04E−01 3 Unchanged High P02794 C12ab6 ferritin; heavy polypeptide 1 35912.81 48700 42075.22 42243.59 2.28E−01 4.41E−01 3 Unchanged High P02792 M10ab3 ferritin; light polypeptide 44225.86 29600 17849.2 30568.13 −1.31E+00 −5.78E−01 3 Unchanged High Q05472 B02ab4 Finkel-Biskis-Reilly murine sarco 10322.94 10400 9704.642 10145.46 −8.91E−02 1.19E−02 3 Unchanged High P20071 F08ab3 FK506 binding protein 1A (12 kD) 2741.389 1870 1414.969 2009.291 −9.54E−01 −5.51E−01 3 Unchanged High P50395 J02ab4 GDP dissociation inhibitor 2 2287.713 1580 2291.27 2051.41 2.24E−03 −5.38E−01 3 Unchanged High P48507 E12ab5 glutamate-cysteine ligase; modi

154.1773 76.2 5937.375 2055.914 5.27E+00 −1.02E+00 3 Unchanged High P36969 D14ab5 glutathione peroxidase 4 (phosp

3397.2 4860 3108.036 3787.13 −1.28E−01 5.15E−01 3 Unchanged High P09211 L10ab3 glutathione S-transferase pi 6392.334 8670 4067.789 6378.198 −6.52E−01 4.40E−01 3 Unchanged High P04406 A01cd8 glyceraldehyde-3-phosphate deh

28809.37 38300 44655.67 37260.67 6.32E−01 4.11E−01 3 Unchanged High P04406 H12cd8 glyceraldehyde-3-phosphate deh

37562.25 60200 57135.41 51621.55 6.05E−01 6.80E−01 3 Unchanged High P04406 P12cd8 glyceraldehyde-3-phosphate deh

12053.5 14900 19061.62 15342.7 6.61E−01 3.07E−01 3 Unchanged High P43304 H01ab3 glycerol-3-phosphate dehydroge

3450.634 2340 3276.264 3023.392 −7.48E−02 −5.58E−01 3 Unchanged High P41250 F02ef7 glycyl-tRNA synthetase 4333.439 3630 6248.604 4736.632 5.28E−01 −2.56E−01 3 Unchanged High P04895 K17ef5 GNAS complex locus 7755.858 9290 9107.558 8718.93 2.32E−01 2.61E−01 3 Unchanged High P24522 B03ef6 growth arrest and DNA-damage-

2792.429 6130 3396.736 4105.138 2.83E−01 1.13E+00 3 Unchanged High Q92847 M24ab5 growth hormone secretagogue re

2827.902 2100 2597.123 2508.414 −1.23E−01 −4.29E−01 3 Unchanged High P04901 B01ef1 guanine nucleotide binding prote

5734.337 7610 5853.112 6398.85 2.96E−02 4.08E−01 3 Unchanged High P25388 E20cd6 guanine nucleotide binding prote

22430.28 15300 19055.7 18939.85 −2.35E−01 −5.49E−01 3 Unchanged High P06351 G08ab6 H3 histone; family 3B (H3.3B) 2448.264 2770 2042.864 2421.658 −2.61E−01 1.80E−01 3 Unchanged High P04792 A16ef5 heat shock 27 kD protein 1 41952.14 34500 31970.86 36135.19 −3.92E−01 −2.83E−01 3 Unchanged High P11021 H01ef1 heat shock 70 kD protein 5 (glucc

3226.183 1600 4101.742 2976.537 3.46E−01 −1.01E+00 3 Unchanged High P38646 O19ab7 heat shock 70 kD protein 9B (mor

2851.743 2180 2220.509 2417.791 −3.61E−01 −3.87E−01 3 Unchanged High Q9UK78 J14ef1 hematological and neurological

26342.33 35400 41099.58 34286.74 6.42E−01 4.27E−01 3 Unchanged High P09651 F12ab7 heterogeneous nuclear ribonucle

2522.253 1650 2524.082 2231.413 1.05E−03 −6.14E−01 3 Unchanged High Q9Y4J5 I23ef1 heterogeneous nuclear ribonucle

3825.912 2370 3770.457 3320.487 −2.11E−02 −6.94E−01 3 Unchanged High P09429 F10ab7 high-mobility group (nonhistone

2534.273 1660 3502.047 2567.093 4.67E−01 −6.06E−01 3 Unchanged High P49773 M03ef6 histidine triad nucleotide binding 6025.978 7790 7379.267 7064.436 2.92E−01 3.70E−01 3 Unchanged High Q92769 N05ab4 histone deacetylase 2 2454.324 2220 1789.508 2155.575 −4.56E−01 −1.43E−01 3 Unchanged High P17693 F08ab7 HLA-G histocompatibility antigen 2048.009 2780 1844.177 2225.106 −1.51E−01 4.42E−01 3 Unchanged High P17483 C15gh2 homeo box B4 2892.488 3490 2902.69 3095.004 5.08E−03 2.71E−01 3 Unchanged High Q9UL99 C01cd8 hyaluronoglucosaminidase 4 3623.461 2050 2189.656 2621.286 −7.27E−01 −8.21E−01 3 Unchanged High Q9GZT3 L18gh7 hypothetical protein DC50 3343.922 3750 4298.676 3797.943 3.62E−01 1.66E−01 3 Unchanged High Q9NWY5 O12gh2 hypothetical protein FLJ20533 3104.471 5460 6184.227 4915.419 9.94E−01 8.14E−01 3 Unchanged High Q9UI30 P08ef2 hypothetical protein HSPC152 3000.217 4060 4396.862 3819.313 5.51E−01 4.37E−01 3 Unchanged High Q9BQB6 P08gh5 hypothetical protein IMAGE3455: 3599.509 5410 8687.307 5897.337 1.27E+00 5.87E−01 3 Unchanged High Q9BWJ5 P18gh7 hypothetical protein MGC3133 2074.073 2520 2719.671 2436.767 3.91E−01 2.79E−01 3 Unchanged High Q9Y683 N11ef2 hypothetical protein MGC8721 2425.475 2730 2939.253 2699.545 2.77E−01 1.73E−01 3 Unchanged High Q16665 P01ef6 hypoxia-inducible factor 1; alpha 3544.753 2960 1526.935 2675.668 −1.22E+00 −2.62E−01 3 Unchanged High O75353 G04ef6 immediate early response 3 4564.408 4690 3129.721 4129.098 −5.44E−01 4.01E−02 3 Unchanged High Q16270 J15ab6 insulin-like growth factor binding 6185.622 21800 18047.34 15334.47 1.54E+00 1.82E+00 3 Unchanged High Q9Y287 A03gh2 integral membrane protein 2B 6908.997 10500 10014.47 9139.933 5.36E−01 6.03E−01 3 Unchanged High P56537 D16ab6 integrin beta 4 binding protein 2594.316 3270 1568.747 2476.062 −7.26E−01 3.32E−01 3 Unchanged High P26006 D08ab6 integrin; alpha 3 (antigen CD49C

2669.777 2740 1339.712 2249.026 −9.95E−01 3.62E−02 3 Unchanged High Q13907 A24ab7 Isopentenyl-diphosphate delta is

2958.139 1660 2475.365 2362.933 −2.57E−01 −8.38E−01 3 Unchanged High P33947 K03cd7 KDEL (Lys-Asp-Glu-Leu) endop

1667.246 1250 3924.993 2281.692 1.24E+00 −4.12E−01 3 Unchanged High P00338 D15ab7 lactate dehydrogenase A 44081.29 34500 42150.03 40260.24 −6.46E−02 −3.52E−01 3 Unchanged High P08865 G21ef7 laminin receptor 1 (6 7 kD; riboso

8548.245 6070 9921.409 8180.607 2.15E−01 −4.93E−01 3 Unchanged High Q08380 D17ab7 lectin; galactoside-binding; solub 2294.491 2850 3014.02 2719.794 3.94E−01 3.13E−01 3 Unchanged High O14949 F17ef3 low molecular mass ubiquinone-

2942.579 3550 3637.463 3377.305 3.06E−01 2.71E−01 3 Unchanged High Q15012 F20ef4 lysosomal-associated protein tra

2815.002 4690 5453.634 4319.567 9.54E−01 7.36E−01 3 Unchanged High P14174 J05ef7 macrophage migration Inhibitory 5544.722 6700 6763.718 6337.062 2.87E−01 2.74E−01 3 Unchanged High P49006 M05ef6 macrophage myristoylated alanir 5857.382 10400 8986.315 8400.725 6.17E−01 8.22E−01 3 Unchanged High P30463 G10ab6 major histocompatibility complex; 2701.757 4890 2255.929 3281.592 −2.60E−01 8.55E−01 3 Unchanged High P10321 A01cd2 major histocompatibility complex; 8949.086 17000 10196.88 12044.89 1.88E−01 9.25E−01 3 Unchanged High P10321 H12cd2 major histocompatibility complex; 7187.905 21600 11111.54 13298.19 6.28E−01 1.59E+00 3 Unchanged High P10321 P12cd2 major histocompatibility complex; 13121.35 16800 11725.68 13868.02 −1.62E−01 3.53E−01 3 Unchanged High P13747 M24ab7 major histocompatibility complex; 2540.911 2790 2053.351 2460.503 −3.07E−01 1.33E−01 3 Unchanged High Q95HC0 P02gh6 major histocompatibility complex; 5067.294 4140 3295.115 4168.835 −6.21E−01 −2.90E−01 3 Unchanged High P13640 D13gh6 metallothionein 1G 6180.376 4750 2940.683 4624.849 −1.07E+00 −3.79E−01 3 Unchanged High P80297 D17gh6 metallothionein 1X 4881.982 5310 5233.749 5142.996 1.00E−01 1.22E−01 3 Unchanged High P02795 L04ab7 metallothionein 2A 6620.235 7330 8067.274 7340.215 2.85E−01 1.48E−01 3 Unchanged High O14880 E04ab7 microsomal glutathione S-transfe 5023.542 7940 4177.165 5712.043 −2.66E−01 6.60E−01 3 Unchanged High Q9NYZ2 M22ef2 mitochondrial solute carrier 2488.07 2850 2240.824 2527.436 −1.51E−01 1.98E−01 3 Unchanged High P26038 K05ab7 moesin 4260.51 4580 3801.298 4212.427 −1.65E−01 1.03E−01 3 Unchanged High O15329 O12ef1 mucin 6; gastric 5574.093 5950 6685.047 6068.269 2.62E−01 9.31E−02 3 Unchanged High P16475 J02gh1 myosin; light polypeptide 6; alkal 48122.62 45200 48882.54 47407.02 2.26E−02 −8.99E−02 3 Unchanged High P19105 N03cd6 myosin; light polypeptide; regula

7920.873 8150 7228.401 7764.994 −1.32E−01 4.04E−02 3 Unchanged High Q9UK23 D06ef1 N-acetylglucosamine-1-phospho

1884.596 2680 2511.293 2357.087 4.14E−01 5.05E−01 3 Unchanged High O15239 E22ab7 NADH dehydrogenase (ubiquino

2859.738 5440 3719.503 4005.894 3.79E−01 9.27E−01 3 Unchanged High O00483 J02ab7 NADH dehydrogenase (ubiquino

5214.222 5540 9086.615 6613.046 8.01E−01 8.70E−02 3 Unchanged High O75438 J04ab8 NADH dehydrogenase (ubiquino

1628.024 2170 2842.647 2212.932 8.04E−01 4.13E−01 3 Unchanged High O95168 J08ab8 NADH dehydrogenase (ubiquino

2297.787 3270 2253.854 2607.423 −2.79E−02 5.09E−01 3 Unchanged High O95298 J12ab8 NADH dehydrogenase (ubiquino

1909.371 2840 2888.281 2544.679 5.97E−01 5.71E−01 3 Unchanged High O43920 J18ab8 NADH dehydrogenase (ubiquino

6241.135 11500 8014.187 8594.08 3.61E−01 8.85E−01 3 Unchanged High Q13765 H09ab7 nascent-polypeptide-associated

2800.535 3390 3897.956 3363.371 4.77E−01 2.76E−01 3 Unchanged High Q15843 K13cd1 neural precursor cell expressed; 3449.484 4710 4139.56 4098.747 2.63E−01 4.48E−01 3 Unchanged High Q9NX14 C01gh3 neuronal protein 17.3 3476.812 3150 5077.834 3902.8 5.46E−01 −1.41E−01 3 Unchanged High Q9Y2R6 F18gh6 NICE-3 protein 1763.974 2250 2329.521 2113.511 4.01E−01 3.49E−01 3 Unchanged High Q15668 H13cd6 Niemann-Pick disease; type C2 1516.592 3640 2828.255 2662.845 8.99−01 1.26E+00 3 Unchanged High O14597 J21ef4 non-functional folate binding pro

2917.293 2170 3004.012 2697.108 4.23E−02 −4.27E−01 3 Unchanged High P15531 E02ef5 non-metastatic cells 1; protein (N 6653.515 6940 7836.897 7143.349 2.36E−01 6.07E−02 3 Unchanged High P22392 L12cd2 non-metastatic cells 2; protein (N 4827.494 5680 4836.596 5114.664 2.72E−03 2.35E−01 3 Unchanged High O00746 D04ef7 non-metastatic cells 4; protein e

2211.058 2270 4300.604 2927.223 9.60E−01 3.80E−02 3 Unchanged High O75534 B01cd4 NRAS-related gene 3478.657 3510 2737.425 3241.269 −3.46E−01 1.20E−02 3 Unchanged High Q9H9A1 C24gh6 nuclear receptor co-repressor/H

5951.715 3290 2990.083 4076.544 −9.93E−01 −8.56E−01 3 Unchanged High Q9NPE3 K15ef4 nucleolar protein family A; memb 3543.239 7130 3639.205 4771.656 3.86E−02 1.01E+00 3 Unchanged High P54368 G10ef1 ornithine decarboxylase anlizym

7212.068 6880 7782.339 7292.818 1.10E−01 −6.72E−02 3 Unchanged High Q9UH52 L23cd8 over-expressed breast tumor pro 2335.527 2320 1884.264 2181.482 −3.10E−01 −6.73E−03 3 Unchanged High Q15070 A09cd1 oxidase (cytochrome c) assembly 2161.529 2500 1436.463 2031.796 −5.90E−01 2.08E−01 3 Unchanged High Q9H230 G14gh5 p53-induced protein PIGPC1 1823.554 3330 1443.914 2199.367 −3.37E−01 8.69E−01 3 Unchanged High O60356 M03cd8 p8 protein (candidate of metasta

1774.942 1940 2740.792 2150.631 6.27E−01 1.25E−01 3 Unchanged High P78337 M22ab8 paired-like homeodomain transcr 15428.96 13300 14490.63 14411.94 −9.05E−02 −2.12E−01 3 Unchanged High Q9C086 P20gh7 PAP-1 binding protein 2992.2 3610 5014.215 3872.969 7.45E−01 2.72E−01 3 Unchanged High Q15165 D06ef6 paraoxonase 2 1325.972 3740 2122.119 2394.717 6.78E−01 1.49E+00 3 Unchanged High P20962 N13ab8 parathymosin 2345.869 2330 3489.616 2722.317 5.73E−01 −8.88E−03 3 Unchanged High P23284 I17ab8 peptidylprolyl isomerase B (cyclo 5298.839 5860 8890.43 6683.166 7.47E−01 1.45E−01 3 Unchanged High Q06830 E18ab8 peroxiredoxin 1 2973.862 2450 2056.112 2493.75 −5.32E−01 −2.79E−01 3 Unchanged High P32119 G04ef7 peroxiredoxin 2 3141.718 3330 2921.471 3130.835 −1.05E−01 8.37E−02 3 Unchanged High P30048 N09ab2 peroxiredoxin 3 2420.936 2010 1671.796 2035.218 −5.34E−01 −2.66E−01 3 Unchanged High Q13162 N07ab2 peroxiredoxin 4 2744.707 2080 3645.718 2822.139 4.10E−01 −4.03E−01 3 Unchanged High P30044 P15cd7 peroxiredoxin 5 2205.14 3820 1714.041 2581.24 −3.63E−01 7.94E−01 3 Unchanged High Q13492 B13cd4 phosphatidylinositol binding clat

2688.917 2690 1861.508 2414.998 −5.31E−01 3.03E−03 3 Unchanged High P08237 P02ab7 phosphofructokinase; muscle 2790.708 1980 2829.743 2533.875 2.00E−02 −4.94E−01 3 Unchanged High P00558 P06ab7 phosphoglycerate kinase 1 5186.346 5130 6341.68 5552.736 2.90E−01 −1.57E−02 3 Unchanged High P18669 K14ab8 phosphoglycerate mutase 1 (brai 1847.463 2730 2859.446 2477.75 6.30E−01 5.61E−01 3 Unchanged High Q14801 B01cd8 phosphoprotein enriched in astrc 23286.56 17400 19729.36 20128.93 −2.39E−01 −4.23E−01 3 Unchanged High O14832 A04cd1 phytanoyl-CoA hydroxylase (Ref

7333.104 7780 8341.917 7819.036 1.86E−01 8.57E−02 3 Unchanged High P53801 L01ef1 pituitary tumor-transforming 1 int

4385.308 5330 4172.137 4627.881 −7.19E−02 2.80E−01 3 Unchanged High Q9HB21 E19gh5 pleckstrin homology domain-con

2318.08 3070 2907.381 2766.359 3.27E−01 4.07E−01 3 Unchanged High Q15365 O09cd1 poly(rC) binding protein 1 4617.635 3130 3156.644 3635.431 −5.49E−01 −5.60E−01 3 Unchanged High P52433 B17ab8 polymerase (RNA) II (DNA direct 2157.353 3780 3657.763 3198.285 −7.62E−01 8.09E−01 3 Unchanged High P52436 L16gh1 polymerase (RNA) II (DNA direct 2161.398 2600 2709.495 2489.343 3.26E−01 2.65E−01 3 Unchanged High Q03052 B19ab8 POU domain; class 3; transcripti

3321.206 2650 2251.677 2740.913 −5.61E−01 −3.26E−01 3 Unchanged High K20gh5 PP1201 protein 7127.293 6650 2688.636 5487.085 −1.41E+00 −1.01E−01 3 Unchanged High P40425 G08ab8 pre-B-cell leukemia transcription 2817.191 2650 3413.81 2958.976 −2.77E−01 −9.05E−02 3 Unchanged High Q99471 K06ab8 prefoldin 5 1827.777 2160 2837.334 2275.038 6.34E−01 2.41E−01 3 Unchanged High Q9UHZ2 E21ef8 PRO1073 protein 1872.208 3140 1690.101 2234.209 −1.48E−01 7.46E−01 3 Unchanged High P07737 A21cd1 profilin 1 29650.38 48900 35394.8 37970.06 2.55E−01 7.21E−01 3 Unchanged High Q92740 E03gh1 prosaposin (variant Gaucher dis

4235.232 5370 4268.459 4622.898 2.55E−01 3.41E−01 3 Unchanged High P07478 N02cd2 protease; serine; 2 (trypsin 2) 77359.27 42600 51746.68 57240.67 1.13E−02 −8.60E−01 3 Unchanged High Q9UL46 N09ab8 proteasome (prosome; macropa

3682.153 4550 2712.172 3648.995 −5.80E−01 3.06E−01 3 Unchanged High P25786 L09ef7 proteasome (prosome; macropa

2270.079 2570 2265.763 2369.437 −4.41E−01 1.80E−01 3 Unchanged High P20618 J17ab8 proteasome (prosome; macropa

2835.653 3590 2820.916 3082.003 −7.52E−03 3.40E−01 3 Unchanged High P49720 J21ab8 proteasome (prosome; macropa

1714.767 2100 2435.426 2081.991 5.06E−01 2.89E−01 3 Unchanged High P28070 J23ab8 proteasome (prosome; macropa

2193.138 1760 2224.325 2058.212 2.04E−02 −3.20E−01 3 Unchanged High Q99436 L03ab8 proteasome (prosome; macropa

4179.694 3450 3072.098 3566.368 −4.44E−01 −2.78E−01 3 Unchanged High Q15249 H13ef5 prothymosin; alpha (gene seque

11382.44 14500 9974.587 11954.68 −1.90E−01 3.50E−01 3 Unchanged High Q9NQ11 G03gh7 putative ATPase 2774.724 2460 2271.593 2501.162 −2.89E−01 −1.75E−01 3 Unchanged High P41567 N06cd5 putative translation initiation fact

7487.872 6600 8909.545 7666.779 2.51E−01 −1.81E−01 3 Unchanged High Q15181 L18gh1 pyrophosphatase (Inorganic) 4914.897 4350 2667.605 3978.537 −8.82E−01 −1.75E−01 3 Unchanged High P14788 M24ab8 pyruvate kinase; muscle 6305.222 8060 9000.504 7787.922 5.13E−01 3.54E−01 3 Unchanged High P57735 G12gh4 RAB25; member RAS oncogene 3343.628 4890 1366.379 3198.699 −1.29E+00 5.47E−01 3 Unchanged High P54725 E21cd1 RAD23 homolog A (S. cerevisiae 2533.36 1790 1753.113 2026.126 −5.31E−01 −5.00E−01 3 Unchanged High P54727 M10ef6 RAD23 homolog B (S. cerevisiae 4038.864 5410 4983.21 4809.132 3.03E−01 4.20E−01 3 Unchanged High O00538 P16cd5 RAS guanyl releasing protein 2 (

2418.688 2310 1906.199 2210.191 −3.44E−01 −6.90E−02 3 Unchanged High P06749 C21gh1 ras homolog gene family; memb

2136.708 1940 3003.841 2358.668 4.91E−01 −1.43E−01 3 Unchanged High P08134 B16ab2 ras homolog gene family; memb

4404.567 4490 2930.236 3943.029 −5.88E−01 2.91E−02 3 Unchanged High P06gh8 ras-like protein VTS58635 5451.542 6580 9066.798 7033.479 7.34E−01 2.72E−01 3 Unchanged High P15154 C01ef6 ras-related C3 botulinum toxin s

10849.13 9720 10044.19 10202.94 −1.11E−01 −1.59E−01 3 Unchanged High Q15347 B20cd6 Ras-related GTP-binding protein 1728.963 2380 2623.418 2244.978 6.02E−01 4.63E−01 3 Unchanged High O95197 A06cd6 reticuion 3 3712.756 3420 3833.411 3654.06 4.61E−02 −1.20E−01 3 Unchanged High P09455 F12ab8 retinol binding protein 1; cellular 2211.12 4480 2383.274 3023.27 1.08E−01 1.02E+00 3 Unchanged High P52565 K13ef6 Rho GDP dissociation inhibitor (

3166.04 3200 3141.434 3169.009 −1.13E−02 1.52E−02 3 Unchanged High P27635 N19cd2 ribosomal protein L10 13406.29 7100 11103.69 10536.25 −2.72E−01 −9.17E−01 3 Unchanged High P53025 G22cd1 ribosomal protein L10a 19374.73 15100 19939.26 18124.91 4.14E−02 −3.63E−01 3 Unchanged High P39026 D07cd1 ribosomal protein L11 14172.29 6760 10346.92 10427.07 −4.54E−01 −1.07E+00 3 Unchanged High P30050 D09cd1 ribosomal protein L12 38376.69 24500 38669.34 33860.13 1.10E−02 −6.45E−01 3 Unchanged High P40429 A01ef1 ribosomal protein L13a 23800.5 22200 28159.37 24735.85 2.43E−01 −9.73E−02 3 Unchanged High P50914 B18cd4 ribosomal protein L14 18507.36 14600 16108.18 16402.14 −2.00E−01 −3.43E−01 3 Unchanged High P39030 C13cd3 ribosomal protein L15 8407.532 8100 10809.12 9104.589 3.62E−01 −5.43E−02 3 Unchanged High P18621 D19cd1 ribosomal protein L17 8779.141 8440 10004.78 9074.168 1.89E−01 −5.71E−02 3 Unchanged High Q07020 D13cd1 ribosomal protein L18 12168.43 10200 15619.17 12658.45 3.60E−01 −2.56E−01 3 Unchanged High Q02543 C15gh1 ribosomal protein L18a 24976.59 27200 28170.19 26796.74 1.74E−01 1.25E−01 3 Unchanged High P14118 D15cd1 ribosomal protein L19 6226.589 5530 5535.643 5762.718 −1.70E−01 −1.72E−01 3 Unchanged High P46778 A13cd3 ribosomal protein L21 11156.59 11800 16742.21 13222.79 5.86E−01 7.72E−02 3 Unchanged High P35268 D17cd1 ribosomal protein L22 16289.45 16200 18991.35 17168.94 2.21E−01 −5.63E−03 3 Unchanged High P23131 F11cd4 ribosomal protein L23 20972.93 20400 25729.93 22356.23 2.95E−01 −4.24E−02 3 Unchanged High P29316 G09cd3 ribosomal protein L23a 6385.675 4840 5446.963 5556.302 −2.29E−01 −4.01E−01 3 Unchanged High P38663 D21cd1 ribosomal protein L24 7805.803 6180 5479.195 6488.503 −5.11E−01 −3.37E−01 3 Unchanged High P08526 F01cd1 ribosomal protein L27 12874.22 5280 10256.69 9469.252 −3.28E−01 −1.29E+00 3 Unchanged High P46776 F05cd1 ribosomal protein L27a 16046.37 17000 20949.85 18008.07 3.85E−01 8.57E−02 3 Unchanged High P46779 F07cd1 ribosomal protein L28 40540.59 32400 45810.52 39577.25 1.76E−01 −3.24E−01 3 Unchanged High P47914 E23cd3 ribosomal protein L29 3346.473 1960 1947.028 2417.223 −7.81E−01 −7.73E−01 3 Unchanged High P39023 B21cd1 ribosomal protein L3 13192.5 10500 13962.55 12535.38 8.18E−02 −3.36E−01 3 Unchanged High P04645 F03cd1 ribosomal protein L30 17693.61 12300 21530.83 17188.03 2.83E−01 −5.20E−01 3 Unchanged High P12947 F09cd1 ribosomal protein L31 9749.468 8980 12591.65 10441.63 3.69E−01 −1.18E−01 3 Unchanged High P02433 A15cd3 ribosomal protein L32 22774.44 24400 30742.77 25982.45 4.33E−01 1.01E−01 3 Unchanged High P49207 F11cd1 ribosomal protein L34 13251.1 11500 13193.66 12661.96 −6.27E−03 −1.99E−01 3 Unchanged High P42766 K16cd7 ribosomal protein L35 10454.27 10500 10655.65 10527.37 2.75E−02 2.47E−03 3 Unchanged High P18077 F13cd1 ribosomal protein L35a 14583.91 10700 8811.726 11356.13 −7.27E−01 −4.50E−01 3 Unchanged High P09896 J06gh1 ribosomal protein L36a 8395.644 8780 12052.18 9742.196 5.22E−01 8.44E−02 3 Unchanged High P09896 A19cd3 ribosomal protein L36a-like 5167.775 5750 4693.401 5203.379 −1.39E−01 1.54E−01 3 Unchanged High P02403 F15cd1 ribosomal protein L37 31895.4 45000 41301.54 39386.47 3.73E−01 4.95E−01 3 Unchanged High P12751 F17cd1 ribosomal protein L37a 18652.48 17300 19955.82 18651.98 9.74E−02 −1.05E−01 3 Unchanged High P23411 F19cd1 ribosomal protein L38 5149.82 5570 7560.21 6091.715 5.54E−01 1.12E−01 3 Unchanged High P02404 A17cd3 ribosomal protein L39 14114.05 21300 22827.16 19427.01 6.94E−01 5.96E−01 3 Unchanged High P36578 B23cd1 ribosomal protein L4 14367.47 10400 10448.85 11723.95 −4.59E−01 −4.72E−01 3 Unchanged High P28751 L06gh1 ribosomal protein L41 35135.75 34300 40372.62 36614.61 2.00E−01 −3.32E−02 3 Unchanged High P46777 E21cd3 ribosomal protein L5 12002.66 8880 10351.69 10411.06 −2.13E−01 −4.35E−01 3 Unchanged High Q02878 D01cd1 ribosomal protein L6 15861.7 7300 10119.01 11094.61 −6.48E−01 −1.12E+00 3 Unchanged High P18124 D03cd1 ribosomal protein L7 21230.67 15900 19538.32 18885.03 −1.20E−01 −4.18E−01 3 Unchanged High P11518 G11cd3 ribosomal protein L7a 13385.5 8240 10586.53 10736.39 −3.38E−01 −7.00E−01 3 Unchanged High P25120 D05cd1 ribosomal protein L8 23580.43 18300 24766.14 22208.81 7.08E−02 −3.67E−01 3 Unchanged High P32969 B19cd1 ribosomal protein L9 28853.42 32200 37288.41 32766.75 3.70E−01 1.56E−01 3 Unchanged High P46783 H13cd1 ribosomal protein S10 7453.342 7660 7511.766 7540.695 1.13E−02 3.89E−02 3 Unchanged High P04643 H15cd1 ribosomal protein S11 13429.85 15600 13623.52 14209.6 2.07E−02 2.14E−01 3 Unchanged High P25398 H17cd1 ribosomal protein S12 16170.73 10600 12294.27 13018.69 −3.95E−01 −6.11E−01 3 Unchanged High Q02546 H19cd1 ribosomal protein S13 13956.88 12600 15289.54 13946.74 1.32E−01 −1.48E−01 3 Unchanged High P11174 H21cd1 ribosomal protein S15 21322.73 19600 23334.6 21408.92 1.30E−01 −1.24E−01 3 Unchanged High P39027 H23cd1 ribosomal protein S15a 16787.1 15100 21854.01 17912.92 3.81E−01 −1.53E−01 3 Unchanged High P17008 J01cd1 ribosomal protein S16 26604.5 15700 24481.55 22257.3 −1.20E−01 −7.62E−01 3 Unchanged High P08708 J03cd1 ribosomal protein S17 13979.25 7990 15360.88 12443.09 1.36E−01 −8.07E−01 3 Unchanged High P25232 A17gh2 ribosomal protein S18 12558.18 12600 20093.07 15089.7 6.78E−01 6.84E−03 3 Unchanged High P17075 J07cd1 ribosomal protein S20 21944.13 19900 31381.43 24400.98 5.16E−01 −1.43E−01 3 Unchanged High P35265 D24ef7 ribosomal protein S21 14046.7 9470 9023.678 10847.43 −6.38E−01 −5.69E−01 3 Unchanged High P39028 J09cd1 ribosomal protein S23 12228.98 10900 14550.17 12545.6 2.51E−01 −1.72E−01 3 Unchanged High P16632 J11cd1 ribosomal protein S24 12913.37 13100 12135.49 12699.84 −8.96E−02 1.53E−02 3 Unchanged High P25111 J13cd1 ribosomal protein S25 6274.159 5630 5123.747 5677.337 −2.92E−01 −1.55E−01 3 Unchanged High P02383 C01cd3 ribosomal protein S26 26138.26 30900 19440.2 25499.92 −4.27E−01 2.42E−01 3 Unchanged High P42677 G01cd3 ribosomal protein S27 (metallop

17556.94 12800 20383.13 16927.4 2.15E−01 −4.51E−01 3 Unchanged High P14798 B18cd1 ribosomal protein S27a 3284.551 3180 2757.252 3073.17 −2.52E−01 −4.77E−02 3 Unchanged High P25112 J15cd1 ribosomal protein S28 30384.24 32000 28529.21 30318.47 −9.09E−02 7.66E−02 3 Unchanged High P30054 J17cd1 ribosomal protein S29 18454.55 20900 25539.27 21630.2 4.69E−01 1.79E−01 3 Unchanged High P23396 H03cd1 ribosomal protein S3 5913.682 2830 5523.561 4754.218 −9.85E−02 −1.07E+00 3 Unchanged High P49241 O16ef5 ribosomal protein S3A 7154.088 6200 8592.248 7316.667 2.64E−01 −2.06E−01 3 Unchanged High P12750 A21cd3 ribosomal protein S4; X-linked 19821.56 16200 21778.05 19282.5 1.36E−01 −2.87E−01 3 Unchanged High P22090 A23cd3 ribosomal protein S5; Y-linked 2629.697 2330 2779.184 2580.924 7.98E−02 −1.72E−01 3 Unchanged High P46782 H05cd1 ribosomal protein S5 15421.08 11000 17355.54 14598.96 1.70E−01 −4.85E−01 3 Unchanged High P10860 H07cd1 ribosomal protein S6 46408.18 26100 40579.46 37695.24 −1.94E−01 −8.30E−01 3 Unchanged High P46781 H12cd5 ribosomal protein S9 8827.416 9710 15295.98 11278.36 7.93E−01 1.38E−01 3 Unchanged High P46781 P12cd5 ribosomal protein S9 9059.523 1790 5725.082 5525.883 −6.62E−01 −2.34E+00 3 Unchanged High P05387 H01cd1 ribosomal protein; large P2 16611.14 12700 17775.72 15695.14 9.78E−02 −3.87E−01 3 Unchanged High P05388 F21cd1 ribosomal protein; large; P0 17127.41 12400 19746.88 16430.54 2.05E−01 −4.64E−01 3 Unchanged High P05386 F23cd1 ribosomal protein; large; P1 2228.298 1880 3134.529 2413.78 4.92E−01 −2.46E−01 3 Unchanged High Q9Y254 C08ef3 ring-box 1 2597.578 4260 3365.165 3408.892 3.74E−01 7.15E−01 3 Unchanged High Q9NWJ8 A23gh3 roundabout homolog 4; magic

1969.602 3940 2093.279 2666.66 8.79E−02 9.99E−01 3 Unchanged High P08206 D06cd1 S100 calcium binding protein A1

38485.73 49800 31745.47 40017.88 −2.78E−01 3.72E−01 3 Unchanged High P31949 E09cd3 S100 calcium binding protein A1

8890.594 11100 5408.269 8466.714 −7.17E−01 3.20E−01 3 Unchanged High P06703 P17gh6 S100 calcium binding protein A6 3403.146 4070 2088.478 3188.753 −7.04E−01 2.60E−01 3 Unchanged High P55735 J04ef4 SEC 13-like 1 (S. cerevisiae) 1695.152 1990 2362.541 2016.062 4.79E−01 2.32E−01 3 Unchanged High P38384 I06ef3 Sec61 gamma 5653.955 7820 7254.423 6908.432 3.60E−01 4.67E−01 3 Unchanged High Q9NZJ3 H06ef2 selenoprotein T 2923.813 2440 1325.491 2230.091 −1.14E+00 −2.60E−01 3 Unchanged High O15532 H16cd1 selenoprotein W; 1 2678.843 2970 3918.44 3189.642 5.49E−01 1.50E−01 3 Unchanged High Q13501 J23cd4 sequestosome 1 3214.395 3170 1164.17 2517.543 −1.47E+00 −1.82E−02 3 Unchanged High P35237 L18ab8 serine (or cysteine) proteinase in 4203.074 8180 2936.72 5105.477 −5.17E−01 9.60E−01 3 Unchanged High P05121 P05ef7 serine (or cysteine) proteinase in 4454.56 7280 9179.863 6972.284 1.04E+00 7.09E−01 3 Unchanged High Q00587 C14cd7 serum constituent protein 2480.698 2660 2044.608 2393.46 −2.79E−01 9.80E−02 3 Unchanged High Q9H299 P16gh7 SH3 domain binding glutamic aci 14473.6 17100 13798.02 15134.74 −6.90E−02 2.43E−01 3 Unchanged High P37108 E21cd2 signal recognition particle 14 kD ( 24326.27 35600 24319.59 28082.56 −3.96E−04 5.49E−01 3 Unchanged High P49458 E19cd2 signal recognition particle 9 kD 1874.967 2640 3141.422 2551.928 7.45E−01 4.93E−01 3 Unchanged High P43308 G15cd2 signal sequence receptor; beta (

4209.147 4810 5876.451 4898.581 4.81E−01 1.31E−01 3 Unchanged High P51571 O15gh1 signal sequence receptor; delta ( 2062.113 2330 2654.968 2349.29 3.65E−01 1.77E−01 3 Unchanged High O00422 M17cd6 sin3-associated polypeptied; 18 k 2502.79 2610 2079.295 2396.002 −2.67E−01 5.83E−02 3 Unchanged High O75918 J10cd5 small EDRK-rich factor 2 5927.595 7010 7926.059 6955.245 4.19E−01 2.42E−01 3 Unchanged High P13500 C15cd3 small inducible cytokine A2 (mon 17077.97 38100 8786.323 21330.26 −9.59E−01 1.16E+00 3 Unchanged High Q15356 A09cd2 small nuclear ribonucleoprotein

2743.428 2150 2819.855 2570.901 3.96E−02 −3.52E−01 3 Unchanged High P14648 A13cd2 small nuclear ribonucleoprotein

899.6242 2800 2362.597 2021.429 1.39E+00 1.64E+00 3 Unchanged High P12236 G01ef1 solute carrier family 25 (mitochor 7384.066 4760 6176.034 6107.995 −2.58E−01 −6.32E−01 3 Unchanged High Q00325 K22ab8 solute carrier family 25 (mitochor 5074.308 3750 3779.577 4200.626 −4.25E−01 −4.37E−01 3 Unchanged High P32745 N01cd1 somatostalin receptor 3 4102.668 4170 4748.989 4340.964 2.11E−01 2.39E−02 3 Unchanged High P30626 E13cd2 sorcin 1895.592 2790 2280.297 2323.149 2.67E−01 5.59E−01 3 Unchanged High Q01826 F18ef6 special AT-rich sequence bindin

26449.32 41300 24225.61 30645.09 −1.27E−01 6.42E−01 3 Unchanged High P21673 D12cd1 spermidine/spermine N1-acetylin 8349.882 16500 6013.659 10275.93 −4.74E−01 9.80E−01 3 Unchanged High P34991 G05cd3 S-phase kinase-associated prote 3072.601 2990 2396.506 2820.643 −3.59E−01 −3.80E−02 3 Unchanged High P23246 B09cd2 splicing factor proline/glutamine

2694.629 2460 3348.423 2834.056 3.13E−01 −1.32E−01 3 Unchanged High P35716 C07cd2 SRY (sex determining region Y)-

5019.988 4860 2125.089 4001.241 −1.24E+00 −4.71E−02 3 Unchanged High P35713 E10ef4 SRY (sex determining region Y)-

2575.791 3100 2024.386 2565.998 −3.48E−01 2.66E−01 3 Unchanged High Q06945 C05cd2 SRY (sex determining region Y)-

2299.474 2210 1636.067 2049.214 −4.91E−01 −5.59E−02 3 Unchanged High P00441 G20ef7 superoxide dismutase 1; soluble 4439.342 4930 3239.195 4202.954 −4.55E−01 1.51E−01 3 Unchanged High P50502 I18cd2 suppression of tumorigenicity 13 2307.599 2530 2358.117 2400.085 3.12E−02 1.35E−01 3 Unchanged High Q9Y5Y6 P20gh1 suppression of tumorigenicity 14 2358.28 2700 1494.856 2183.041 −6.58E−01 1.93E−01 3 Unchanged High P17600 J06cd2 synapsin I 1969.157 2220 2010.908 2067.417 3.03E−02 1.74E−01 3 Unchanged High O43759 G11cd5 synaptogyrin 1 14516.6 10700 10060.61 11775.53 −5.29E−01 −4.33E−01 3 Unchanged High Q12962 P19cd2 TAF10 RNA polymerase II; TATA 5937.255 5080 3962.323 4992.528 −5.83E−01 −2.26E−01 3 Unchanged High Q15763 B20cd2 t-complex-associated-testis-expn 2022.997 2890 2885.017 2600.459 5.12E−01 5.16E−01 3 Unchanged High P10599 B23cd4 thioredoxin 11525.16 11900 6440.37 9965.777 −8.40E−01 5.00E−02 3 Unchanged High P13472 O02ef7 thymosin; beta 10 46982.91 74300 54263.48 58508.68 2.08E−01 6.61E−01 3 Unchanged High P01253 L12gh1 thymosin; beta 4; X chromosome 23145.54 26000 16231.51 21783.42 −5.12E−01 1.66E−01 3 Unchanged High Q01085 C02cd2 TIA1 cytotoxic granule-associate 2250.456 1770 2917.342 2312.231 3.74E−01 −3.47E−01 3 Unchanged High Q15370 J12cd2 transcription elongation factor B

2616.595 3980 3919.327 3505.384 5.83E−01 6.05E−01 3 Unchanged High O43680 O11cd2 transcription factor 21 1789.295 1790 3044.118 2209.014 7.67E−01 3.49E−03 3 Unchanged High P21980 O16cd2 transglutaminase 2 (C polypeptid 3131.079 3490 1857.596 2827.774 −7.53E−01 1.58E−01 3 Unchanged High P29401 N15cd1 transkelolase (wernicke-Korsak

3258.575 2040 2715.206 2671.504 −2.63E−01 −6.75E−01 3 Unchanged High O60739 O01cd6 translation factor sui 1 homolog 2671.935 3400 3868.727 3315.099 5.34E−01 3.50E−01 3 Unchanged High Q9NS69 I02gh7 translocase of outer mitochondri

2988.423 2450 3754.914 3062.809 3.29E−01 −2.89E−01 3 Unchanged High P00938 M24cd1 triosephosphate isomerase 1 5701.29 5820 8345.738 6622.243 5.50E−01 2.97E−02 3 Unchanged High P07226 G10cd2 tropomyosin 4 2636.256 2300 3755.882 2897.509 5.11E−01 −1.97E−01 3 Unchanged High P04687 F09cd4 tubulin; alpha 3 20220.03 14500 22303.88 18992.31 1.42E−01 −4.84E−01 3 Unchanged High P04687 A01cd1 tubulin; beta; ubiquitous 15258.81 7840 22478.65 15193.76 5.59E−01 −9.60E−01 3 Unchanged High Q13509 E04cd6 tubulin; beta; 4 2338.877 2990 1853.273 2394.89 −3.36E−01 3.56E−01 3 Unchanged High P04350 F01gh6 tubulin; beta; 5 7573.765 4430 3448.455 5149.498 −1.14E+00 −7.75E−01 3 Unchanged High O75347 O08cd2 tubulin-specific chaperone a 3000.065 3900 3275.629 3390.719 1.27E−01 3.77E−01 3 Unchanged High O75509 L10ef3 tumor necrosis factor receptor su 2245.338 4890 1881.231 3007.078 −2.55E−01 1.12E+00 3 Unchanged High P13693 G16cd2 tumor protein; translationally-con 39878.18 60800 48468.25 49731.11 2.61E−01 6.10E−01 3 Unchanged High P14625 G24cd2 tumor rejection antigen (gp96) 1 2185.187 2060 4905.342 3049.346 1.17E+00 −8.69E−02 3 Unchanged High P42655 K04cd4 tyrosine 3-monooxygenase/trypt

6584.565 5730 5558.974 5956.713 −2.44E−01 −2.01E−01 3 Unchanged High Q04917 G06cd3 tyrosine 3-monooxygenase/trypt

8621.322 8150 4562.366 7111.932 −9.18E−01 −8.07E−02 3 Unchanged High P29312 A01cd4 tyrosine 3-monooxygenase/trypt

5873.282 4670 2279.148 4275.506 −1.37E+00 −3.29E−01 3 Unchanged High P29312 P12cd4 tyrosine 3-monooxygenase/trypt

4562.964 1140 1520.2 2406.497 −1.59E+00 −2.01E+00 3 Unchanged High O14957 G17cd7 ubiquinol-cytochrome c reductas 2728.765 3990 3332.422 3351.45 2.88E−01 5.49E−01 3 Unchanged High P14793 D01cd4 ubiquitin A-52 residue ribosomal 3536.225 1730 3258.439 2840.732 −1.18E−01 −1.03E+00 3 Unchanged High P02248 D22gh1 ubiquitin B 2753.942 4430 4152.235 3779.352 5.92E−01 6.86E−01 3 Unchanged High O76069 B12cd4 ubiquitin-conjugating enzyme E2 2001.262 1980 2223.574 2068.646 1.52E−01 −1.46E−02 3 Unchanged High Q9BZL1 B17gh7 ubiquitin-like 5 4339.474 9100 5279.835 6239.513 2.83E−01 1.07E+00 3 Unchanged High P08670 C24cd3 vimentin 5940.876 8720 17783.4 10813.94 1.58E+00 5.53E−01 3 Unchanged High P45880 C18cd3 voltage-dependent anion channe 7005.537 7280 4758.179 6347.014 −5.58E−01 5.49E−02 3 Unchanged High Q9Y277 C04cd4 voltage-dependent anion channe 1863.424 2210 2573.885 2216.75 4.66E−01 2.48E−01 3 Unchanged High P17861 O15cd4 X-box binding protein 1 3398.445 1600 2040.224 2347.333 −7.36E−01 −1.08E+00 3 Unchanged High O43670 M04cd3 zinc finger protein 207 3338.117 3170 3176.631 3226.643 −7.15E−02 −7.67E−02 3 Unchanged High Q07352 N21ef6 zinc finger protein 36; C3H type-I 6097.384 5750 4958.224 5601.518 −2.98E−01 −8.49E−02 3 Unchanged High Q15942 M10cd3 zyxin 2570.21 2070 2519.748 2387.987 −2.86E−02 −3.09E−01 3 Unchanged High Q16659 B17ef5 mitogen-activated protein kinase 144.6425 141 100.0111 128.6073 −5.32E−01 −3.51E−02 1 Unchanged Low O75324 B05cd3 stannin 131.7242 172 100.0655 134.7009 −3.97E−01 3.88E−01 1 Unchanged Low Q9BYP8 E16gh8 keratin associated protein 17.1 176.4958 174 100.1011 150.0893 −8.18E−01 −2.33E−02 1 Unchanged Low P55291 J01ab4 cadherin 15; M-cadherin (myotut 158.7215 128 100.3297 128.8583 −6.62E−01 −3.16E−01 1 Unchanged Low P49768 L14ab7 presenilin 1 (Alzheimer disease

127.9653 124 100.3504 117.5823 −3.51E−01 −4.04E−02 1 Unchanged Low P55107 G10ab5 growth differentiation factor 10 114.7206 168 100.6326 127.9343 −1.89E−01 5.54E−01 1 Unchanged Low P17082 P18cd7 related RAS viral (r-ras) oncoger 433.219 176 100.8465 236.7776 −2.10E+00 −1.30E+00 1 Unchanged Low P23634 N08ab2 ATPase; Ca++ transporting; plas 179.3836 276 100.9041 185.4081 −8.30E−01 6.21E−01 1 Unchanged Low P78347 J20ab5 general transcription factor II;

151.6834 103 100.9514 118.6963 −5.87E−01 −5.52E−01 1 Unchanged Low P09912 F08ef7 Interferon; alpha-Inducible protein 183.6419 1050 101.0749 444.3716 −8.61E−01 2.51E+00 1 Unchanged Low Q9H2F5 F13gh7 enhancer of polycomb 1 127.3938 115 101.3763 114.5773 −3.30E−01 −1.48E−01 1 Unchanged Low O14811 M06cd7 programmed cell death 10 152.3457 132 101.598 128.8019 −5.85E−01 −2.02E−01 1 Unchanged Low O60942 A17cd4 RNA guanylyltransferase and 5

176.7836 97.1 101.6765 125.1735 −7.98E−01 −8.65E−01 1 Unchanged Low Q9Y5Y3 M18cd7 G protein-coupled receptor 45 174.3335 161 101.8478 145.8365 −7.75E−01 −1.12E−00 1 Unchanged Low P11908 H15ab8 phosphoribosyl pyrophosphate s

166.1373 174 101.9334 147.2722 −7.05E−01 6.46E−02 1 Unchanged Low Q92851 P18ab3 caspase 10; apoptosis-related cy

135.919 107 101.9435 115.0308 −4.15E−01 −3.42E−01 1 Unchanged Low Q9BQE5 M03gh7 apolipoprotein L; 2 109.8196 148 102.0533 119.8218 −1.06E−01 4.26E−01 1 Unchanged Low P55327 D05cd2 tumor protein D52 136.2596 112 102.1111 116.9522 −4.16E−01 −2.77E−00 1 Unchanged Low P28332 K03ab2 alcohol dehydrogenase 6 (class

142.4055 97.7 102.1575 114.0924 −4.79E−01 −5.43E−01 1 Unchanged Low O95861 E02cd6 3′(2′); 5′-bisphosphate nucleotid

128.1251 116 102.1715 115.4153 −3.27E−01 −1.44E−01 1 Unchanged Low Q9NXJ5 A10gh2 hypothetical protein FLJ20208 122.4219 151 102.3038 125.322 −2.59E−01 3.05E−01 1 Unchanged Low Q15642 K09gh1 thyroid hormone receptor interac 120.9158 142 102.3082 121.6641 −2.41E−01 2.30E−01 1 Unchanged Low O94997 O09cd7 decidual protein induced by prog 174.3087 140 102.3137 138.8592 −7.69E−01 −3.17E−01 1 Unchanged Low O95453 G02ab8 poly(A)-specific ribonuclease (de 139.9344 105 102.3217 115.7147 −4.52E−01 −4.16E−01 1 Unchanged Low Q9H9C5 F01gh7 KIAA1453 protein 135.8299 126 102.4347 121.5247 −4.07E−01 −1.05E−01 1 Unchanged Low P10451 B13cd1 secreted phosphoprotein 1 (oster 190.4604 76.7 102.5193 123.2388 −8.94E−01 −1.31E+00 1 Unchanged Low P53992 B03cd5 SEC24 related gene family; mem 134.307 105 102.5437 113.9998 −3.89E−01 −3.53E−01 1 Unchanged Low Q9NQW1 F22gh6 secretory pathway component Se

111.3643 158 102.6234 123.8833 −1.18E−01 5.02E−01 1 Unchanged Low Q01449 A17gh5 myosin light chain 2a 179.1031 170 103.0725 150.5611 −7.97E−01 −7.94E−02 1 Unchanged Low Q9NX46 K12gh2 hypothetical protein FLJ20446 109.5374 159 103.1083 123.8664 −8.73E−02 5.37E−01 1 Unchanged Low P53609 A23cd1 protein geranyigeranyltransferas

140.0296 128 103.1248 123.8135 −4.41E−01 −1.28E−01 1 Unchanged Low Q15029 J16cd4 U5 snRNP-specific protein; 116

119.3284 126 103.1503 115.9932 −2.10E−01 7.28E−02 1 Unchanged Low P50458 O23cd5 LIM homeobox protein 2 145.905 120 103.1971 122.9669 −5.00E−01 −2.84E−01 1 Unchanged Low P33764 B24cd1 S100 calcium binding protein A3 150.5991 204 103.3783 152.5858 −5.43E−01 4.36E−01 1 Unchanged Low Q9P289 G03ef3 Mst3 and SOK1-related kinase 133.5225 116 103.4345 117.7841 −3.68E−01 −1.98E−01 1 Unchanged Low P52429 P17cd3 diacylglycerol kinase; epsilon (64 128.7238 123 103.5015 118.2956 −3.15E−01 −6.96E−02 1 Unchanged Low P54578 H17cd5 ubiquitin specific protease 14 (tR 160.7495 108 103.6864 124.2132 −6.33E−01 −5.71E−01 1 Unchanged Low Q13219 E24ab8 pregnancy-associated plasma p

112.9052 154 103.7948 123.4254 −1.21E−01 4.44E−01 1 Unchanged Low O60547 M12ab5 GDP-mannose 4; 6-dehydratase 147.2805 108 103.8044 119.8044 −5.05E−01 −4.43E−01 1 Unchanged Low P23297 I17ef6 S100 calcium binding protein A1 145.2558 126 103.9033 124.9008 −4.83E−01 −2.10E−01 1 Unchanged Low Q9H5J8 M01gh8 hypothetical protein MGC5306 216.091 91.7 104.0432 137.2762 −1.05E+00 −1.24E+00 1 Unchanged Low Q14493 I08cd4 stem-loop (histone) binding protein 126.7755 155 104.1318 128.4702 −2.84E−01 2.85E−01 1 Unchanged Low Q9NZU0 O16cd8 fibronectin leucine rich transmerr 284.9107 268 104.3033 219.1816 −1.45E+01 −8.65E−02 1 Unchanged Low P80370 B01ef7 delta-like 1 homolog (Drosophila 160.1421 80 104.328 114.8185 −6.18E−01 −1.00E+00 1 Unchanged Low Q9NYV4 C23ef3 CDC2-related protein kinase 7 128.5947 107 104.3521 113.4542 −3.01E−01 −2.60E−01 1 Unchanged Low P09016 C23ef5 homeo box D4 173.2254 192 104.3556 156.5829 −7.31E−01 1.50E−01 1 Unchanged Low Q13873 A16ab3 bone morphogenetic protein rece

155.8113 86.8 104.4206 115.6624 −5.77E−01 −8.45E−01 1 Unchanged Low O14878 B22ef4 inosine triphosphatase (nucleos

124.8814 120 104.4238 116.398 −2.58E−01 −5.89E−02 1 Unchanged Low P52848 J01ab6 N-deacetylase/N-sulfotransferase

166.2411 84.4 104.4555 118.3793 −6.70E−01 −9.77E−01 1 Unchanged Low Q14848 A05cd5 TNF receptor-associated factor 4 124.2461 136 104.4604 121.4689 −2.50E−01 1.27E−01 1 Unchanged Low O00204 O04cd2 sulfotransferase family; cytosolic 185.8106 117 104.4824 135.653 −8.31E−01 −6.71E−01 1 Unchanged Low P35610 E13gh1 sterol O-acyltransferase (acyl-Cc 143.8417 88 104.5518 112.1404 −4.60E−01 −7.08E−01 1 Unchanged Low Q04760 L03ab5 glyoxalase I 132.6871 107 104.5782 114.7132 −3.43E−01 −3.12E−01 1 Unchanged Low P51690 H06ab2 arylsulfatase E (chondrodysplasi 177.023 76.2 104.5865 119.2772 −7.59E−01 −1.22E+00 1 Unchanged Low P26012 C11ef7 integrin; beta B 110.7396 170 104.6296 128.4899 −8.19E−02 6.19E−01 1 Unchanged Low Q14978 K11cd5 nucleolar and coiled-body phosp 117.0048 131 104.685 117.4911 −1.61E−01 1.61E−01 1 Unchanged Low O00764 D16cd3 pyridoxal (pyridoxine; vitamin B6 160.2678 140 104.6915 135.073 −6.14E−01 −1.92E−01 1 Unchanged Low Q9Y6Q5 P13cd5 adaptor-related protein complex 149.3929 107 104.7705 120.3004 −5.12E−01 −4.85E−01 1 Unchanged Low O95350 G04cd5 Homer; neuronal immediate early 137.2833 126 104.7829 122.6314 −3.90E−01 −1.26E−01 1 Unchanged Low P49748 C13ab2 acyl-Coenzyme A dehydrogenase 121.151 141 104.7897 122.4441 −2.09E−01 2.23E−01 1 Unchanged Low P08100 O24cd1 rhodopsin (opsin 2; rod pigment) 125.3282 116 104.8101 115.4338 −2.58E−01 −1.10E−01 1 Unchanged Low Q15477 F24cd2 superkiller virallcidic activity 2-like 102.5551 186 104.8138 131.0636 3.14E−02 8.58E−01 1 Unchanged Low O43520 I17cd1 ATPase; Class I; type 8B; memb

199.1157 91.5 104.8252 131.8072 −9.26E−01 −1.12E+00 1 Unchanged Low O13039 P02ef4 ATP-binding cassette; sub-family 175.7841 80.5 104.8585 120.383 −7.45E−01 −1.13E+00 1 Unchanged Low O15291 L12cd1 solute carrier family 7 (cationic a

276.3689 176 104.904 185.7368 −1.40E+00 −6.52E−01 1 Unchanged Low Q9NR71 L23gh4 mitochondrial ceramidase 108.9644 152 104.9361 122.091 −5.43E−02 4.84E−01 1 Unchanged Low O60884 H10cd4 DnaJ (Has40) homolog; subfamily 221.9835 239 104.9441 188.5763 −1.08E+00 1.05E−01 1 Unchanged Low Q9BYE0 J17gh8 hairy and enhancer of split 7 (Dr

128.0255 108 104.9542 113.8134 −2.87E−01 −2.39E−01 1 Unchanged Low Q9Y272 L01ef2 RAS; dexamethasone-induced 1 101.2051 166 104.9825 124.0354 5.29E−02 7.13E−01 1 Unchanged Low Q9BUR5 M13gh8 hyphothetical protein MGC4825 78.2636 239 105.0137 140.65 4.24E−01 1.61E+00 1 Unchanged Low O60859 A13cd7 neuropathy target esterase 123.9707 117 105.029 115.3513 −2.39E−01 −8.28E−02 1 Unchanged Low Q9GZU1 A20gh4 mucolipin 1 85.32301 243 105.1039 144.4516 3.01E−01 1.51E+00 1 Unchanged Low P19878 B15ab6 neutrophil cytosolic factor 2 (65id 310.5103 515 105.1041 310.3051 −1.56E+00 7.31E−01 1 Unchanged Low Q13277 K12cd2 syntaxin 3A 118.5375 185 105.2511 136.1937 −1.72E−01 6.41E−01 1 Unchanged Low B04gh8 reserved 130.849 124 105.2594 120.0361 −3.14E−01 −7.76E−02 1 Unchanged Low P32456 N18ab4 guanyiate binding protein 2; inter 109.3786 142 105.2611 118.8515 −5.54E−02 3.76E−01 1 Unchanged Low Q9H4M9 E01cd7 EH-domain containing 1 149.0051 151 105.3893 134.9992 −5.00E−01 1.54E−02 1 Unchanged Low Q9BTX7 O19gh6 chromosome 20 open reading fra

115.9099 157 105.4128 126.203 −1.37E−01 4.40E−01 1 Unchanged Low Q9NVN2 M02gh3 solute carrier family 4 (anion exc

123.8178 114 105.466 114.476 −2.31E−01 −1.17E−01 1 Unchanged Low Q99758 A17ab2 ATP-binding cassette; sub-family 238.456 145 105.5504 163.1362 −1.18E+00 −7.14E−01 1 Unchanged Low P43694 B06ef6 GATA binding protein 4 107.7539 161 105.5891 124.6996 −2.93E−02 5.77E−01 1 Unchanged Low Q13825 C07ab3 AU RNA binding protein/enoyi-C

123.4494 140 105.6272 123.0884 −2.25E−01 1.83E−01 1 Unchanged Low Q92550 L23ef3 ring finger protein 10 197.4603 112 105.7052 138.2365 −9.02E−01 −8.24E−01 1 Unchanged Low Q9UJS0 C12ef3 solute carrier family 25; member 119.1806 139 105.8216 121.1782 −1.72E−01 2.17E−01 1 Unchanged Low Q99611 O05ef3 seleriophosphate synthetase 2 168.8742 128 105.8955 134.292 −6.73E−01 −3.99E−01 1 Unchanged Low P17275 F08ab6

un B proto-oncogene 135.9478 94.9 105.9141 112.2701 −3.60E−01 −5.18E−01 1 Unchanged Low Q13477 B09cd4 mucosal vascular addressin cell 127.8352 110 105.9239 114.7415 −2.71E−01 −2.11E−01 1 Unchanged Low P50991 H09cd6 chaperonin containing TCP1; su

181.4396 148 106.0337 138.5813 −6.06E−01 −1.23E−01 1 Unchanged Low P35548 K11ab7 msh homeo box homolog 2 (Dro

182.4309 124 106.057 137.5011 −7.83E−01 −5.57E−01 1 Unchanged Low P11309 M14ab8 pim-1 oncogene 136.3951 99 106.0757 113.8227 −3.63E−01 −4.62E−01 1 Unchanged Low O75570 A03cd5 mitochondrial transiational relea

128.9238 118 106.1208 117.597 −2.81E−01 −1.31E−01 1 Unchanged Low Q9NY61 O01ef3 apoplosis antagonizing transcrip

120.3605 124 106.1404 116.8527 −1.81E−01 4.36E−02 1 Unchanged Low Q9BTY8 D01gh7 hypothetical protein MGC4342 139.5304 92.9 106.2168 112.876 −3.94E−01 −5.87E−01 1 Unchanged Low Q9NWS2 F09gh2 hypothetical protein FLJ20640 183.0823 140 106.2384 143.0354 −7.85E−01 −3.89E−01 1 Unchanged Low O00180 H06ab6 potassium channel; subfamily K; 129.4915 122 106.2703 119.3824 −2.85E−01 −8.14E−02 1 Unchanged Low O15382 I05ab3 branched chain aminotransferas

136.8391 95.5 106.3058 112.8868 −3.64E−01 −5.19E−01 1 Unchanged Low Q9Y2Z1 D05ef2 CGI-01 protein 156.4563 196 106.3369 153.067 −5.57E−01 3.28E−01 1 Unchanged Low Q9Y315 E18ef2 CGI-26 protein 135.7793 111 106.6662 117.8557 −3.48E−01 −2.89E−01 1 Unchanged Low Q9Y592 P20ef1 NY-REN-58 antigen 118.6541 121 106.7049 115.3792 −1.53E−01 2.56E−02 1 Unchanged Low Q9NYT0 D20ef3 pleckstrin 2 (mouse) homolog 114.999 153 106.7508 124.8364 −1.07E−01 4.10E−01 1 Unchanged Low Q9Y343 M10ef4 SBBI31 protein 123.0625 120 106.8362 116.6438 −2.04E−01 −3.60E−02 1 Unchanged Low Q9BVI4 G09gh8 hypothetical protein MGC3162 140.5988 123 106.8523 123.6298 −3.96E−01 −1.88E−01 1 Unchanged Low P30622 B20cd1 restin (Reed-Steinberg cell-expr

116.8074 136 107.0013 119.7985 −1.27E−01 2.15E−01 1 Unchanged Low Q08345 F08ef5 discoidin domain receptor family; 266.6468 264 107.136 212.6497 −1.32E+00 −1.35E−02 1 Unchanged Low P33176 C16ab7 kinesin family member 5B 123.5679 113 107.2314 114.5075 −2.05E−01 −1.33E−01 1 Unchanged Low P55273 D14ab4 cyclin-dependent kinase inhibitor 99.64375 174 107.4234 126.8971 1.08E−01 8.01E−01 1 Unchanged Low Q9NW92 E10gh3 hypothetical protein FLJ10209 177.1237 166 107.454 150.3287 −7.21E−01 −9.00E−02 1 Unchanged Low Q9NZC3 K03ef3 membrane interacting protein of

105.8303 152 107.465 121.8015 2.21E−02 5.23E−01 1 Unchanged Low P15172 M19ab7 myogenic factor 3 132.7839 110 107.4694 116.7347 −3.05E−01 −2.72E−01 1 Unchanged Low P27144 A06ab2 adenylate kinase 3 118.5733 124 107.5998 116.7128 −1.40E−01 6.42E−02 1 Unchanged Low O60508 A06ef2 pre-mRNA splicing factor 17 150.1968 130 107.6187 129.259 −4.81E−01 −2.09E−01 1 Unchanged Low Q14012 B08cd3 calcium/calmodulin-dependent p

113.9231 135 107.6204 118.8965 −8.21E−02 2.46E−01 1 Unchanged Low P98179 G12cd1 RAN binding motif protein 3 140.1356 93.2 107.7553 113.6891 −3.79E−01 −5.89E−01 1 Unchanged Low Q13223 E10ab5 BRF1 homolog; subunit of RNA

150.0469 115 107.7567 124.3969 −4.78E−01 −3.79E−01 1 Unchanged Low P55198 N09ab7 myeloid/lymphoid or mixed-linear

180.7113 122 107.7762 136.7788 −7.46E−01 −5.69E−01 1 Unchanged Low P46459 G02ef1 N-ethylmaleimide-sensitive facto

138.9363 95.7 107.8044 114.1635 −3.66E−01 −5.37E−01 1 Unchanged Low P34969 I21ef1 5-hydroxytryptamine (serotonin)

218.7666 181 107.8181 169.3507 −1.02E+00 −2.70E−01 1 Unchanged Low Q14667 K02gh1 KIAA0100 gene product 105.9471 222 107.8612 145.1883 2.58E−02 1.07E+00 1 Unchanged Low Q92830 J14cd8 GCN5 general control of amino-

129.4527 106 107.863 114.5758 −2.63E−01 −2.83E−01 1 Unchanged Low P14cd2 RNA binding motif protein; Y chr

112.3917 153 107.9125 124.4395 −5.87E−02 4.45E−01 1 Unchanged Low O43252 J01cd5 3′-phosphoadenosine 5′-phosph

194.4946 188 107.9154 163.4169 −8.50E−01 −5.02E−02 1 Unchanged Low Q9NS93 G09ef3 seven transmembrane protein T

138.0932 237 107.9483 160.8518 −3.55E−01 7.76E−01 1 Unchanged Low O60618 E20ab8 core-binding factor; runt domain; 489.0924 48.1 107.9969 215.0608 −2.81E+00 −3.35E+00 1 Unchanged Low P02261 D19cd4 H2A histone family; member C 145.0821 84.1 108.023 112.4051 −4.26E−01 −7.87E−01 1 Unchanged Low Q14701 F18ef7 DNA cross-link repair 1A (PSO2 119.2486 307 108.208 178.2467 −1.40E−01 1.37E+00 1 Unchanged Low Q9P025 A04ef8 HSPC135 protein 160.3109 135 108.2493 134.6437 −5.67E−01 −2.44E−01 1 Unchanged Low P06702 O12ef7 S100 calcium binding protein A9 144.7319 163 108.2576 138.5985 −4.19E−01 1.70E−01 1 Unchanged Low Q9Y5Q9 P05cd7 general transcription factor IIIC;

138.644 220 108.3524 155.7377 −3.56E−01 6.68E−01 1 Unchanged Low p19075 O20cd2 transmembrane 4 superfamily m

129.5468 103 108.6355 113.7491 −2.54E−01 −3.30E−01 1 Unchanged Low O60905 B16cd4 sperm associated antigen 9 110.7683 139 108.6913 119.4574 −2.73E−02 3.27E−01 1 Unchanged Low Q13322 F24ef5 growth factor receptor-bound pro 120.8593 115 106.7182 114.7351 −1.53E−01 −7.64E−02 1 Unchanged Low Q9UQ09 L01gh1 KIAA0470 gene product 190.3667 103 108.9005 134.0152 −8.06E−01 −8.89E−01 1 Unchanged Low P57053 J20gh6 H2B histone family; member S 113.6057 199 108.9238 140.5964 −6.07E−02 8.11E−01 1 Unchanged Low Q92878 J03ab8 kallikrein 6 (neurosin; zyme) 197.2979 130 108.9308 145.5667 −8.57E−01 −5.97E−01 1 Unchanged Low P09960 F21ab6 leukotriene A4 hydrolase 96.36818 185 109.0526 130.2822 1.78E−01 9.44E−01 1 Unchanged Low Q9HBH1 O02gh5 peptide deformylase-like protein 138.0653 91 109.0612 112.7249 −3.40E−01 −6.01E−01 1 Unchanged Low P55082 L15ab7 microfibrillar-associated protein

121.4467 124 109.134 118.1545 −1.54E−01 2.87E−02 1 Unchanged Low Q9NVH6 B01gh3 trimethyllysine hydroxylase; epsil 174.7559 81.6 109.1442 121.828 −6.79E−01 −1.10E+00 1 Unchanged Low O95249 K10cd5 golgi SNAP receptor complex m

107.5878 143 109.1657 119.983 2.10E−02 4.12E−01 1 Unchanged Low Q13891 M15ab8 basic transcription factor 3; like 2 126.6543 120 109.1942 118.5076 −2.14E−01 −8.18E−02 1 Unchanged Low Q9BZM5 H05gh7 UL16 binding protein 2 133.6731 245 109.2193 162.5485 −2.91E−01 8.73E−01 1 Unchanged Low O94913 O20ef2 PCF11p homolog 205.6752 80.3 109.2409 131.7517 −9.13E−01 −1.36E+00 1 Unchanged Low Q12987 E03ef4 acidic 82 kDa protein mRNA 132.1136 117 109.4318 119.3623 −2.72E−01 −1.81E−01 1 Unchanged Low Q92499 D05ab5 DEAD/H (Asp-Glu-Ala-Asp/His)

176.6983 124 109.4356 136.6656 −6.91E−01 −5.13E−01 1 Unchanged Low Q13688 B19ab2 alkylation repair; alkB homolog 105.5169 143 109.4797 119.4385 5.32E−02 4.42E−01 1 Unchanged Low P43250 I08ab4 G protein-coupled receptor kinas 120.3579 113 109.4844 114.2814 −1.37E−01 −9.10E−02 1 Unchanged Low Q9UMX0 L03ef4 ubiquilin 1 122.0111 141 109.5522 124.0398 −1.55E−01 2.04E−01 1 Unchanged Low O94905 G12cd7 chromosome 8 open reading fra

127.8659 107 109.6202 114.8261 −2.22E−01 −2.57E−01 1 Unchanged Low Q9UHK0 K01cd8 nuclear fragile X mental retardat

157.4757 87.6 109.6296 118.2396 −5.22E−01 −8.46E−01 1 Unchanged Low P25189 D01ab6 myelin protein zero (Charcot-Ma

110.5502 132 109.6859 117.3068 −1.13E−02 2.52E−01 1 Unchanged Low Q10567 M11ab2 adaptor-related protein complex 208.9283 187 109.8204 168.4738 −9.28E−01 −1.62E−01 1 Unchanged Low O15230 D18cd8 laminin; alpha 5 11.864 141 109.8469 120.9363 −2.63E−02 3.35E−01 1 Unchanged Low P52294 J10ab6 karyopherin alpha 1 (Importin alc 178.7513 169 109.9831 152.7331 −7.01E−01 −7.70E−02 1 Unchanged Low O60668 M03cd2 TAF2 RNA polymerase II; TATA 123.6244 111 110.0571 114.8794 −1.68E−01 −1.56E−01 1 Unchanged Low P11686 J02cd1 surfactant; pulmonary-associate

136.0267 117 110.0847 121.0017 −3.05E−01 −2.19E−01 1 Unchanged Low Q9NWB6 P03gh2 hypothetical protein FLJ10154 174.7789 75 110.1306 119.9579 −6.66E−01 −1.22E+00 1 Unchanged Low Q9H028 E22gh8 histone deacetylase 10 107.5034 138 110.1585 118.4626 3.52E−02 3.57E−01 1 Unchanged Low Q9UMZ2 O22cd7 AP1 gamma subunit binding prot 120.2821 119 110.2219 116.5628 −1.26E−01 −1.32E−02 1 Unchanged Low P24752 C15ab2 acetyl-Coenzyme A acetyltransfe 216.1409 114 110.2562 146.8035 −9.71E−01 −9.23E−01 1 Unchanged Low P11230 B06ab3 chollnergic receptor; nicotinic; be 106.1774 151 110.2999 122.607 5.50E−02 5.11E−01 1 Unchanged Low O14977 O18ef2 ornithine decarboxylase antizym

119.9172 129 110.3 119.7626 −1.21E−01 1.06E−01 1 Unchanged Low E15ef5 T cell receptor beta locus 139.7091 844 110.3287 364.6946 −3.41E−01 2.59E+00 1 Unchanged Low P56937 N06ef2 hydroxysteroid (17-beta) dehydr

227.1137 74.5 110.3428 137.3284 −1.04E+00 −1.61E+00 1 Unchanged Low O75299 B21ab7 kinesin family member C3 113.15 128 110.3535 117.1803 −3.61E−02 1.78E−01 1 Unchanged Low P16219 C09ab2 acyl-Coenzyme A dehydrogenase 109.4688 136 110.3636 118.69 1.17E−02 3.16E−01 1 Unchanged Low Q9NZ48 J20gh3 uncharacterized hematopoletic s

112.5665 189 110.3995 137.2614 −2.80E−02 7.46E−01 1 Unchanged Low Q9P163 L10gh4 hypothetical protein PRO2521 101.1317 159 110.4184 123.4514 1.27E−01 6.51E−01 1 Unchanged Low Q9BVT8 I07gh8 hypothetical protein MGC5442 135.5302 137 110.5044 127.7419 −2.95E−01 1.76E−02 1 Unchanged Low Q99933 E02ef6 BCL2-associated athanogene 119.7332 115 110.533 115.0469 −1.15E−01 −5.98E−02 1 Unchanged Low O14645 M12cd3 dynein; axonernal; light intermed

164.1806 207 110.5493 160.4204 −5.71E−01 3.31E−01 1 Unchanged Low Q9BRR9 E01gh8 Rho GTPase activating protein 9 120.3646 115 110.5606 115.1711 −1.23E−01 −7.10E−02 1 Unchanged Low Q9Y3E7 J19ef2 CGI-149 protein 158.4397 202 110.6074 157.1807 −5.18E−01 3.54E−01 1 Unchanged Low P46976 C09ab6 glycogenin 127.6502 117 110.6815 118.5706 −2.06E−01 −1.21E−01 1 Unchanged Low O75928 C01cd5 Protein Inhibitor of activated STA 98.84393 173 110.7286 127.4786 1.64E−01 8.06E−01 1 Unchanged Low Q9NX63 I18gh2 hypothetical protein FLJ20420 123.3725 159 110.8068 131.146 −1.55E−01 3.68E−01 1 Unchanged Low Q9UBS0 I20cd2 ribosomal protein S6 kinase; 70 k 186.953 155 110.8188 150.9199 −7.54E−01 −2.71E−01 1 Unchanged Low Q15185 F18cd6 unactive progesterone receptor;

169.4269 72.3 110.8534 117.54 −6.12E−01 −1.23E+00 1 Unchanged Low O60516 J18cd3 eukaryotic translation Initiation fa 104.3739 147 110.9085 120.8526 8.76E−02 4.97E−01 1 Unchanged Low Q16651 J01ab8 protease; serine; B (prostasin) 334.0498 125 110.9253 190.1399 −1.59E+00 −1.41E+00 1 Unchanged Low P48788 E22cd2 troponin I; skeletal; fast 121.3602 110 110.9357 114.1376 −1.30E−01 −1.40E−01 1 Unchanged Low Q01968 N06ab7 oculocerebrorenal syndrome of L 169.0079 95.9 110.9507 125.3025 −6.07E−01 −8.17E−01 1 Unchanged Low Q9H6Z6 L11gh7 hypothetical protein FLJ21628 115.1546 126 111.0337 117.2667 −5.26E−02 1.25E−01 1 Unchanged Low Q9NQ55 B01gh4 peter pan homolog (Drosophila) 122.449 120 111.0627 117.676 −1.41E−01 −3.50E−02 1 Unchanged Low O95359 A24gh1 transforming; acidic colled-coil c

108.2194 139 111.0999 119.4624 3.79E−02 3.62E−01 1 Unchanged Low P01189 I15ab8 proopiomelanocortin (adrenocort 145.0634 90.4 111.1389 115.5442 −3.84E−01 −6.82E−01 1 Unchanged Low Q9Y525 G13cd8 v-maf musculoaponeurotic fibros

119.023 141 111.1934 123.6546 −9.82E−02 2.42E−01 1 Unchanged Low Q9UHC9 L09cd8 NPC1 (Niemann-Pick disease; ty 107.7403 138 111.3741 118.9021 4.79E−02 3.53E−01 1 Unchanged Low Q9HBT2 P14gh7 hypothetical protein PP1057 147.5097 98 111.4385 118.9743 −4.05E−01 −5.90E−01 1 Unchanged Low O00219 M22ef1 hyaluronan synthase 3 224.5087 89 111.4539 141.641 −1.01E+00 −1.34E+00 1 Unchanged Low P22735 M16cd1 transglutaminase 1 (K polypeptid 136.8808 91 111.5589 113.1407 −2.95E−01 −5.89E−01 1 Unchanged Low O15388 A11ab4 stalic acid binding Ig-like lectin 6 105.2847 147 111.6016 121.3043 8.41E−02 4.82E−01 1 Unchanged Low O95389 J01cd4 WNT1 inducible signalling pathw

134.8825 94 111.6123 113.4959 −2.73E−01 −5.21E−01 1 Unchanged Low Q06190 D21ab8 protein phosphatase 2 (formerity: 134.6973 102 111.6192 116.2494 −2.69E−01 −3.98E−01 1 Unchanged Low P50226 C03cd3 sulfotransferase family; cytosolic 147.6874 101 111.8328 120.0792 −4.01E−01 −5.52E−01 1 Unchanged Low Q16632 N10ab5 general transcription factor IIIC;

120.7982 116 111.85 116.1383 −1.11E−01 −6.14E−02 1 Unchanged Low P54762 A24ef7 EohB1 107.3397 168 111.8669 129.1191 5.96E−02 6.48E−01 1 Unchanged Low Q15269 E15cd1 PWP2 periodic tryptophan protei 125.0688 107 111.8713 114.654 −1.61E−01 −2.25E−01 1 Unchanged Low O14495 H10cd3 phosphatidic acid phosphatase

120.761 109 111.9087 113.9808 −1.10E−01 −1.44E−01 1 Unchanged Low Q9P0U0 N24ef3 PC326 protein 152.5639 101 111.9543 121.9267 −4.47E−01 −5.91E−01 1 Unchanged Low P50120 J02ab8 retinol binding protein 2; cellular 231.806 217 111.9639 187.0028 −1.05E+00 −9.36E−02 1 Unchanged Low Q9UHR0 D08gh1 G protein-coupled receptor kinas 111.83 151 111.9778 124.9147 1.91E−03 4.33E−01 1 Unchanged Low Q13977 A12ef1 cerebellar degeneration-related

105.2052 180 112.0477 132.4319 9.09E−02 7.75E−01 1 Unchanged Low P51692 C18cd8 signal transducer and activator o 126.7779 100 112.0645 112.9412 −1.78E−01 −3.43E−01 1 Unchanged Low P51164 N12ab2 ATPase; H+/K+ exchanging; bet

136.4695 112 112.2007 120.3347 −2.82E−01 −2.81E−01 1 Unchanged Low Q9NXH3 C02gh2 protein phosphatase 1; regulator 113.3081 127 112.2521 117.6836 −1.35E−01 1.70E−01 1 Unchanged Low C04gh7 ER to nucleus signalling 2 112.9203 125 112.2701 116.8658 −8.33E−03 1.51E−01 1 Unchanged Low P16435 G16ef6 P450 (cytochrome) oxidoreducta

110.2003 132 112.2899 118.227 2.71E−02 2.62E−01 1 Unchanged Low E05gh6 hypothetical protein MGC5338 116.1511 137 112.3522 121.7814 −4.80E−02 2.36E−01 1 Unchanged Low Q02080 L03ab7 MADS box transcription enhance 138.6124 100 112.3745 117.0502 −3.03E−01 −4.69E−01 1 Unchanged Low Q15334 J06ab7 lethal giant larvae homolog 1 (Dr 123.3076 110 112.3893 115.3049 −1.34E−01 −1.62E−01 1 Unchanged Low P10636 J13ab7 microtubule-associated protein

115.8818 142 112.4092 123.46 −4.39E−02 2.94E−01 1 Unchanged Low Q9Y4J6 A01gh2 zinc finger protein 6 (CMPX1) 138.8767 102 112.4376 117.8247 −3.05E−01 −4.43E−01 1 Unchanged Low Q9UHY7 P18gh4 E-1 enzyme 108.9217 134 112.5485 118.5336 4.73E−02 3.00E−01 1 Unchanged Low Q14147 K04gh1 DEAD/H (Asp-Glu-Ala-Asp-/His)

117.5358 119 112.7866 116.4348 −5.95E−02 1.76E−02 1 Unchanged Low O95880 N06gh4 KIAA1513 protein 168.2097 104 112.9115 128.5046 −5.75E−01 −6.88E−01 1 Unchanged Low Q15013 J23ef3 gene predicted from cDNA with a 104.556 198 113.0807 138.5918 1.13E−01 9.22E−01 1 Unchanged Low Q9P1E2 E01gh4 hypothetical protein PRO2219 138.6039 107 113.1066 119.6869 −2.93E−01 −3.69E−01 1 Unchanged Low P07203 H23ef1 glutathione peroxidase 1 120.5127 114 113.1788 115.8519 −9.06E−02 −8.19E−02 1 Unchanged Low Q13206 M07ab5 DEAD/H (Asp-Glu-Ala-Asp/His)

140.5274 92.5 113.1804 115.4153 −3.12E−01 −6.03E−01 1 Unchanged Low O15085 L15ef3 Rho guanine nucleotide exchang 121.8405 111 113.2492 115.3055 −1.05E−01 −1.37E−01 1 Unchanged Low P48426 C07cd1 phosphatidylinositol-4-phosphate 232.9191 163 113.2533 169.6778 −1.04E−00 −5.16E−01 1 Unchanged Low Q9NRQ2 K20gh4 phospholipid scramblase 4 126.2397 116 113.2849 118.4782 −1.56E−01 −1.23E−01 1 Unchanged Low O43171 B24cd3 CDC14 cell division cycle 14 hon 126.784 113 113.382 117.8862 −1.61E−01 −1.60E−01 1 Unchanged Low Q9HB90 M02gh5 Rag C protein 132.9037 136 113.4299 127.5658 −2.29E−01 3.71E−02 1 Unchanged Low Q9H733 I21gh5 single Ig IL-1R-related molecule 113.5449 137 113.4753 121.334 −8.84E−04 2.71E−01 1 Unchanged Low P43353 C06ab2 aldehyde dehydrogenase 3 famil 141.7651 101 113.5244 118.734 −3.21E−01 −4.90E−01 1 Unchanged Low Q15053 G14gh1 KIAA0040 gene product 111.1705 146 113.5775 123.496 3.09E−02 3.91E−01 1 Unchanged Low P22301 H01ef7 Interleukin 10 174.8595 108 113.5877 132.021 −6.22E−01 −7.00E−01 1 Unchanged Low Q9BW47 N12gh5 chromosome 20 open reading fr

125.8289 154 113.6231 131.1841 −1.47E−01 2.92E−01 1 Unchanged Low P21917 M03ab8 dopamine receptor D4 158.6974 151 113.7899 141.2355 −4.80E−01 −6.96E−02 1 Unchanged Low Q9Y6K5 M19cd1 2′-5′-oligoadenylate synthetase 3 127.2648 142 113.9993 127.6931 −1.59E−01 1.56E−01 1 Unchanged Low Q9Y2A4 N22cd5 Kruppel-type zinc finger (C2H2) 136.0849 133 114.1396 127.5854 −2.54E−01 −3.82E−02 1 Unchanged Low Q16880 A16cd3 UDP glycosyltransferase 8 (UDP 112.9309 133 114.1612 119.9407 1.56E−02 2.33E−01 1 Unchanged Low O95747 D09cd5 oxidative-stress responsive 1 113.39 123 114.2384 116.7318 1.08E−02 1.12E−01 1 Unchanged Low P25108 L12ef4 G protein-coupled receptor 100.7123 147 114.2482 120.5368 1.82E−01 5.42E−01 1 Unchanged Low H23ab6 Immunoglbulin superfamily; me

102.6971 145 114.3219 120.6924 1.55E−01 4.98E−01 1 Unchanged Low P45984 L18ef5 mitogen-activated protein kinase 139.4168 88 114.3405 113.914 −2.86E−01 −6.64E−01 1 Unchanged Low Q9NPF7 I03ef3 Interleukin 23; alpha subunit p19 98.83593 182 114.4153 131.5891 2.11E−01 8.77E−01 1 Unchanged Low Q9UH94 L07cd8 prolactin regulatory element bind 140.4102 106 114.4158 120.3231 −2.95E−01 −4.04E−01 1 Unchanged Low Q16559 F05cd2 T-cell acute lymphocytic leukem

131.4974 111 114.5482 118.9991 −1.99E−01 −2.45E−01 1 Unchanged Low Q9UGH0 C02cd8 solute carrier family 17 (auion/su 98.73308 158 114.6616 123.6748 2.16E−01 6.75E−01 1 Unchanged Low Q15544 J13cd2 TAF11 RNA polymerase II; TATA 117.4634 123 114.6792 118.4317 −3.46E−02 6.82E−02 1 Unchanged Low O00628 N24ab7 peroxisomal biogenesis factor 7 156.16 96.9 114.7281 122.588 −4.45E−01 −6.89E−01 1 Unchanged Low O43241 F07ab5 golgi autoantigen; golgin subfam 123.9421 104 114.8381 114.422 −1.10E−01 −2.46E−01 1 Unchanged Low Q9Y6N1 M14ab4 COX11 homolog; cytochrome c c 127.1203 100 114.8993 114.0678 −1.46E−01 −3.44E−01 1 Unchanged Low Q9UHX5 O01ef4 HT002 protein; hypertension-rela 98.26523 155 114.9242 122.8348 2.26E−01 6.60E−01 1 Unchanged Low Q01664 A02cd2 transcription factor AP-4 (activati 268.3453 68.7 115.0377 150.0321 −1.22E+00 −2.01E+00 1 Unchanged Low Q9BUI1 O03gh6 leukocyte receptor cluster (LRC) 112.2417 125 115.039 117.3611 3.55E−02 1.53E−01 1 Unchanged Low Q9HBL5 M17gh4 AD023 protein 103.9999 137 115.0443 118.5457 1.46E−01 3.93E−01 1 Unchanged Low Q9NXV2 N08gh2 hypothetical protein FLJ20040 126.6647 147 115.1386 129.6462 −1.38E−01 2.16E−01 1 Unchanged Low Q15424 D08cd1 scaffold attachment factor B 134.9613 92.7 115.1845 114.2781 −2.29E−01 −5.42E−01 1 Unchanged Low P26440 F06ab6 Isovaleryl Coenzyme A dehydrog 178.7093 115 115.2412 136.2534 −6.33E−01 −6.38E−01 1 Unchanged Low O60264 J11cd3 SWI/SNF related; matrix associa 105.7775 132 115.2498 117.7402 1.24E−01 3.22E−01 1 Unchanged Low Q15286 K07cd7 RAB35; member RAS oncogene 138.2768 183 115.3443 145.6 −2.62E−01 4.06E−01 1 Unchanged Low Q9UGK0 I10ef4 DIPB protein 303.2745 172 115.4096 196.7868 −1.39E+00 −8.21E−01 1 Unchanged Low Q92980 J06cd5 putative protein similar to nessy

142.089 181 115.4166 146.2003 −3.00E−01 3.50E−01 1 Unchanged Low Q99726 M06cd3 solute carrier family 30 (zinc tran 112.8008 121 115.4854 116.3247 3.39E−02 9.75E−02 1 Unchanged Low P01111 O17ab8 neuroblastoma RAS viral (v-ras) 123.6283 108 115.5932 115.8629 −9.70E−02 −1.80E−01 1 Unchanged Low Q92574 G13cd3 tuberous scierosis 1 109.8519 128 115.7107 117.8303 7.50E−02 2.20E−01 1 Unchanged Low P16106 C01gh7 H3 histone family; member I 134.9364 118 115.868 122.8016 −2.20E−01 −1.98E−01 1 Unchanged Low Q9NWX5 O24gh2 hypothetical protein FLJ20548 118.1581 112 115.9919 115.5043 −2.67E−02 −7.26E−02 1 Unchanged Low Q9Y687 M05ab3 adaptor-related protein complex

217.8572 170 116.0173 168.0108 −9.09E−01 −3.57E−01 1 Unchanged Low Q9Y4F1 J04cd5 FERM; RhoGEF (ARHGEF) and 108.6215 130 116.0342 118.0819 9.52E−02 2.55E−01 1 Unchanged Low Q06710 M14cd3 paired box gene 8 120.1357 129 116.1006 121.7541 −4.93E−02 1.03E−01 1 Unchanged Low Q9H6N1 J17gh5 hypothetical protein FLJ22056 214.4909 242 116.2509 190.8582 −8.84E−01 1.73E−01 1 Unchanged Low Q9NSY1 K09gh3 homolog of mouse BMP-2 Inducil 111.9034 123 116.2514 117.0914 5.50E−02 1.38E−01 1 Unchanged Low Q14106 H20cd6 transducer of ERBB2; 2 117.9634 134 116.2536 122.8358 −2.11E−02 1.87E−01 1 Unchanged Low Q9UK11 B02ef4 zinc finger protein 223 119.1221 133 116.2873 122.8322 −3.47E−02 1.60E−01 1 Unchanged Low P08069 O17ef6 insulin-like growth factor 1 recep

106.3434 178 116.3103 133.4883 1.29E−01 7.42E−01 1 Unchanged Low Q9H6F5 I21gh6 hypothetical protein MGC2574 120.5097 112 116.3129 116.1638 −5.11E−02 −1.10E−01 1 Unchanged Low Q14373 O04ab3 galactose-1-phosphate uridylyltt

157.7476 231 116.3555 168.3955 −4.39E−01 5.51E−01 1 Unchanged Low P20393 G04ef5 nuclear receptor subfamily 1; gro 107.1138 138 116.4228 120.571 1.20E−01 3.67E−01 1 Unchanged Low P36915 O01ab5 guanine nucleotide binding prote 120.9306 111 116.4819 116.2706 −5.41E−02 −1.18E−01 1 Unchanged Low O95109 G02cd8 chromosome 20 open reading fr

143.5728 103 116.5321 121.0452 −3.01E−01 −4.79E−01 1 Unchanged Low Q9NVS2 I24gh3 mitochondrial ribosomal protein

117.9573 124 116.6011 119.5497 −1.67E−02 7.31E−02 1 Unchanged Low Q92950 B08cd6 CUG triplet repeat; RNA binding 109.8876 129 116.7366 118.6125 8.72E−02 2.34E−01 1 Unchanged Low Q14977 C04ab7 SP110 nuclear body protein 107.0969 158 116.8973 127.3783 1.26E−01 5.62E−01 1 Unchanged Low P16105 O04gh6 H3 histone family; member A 94.76745 159 116.9796 123.5385 3.04E−01 7.45E−01 1 Unchanged Low Q9Y3C1 N18ef2 hypothetical protein HSPC111 145.1935 164 117.0185 141.934 −3.11E−01 1.72E−01 1 Unchanged Low P37287 C11ef1 phosphatidylinositol glycan; clas

132.5354 109 117.2467 119.4716 −1.77E−01 −2.87E−01 1 Unchanged Low Q9UIG5 G05ef4 SEEK1 protein 102.5149 148 117.279 122.443 1.94E−01 5.25E−01 1 Unchanged Low Q9UNE2 G15cd6 rabphilin 3A-like (without C2 dorr 110.3023 123 117.2874 117.0111 8.86E−02 1.62E−01 1 Unchanged Low Q14123 A17cd1 phosphodiesterase 1C; calmodul 121.3078 132 117.3754 123.5304 −4.75E−02 1.21E−01 1 Unchanged Low Q16206 P03ab2 cytosolic ovarian carcinoma anti

116.5183 157 117.4492 130.1671 1.15E−02 4.26E−01 1 Unchanged Low Q9NWT1 D21gh2 hypothetical protein FLJ20624 116.0517 116 117.4816 116.4708 1.77E−02 −2.15E−03 1 Unchanged Low Q12756 C05ab3 axonal transport of synaptic vesi

138.4398 232 117.5489 162.7767 −2.36E−01 7.47E−01 1 Unchanged Low P28288 B10ab8 ATP-binding cassette; sub-family 140.4464 95.9 117.5959 117.9674 −2.56E−01 −5.51E−01 1 Unchanged Low P05198 G08ab5 eukaryotic translation initiation fa

115.5074 119 117.6033 117.2266 2.59E−02 3.77E−02 1 Unchanged Low Q9H0V9 D08gh7 hypothetical protein DKFZp564L

128.832 101 117.6689 115.9248 −1.31E−01 −3.47E−01 1 Unchanged Low Q92984 M10ef1 interferon-induced protein 35 258.0737 221 117.8182 198.9799 −1.13E+00 −2.23E−01 1 Unchanged Low O95498 A13cd5 vanin 2 109.7731 123 117.8273 116.8572 1.02E−01 1.64E−01 1 Unchanged Low Q9H1E1 J01gh8 ribonuclease 7 109.332 131 117.8377 119.4295 1.08E−01 2.62E−01 1 Unchanged Low Q9NV88 H01gh3 hypothetical protein FLJ10871 108.5849 125 117.8411 117.172 1.18E−01 2.04E−01 1 Unchanged Low Q9Y310 F06cd6 SnRNP assembly defective 1 ho

119.9305 113 117.8563 117.0556 −2.52E−02 −8.10E−02 1 Unchanged Low P48382 O06cd1 regulatory factor X; 5 (influences 191.5142 122 118.0773 143.9771 −6.98E−01 −6.47E−01 1 Unchanged Low P52738 K04cd3 zinc finger protein 140 (clone pH 136.6586 154 118.1501 136.2205 −2.10E−01 1.71E−01 1 Unchanged Low Q9NRW1 G23ef3 RAB6B; member RAS oncogene 100.578 179 118.1659 132.4668 2.32E−01 8.29E−01 1 Unchanged Low O15298 A02ab3 basic leucine zipper nuclear fact

266.9887 110 118.2062 165.1797 −1.18E+00 −1.27E+00 1 Unchanged Low Q9NUN5 D14gh3 hypothetical protein FLJ11240 114.5392 116 118.2691 116.1573 4.62E−02 1.41E−02 1 Unchanged Low Q07699 L03cd1 sodium channel; voltage-gated;

116.5431 113 118.3239 115.8757 2.19E−02 −4.76E−02 1 Unchanged Low P27701 F10ab6 kangal 1 (suppression of tumorig 116.2761 108 118.3881 114.2624 2.60E−02 −1.05E−01 1 Unchanged Low Q9UER5 O02ef3 TNF-induced protein 104.9755 131 118.4653 118.2694 1.74E−01 3.24E−01 1 Unchanged Low Q8TAC6 I24gh7 chromosome 11 open reading fr

117.4257 138 118.5887 124.5089 1.42E−02 2.28E−01 1 Unchanged Low Q9NRW9 K16gh4 angiotensin II; type I receptor-as

136.6357 105 118.6777 120.1901 −2.03E−01 −3.76E−01 1 Unchanged Low O95147 O15cd7 dual specificity phosphatase 14 181.9968 200 118.7007 166.9415 −6.17E−01 1.37E−01 1 Unchanged Low Q13895 A19ef7 bystin-like 108.0232 124 118.7967 116.9004 1.37E−01 1.98E−01 1 Unchanged Low P31645 N03ef5 solute carrier family 6 (neurotran

114.6464 189 118.8487 140.7231 5.19E−02 7.19E−01 1 Unchanged Low P51511 N17ef7 matrix metalloproteinase 15 (me

122.9018 125 118.8609 122.1739 −4.82E−02 2.16E−02 1 Unchanged Low Q15154 O11cd1 pericentriolar material 1 127.8378 139 118.8759 128.7076 −1.05E−01 1.25E−01 1 Unchanged Low Q00007 E17ef6 protein phosphatase 2 (formerly; 108.364 123 118.9838 116.7703 1.35E−01 1.82E−01 1 Unchanged Low P55822 L08cd2 SH3 domain binding glutamic ac

131.7189 133 119.0263 128.0275 −1.46E−01 1.76E−02 1 Unchanged Low Q14442 L20ab8 phosphatidylinositol glycan; clas

121.0635 114 119.0306 118.0476 −2.44E−02 −8.61E−02 1 Unchanged Low P54792 L04ab4 dishevelied; dsh homolog 1 (Dro

126.677 113 119.067 119.4338 −8.94E−02 −1.70E−01 1 Unchanged Low P42336 A03ef6 phosphoinositide-3-kinase; catal

101.0905 143 119.1581 121.01 2.37E−01 4.98E−01 1 Unchanged Low Q9UMQ3 G15ab3 BarH-like homeobox 2 99.5713 179 119.1741 132.6879 2.59E−01 8.49E−01 1 Unchanged Low Q9UPY5 M04ef3 solute carrier family 7; (cationic

173.9407 69.5 119.3079 120.9226 −5.44E−01 −1.32E+00 1 Unchanged Low P19113 H01ef6 histidine decarboxylase 111.9277 119 119.3155 116.6743 9.22E−02 8.57E−02 1 Unchanged Low O95394 B16ef3 N-acetylglucosamine-phosphate 124.8164 112 119.3184 118.8198 −6.50E−02 −1.52E−01 1 Unchanged Low P22557 A14ab2 aminolevulinate; delta-; synthase 202.1179 129 119.3857 150.2281 −7.60E−01 −6.46E−01 1 Unchanged Low Q9Y3A2 G10ef2 CGI-94 protein 108.7497 167 119.4751 131.6512 1.36E−01 6.16E−01 1 Unchanged Low Q9H5J4 I05gh6 long-chain fatty-acyl elongase 135.0119 87 119.5181 113.8461 −1.76E−01 −6.34E−01 1 Unchanged Low P16083 E15ab8 NAD(P)H dehydrogenase; quino

154.7986 98.6 119.5724 124.3296 −3.73E−01 −6.50E−01 1 Unchanged Low Q99819 D02ab2 Rho GDP dissociation inhibitor (

125.7962 106 119.5853 117.2457 −7.30E−02 −2.42E−01 1 Unchanged Low O75569 F06cd3 protein kinase; interferon-inducib 100.3086 137 119.6257 118.9057 2.54E−01 4.47E−01 1 Unchanged Low O15038 F12ef7 serine/arginine repetitive matrix

125.19 96.6 119.719 113.8294 −6.45E−02 −3.74E−01 1 Unchanged Low Q9HBH5 K09gh4 PAN2 protein 102.0601 139 119.7321 120.3437 2.30E−01 4.48E−01 1 Unchanged Low P41231 C22ab8 purinergic receptor P2Y; G-prote 131.9219 130 119.8105 127.3275 −1.39E−01 −1.84E−02 1 Unchanged Low O15397 D01cd6 RAN binding protein 8 114.6925 118 119.9197 117.4304 6.43E−02 3.71E−02 1 Unchanged Low Q9UDY8 C17cd7 mucosa associated lymphoid tiss 114.4769 120 119.9403 118.129 6.73E−02 6.76E−02 1 Unchanged Low O95819 E22cd5 mitogen-activated protein kinase 92.42403 156 119.956 122.7769 3.76E−01 7.55E−01 1 Unchanged Low Q12999 J01ef5 sarcoma amplified sequence 114.9397 110 119.9579 114.8641 6.17E−02 −6.74E−02 1 Unchanged Low P25440 D07cd2 bromodomain containing 2 116.6707 108 120.0152 114.7701 4.08E−02 −1.16E−01 1 Unchanged Low P20827 H21ef7 ephrin-A1 298.0458 760 120.3333 392.8203 −1.31E+00 1.35E+00 1 Unchanged Low Q9H652 P20gh8 hypothetical protein MGC4171 129.5733 107 120.4428 118.9065 −1.05E−01 −2.80E−01 1 Unchanged Low P31483 L20ef4 TIA1 cytotoxic granule-associate 105.4425 129 120.5386 118.2227 1.93E−01 2.87E−01 1 Unchanged Low Q9BSM8 G15gh8 hypothetical protein MGC10812 148.2279 273 120.573 180.6391 −2.98E−01 8.82E−01 1 Unchanged Low P36897 F04ef5 transforming growth factor; beta

115.7567 108 120.6724 114.8546 6.00E−02 −9.83E−02 1 Unchanged Low Q9UMR9 E08ef3 YME1-like 1 (S. cerevisiae) 256.0314 197 120.7227 191.0958 −1.08E+00 −3.82E−01 1 Unchanged Low Q92560 G11ab3 BRCA1 associated protein-1 (ubi 101.36 161 120.7575 127.8687 2.53E−01 6.72E−01 1 Unchanged Low Q9NWU1 D05gh2 hypothetical protein FLJ20604 99.76081 154 120.7609 124.8325 2.76E−01 6.26E−01 1 Unchanged Low Q92696 N14ab8 Rab geranylgeranyltransferase;

222.7157 272 120.7706 205.3234 −8.83E−01 2.91E−01 1 Unchanged Low O95236 M24ef3 apolipoprotein L; 3 106.592 130 120.798 119.1528 1.80E−01 2.87E−01 1 Unchanged Low Q13202 E21ab5 dual specificity phosphatase 8 146.3963 129 120.7987 131.9045 −2.77E−01 −1.88E−01 1 Unchanged Low P11277 M02cd1 spectrin; beta; erythrocytic (inclu

112.72 114 120.8055 116.0084 9.99E−02 2.26E−02 1 Unchanged Low O95397 P18ef1 putative glycolipid transfer protei 99.78536 143 120.8708 121.1071 2.77E−01 5.16E−01 1 Unchanged Low P05423 A20ab3 BN51 (BHK21) temperature sens 131.8122 95.5 120.9201 116.0734 −1.24E−01 −4.65E−01 1 Unchanged Low Q14338 I17ab6 fucosyltransferase 2 (secretor st

99.71915 181 120.9483 133.9938 2.78E−01 8.63E−01 1 Unchanged Low Q9BYI8 A22gh8 AIE-75 binding protein protein 90.11911 164 121.0209 125.1864 4.25E−01 8.67E−01 1 Unchanged Low Q06203 D01ab8 phosphoribosyl pyrophosphate a 216.3154 105 121.029 147.3953 −8.38E−01 −1.04E+00 1 Unchanged Low Q9NZ33 P10gh4 brain expressed; X-linked 1 113.8613 162 121.0508 132.4428 8.83E−02 5.12E−01 1 Unchanged Low P04198 O10ab6 histidine-rich glycoprotein 116.1305 116 121.1163 117.5882 6.06E−02 −7.63E−03 1 Unchanged Low O96029 F03cd7 opioid growth factor receptor 201.3579 93.5 121.2888 138.7174 −7.31E−01 −1.11E+00 1 Unchanged Low Q01196 I16ab5 runt-related transcription factor 1 441.1217 136 121.3316 232.9078 −1.86E+00 −1.69E+00 1 Unchanged Low Q9UHL4 J17cd8 dipeptidylpeptidase 7 180.3445 191 121.351 164.207 −5.72E−01 8.23E−02 1 Unchanged Low P55211 P16ab3 caspase 9; apoptosis-related cys 113.5416 111 121.3742 115.3899 9.62E−02 −2.94E−02 1 Unchanged Low P21283 A07ab3 ATPase; H+ transporting; lysoso

288.6034 288 121.3828 232.7446 −1.25E+00 −1.78E−03 1 Unchanged Low O43422 P02ab8 protein-kinase; interferon-inducit 131.8635 100 121.394 117.7416 −1.19E−01 −4.00E−01 1 Unchanged Low P78406 L01cd3 RAE1 RNA export 1 homolog (S. 147.1192 97.1 121.4625 121.9098 −2.76E−01 −5.99E−01 1 Unchanged Low P43362 J18ab7 melanoma antigen; family A; 9 99.05783 139 121.5326 119.97 2.95E−01 4.92E−01 1 Unchanged Low Q9H693 E12gh6 hypothetical protein FLJ22477 171.7699 96.4 121.6097 129.9396 −4.98E−01 −8.33E−01 1 Unchanged Low Q9UJ83 A11cd8 2-hydroxyphytanoyl-CoA lyase 99.45467 141 121.6399 120.5495 2.91E−01 4.99E−01 1 Unchanged Low Q05048 I15ab4 cleavage stimulation factor: 3′ pn 124.1609 105 121.6764 117.088 −2.92E−02 −2.36E−01 1 Unchanged Low P19784 D11ab4 casein kinase 2; alpha prime pol

94.68573 152 121.7819 122.6579 3.63E−01 6.78E−01 1 Unchanged Low Q9BUX8 D06gh6 homolog of yeast ribosome biog

167.4752 178 121.8214 155.6701 −4.59E−01 8.56E−02 1 Unchanged Low Q9Y5P6 D23cd8 GDP-mannose pyrophosphoryla

166.4572 89.4 121.8219 125.8828 −4.50E−01 −8.97E−01 1 Unchanged Low Q9Y3E1 F16af1 hepatoma-derived growth factor: 97.00713 148 121.9163 122.172 3.30E−01 6.05E−01 1 Unchanged Low P40426 O07cd1 pre-B-cell leukemia transcription 122.6888 94.8 121.9253 113.1427 −9.01E−03 −3.72E−01 1 Unchanged Low P11217 K01cd1 phosphorylase; glycogen; muscl

314.8041 110 122.008 182.286 −1.37E+00 −1.52E+00 1 Unchanged Low Q16563 D18cd2 synaptophysin-like protein 97.62823 144 122.0944 121.3173 3.23E−01 5.63E−01 1 Unchanged Low O95698 L07ab6 Inhibitor of growth family; membe 102.2388 135 122.1358 119.6732 2.57E−01 3.97E−01 1 Unchanged Low P19447 K24ef6 excision repair cross-complemen 95.41189 148 122.1425 121.7269 3.56E−01 6.30E−01 1 Unchanged Low Q9UK39 D08cd7 CCR4 carbon catabolite repressi 173.8761 262 122.1589 185.8825 −5.09E−01 5.89E−01 1 Unchanged Low Q15785 E23cd7 translocase of outer mitochondri

296.8521 144 122.1776 187.6861 −1.28E+00 −1.04E+00 1 Unchanged Low Q99571 C14ab8 purinergic receptor P2X; ligand-

418.1812 410 122.3053 316.7241 −1.77E+00 −2.96E−02 1 Unchanged Low Q9BTY2 E24gh8 hypothetical protein MGC1314 si 131.9449 91.5 122.3524 115.258 −1.09E−01 −5.28E−01 1 Unchanged Low Q9P0P1 D12ef1 hypothetical protein FLJ10769 147.9172 191 122.4861 153.8845 −2.72E−01 3.71E−01 1 Unchanged Low Q9Y324 P01ef1 CGI-35 protein 129.1118 97 122.5531 116.2093 −7.52E−02 −4.13E−01 1 Unchanged Low P37286 O17cd3 ubiquitin-conjugating enzyme E2 98.88763 165 122.5669 128.7921 3.10E−01 7.38E−01 1 Unchanged Low Q00577 O07ef5 purine-rich element binding prot

116.0341 123 122.5705 120.658 7.91E−02 8.84E−02 1 Unchanged Low O75152 L21gh1 KIAA0663 gene product 101.4464 140 122.5789 121.2139 2.73E−01 4.61E−01 1 Unchanged Low P23610 H06cd7 coagulation factor VIII-associate

164.911 103 122.5902 130.3149 −4.28E−01 −6.73E−01 1 Unchanged Low O75436 M20cd5 vacuolar protein sorting 26 (yeas 118.1135 108 122.6522 116.2363 5.44E−02 −1.30E−01 1 Unchanged Low Q9HA40 B23gh5 hypothetical protein FLJ12287 si 104.6286 126 122.666 117.8494 2.29E−01 2.71E−01 1 Unchanged Low Q9NX62 I20gh2 hypothetical protein FLJ20421 103.7764 136 122.701 120.7522 2.42E−01 3.88E−01 1 Unchanged Low O76062 E04cd2 transmembrane 7 superfamily m

301.1903 215 122.7645 212.8749 −1.29E+00 −4.89E−01 1 Unchanged Low Q16445 H02ab3 gamma-aminobutyric acid (GAB

150.641 87.5 122.7829 120.3177 −2.95E−01 −7.83E−01 1 Unchanged Low Q08462 G11ef6 adenylate cyclase 2 (brain) 107.541 146 122.8502 125.3933 1.92E−01 4.39E−01 1 Unchanged Low P78560 A22ef6 CASP2 and RIPK1 domain conta 108.4508 153 122.8627 128.1152 1.80E−01 4.97E−01 1 Unchanged Low P19634 N17ef5 solute carrier family 9 (sodium/hy 118.9969 99 122.898 113.6214 4.65E−02 −2.66E−01 1 Unchanged Low P28370 N12cd1 SWI/SNF related; matrix associa 115.471 106 122.9184 114.9572 9.02E−02 −1.17E−01 1 Unchanged Low Q92503 H06cd1 SEC14-like 1 (S. cerevisiae) 151.5939 151 122.9424 141.9225 −3.02E−01 −3.46E−03 1 Unchanged Low Q9UL02 H24ef1 L-kynurenine/alpha-aminoadipat

105.6951 124 123.0487 117.4294 2.19E−01 2.25E−01 1 Unchanged Low Q9Y5T5 J13cd6 ubiquitin specific protease 16 117.1056 120 123.0646 120.0007 7.16E−02 3.32E−02 1 Unchanged Low G03gh8 protocadherin 15 153.0978 126 123.1548 134.1729 −3.14E−01 −2.78E−01 1 Unchanged Low P15848 H02ab2 arylsulfatase B 149.4791 95.6 123.1651 122.7499 −2.79E−01 −6.45E−01 1 Unchanged Low Q9UP66 P24ab6 low density lipoprotein receptor-

114.2435 124 123.2083 120.4437 1.09E−01 1.17E−01 1 Unchanged Low O75160 P07gh1 KIAA0672 gene product 121.9398 117 123.2554 120.8501 1.55E−02 −5.53E−02 1 Unchanged Low P78385 L14ab6 keratin; hair; basic; 3 100.703 135 123.2569 119.6793 2.92E−01 4.24E−01 1 Unchanged Low O94967 B21ef8 KIAA0893 protein 92.15324 158 123.2707 124.6247 4.20E−01 7.82E−01 1 Unchanged Low O95719 K01cd5 xenotropic and polytropic retrovir 108.0877 122 123.3497 117.7043 1.91E−01 1.71E−01 1 Unchanged Low P48147 F09ab8 prolyl endopeptidase 130.0641 129 123.3564 127.6048 −7.64E−02 −7.45E−03 1 Unchanged Low P20231 B15gh7 tryptase beta 2 106.6865 130 123.4905 119.9323 2.11E−01 2.81E−01 1 Unchanged Low O95299 G02ab7 NADH dehydrogenase (ubiquino

107.385 129 123.5991 119.8634 2.03E−01 2.60E−01 1 Unchanged Low O75033 I18gh1 KIAA0445 gene product 121.5196 122 123.624 122.4835 2.48E−02 9.32E−03 1 Unchanged Low P61668 D03cd4 ubiquitin-conjugating enzyme E2 99.84401 137 123.637 120.3 3.08E−01 4.61E−01 1 Unchanged Low P28289 E08cd2 tropomodulin 303.877 272 123.6484 233.0271 −1.30E+00 −1.62E−01 1 Unchanged Low Q15631 O12ef6 translin 173.134 152 123.6887 149.5989 −4.85E−01 −1.88E−01 1 Unchanged Low P49888 F03cd2 sulfotransferase; estrogen-prefer 122.2586 95.1 123.7564 113.6937 1.76E−02 −3.63E−01 1 Unchanged Low P51959 O12ef5 cyclin G1 116.6841 102 123.7661 114.0387 8.50E−02 −1.99E−01 1 Unchanged Low Q9Y5V0 J16ef1 HSPC038 protein 114.0123 179 123.7928 139.0584 1.19E−01 6.54E−01 1 Unchanged Low P56270 I12ef1 MYC-associated zinc finger prot

248.3395 140 123.8618 170.7774 −1.00E+00 −8.26E−01 1 Unchanged Low Q9HD23 O11gh4 MRS2-like; magnesium homeost

140.8864 117 123.8621 127.1502 −1.86E−01 −2.72E−01 1 Unchanged Low P78358 O03ab6 cancer/testis antigen 1 217.9167 137 123.9307 159.681 −8.14E−01 −6.68E−01 1 Unchanged Low O00327 D24ab2 aryl hydrocarbon receptor nuclea 118.2008 185 123.9698 142.5298 6.87E−02 6.50E−01 1 Unchanged Low Q9H969 F08gh5 hypothetical protein FLJ12969 89.23821 177 123.0248 130.1172 4.75E−01 9.89E−01 1 Unchanged Low O15504 F01cd7 nucleoporin-like protein 1 200.4449 124 124.2046 149.5876 −6.90E−01 −6.92E−01 1 Unchanged Low P35250 I24ef8 replication factor C (activator 1); 111.3418 112 124.3534 115.9922 1.59E−01 1.21E−02 1 Unchanged Low Q9BXC0 F17gh8 G protein-coupled receptor 81 104.4833 128 124.3568 118.786 2.51E−01 2.87E−01 1 Unchanged Low O15232 A19ef1 matrilin 3 113.1634 110 124.4317 115.8185 1.37E−01 −4.27E−02 1 Unchanged Low O76049 L19cd5 spectrin SH3 domain binding pro 171.9625 299 124.5037 198.6303 −4.66E−01 8.00E−01 1 Unchanged Low Q14145 C21cd8 Kelch-like ECH-associated protei 193.9671 120 124.5928 146.2645 −6.39E−01 −6.90E−01 1 Unchanged Low P20848 A10cd1 serine (or cysteine) proteinase in 97.77909 161 124.6004 127.9292 3.50E−01 7.23E−01 1 Unchanged Low Q9P0N6 C19ef3 hypothetical protein HSPC242 112.0065 109 124.6034 115.304 1.54E−01 −3.53E−02 1 Unchanged Low P05188 E12ab2 alkaline phosphatase; placental

88.50098 164 124.6125 125.869 4.94E−01 8.94E−01 1 Unchanged Low Q9UBJ4 A01gh5 transposon-derived Buster1 tran

131.0923 97.3 124.7023 117.695 −7.21E−02 −4.30E−01 1 Unchanged Low Q13876 I24ef7 quiescin Q6 144.3305 109 124.7205 125.9829 −2.11E−01 −4.06E−01 1 Unchanged Low Q9UBF2 F12cd7 coatomer protein complex; subur 110.1673 115 124.9117 116.849 1.18E−01 6.78E−02 1 Unchanged Low P43026 I23cd3 growth differentiation factor 5 (ca 101.9864 152 124.9218 126.3658 2.93E−01 5.77E−01 1 Unchanged Low Q9HD20 E14gh4 CGI-152 protein 111.6731 134 124.9301 123.6472 1.62E−01 2.67E−01 1 Unchanged Low Q96KK6 P04ab8 RAB2; member RAS oncogene f

119.8171 106 124.9467 116.8445 6.05E−02 −1.80E−01 1 Unchanged Low P40617 D18ab2 ADP-ribosylation factor-like 4 124.1402 143 125.0573 130.7449 1.06E−02 2.04E−01 1 Unchanged Low O75651 L12gh2 unc-93 homolog A (C. elegans) 131.989 128 125.0667 128.2583 −7.77E−02 −4.74E−02 1 Unchanged Low Q9Y2S1 L04ef1 galanin-related peptide 135.6724 134 125.067 131.4839 −1.17E−01 −2.10E−02 1 Unchanged Low Q13330 M20ef5 metastasis associated 1 104.9962 118 125.1131 116.0949 2.53E−01 1.71E−01 1 Unchanged Low Q9Y389 L22gh4 aminoadipate-semialdehyde detr 115.3352 104 125.222 114.7055 1.19E−01 −1.55E−01 1 Unchanged Low O60513 I03gh1 UDP-Gal:betaGlcNAc beta 1; 4-

113.705 106 125.2504 115.0129 1.40E−01 −1.00E−01 1 Unchanged Low O00212 C15ef6 ras homolog gene family; memb

407.7018 492 125.2682 341.5178 −1.70E+00 2.70E−01 1 Unchanged Low Q9NXE1 J04gh2 membrane-associated nucleic ac 96.25484 146 125.3861 122.4125 3.81E−01 5.97E−01 1 Unchanged Low O95405 A16cd5 MAD; mothers against decapent

113.9303 223 125.3908 154.2554 1.38E−01 9.72E−01 1 Unchanged Low P01112 K12ab7 v-Ha-ras Harvey rat sarcoma vir

129.7326 104 125.3947 119.6125 −4.91E−02 −3.23E−01 1 Unchanged Low O15120 F11cd6 1-acylglycerol-3-phosphate O-ac 264.2959 238 125.4039 209.3705 −1.08E+00 −1.49E−01 1 Unchanged Low P12645 N10ab3 bone morphogenetic protein 3 (o 107.6548 117 125.4244 116.6372 2.20E−01 1.18E−01 1 Unchanged Low P50579 I01cd7 methionyl aminopeptidase 2 144.5853 95.1 125.4613 121.7158 −2.05E−01 −6.04E−01 1 Unchanged Low O14908 K01cd8 regulator of G-protein signalling 204.527 200 125.5241 176.6683 −7.04E−01 −3.26E−02 1 Unchanged Low Q9HCC6 I17gh4 bHLH factor Hes4 82.07855 213 125.5621 140.2118 6.13E−01 1.38E+00 1 Unchanged Low Q15737 E23gh1 suppressor of Ty 6 homolog (S.

112.2771 140 125.5917 125.8246 1.62E−01 3.14E−01 1 Unchanged Low Q9Y519 A17cd8 chromosome 22 open reading fra 100.4037 131 125.6586 119.1056 3.24E−01 3.87E−01 1 Unchanged Low Q9Y5J0 J01ef2 mitochondrial ribosomal protein

117.4353 107 125.8555 116.7986 9.99E−02 −1.33E−01 1 Unchanged Low P51687 O16cd1 sulfite oxidase 105.2314 128 125.9497 119.5637 2.59E−01 2.77E−01 1 Unchanged Low P51178 A13ef6 phospholipase C; delta 1 126.4221 162 126.0345 138.0904 −4.43E−03 3.56E−01 1 Unchanged Low Q9H8J6 H23gh5 NDRG family member 3 121.7115 198 126.048 148.4766 5.05E−02 7.00E−01 1 Unchanged Low O95900 B20ef8 hypothetical protein CLONE2492 165.6404 257 126.0637 182.738 −3.94E−01 6.31E−01 1 Unchanged Low Q9Y6N3 B01cd5 chloride channel; calcium activat 99.89597 135 126.1695 120.3564 3.37E−01 4.35E−01 1 Unchanged Low Q07869 C21cd1 peroxisome proliferative activate

120.1031 112 126.2127 119.4872 7.16E−02 −9.89E−02 1 Unchanged Low Q9Y333 I07gh4 chromosome 6 open reading frar 109.0761 114 126.2563 116.4501 2.11E−01 6.39E−02 1 Unchanged Low Q9NPD1 L06gh2 G protein-coupled receptor 85 206.0578 285 126.2683 205.7432 −7.07E−01 4.67E−01 1 Unchanged Low Q15928 K06cd3 zinc finger protein 141 (clone pH 101.1559 188 126.2732 138.6304 3.20E−01 8.98E−01 1 Unchanged Low O43826 I04ab4 glucose-6-phosphatase; transpo

229.7084 111 126.3113 155.5451 −8.63E−01 −1.05E+00 1 Unchanged Low Q9NWL0 J05gh2 hypothetical protein FLJ20758 114.0453 120 126.3891 120.1186 1.48E−01 7.25E−02 1 Unchanged Low P31629 B04ef6 human immunodeficiency virus t

116.0174 211 126.4284 151.1911 1.24E−01 8.64E−01 1 Unchanged Low O15530 I10ab8 3-phosphoinositide dependent p

186.1234 193 126.45 168.488 −5.58E−01 5.15E−02 1 Unchanged Low Q9Y2R5 L21ef4 mitochondrial ribosomal protein

106.3741 136 126.4713 122.8701 2.50E−01 3.52E−01 1 Unchanged Low Q15208 D01cd7 serine/threonine kinase 3B 158.8765 204 126.5253 163.2891 −3.28E−01 3.64E−01 1 Unchanged Low Q9UET6 J19gh6 FisJ homolog 1 (E. coli) 102.5266 120 126.5378 116.4386 3.04E−01 2.30E−01 1 Unchanged Low Q9H5N0 F15gh5 chromosome 7 open reading frar 102.3349 129 126.5687 119.1911 3.07E−01 3.30E−01 1 Unchanged Low Q9H019 B22gh4 hypothetical protein RP1-317E23 102.5329 150 126.5974 126.5367 3.04E−01 5.53E−01 1 Unchanged Low Q9Y673 F05cd8 Alg5; S. cerevisiae; homolog of 100.2543 131 126.6884 119.1797 3.38E−01 3.81E−01 1 Unchanged Low O75690 M08gh7 UHS KerB 121.3598 150 126.7819 132.5659 6.31E−02 3.01E−01 1 Unchanged Low Q9NUP6 H22gh2 hypothetical protein FLJ11220 95.908 144 126.8164 122.1684 4.03E−01 5.84E−01 1 Unchanged Low Q14296 C03cd7 FAST kinase 122.4924 92.9 126.9021 114.1093 5.10E−02 −3.98E−01 1 Unchanged Low Q9NW55 B20gh2 hypothetical protein FLJ10307 94.73914 141 126.9877 120.8058 4.23E−01 5.70E−01 1 Unchanged Low O43639 H01cd3 NCK adaptor protein 2 139.9609 79.6 127.0293 115.5457 −1.40E−01 −8.13E−01 1 Unchanged Low P17544 L08ab2 activating transcription factor 7 108.5839 112 127.0848 115.9726 2.27E−01 4.79E−02 1 Unchanged Low O75911 M01cd5 short-chain dehydrogenase/redu

156.3658 173 127.1125 152.0313 −2.99E−01 1.43E−01 1 Unchanged Low Q06430 K15ef3 glucosaminyl (N-acetyl) transfera 94.56995 139 127.1541 120.315 4.27E−01 5.58E−01 1 Unchanged Low Q13769 D10cd3 chromosome 22 open reading fra 122.7812 121 127.1547 123.5081 5.05E−02 −2.60E−02 1 Unchanged Low Q9H864 J14gh5 hypothetical protein FLJ11021 sl 97.58044 142 127.1909 122.387 3.82E−01 5.45E−01 1 Unchanged Low O95500 F06cd7 claudin 14 183.0294 181 127.2815 163.6478 −5.24E−01 −1.90E−02 1 Unchanged Low P14222 P02cd2 perforin 1 (pore forming protein) 99.11893 135 127.3674 120.5243 3.62E−01 4.47E−01 1 Unchanged Low Q9Y4C8 B06ef2 KIAA0682 gene product 105.4769 146 127.3803 126.2296 2.72E−01 4.67E−01 1 Unchanged Low Q9H3H5 M23ab4 dolichyl-phosphate (UDP-N-acet

193.8179 108 127.5134 143.2265 −6.04E−01 −8.39E−01 1 Unchanged Low Q13433 G05cd8 LIV-1 protein; estrogen regulate

118.096 105 127.6623 116.7563 1.12E−01 −1.76E−01 1 Unchanged Low Q00059 O07cd2 transcription factor A; mitochond

111.4615 131 127.6629 123.3486 1.96E−01 2.32E−01 1 Unchanged Low Q15119 I06ab8 pyruvate dehydrogenase kinase; 97.01115 135 127.6675 120.0132 3.96E−01 4.81E−01 1 Unchanged Low O43791 F03cd3 speckle-type POZ protein 111.349 114 127.7061 117.7111 1.98E−01 3.49E−02 1 Unchanged Low Q14206 P10cd5 Down syndrome critical region g

119.8147 263 127.7164 170.2393 9.21E−02 1.14E+00 1 Unchanged Low Q92926 N24cd1 SWI/SNF related; matrix associa

115.147 105 127.7503 116.1179 1.50E−01 −1.27E−01 1 Unchanged Low Q9P288 G15ef3 BRCA2 and CDKN1A interacting 148.9477 132 127.8623 136.3262 −2.20E−01 −1.72E−01 1 Unchanged Low Q9NZU5 C16ef4 LIM and cysteine-rich domains 1 164.1438 128 127.9349 139.9549 −3.60E−01 −3.61E−01 1 Unchanged Low Q13569 O13cd2 thymine-DNA glycosylase 83.16502 172 127.9545 127.6936 6.22E−01 1.05E+00 1 Unchanged Low P48167 D17ef6 glycine receptor; beta 109.5501 139 127.9738 125.3664 2.24E−01 3.39E−01 1 Unchanged Low Q9NQR1 I02gh4 PR/SET domain containing prote 154.2185 92.7 128.0258 124.9651 −2.69E−01 −7.35E−01 1 Unchanged Low O43405 B23ab4 coagulation factor C homolog; cc 103.0764 121 128.1793 117.417 3.14E−01 2.31E−01 1 Unchanged Low Q9P028 N24ef2 CCR4-NOT transcription comple

104.0341 133 128.2089 121.9053 3.01E−01 3.59E−01 1 Unchanged Low Q9Y6E8 P04cd7 sirtuin silent mating type informa

109.1684 110 128.2444 115.6628 2.32E−01 5.37E−03 1 Unchanged Low Q9NV65 H17gh3 hypothetical protein FLJ10901 92.33747 188 128.3243 136.3658 4.75E−01 1.03E+00 1 Unchanged Low Q9H0R8 M13gh7 GABA(A) receptor-associated pr

122.091 179 128.3386 143.1503 7.20E−02 5.52E−01 1 Unchanged Low O95817 P02cd4 BCL2-associated athanogene 3 107.1752 114 128.4319 116.5745 2.61E−01 9.05E−02 1 Unchanged Low P36956 K10cd2 sterol regulatory element binding 140.2284 109 128.532 125.9988 −1.26E−01 −3.60E−01 1 Unchanged Low P08236 D05ab3 glucuronidase; beta 123.7102 114 128.6103 122.0379 5.60E−02 −1.21E−01 1 Unchanged Low Q13425 D12cd2 syntrophin; beta 2 (dystrophin-as 106.7241 122 128.6723 119.2218 2.70E−01 1.96E−01 1 Unchanged Low Q14676 E18gh1 KIAA0170 gene product 93.41288 145 128.7328 122.2375 4.63E−01 6.30E−01 1 Unchanged Low P16106 O12gh6 H3 histone family; member F 98.02235 136 128.7695 120.7804 3.94E−01 4.68E−01 1 Unchanged Low Q14773 J03ab6 intercellular adhesion molecule 4 101.85 137 128.8098 122.427 3.39E−01 4.24E−01 1 Unchanged Low O14736 N19gh4 putative methyltransferase 124.8741 126 128.8151 126.6152 4.48E−02 1.47E−02 1 Unchanged Low Q9Y297 N21cd4 beta-transducin repeat containin

152.2864 142 128.8641 141.0555 −2.41E−01 −1.01E−01 1 Unchanged Low Q13585 H16cd4 G protein-coupled receptor 50 121.9424 113 128.8853 121.1757 7.99E−02 −1.14E−01 1 Unchanged Low O60858 L24cd5 ret finger protein 2 110.1643 110 128.8939 116.2529 2.27E−01 −6.09E−03 1 Unchanged Low Q9Y2Z6 E06ef2 CGI-07 protein 96.22816 139 128.9272 121.3443 4.22E−01 5.29E−01 1 Unchanged Low Q9UG66 P16ef7 hypothetical protein DKFZp586G 318.3297 374 128.9795 273.7118 −1.30E+00 2.32E−01 1 Unchanged Low Q9Y6G5 N17ef2 PTD002 protein 107.7937 141 129.1324 125.8408 2.61E−01 3.83E−01 1 Unchanged Low P98155 E06cd3 very low density lipoprotein rece

113.1365 104 129.1355 115.483 1.91E−01 −1.19E−01 1 Unchanged Low Q9NP50 C07gh5 TERA protein 94.63638 199 129.2792 140.8474 4.50E−01 1.07E+00 1 Unchanged Low P28328 C01ab8 peroxisomal membrane protein 3 321.6292 219 129.3474 223.2274 −1.31E+00 −5.56E−01 1 Unchanged Low Q969T4 M24cd6 ubiquitin-conjugating enzyme E2 117.2071 100 129.3512 115.6428 1.42E−01 −2.24E−01 1 Unchanged Low P19827 D18ab6 Inter-alpha (globulin) inhibitor; H

239.4455 186 129.3613 185.0551 −8.88E−01 −3.62E−01 1 Unchanged Low O15096 M18ab8 phosphatidylinositol 4-kinase; ca 117.2574 115 129.4365 120.4316 1.43E−01 −3.31E−02 1 Unchanged Low Q9Y5J6 J16cd7 fracture callus 1 homolog (rat) 102.357 127 129.4503 119.4401 3.39E−01 3.06E−01 1 Unchanged Low Q92889 M24ab4 excision repair cross-complemen 157.5735 97.6 129.5255 128.238 −2.83E−01 −6.91E−01 1 Unchanged Low P08697 C07ef1 serine (or cysteine) proteinase in 138.5253 136 129.5425 134.8048 −9.67E−02 −2.29E−02 1 Unchanged Low Q9UBX1 A05cd4 cathepsin F 113.4065 118 129.6557 120.4495 1.93E−01 6.08E−02 1 Unchanged Low Q9NPI7 D22ef1 hypothetical protein LOC51315 240.5378 171 129.76 180.4148 −8.90E−01 −4.93E−01 1 Unchanged Low P11586 D14ef7 methylenetetrahydrofolate dehyd 141.2456 106 129.8444 125.7751 −1.21E−01 −4.11E−01 1 Unchanged Low O96010 J15cd4 LIM domain binding 1 90.9506 155 129.8567 125.1912 5.14E−01 7.67E−01 1 Unchanged Low Q13188 P13cd2 serine/threonine kinase 3 (STE2

117.4664 135 129.8809 127.4091 1.45E−01 1.99E−01 1 Unchanged Low Q13845 I21ab3 B-cell CLL/lymphoma 7B 145.9359 88.3 129.9273 121.3988 −1.68E−01 −7.24E−01 1 Unchanged Low Q9Y5W9 D07cd8 sorting nexin 11 144.6605 198 130.0152 157.7019 −1.54E−01 4.56E−01 1 Unchanged Low O60539 I02cd7 Ras association (RalGDS/AF-6)

126.8466 102 130.0346 119.7412 3.58E−02 −3.10E−01 1 Unchanged Low O60885 I02ef3 bromodomain-containing 4 114.9928 98.1 130.1093 114.4111 1.78E−01 −2.29E−01 1 Unchanged Low Q9H2B0 O16gh5 nucleosome assembly protein 1-

122.5782 147 130.1112 133.1825 8.60E−02 2.61E−01 1 Unchanged Low P51582 C24ab8 pyrimidinergic receptor P2Y; G-p 116.4263 109 130.158 118.649 1.61E−01 −9.03E−02 1 Unchanged Low O00585 F08cd1 small inducible cytokine subfamil 168.745 216 130.1849 171.5056 −3.74E−01 3.53E−01 1 Unchanged Low Q15131 B23ef5 cyclin-dependent kinase (CDC2-

168.6104 108 130.2201 135.7223 −3.73E−01 −6.38E−01 1 Unchanged Low O75148 F08cd8 cryptochrome 2 (photolyase-like) 86.14249 172 130.27 129.5265 5.97E−01 9.99E−01 1 Unchanged Low Q15691 G17cd8 microtubule-associated protein;

173.7024 168 130.2758 157.4437 −4.15E−01 −4.51E−02 1 Unchanged Low Q15779 H21ab8 procollagen (type III) N-endopep

141.4408 133 130.2905 135.0227 −1.18E−01 −8.51E−02 1 Unchanged Low Q9UHD2 K14cd8 TANK-binding kinase 1 82.31867 172 130.2947 128.1679 6.62E−01 1.06E+00 1 Unchanged Low Q9NSS3 K15gh3 hypothetical protein DKFZp434E 107.5389 115 130.3095 117.5518 2.77E−01 9.44E−02 1 Unchanged Low Q13797 I01ef7 integrin; alpha 9 156.9946 85 130.4752 124.1726 −2.67E−01 −8.84E−01 1 Unchanged Low P46531 M10ef5 Notch homolog 1; translocation-

86.01963 164 130.4897 126.8111 6.01E−01 9.30E−01 1 Unchanged Low O43262 C01cd6 deleted in lymphocytic leukemia; 76.79463 195 130.4943 134.2594 7.65E−01 1.35E+00 1 Unchanged Low Q9Y2H6 k12ef8 KIAA0970 protein 170.8655 128 130.5238 142.9858 −3.89E−01 −4.22E−01 1 Unchanged Low P25788 J11ab8 proteasome (prosome; macropah 258.6025 285 130.5899 224.7239 −9.86E−01 1.40E−01 1 Unchanged Low Q98QS8 D09gh7 FYVE and coiled-coil domain cor 164.6348 207 130.6451 167.5571 −3.34E−01 3.33E−01 1 Unchanged Low Q9Y396 J04ef1 elongation of very long chain fatt 162.6431 82.2 130.6722 125.1558 −3.16E−01 −9.85E−01 1 Unchanged Low Q9P0R7 K06ef2 hypothetical protein LOC51242 126.7302 218 130.6804 158.5209 4.43E−02 7.84E−01 1 Unchanged Low O15269 F17cd6 serine palmitoyltransferase; long 97.42808 133 130.7429 120.3129 4.24E−01 4.46E−01 1 Unchanged Low Q9UFX0 B02ef2 calcium binding atopy-related au

233.5089 287 130.8943 217.1357 −8.35E−01 2.98E−01 1 Unchanged Low Q9H663 F24gh5 likely ortholog of mouse actin-rel

98.1679 128 130.9258 119.1698 4.15E−01 3.87E−01 1 Unchanged Low O75410 P17cd2 transforming; acidic coiled-coil α 224.1188 133 130.9827 162.703 −7.75E−01 −7.53E−01 1 Unchanged Low Q9Y5N5 I14cd8 putative N6-DNA-methyltransfera 99.34841 133 131.0924 121.2285 4.00E−01 4.24E−01 1 Unchanged Low Q9BQ72 F02gh7 hypothetical protein MGC10471 106.3824 115 131.1126 117.4135 3.02E−01 1.09E−01 1 Unchanged Low Q9Y303 E10ef2 CGI-14 protein 153.5787 101 131.2035 128.5162 −2.27E−01 −6.08E−01 1 Unchanged Low Q9P005 A22ef8 HSPC159 protein 341.3083 579 131.3146 350.7027 −1.38E+00 7.64E−01 1 Unchanged Low Q9Y3A1 H19ef2 DKFZP566O084 protein 200.4927 262 131.514 198.1031 −6.08E−01 3.88E−01 1 Unchanged Low Q15172 C12cd1 protein phosphatase 2; regulator 168.3914 140 131.5524 146.553 −3.56E−01 −2.69E−01 1 Unchanged Low Q9BV19 I19gn6 hypothetical protein MGC955 96.47316 141 131.6188 122.8739 4.48E−01 5.43E−01 1 Unchanged Low Q14534 E11cd2 squalene epoxidase 155.5799 71.3 131.8107 119.574 −2.39E−01 −1.13E+00 1 Unchanged Low Q9BS43 G19gh8 hypothetical protein MGC12435 592.1694 121 131.9022 281.8569 −2.17E+00 −2.29E+00 1 Unchanged Low P49788 D24ab8 retinoic acid receptor responder

97.19637 135 131.9355 121.3412 4.41E−01 4.73E−01 1 Unchanged Low Q9UP83 M10cd6 component of oligomeric golgi cc 100.2446 141 131.938 124.3058 3.96E−01 4.89E−01 1 Unchanged Low Q9Y2X0 N11cd5 thyroid hormone receptor-associ

116.8982 97.9 131.9541 115.5741 1.75E−01 −2.56E−01 1 Unchanged Low Q9Y3E3 I15ef2 CGI-145 protein 94.76733 132 131.9919 119.5355 4.78E−01 4.76E−01 1 Unchanged Low O95183 J14cd6 vesicle-associated membrane pr

91.19765 157 132.0539 126.6473 5.34E−01 7.81E−01 1 Unchanged Low Q13242 N22cd3 splicing factor; arginine/serine-ri

156.0624 141 132.0637 143.0016 −2.41E−01 −1.48E−01 1 Unchanged Low Q9Y5R5 A06gh1 doublesex and mab-3 related tra

100.8446 162 132.1528 131.5571 3.90E−01 6.81E−01 1 Unchanged Low P04181 N02ab7 ornithine aminotransferase (gyra

112.3954 106 132.1687 116.724 2.34E−01 −8.99E−02 1 Unchanged Low Q14254 B15ab4 flotlllin 2 130.1586 154 132.2038 138.6301 2.25E−02 2.38E−01 1 Unchanged Low Q9Y6E6 P08cd7 sirtuin silent mating type informa

94.40989 136 132.2501 121.0265 4.86E−01 5.31E−01 1 Unchanged Low Q9H237 D20gh5 porcupine 148.2204 258 132.2656 179.3923 −1.64E−01 7.98E−01 1 Unchanged Low Q92785 N21cd2 requiern; apoptosis response zin

118.3718 108 132.3893 119.7533 1.61E−01 −1.26E−01 1 Unchanged Low O95458 N11cd2 tubulin-specific chaperone d 128.9522 100 132.4761 120.4814 3.89E−02 −3.67E−01 1 Unchanged Low P20749 P23ef6 B-cell CLL/lymphoma 3 264.1174 186 132.484 194.2507 −9.95E−01 −5.05E−01 1 Unchanged Low Q9H2N8 D24gh7 hypothetical protein GL012 104.3233 160 132.5137 132.1507 3.45E−01 6.14E−01 1 Unchanged Low Q15020 M08gh1 squamous cell carcinoma antige

117.2757 147 132.5393 132.2727 1.77E−01 3.26E−01 1 Unchanged Low P42025 O01gh1 ARP1 actin-related protein 1 hon 243.7979 92 132.554 156.1129 −8.79E−01 −1.41E+00 1 Unchanged Low P98173 I23gh5 2.19 gene 113.0426 116 132.6703 120.727 2.31E−01 4.31E−02 1 Unchanged Low O95295 C06cd8 SNARE associated protein snapl 324.3312 119 132.6986 192.0882 −1.29E+00 −1.44E+00 1 Unchanged Low Q9NVA1 F15gh3 chromosome 20 open reading fr

111.7508 100 132.7232 114.8529 2.48E−01 −1.59E−01 1 Unchanged Low P35573 O03ab2 amylo-1; 6-glucosidase; 4-alpha- 111.9583 106 132.7432 116.8065 2.46E−01 −8.27E−02 1 Unchanged Low Q13126 K13ab7 methylthioadenosine phosphoryl

202.8169 236 132.9211 190.4847 −6.10E−01 2.17E−01 1 Unchanged Low P43034 C11ab8 platelet-activating factor acetylhy 106.8174 125 132.987 121.4511 3.16E−01 2.22E−01 1 Unchanged Low Q01844 E15ab5 Ewing sarcoma breakpoint regio

111.2628 102 133.001 115.5021 2.57E−01 −1.22E−01 1 Unchanged Low P27482 E18ab6 calmodulin-like 3 114.7017 104 133.018 117.2725 2.14E−01 −1.40E−01 1 Unchanged Low Q9NUW4 N23gh3 BRIX 223.8591 77.1 133.0208 144.6673 −7.51E−01 −1.54E+00 1 Unchanged Low P78552 J23ab6 interleukin 13 receptor; alpha 1 118.2476 93.9 133.0765 115.0749 1.70E−01 −3.33E−01 1 Unchanged Low P51843 O24ab2 nuclear receptor subfamily 0; gr

104.7329 112 133.1401 116.7757 3.46E−01 1.03E−01 1 Unchanged Low P15822 L23ab5 human immunodeficiency virus

83.26942 160 133.2118 125.3978 6.78E−01 9.40E−01 1 Unchanged Low Q9BXY9 O13gh8 RALBP1 associated Eps domain 90.84238 140 133.274 121.2561 5.53E−01 6.20E−01 1 Unchanged Low Q9ULB4 P10ef1 cadherin 9; type 2 (T1-cadherin) 275.2974 137 133.4641 181.8847 −1.04E+00 −1.01E+00 1 Unchanged Low Q9NZZ7 C08ef8 HSPC171 protein 214.9523 265 133.5412 204.594 −6.87E−01 3.04E−01 1 Unchanged Low Q02086 C09cd2 Sp2 transcription factor 101.0989 133 133.5465 122.3826 4.02E−01 3.90E−01 1 Unchanged Low Q9BUV9 H14gh6 DKFZP586J0119 protein 102.1174 119 133.5923 118.2651 3.88E−01 2.22E−01 1 Unchanged Low Q9UHJ9 A09ef4 FGF receptor activating protein 1 100.7903 121 133.6008 118.5627 4.07E−01 2.67E−01 1 Unchanged Low Q16401 E11cd1 proteasome (prosome; macropa

143.6091 120 133.6156 132.2946 −1.04E−01 −2.63E−01 1 Unchanged Low Q9Y4K4 D04cd6 mitogen-activated protein kinase 132.4072 158 133.6676 141.2069 1.37E−02 2.51E−01 1 Unchanged Low O60463 H06cd3 phosphalidic acid phosphatase

103.2417 151 133.6898 129.2479 3.73E−01 5.47E−01 1 Unchanged Low O95639 P20cd6 cleavage and polyadenylation sp 183.1762 67.6 133.7241 128.1539 −4.54E−01 −1.44E+00 1 Unchanged Low P50539 N19ab7 MAX interacting protein 1 175.6646 187 133.7304 165.4016 −3.93E−01 8.87E−02 1 Unchanged Low Q9UH62 I15ef3 ALEX3 protein 118.2527 171 133.7314 140.9912 1.77E−01 5.32E−01 1 Unchanged Low O15525 C13ab7 v-maf musculoaponeurotic fibros 105.3252 109 133.7521 116.1167 3.45E−01 5.31E−02 1 Unchanged Low Q9H8T0 H21gh5 fused toes homolog (mouse) 106.2145 241 133.7606 160.2791 3.33E−01 1.18E+00 1 Unchanged Low Q9Y4X5 K03cd6 ariadne homolog; ubiquitin-conju 99.46477 128 133.8771 120.4976 4.29E−01 3.66E−01 1 Unchanged Low Q9H9E1 O01gh5 ankyrin repeat; family A (RFXAN 172.6268 78.8 134.052 128.4841 −3.65E−01 −1.13E+00 1 Unchanged Low Q93063 F13ab3 exostoses (multiple) 2 123.2886 161 134.3468 139.4501 1.24E−01 3.82E−01 1 Unchanged Low Q9H992 D22gh5 axotrophin 89.54768 149 134.4784 124.4411 5.87E−01 7.37E−01 1 Unchanged Low Q43237 P02ab4 dynein; cytoplasmic; light interms 290.6769 119 134.4914 181.4903 −1.11E+00 −1.28E+00 1 Unchanged Low Q99643 H02cd1 succinate dehydrogenase compl

143.4474 125 134.5527 134.443 −9.24E−02 −1.95E−01 1 Unchanged Low Q24386 F11ef1 choroideremia (Rab escort protei 93.86058 129 134.5538 119.0446 5.20E−01 4.56E−01 1 Unchanged Low Q9Y5F7 F12gh4 protocadherin gamma subfamily 101.7878 114 134.5585 116.632 4.03E−01 1.58E−01 1 Unchanged Low P06756 D14ab6 integrin: alpha V (vitronectin recs 200.0782 219 134.6115 184.6891 −5.72E−01 1.33E−01 1 Unchanged Low Q9H5L7 C02gh6 chromosome 1 open reading frar 173.8108 148 134.6601 152.0822 −3.68E−01 −2.34E−01 1 Unchanged Low O15517 A14ef8 tumor necrosis factor receptor su 92.33364 207 134.6603 144.7566 5.44E−01 1.17E+00 1 Unchanged Low Q9P0N5 K24ef2 HSPC244 107.9991 129 134.6618 123.7736 3.18E−01 2.53E−01 1 Unchanged Low Q9NWT2 D19gh2 hypothetical protein FLJ20623 107.8864 105 134.7112 115.8334 3.20E−01 −4.05E−02 1 Unchanged Low Q9Y2A0 O02cd7 TP53 target gene 1 127.408 88.2 134.8491 116.8334 8.19E−02 −5.30E−01 1 Unchanged Low Q9NZ43 N16gh4 uncharacterized hematopoietic s

141.2548 137 134.9524 137.7883 −6.58E−02 −4.24E−02 1 Unchanged Low P27986 A10af1 phosphoinosi

de-3-kinase; regul 111.3806 112 134.9586 119.3503 2.77E−01 4.28E−03 1 Unchanged Low Q9UBP6 J13ef1 methyltransferase-like 1 107.2187 122 134.986 121.358 3.32E−01 1.85E−01 1 Unchanged Low Q9BWK5 P24gh5 hypothetical protein MGC5242 101.1324 123 134.9881 119.8654 4.17E−01 2.88E−01 1 Unchanged Low P54802 M24ab6 N-acelylglucosaminidase; alpha- 206.038 66.3 135.077 135.7965 −6.09E−01 −1.64E+00 1 Unchanged Low O75963 H09cd7 G-protein coupled receptor 110.3888 184 135.3412 143.3711 2.94E−01 7.40E−01 1 Unchanged Low Q9NXZ4 F03ef4 ELG protein 124.5205 105 135.3934 121.5448 1.21E−01 −2.50E−01 1 Unchanged Low O60353 B11cd3 frizzled homolog 6 (Drosophila) 85.64918 146 135.5169 122.5147 6.62E−01 7.73E−01 1 Unchanged Low Q9NQS6 F13gh4 latexin protein 94.21822 163 135.5761 130.917 5.25E−01 7.80E−01 1 Unchanged Low O14776 A19cd7 transcription elongation regulator 113.3803 117 135.6603 122.1137 2.59E−01 4.90E−02 1 Unchanged Low Q9Y5A2 L13ef1 putative zinc finger protein NY-R 154.0704 186 135.6708 158.5684 −1.83E−01 2.71E−01 1 Unchanged Low P49842 G23cd6 serine/threonine kinase 19 133.3557 171 135.7013 146.5953 2.52E−02 3.56E−01 1 Unchanged Low Q06546 J14ab5 GA binding protein transcription

88.93312 138 135.7488 120.885 6.10E−01 6.34E−01 1 Unchanged Low Q9Y2E7 I02ef8 KIAA0938 protein 109.8218 105 135.7763 116.739 3.06E−01 −7.00E−02 1 Unchanged Low Q9UM11 I02ef2 Fzrl protein 80.82847 186 135.8949 134.12 7.50E−01 1.20E+00 1 Unchanged Low Q99447 B14ab8 phosphate cytidylyltransferase 2; 174.8201 77.4 135.988 129.39 −3.62E−01 −1.18E+00 1 Unchanged Low Q9H1R3 F22gh8 myosin light chain kinase 2; skel

93.58977 129 136.0458 119.5324 5.40E−01 4.63E−01 1 Unchanged Low P28358 P05ab6 homeo box D10 108.9905 102 136.1419 115.6766 3.21E−01 −9.71E−02 1 Unchanged Low O76070 P18cd1 synuclein; gamma (breast cancer 128.551 140 136.1645 134.744 8.30E−02 1.18E−01 1 Unchanged Low Q9Y5A7 N07ef2 NEDD8 ultimate buster-1 119.0653 195 136.2606 149.951 1.95E−01 7.08E−01 1 Unchanged Low Q9NWY7 A16gh3 hypothetical protein FLJ20530 103.7638 110 136.3026 116.6328 3.94E−01 8.20E−02 1 Unchanged Low O43715 P02ef2 hypothetical protein HSPC132 137.4694 110 136.3043 127.9562 −1.23E−02 −3.20E−01 1 Unchanged Low Q9BY75 K19gh8 itchy homolog E3 ubiqultin prote

118.5721 127 136.5094 127.3323 2.03E−01 9.81E−02 1 Unchanged Low O43431 A12ef7 endothelial differentiation; lysopt 126.4659 171 136.5393 144.6131 1.11E−01 4.34E−01 1 Unchanged Low O43567 D15cd7 ring finger protein 13 110.4449 153 136.5722 133.3964 3.06E−01 4.72E−01 1 Unchanged Low Q9Y2S7 P13ef8 DKFZP586F1524 protein 113.1366 104 136.7041 117.8414 2.73E−01 −1.26E−01 1 Unchanged Low O14582 O24ef2 spondyloepiphyseal dysplasia; la 135.1666 135 136.7342 135.7349 1.66E−02 1.46E−03 1 Unchanged Low O75056 G12gh1 syndecan 3 (N-syndecan) 120.0661 162 136.797 139.562 1.88E−01 4.31E−01 1 Unchanged Low Q9P2Y2 D18gh4 beta-1; 4 mannosyltransferase 89.6857 143 136.8208 123.2251 6.08E−01 6.75E−01 1 Unchanged Low Q16595 M08ab3 Friedreich ataxia 139.5657 130 136.8314 135.5917 −2.85E−02 −9.82E−02 1 Unchanged Low Q14807 B18ab7 kinesin-like 4 114.4726 94.2 136.9298 115.2048 2.58E−01 −2.81E−01 1 Unchanged Low Q98ZL4 L10gh6 protein phosphatase 1; regulator 110.5367 123 137.0777 123.5234 3.10E−01 1.54E−01 1 Unchanged Low P30876 I13ab8 polymerase (RNA) II (DNA direct 265.5337 200 137.1153 200.7168 −9.54E−01 −4.12E−01 1 Unchanged Low Q9UGP6 B17cd7 coatomer protein complex; subu

94.73601 134 137.3091 122.0845 5.35E−01 5.02E−01 1 Unchanged Low P52655 M01ef2 general transcritpion factor IIA; 1 121.4896 128 137.3707 129.1154 1.77E−01 8.08E−02 1 Unchanged Low Q9HB07 G23gh5 chromosome 12 open reading

121.2547 118 137.4723 125.5248 1.81E−01 −4.11E−02 1 Unchanged Low Q92940 H23ab7 MAD; mothers against decapent

414.4889 223 137.6028 258.3032 −1.59E+00 −8.95E−01 1 Unchanged Low Q9NWN1 H19gh2 hypothetical protein FLJ20727 117.7514 120 137.6351 124.9938 2.25E−01 2.24E−02 1 Unchanged Low O43664 A10cd6 G protein-coupled receptor 66 108.1311 102 137.6789 116.0604 3.49E−01 −7.90E−02 1 Unchanged Low O14647 C19ab4 chromodomain helicase DNA bin 96.14804 164 137.7441 132.5407 5.19E−01 7.68E−01 1 Unchanged Low O75333 N15cd2 T-box 10 126.0065 129 137.7737 130.9257 1.29E−01 3.38E−02 1 Unchanged Low Q16539 J04ef5 mitogen-activated protein kinase 148.7339 219 137.8 168.4312 −1.10E−01 5.57E−01 1 Unchanged Low Q9NQG5 A07gh5 chromosome 20 open reading fr

86.80552 143 137.803 122.4598 6.67E−01 7.18E−01 1 Unchanged Low Q15149 E05ab8 plectin 1; intermediate filament bi 125.7248 83.9 138.0785 115.8848 1.35E−01 −5.84E−01 1 Unchanged Low Q9NVZ7 G12gh3 hypotheitical protein FLJ10407 166.213 175 138.1444 159.6342 −2.67E−01 7.06E−02 1 Unchanged Low Q15800 D02cd2 sterol-C4-methyl oxidase-like 171.8648 71.2 138.1497 127.0641 −3.15E−01 −1.27E+00 1 Unchanged Low Q9H086 D16gh5 hypothetical protein FLJ12387 si 96.54943 129 138.1542 121.3672 5.17E−01 4.22E−01 1 Unchanged Low P09001 K14cd7 mitochondrial ribosomal protein

94.17331 128 138.1601 120.1502 5.53E−01 4.44E−01 1 Unchanged Low O00301 D24cd3 KH-type splicing regulatory prote

126.0509 88.3 138.3014 117.5428 1.34E−01 −5.14E−01 1 Unchanged Low P55786 J19ef7 aminopeptidase puromycin sensi 273.7328 98.9 138.3924 170.346 −9.84E−01 −1.47E+00 1 Unchanged Low Q9Y5Y9 B14cd2 sodium channel; voltage-gated;

127.3727 139 138.4331 134.9928 1.20E−01 1.28E−01 1 Unchanged Low P19235 M01ef7 erythropoietin receptor 198.5954 77.3 138.4803 138.1099 −5.20E−01 −1.36E+00 1 Unchanged Low O15228 A16ef3 glyceronephosphate O-acyltrans 225.1315 186 138.5137 183.349 −7.01E−01 −2.72E−01 1 Unchanged Low Q9UK97 K05cd8 F-box only protein 9 151.0501 104 138.5593 131.097 −1.25E−01 −5.43E−01 1 Unchanged Low P50990 D20cd6 chaperonin containing TCP1; sut 274.982 178 138.6001 197.1593 −9.88E−01 −6.28E−01 1 Unchanged Low Q9NZM1 P19cd8 fer-1-like 3; myoferlin (C. elegans

218.8411 202 138.6209 186.4122 −6.59E−01 −1.17E−01 1 Unchanged Low Q92924 N20cd1 SWI/SNF related; matrix associa

131.7669 82.7 138.6764 117.704 7.37E−02 −6.73E−01 1 Unchanged Low O75845 A18gh1 sterol-C5-desaturase (ERG3 dell 101.9285 153 138.7232 131.1198 4.45E−01 5.83E−01 1 Unchanged Low Q9NQ88 I10gh4 chromosome 12 open reading frs 80.2401 158 138.8274 125.605 7.91E−01 9.75E−01 1 Unchanged Low Q16515 C19ab2 amiloride-sensitive cation channe

102.1159 109 138.9915 116.6136 4.45E−01 9.06E−02 1 Unchanged Low P49759 F16ab5 CDC-like kinase 1 86.24615 147 139.0985 124.2553 6.90E−01 7.73E−01 1 Unchanged Low P33552 A22ab5 CDC28 protein kinase 2 109.5671 96 139.1297 114.8881 3.45E−01 −1.91E−01 1 Unchanged Low O75808 H21cd2 small optic lobes homolog (Dros

115.654 98.9 139.1625 117.8898 2.67E−01 −2.26E−01 1 Unchanged Low Q9NXR1 M07gh2 LIS1-interacting protein NUDE1; 96.20481 123 139.1939 119.5057 5.33E−01 3.56E−01 1 Unchanged Low O75381 L12ab8 peroxisomal biogenesis factor 14 473.8395 113 139.2209 241.8793 −1.77E+00 −2.07E+00 1 Unchanged Low O60930 P23cd1 ribonuclease H1 167.3611 111 139.2393 139.1464 −2.65E−01 −5.95E−01 1 Unchanged Low O14653 P14cd4 golgl SNAP receptor complex me 115.7917 89.7 139.2541 114.9152 2.66E−01 −3.68E−01 1 Unchanged Low Q16540 L24gh1 mitochondrial ribosomal protein

209.2433 120 139.3426 156.1365 −5.87E−01 −8.04E−01 1 Unchanged Low O14658 P08cd2 ras-related C3 botulinum toxin SL 158.176 166 139.3634 154.6374 −1.83E−01 7.29E−02 1 Unchanged Low Q15814 M17cd2 tubulin-specific chaperone c 103.3699 112 139.6311 118.2869 4.34E−01 1.14E−01 1 Unchanged Low Q9Y3C9 J09ef2 CGI-127 protein 83.4762 163 139.6599 128.8568 7.42E−01 9.69E−01 1 Unchanged Low P18827 F22cd1 syndecan 1 114.4045 92.7 139.6607 115.5895 2.88E−01 −3.03E−01 1 Unchanged Low P04150 B21ab3 nuclear receptor subfamily 3; gro 106.6921 103 139.6889 116.6017 3.89E−01 −4.49E−02 1 Unchanged Low Q9Y301 N05ef1 CGI-12 protein 108.0511 101 139.7035 116.3594 3.71E−01 −9.27E−02 1 Unchanged Low O00626 F10cd1 small Inducible cytokine subfamil 113.478 106 139.8189 119.8588 3.01E−01 −9.45E−02 1 Unchanged Low B18cd8 neural precursor cell expressed; 108.1711 133 139.9597 127.048 3.72E−01 2.98E−01 1 Unchanged Low Q9Y311 C01ef2 mitochondrial ribosomal protein

162.8519 74.8 139.9856 125.8788 −2.18E−01 −1.12E+00 1 Unchanged Low Q15633 K14cd2 TAR (HIV) RNA binding protein

169.3779 125 140.0138 144.9588 −2.75E−01 −4.33E−01 1 Unchanged Low P02278 M22gh6 H2B histone family; member K 100.2794 216 140.0965 152.2309 4.82E−01 1.11E+00 1 Unchanged Low P53672 J11cd7 crystallin; beta A2 101.7321 187 140.2804 142.8494 4.64E−01 8.75E−01 1 Unchanged Low P09417 C05ab8 quinoid dihydropteridine reducta

126.6361 161 140.3564 142.5395 1.48E−01 3.43E−01 1 Unchanged Low Q9HAY2 K14gh5 MAGEF1 protein 96.01675 126 140.3654 120.9341 5.48E−01 3.97E−01 1 Unchanged Low P30273 A20ab5 Fc fragment of IgE; high affinity

88.48289 171 140.4541 133.3475 6.67E−01 9.51E−01 1 Unchanged Low Q92949 G10ab4 forkhead box J1 250.4112 167 140.5084 185.89 −8.34E−01 −5.87E−01 1 Unchanged Low Q9GZT9 G01gh7 egl nine homolog 1 (C. elegans) 112.8025 99.2 140.6558 117.5626 3.18E−01 −1.85E−01 1 Unchanged Low P35658 O23cd4 nucleoporin 214 kD (CAIN) 141.8279 137 140.7761 139.8811 −1.07E−02 −4.96E−02 1 Unchanged Low Q9HB40 G01gh5 likely homolog of rat mouse

105.9316 99.3 140.9548 115.3964 4.12E−01 −9.32E−02 1 Unchanged Low O14686 O16cd3 myeloid/lymphoid or mixed-linea

117.844 157 141.0674 138.5398 2.60E−01 4.11E−01 1 Unchanged Low Q92911 O12cd1 solute carrier family 5 (sodium Io

264.1256 125 141.0904 176.594 −9.05E−01 −1.08E+00 1 Unchanged Low Q9Y5E4 B18ef3 protocadherin beta 5 95.08061 148 141.1894 127.9379 5.70E−01 6.34E−01 1 Unchanged Low Q13057 H17gh7 nucleotide binding protein 186.8796 125 141.2202 151.0906 −4.04E−01 −5.78E−01 1 Unchanged Low Q14863 B23ab8 POU domain; class 6; transcripti

103.2077 103 141.3258 115.7954 4.53E−01 −4.97E−03 1 Unchanged Low P36610 G10ef3 frequenin homolog (Drosophila) 110.2191 136 141.4925 129.0874 3.60E−01 2.98E−01 1 Unchanged Low O60240 O12ab8 perilipin 1121.108 52.2 141.5046 438.2653 −2.99E+00 −4.43E+00 1 Unchanged Low Q9H9B4 P05gh5 hypothetical protein FLJ12876 87.99841 133 141.7125 120.8973 6.87E−01 5.96E−01 1 Unchanged Low O00584 J14cd3 ribonuclease 6 precursor 124.6932 250 141.8008 172.0542 1.85E−01 1.00E+00 1 Unchanged Low Q9H658 M04gh7 G protein-coupled receptor 107 158.2595 214 141.8139 171.1973 −1.58E−01 4.32E−01 1 Unchanged Low P18858 K14ef6 ligase I; DNA; ATP-dependent 92.33071 128 141.8761 120.8853 6.20E−01 4.76E−01 1 Unchanged Low Q02877 D23cd1 ribosomal protein L26 449.1728 297 141.8851 295.8854 −1.66E+00 −5.99E−01 1 Unchanged Low P15588 J07ab4 glucosamine (N-acetyl)-6-sulfat

261.466 119 141.968 174.2861 −8.81E−01 −1.13E+00 1 Unchanged Low P42696 H08ef4 KIAA0117 protein 110.9202 231 141.9948 161.4649 3.56E−01 1.06E+00 1 Unchanged Low O75710 A17ef1 molybdenum cofactor synthesis

105.3087 101 142.0352 116.2449 4.32E−01 −5.47E−02 1 Unchanged Low Q9NPI8 C01gh2 Fanconl anemia; complementalic 193.8104 214 142.0643 183.3737 −4.48E−01 1.45E−01 1 Unchanged Low Q9HAR6 O10gh5 uterine-derived 14 kDa protein 118.9551 198 142.0669 152.8734 2.56E−01 7.32E−01 1 Unchanged Low P15018 O18ef7 leukemia inhibitory factor (cholin

253.8099 309 142.2733 235.0602 −8.35E−01 2.84E−01 1 Unchanged Low Q13546 A23cd4 receptor (TNFRSF)-interacting s

139.7074 131 142.2746 137.7012 2.63E−02 −9.15E−02 1 Unchanged Low P24298 H01ab4 glutamic-pyruvate transaminase

210.426 97.1 142.3123 149.9584 −5.64E−01 −1.12E+00 1 Unchanged Low Q14129 C22cd4 DIGeorge syndrome critical regio 112.1253 141 142.4302 131.8973 3.45E−01 3.32E−01 1 Unchanged Low Q9BQA2 K09gh8 KIAA1882 protein 164.9357 187 142.4325 164.7437 −2.12E−01 1.80E−01 1 Unchanged Low Q9UJX9 B12ef3 hypothetical protein; estradiol-in

121.7396 98.5 142.5053 120.9085 2.27E−01 −3.06E−01 1 Unchanged Low Q99590 I01cd5 splicing factor; arginine/serine-ri

231.0328 199 142.5273 190.7413 −6.97E−01 −2.18E−01 1 Unchanged Low O14798 C06ef7 tumor necrosis factor receptor su 142.6951 213 142.5294 166.073 −1.68E−03 5.78E−01 1 Unchanged Low P32238 P01ab3 cholecystokinin A receptor 487.368 168 142.5911 265.9537 −1.77E+00 −1.54E+00 1 Unchanged Low Q9UQ90 C17cd2 spastic paraplegia 7; paraplegin 101.2857 146 142.6321 129.9052 4.94E−01 5.26E−01 1 Unchanged Low P82980 M03gh8 retinot binding protein 5; cellular 111.2191 93.9 142.6923 115.9454 3.60E−01 −2.44E−01 1 Unchanged Low P49716 P15ab5 CCAAT/enhancer binding protei

169.1889 73.4 142.8277 128.4871 −2.44E−01 −1.20E+00 1 Unchanged Low P20062 M12cd1 transcobalamin II; macrocytic an

125.6347 141 142.8402 136.6279 1.85E−01 1.71E−01 1 Unchanged Low P21580 B06cd2 tumor necrosis factor, alpha-indu 275.8225 317 142.8664 245.0939 −9.49E−01 1.99E−01 1 Unchanged Low Q99774 H01cd5 protein phosphatase 4; regulator 195.85 173 143.1867 170.7835 −4.52E−01 −1.76E−01 1 Unchanged Low Q9P0T1 A17ef3 hypothetical protein HSPC192 104.4363 101 143.2517 116.1881 4.56E−01 −5.00E−02 1 Unchanged Low P06737 B18ab8 phosphorylase; glycogen; liver (

85.14818 139 143.2732 122.6343 7.51E−01 7.12E−01 1 Unchanged Low O15063 K10gh1 KIAA0355 gene product 149.9191 144 143.2945 145.705 −6.52E−02 −5.91E−02 1 Unchanged Low P02743 K14ab2 amyloid P component; serum 108.0152 94.7 143.3031 115.3343 4.08E−01 −1.90E−01 1 Unchanged Low Q9NVT0 I14gh3 hypothetical protein FLJ10534 136.4264 109 143.3056 129.6057 7.10E−02 −3.23E−01 1 Unchanged Low Q9Y4P3 O07ef3 transducin (beta)-like 2 112.0852 104 143.4853 119.7013 3.56E−01 −1.14E−01 1 Unchanged Low Q13886 N14ab3 basic transcription element bindi

164.4049 88.7 143.5269 132.2194 −1.96E−01 −8.90E−01 1 Unchanged Low Q9NVP8 L19gh4 hypothetical protein FLJ10595 101.7956 106 143.5829 117.1232 4.96E−01 5.83E−02 1 Unchanged Low P08240 G05cd2 signal recognition particle recept

158.3565 132 143.6823 144.5673 −1.40E−01 −2.66E−01 1 Unchanged Low P49459 M19ef5 ubiquitin-conjugating enzyme E2 98.6462 170 143.74 137.6267 5.43E−01 7.89E−01 1 Unchanged Low Q9NVAB L16gh2 solute carrier family 38; member 112.6488 127 143.7595 127.9498 3.52E−01 1.78E−01 1 Unchanged Low P25325 K23cd3 mercaptopyruvate sulfurtransfer

288.1435 274 143.8077 235.1972 −1.00E+00 −7.45E−02 1 Unchanged Low Q9UHI6 K08cd7 DEAD/H (Asp-Glu-Ala-Asp-His) t 135.6699 209 143.8383 162.7208 8.43E−02 6.21E−01 1 Unchanged Low P52298 H01cd7 nuclear cap binding protein subu 138.9223 191 143.8819 157.996 5.06E−02 4.61E−01 1 Unchanged Low Q9NQ30 A10cd7 endothelial cell-specific molecul

104.1846 122 143.9703 123.2921 4.67E−01 2.24E−01 1 Unchanged Low O00541 I08ef3 pescadillo homolog 1; containing 180.43 204 144.0988 176.2086 −3.24E−01 1.78E−01 1 Unchanged Low Q9H2V9 B06gh7 hypothetical protein CDA08 173.5608 169 144.1057 162.3327 −2.68E−01 −3.56E−02 1 Unchanged Low Q9NNX1 F12gh1 tuftelin 1 147.0323 175 144.106 155.2699 −2.90E−02 2.49E−01 1 Unchanged Low Q13508 H14ab2 ADP-ribosyltransferase 3 109.4052 101 144.1545 118.095 3.98E−01 −1.19E−01 1 Unchanged Low Q9NR30 B21gh6 DEADE/H (Asp-Glu-Ala-Asp/His) t 110.4836 130 144.2348 128.2929 3.85E−01 2.36E−01 1 Unchanged Low Q14320 E15cd5 DNA segment on choromosome X 102.5057 178 144.2677 141.6929 4.93E−01 7.99E−01 1 Unchanged Low Q04726 D03cd2 transducin-like enhancer of split: 211.8773 115 144.3217 156.9544 −5.54E−01 −8.86E−01 1 Unchanged Low P20061 N13cd1 transcobalamin I (vitamin B12 bi

177.3445 85.5 144.4835 115.787 3.00E−01 −4.56E−01 1 Unchanged Low Q9Y2Y1 J12ef2 polymerase (RNA) III (DNA direc 153.7426 145 144.5561 147.7222 −8.89E−02 −8.58E−02 1 Unchanged Low P35754 G22ab5 glutaredoxin (thioltransferase) 153.823 138 144.7308 145.4287 −8.79E−02 −1.59E−01 1 Unchanged Low Q02978 F01cd3 solute carrier family 25 (mitocho

106.877 98.2 144.7822 116.628 4.38E−01 −1.22E−01 1 Unchanged Low O95792 N20gh2 protein associated with PRK1 130.6914 146 144.7909 140.5872 1.48E−01 1.63E−01 1 Unchanged Low Q13232 D20ef7 non-metastaic cells 3; protein e

90.7906 156 144.8861 130.592 6.74E−01 7.82E−01 1 Unchanged Low Q9NVH2 L01ef8 DKFZP434B168 protein 117.6587 91.2 144.9821 117.932 3.01E−01 −3.68E−01 1 Unchanged Low Q15561 O15cd2 TEA domain family member 4 234.306 172 145.3307 183.8604 −6.89E−01 −4.46E−01 1 Unchanged Low Q9UPN9 B01ef2 tripartite motif-containing 33 110.9269 135 145.3321 130.2668 3.90E−01 2.78E−01 1 Unchanged Low Q14353 O06ab3 guanidinoaceate N-methyltrans

109.1385 103 145.3798 119.1987 4.14E−01 −8.24E−02 1 Unchanged Low Q9NZM5 A18ef4 glioma tumor suppressor candid

150.098 122 145.587 139.1802 −4.40E−02 −3.01E−01 1 Unchanged Low O43255 B11cd2 seven in absentia homolog 2 (D

114.6318 101 145.653 120.4593 3.46E−01 −1.81E−01 1 Unchanged Low Q14331 G04ab5 FSHD region gene 1 164.0964 176 145.6576 161.7807 −1.72E−01 9.77E−02 1 Unchanged Low P18847 N23ab5 activating transcription factor 3 127.5442 154 145.6654 142.5299 1.92E−01 2.75E−01 1 Unchanged Low O60258 I07cd4 fibroblast growth factor 17 159.7671 223 145.6821 176.0472 −1.33E−01 4.79E−01 1 Unchanged Low P47929 P02ab6 lectin; galactoside-binding; solub 151.1595 92.8 145.699 129.8767 −5.31E−02 −7.04E−01 1 Unchanged Low P35227 O14cd4 zinc finger protein 144 (Mel-18) 108.2295 151 145.8554 135.0089 4.30E−01 4.80E−01 1 Unchanged Low Q15599 O15cd5 solute carrier family 9 (sodium/h

168.9673 80.5 145.993 131.8082 −2.11E−01 −1.07E−00 1 Unchanged Low Q9UKJ5 B20cd7 cystein-rich hydrophobic domain 184.4717 206 145.9967 178.8637 −3.37E−01 1.60E−01 1 Unchanged Low Q9HCB9 C10gh5 chromosome 1 open reading frar 94.16759 126 146.1683 122.1779 6.34E−01 4.22E−01 1 Unchanged Low Q9Y3A0 K07ef2 CGI-92 protein 119.1033 176 146.1698 147.7783 2.95E−01 5.80E−01 1 Unchanged Low P49815 M17ef6 tuberous sclerosis 2 106.0159 163 146.2712 138.4231 4.64E−01 6.20E−01 1 Unchanged Low P25116 L19ab4 coagulation factor II (thrombin) r

82.48228 143 146.2742 123.8585 8.27E−01 7.92E−01 1 Unchanged Low O75829 O01cd7 chondromodulin I precursor 121.7658 119 146.4876 128.9495 2.67E−01 −3.81E−02 1 Unchanged Low Q9NYI1 M16ef2 ECSIT 111.7926 110 146.6345 122.8588 3.91E−01 −2.14E−02 1 Unchanged Low P24347 I24ef5 matrix metalloproteinase 11 (stro 97.57916 136 146.649 126.9018 5.88E−01 4.84E−01 1 Unchanged Low O43189 K24ab8 PHD finger protein 1 112.1101 101 146.6925 120.038 3.88E−01 −1.46E−01 1 Unchanged Low Q9P029 N22ef2 TH1-like (Drosophila) 201.2292 159 146.6998 168.9188 −4.56E−01 −3.41E−01 1 Unchanged Low Q9NZP9 E17ef2 immediate early response 5 105.1683 157 146.761 136.3041 4.81E−01 5.78E−01 1 Unchanged Low Q9UIA3 I12ef2 neutral sphingomyelinase 165.6408 147 146.8134 153.0756 −1.74E−01 −1.74E−01 1 Unchanged Low Q99734 M12ef5 Notch homolog 2 (Drosophila) 220.4251 263 147.0111 210.2011 −5.84E−01 2.56E−01 1 Unchanged Low O00411 C19cd1 polymerase (RNA) mitochondrial

120.5078 105 147.0481 124.1084 2.87E−01 −2.02E−01 1 Unchanged Low P28347 P04gh1 TEA domain family member 1 (S

230.2101 174 147.0913 183.776 −6.46E−01 −4.04E−01 1 Unchanged Low Q13619 G19gh1 cullin 4A 153.1592 218 147.2043 172.6621 −5.72E−02 5.07E−01 1 Unchanged Low O94929 O06ef8 KIAA0843 protein 108.7821 99.4 147.2921 118.4779 4.37E−01 −1.31E−01 1 Unchanged Low Q9P026 A02ef8 HSPC134 protein 115.4895 184 147.3205 149.0331 3.51E−01 6.74E−01 1 Unchanged Low P28067 D08ab5 major histocompatibility complex; 128.7098 100 147.3934 125.4983 1.96E−01 −3.58E−01 1 Unchanged Low Q14126 E11ef7 desmoglein 2 426.8387 366 147.4196 313.3393 −1.53E+00 −2.23E−01 1 Unchanged Low Q14267 P01cd1 regulatory factor X: 4 (influences 127.7912 98.9 147.4351 124.7021 2.06E−01 −3.70E−01 1 Unchanged Low P55197 H09ab2 myeloid/lymphold or mixed-linea

160.668 185 147.4439 164.3164 −1.24E−01 2.02E−01 1 Unchanged Low Q9NP87 O20cd8 polymerase (DNA directed); mu 115.1765 86.7 147.4845 116.4497 3.57E−01 −4.10E−01 1 Unchanged Low P04155 A04cd2 trefoil factor 1 (breast cancer; es

258.058 136 147.487 180.4791 −8.07E−01 −9.25E−01 1 Unchanged Low Q9C069 N02gh7 sec13-like protein 52.65015 424 147.5255 207.9658 1.49E+00 3.01E+00 1 Unchanged Low P12270 G14cd2 translocated promoter region (to 104.4493 136 147.7447 129.4065 5.00E−01 3.81E−01 1 Unchanged Low Q9UIG6 I14ef2 LPAP for lysophosphatidic acid

218.3106 325 147.8779 230.2685 −5.62E−01 5.72E−01 1 Unchanged Low O15453 P08cd5 NBR2 99.08545 108 147.9143 118.2765 5.78E−01 1.22E−01 1 Unchanged Low Q9UNW8 F17cd8 G protein-coupled receptor 239.3255 347 148.021 244.7569 −6.93E−01 5.36E−01 1 Unchanged Low P06746 I10ef6 polymerase (DNA directed); beta 142.5013 225 148.0351 171.8166 5.50E−02 6.58E−01 1 Unchanged Low O15414 I08cd7 trinucleotide repeat containing 4 131.6219 199 148.0947 159.7305 1.70E−01 6.00E−01 1 Unchanged Low O15259 L22ab7 nephronophthisis 1 (juvanile) 115.0436 110 148.3613 124.437 3.67E−01 −6.59E−02 1 Unchanged Low Q9NRA8 P05gh4 eIF4E-transporter 106.343 178 148.4323 144.3142 4.81E−01 7.45E−01 1 Unchanged Low Q9NP77 C10ef8 HSPC182 protein 171.17 175 148.5234 165.0639 −2.05E−01 3.60E−02 1 Unchanged Low Q06587 P17cd1 ring finger protein 1 119.2377 127 148.657 131.6381 3.81E−01 9.12E−02 1 Unchanged Low Q9Y5Z5 E22ef2 heme binding protein 1 181.0768 196 148.7681 175.2357 −2.84E−01 1.13E−01 1 Unchanged Low O15327 I05cd4 inositol polyphosphate-4-phosph 183.6815 131 148.785 154.5722 −3.04E−01 −4.85E−01 1 Unchanged Low P49646 P19cd1 regulator of mitotic spindle assen 143.9463 117 148.8487 136.7074 4.83E−02 −2.95E−01 1 Unchanged Low Q99809 F16cd5 conserved gene amplified in oste

134.0126 91.3 148.9901 124.7728 1.53E−01 −5.53E−01 1 Unchanged Low Q9UBM1 G02cd7 phosphatidylethanolamine N-mel 138.4849 122 149.0109 136.3565 1.06E−01 −1.86E−01 1 Unchanged Low P16403 G04ab6 H1 histone family; member 2 427.1258 558 149.1016 377.9287 −1.52E+00 3.84E−01 1 Unchanged Low O75503 B01ab4 ceroid-lipofuscinosis; neuronal 5 148.9991 75.4 149.1361 124.5021 1.33E−03 −9.83E−01 1 Unchanged Low P15814 P20gh6 immunoglobulin lambada-like poly 78.91644 144 149.2005 123.9169 9.19E−01 6.64E−01 1 Unchanged Low Q03164 N01ab7 myeloid/lymphoid or mixed-linea

157.0713 81.9 149.358 129.4559 −7.26E−02 −9.39E−01 1 Unchanged Low Q13624 B08ef6 interleukin enhancer binding fact 136.4076 130 149.4265 138.6386 1.32E−01 −6.85E−02 1 Unchanged Low Q14118 M02ab5 dystroglycan 1 (dystrophin-assoc 105.7987 99 149.6192 118.1383 5.00E−01 −9.59E−02 1 Unchanged Low Q13286 E20ab3 ceroid-lipofuscinosis; neuronal 3; 240.521 302 149.6542 230.6187 −6.85E−01 3.27E−01 1 Unchanged Low Q9Y5Q0 E15gh7 fatty acid desaturase 3 117.0825 115 149.704 127.2281 3.55E−01 −2.72E−02 1 Unchanged Low Q9P0R1 K08ef2 forkhead box P1 99.17408 114 149.7517 120.8481 5.95E−01 1.96E−01 1 Unchanged Low P41182 C24ab5 B-cell CLL/lymphoma 6 (zinc fing 115.9704 85.9 149.853 117.2275 3.70E−01 −4.34E−01 1 Unchanged Low O75497 K14cd6 microspherute protein 1 145.7927 163 149.9313 153.0143 4.04E−02 1.64E−01 1 Unchanged Low Q14185 M19ab4 dedicator of cyto-kinesis 1 95.3322 112 150.0398 118.9819 6.54E−01 2.27E−01 1 Unchanged Low O95163 P05cd3 inhibitor of kappa light polypeptic 203.0161 120 150.0489 157.6357 −4.36E−01 −7.60E−01 1 Unchanged Low Q14508 L05ef7 WAP four-disulfide core domain: 102.6084 201 150.0782 151.3745 5.49E−01 9.73E−01 1 Unchanged Low P25942 M21ef7 tumor necrosis factor receptor su 110.0933 239 150.083 166.2403 4.47E−01 1.12E+00 1 Unchanged Low Q9Y6E0 F15cd3 serine/threonine kinase 24 (STE: 206.7079 225 150.279 194.1145 −4.60E−01 1.25E−01 1 Unchanged Low Q9UQF2 J21cd5 mitogen-activated protein kinase 229.9384 182 150.2902 187.4786 −6.13E−01 −3.36E−01 1 Unchanged Low Q9Y285 D11ab5 phenylalanine-tRNA synthetase-

179.7613 145 150.3716 158.2291 −2.58E−01 −3.14E−01 1 Unchanged Low Q04762 F09ab4 cell matrix adhesion regulator 134.1594 176 150.3997 153.4581 1.65E−01 3.90E−01 1 Unchanged Low Q9Y6J9 P19ef6 TAF6-like RNA polymerase II; p3 77.59128 158 150.4181 128.6968 9.55E−01 1.03E+00 1 Unchanged Low O43913 C06ab8 origin recognition complex; subu

147.9187 168 150.4866 155.6272 2.48E−02 1.88E−01 1 Unchanged Low P25208 M05cd1 nuclear transcription factor Y; be

106.4662 138 150.5231 131.7807 4.99E−01 3.77E−01 1 Unchanged Low Q9H9X4 F03gh5 hypothetical protein FLJ11618 189.58 179 150.5879 173.1977 −3.32E−01 −7.94E−02 1 Unchanged Low O95297 P17cd4 myelin protein zero-like 1 127.461 121 150.7509 133.0095 2.42E−01 −7.72E−02 1 Unchanged Low Q9UPG8 O06ab8 pleiomorphic adenoma gene-like 134.8747 165 150.9533 150.4388 1.62E−01 2.95E−01 1 Unchanged Low P16333 H16ef5 NCK adaptor protein 1 237.1463 351 150.9549 246.4108 −6.52E−01 5.66E−01 1 Unchanged Low Q14108 I22ab5 CD36 antigen (collagen type I re

155.206 139 150.9785 148.3416 −3.98E−02 −1.61E−01 1 Unchanged Low Q9UFF9 O05cd5 CCR4-NOT transcription comple

162.9025 208 151.0687 174.1041 −1.09E−01 3.55E−01 1 Unchanged Low O15242 O19ab8 nardilysin (N-arginine dibasic co

210.0164 198 151.1245 186.2788 −4.75E−01 −8.72E−02 1 Unchanged Low Q13442 N15ef3 PDGFA associated protein 1 156.1376 188 151.1314 165.0545 −4.70E−02 2.67E−01 1 Unchanged Low Q99755 A15ef6 phosphatidylinositol-4-phosphat

112.2177 146 151.3432 136.4804 4.32E−01 3.78E−01 1 Unchanged Low Q9NZV1 E09gh2 cysteine-rich motor neuron 1 112.5932 99.1 151.3541 121.0073 4.27E−01 −1.85E−01 1 Unchanged Low Q05195 C09ab7 MAX dimerization protein 136.8996 254 151.5662 180.6838 1.47E−01 8.89E−01 1 Unchanged Low O95671 J14ab2 acetylserotonin O-methyltransfer

99.67178 98.5 151.7064 116.6189 6.06E−01 −1.74E−02 1 Unchanged Low Q9Y658 A09ef2 RNA helicase 112.9715 95.3 151.8988 120.0494 4.27E−01 −2.46E−01 1 Unchanged Low Q9BTU6 N12gh6 phosphatidylinositol 4-kinase typ 97.30862 178 151.965 142.5367 6.43E−01 8.74E−01 1 Unchanged Low Q9UPN6 G04ef8 KIAA1116 protein 127.681 113 152.0268 130.9046 2.52E−01 −1.76E−01 1 Unchanged Low O00170 J03ab2 aryl hydrocarbon receptor intera

555.1127 223 152.0508 310.1793 −1.87E+00 −1.31E+00 1 Unchanged Low Q9UJW6 P01ef3 activity-regulated cytosketelon-a

221.8559 185 152.1474 186.4423 −5.44E−01 −2.60E−01 1 Unchanged Low Q9HCT0 N02ef8 fibroblast growth factor 22 157.7471 126 152.2042 145.1536 −5.16E−02 −3.30E−01 1 Unchanged Low Q15459 O03cd6 splicing factor 3a; subunit 1; 120

163.4432 145 152.3945 153.5048 −1.01E−01 −1.76E−01 1 Unchanged Low O95400 G16cd6 CD2 antigen (cytoplasmic tail) b

192.2313 238 152.5257 194.1745 −3.34E−01 3.07E−01 1 Unchanged Low P07954 M06ab3 fumarate hydratase 121.2546 142 152.5652 138.7259 3.31E−01 2.31E−01 1 Unchanged Low Q9H6Z5 C16gh5 hypothetical protein FLJ21634 101.1467 152 152.6745 135.2933 5.94E−01 5.88E−01 1 Unchanged Low Q9HCN8 A05gh1 stromal cell-derived factor 2-like 136.5604 128 152.9097 139.1775 1.63E−01 −9.27E−02 1 Unchanged Low Q92890 A24cd4 ubiquitin fusion degradation 1-lik 157.2559 220 152.9538 176.6159 −4.00E−02 4.82E−01 1 Unchanged Low O43324 N24cd4 eukaryotic translation elongation 150.6748 112 152.9613 138.6164 2.17E−02 −4.25E−01 1 Unchanged Low Q9NVU8 H10gh2 hypothetical protein FLJ10496 145.4398 119 152.9651 139.1241 7.28E−02 −2.90E−01 1 Unchanged Low Q9NQW6 H01ef4 anillin; actin binding protein (scr

113.8655 85.6 152.992 117.4953 4.26E−01 −4.11E−01 1 Unchanged Low Q9NWH4 L01gh2 mitochondrial ribosomal protein

173.4347 107 153.0783 144.3461 −1.80E−01 −7.03E−01 1 Unchanged Low Q9UBV8 M13cd8 PEF protein with a long N-termin

146.0371 144 153.0828 148.3188 4.84E−02 −4.15E−02 1 Unchanged Low P15328 F10ab3 folate receptor 1 (adult) 152.5051 123 153.1163 142.7655 5.77E−03 −3.14E−01 1 Unchanged Low Q9Y583 B01cd6 NS1-associated protein 1 143.6283 177 153.2797 157.8847 9.38E−02 2.99E−01 1 Unchanged Low Q07326 M08ab8 phosphatidylinositol glycan; clas

132.6521 93 153.3084 126.3257 2.09E−01 −5.12E−01 1 Unchanged Low O75396 M12cd5 SEC22 vesicle trafficking protein

143.9018 153 153.3626 150.1024 9.19E−02 8.88E−02 1 Unchanged Low Q9Y2Z8 D09ef2 CGI-09 protein 117.2943 110 153.5282 126.8764 3.88E−01 −9.52E−02 1 Unchanged Low Q9H3P7 N05gh5 golgi phosphoprotein 1 251.3681 258 153.65 220.9899 −7.10E−01 3.73E−02 1 Unchanged Low O95678 E03cd5 cytokeratin type II 339.3692 195 153.797 229.3684 −1.14E+00 −8.00E−01 1 Unchanged Low P17026 M04cd4 zinc finger protein 22 (KOX 15) 152.726 88.3 153.8779 131.6407 1.08E−02 −7.90E−01 1 Unchanged Low Q9Y3N9 M05gh7 olfactory receptor; family 2; subf

127.2527 137 153.9228 139.4653 2.75E−01 1.09E−01 1 Unchanged Low Q9BYT8 K08gh7 neurolysin (metallopeptidase M3 85.99781 193 154.0005 144.2719 8.41E−01 1.16E+00 1 Unchanged Low Q9UHQ7 F02ef8 pp21 homolog 119.2248 136 154.0057 136.5651 3.69E−01 1.95E−01 1 Unchanged Low O60921 A22ab7 HUS1 checkpoint homolog (S. p

148.5716 204 154.126 169.0172 5.29E−02 4.60E−01 1 Unchanged Low O00400 D05ab2 acetyl-Coenzyme A transporter 196.9505 124 154.2012 158.3654 −3.53E−01 −6.68E−01 1 Unchanged Low Q9Y690 H01gh6 mortality factor 4 253.2426 259 154.2307 222.1522 −7.15E−01 3.23E−02 1 Unchanged Low Q9NZL9 L24ef7 methionine adenosyltransferase 128.4144 99.7 154.2681 127.4733 2.65E−01 −3.65E−01 1 Unchanged Low O60563 A05ab4 cyclin T1 179.5706 171 154.2911 168.3854 −2.19E−01 −6.81E−02 1 Unchanged Low P20591 M03ab7 myxovirus (influenza virus) resist 459.0611 873 154.338 495.4752 −1.57E+00 9.27E−01 1 Unchanged Low Q9BQC6 P14gh5 mitochondrial ribosomal protein

188.6422 74.3 154.357 139.1028 −2.89E−01 −1.34E+00 1 Unchanged Low P28838 J02ef1 leucine aminopeptidase 3 409.1007 383 154.3828 315.6553 −1.41E+00 −9.33E−02 1 Unchanged Low Q9NZE5 P08ef1 hypothetical protein LOC51319 135.1502 171 154.3904 153.3881 1.92E−01 3.36E−01 1 Unchanged Low Q9NX47 K10gh2 hypothetical protein FLJ20445 299.3918 338 154.4327 263.9291 −9.55E−01 1.75E−01 1 Unchanged Low O60612 K11cd2 supervillin 113.628 270 154.4497 179.421 4.43E−01 1.25E+00 1 Unchanged Low O00559 F22cd4 estrogen receptor binding site as 181.5726 147 154.679 160.9495 −2.31E−01 −3.09E−01 1 Unchanged Low Q9NUU9 E17gh3 hypothetical protein F23149_1 140.3785 224 154.7106 172.9723 1.40E−01 6.73E−01 1 Unchanged Low P22059 C10ab8 oxysterol binding protein 133.2924 93.6 154.8714 127.2507 2.16E−01 −5.10E−01 1 Unchanged Low O00408 I05ef6 phosphodiesterase 2A; cGMP-sti 860.2983 169 154.9688 394.9107 −2.47E+00 −2.34E+00 1 Unchanged Low O94935 P22ef7 SAC1 suppressor of actin mutati

146.0417 128 154.9914 142.9113 8.58E−02 −1.94E−01 1 Unchanged Low P41134 H15ef5 inhibitor of DNA binding 1; domi

434.1844 292 155.0439 293.8674 −1.49E+00 −5.70E−01 1 Unchanged Low P24407 M08ab7 mel transforming oncogene (deri

224.1153 189 155.1684 189.5598 −5.30E−01 −2.43E−01 1 Unchanged Low O00232 N05ab8 proteasome (prosome; macropa

122.517 139 155.2465 139.0276 3.42E−01 1.85E−01 1 Unchanged Low Q01432 G04ab2 adenosine monophosphate dea

111.1766 117 155.341 127.7664 4.83E−01 7.10E−02 1 Unchanged Low Q13525 G15cd4 interleukin 1 receptor-like 2 136.0802 130 155.4674 140.5051 1.92E−01 −6.63E−02 1 Unchanged Low Q16611 N04ab3 BCL2-antagonist/killer 1 280.4131 194 155.5414 210.0516 −8.50E−01 −5.30E−01 1 Unchanged Low Q9NPA3 C11gh5 hyphothetical protein STRAIT114

112.5378 85.5 155.5531 117.8671 4.67E−01 −3.96E−01 1 Unchanged Low Q9GZM8 D14gh7 LIS1-interacting protein NUDEL; 137.8235 131 155.5611 141.4354 1.75E−01 −7.41E−02 1 Unchanged Low P42702 P06ab6 leukemia inhibitory factor recept

92.44914 112 155.6189 120.0363 7.51E−01 2.77E−01 1 Unchanged Low Q05940 P07ef5 solute carrier family 10 (vesicular 374.4901 153 155.637 227.6447 −1.27E+00 −1.29E+00 1 Unchanged Low Q9Y3Q5 H18cd6 putative DNA/chromatin binding

75.96908 150 155.6726 127.0621 1.04E+00 9.77E−01 1 Unchanged Low Q15756 H08ab7 potassium inwardly-rectifying ch

149.0689 80.9 155.7504 128.583 6.33E−02 −8.81E−01 1 Unchanged Low O75386 M17cd3 tubby like protein 3 128.6914 82.7 155.7811 122.3782 2.76E−01 −6.39E−01 1 Unchanged Low P50750 D03ef5 cyclin-dependent kinase 9 (CDC: 270.8229 215 155.8317 213.7777 −7.97E−01 −3.35E−01 1 Unchanged Low Q9NWY6 A18gh3 hypothetical protein FLJ20531 91.85185 130 156.1332 125.9903 7.65E−01 5.01E−01 1 Unchanged Low P50391 K05cd1 pancreatic polypeptide receptor 136.5278 112 156.1953 134.9143 1.94E−01 −2.85E−01 1 Unchanged Low Q9NX07 L20gh6 tRNA selenocysteine associated 258.434 287 156.2449 233.9363 −7.26E−01 1.52E−01 1 Unchanged Low O75354 A15ab4 ectonucleoside triphosphate dip

386.4989 258 156.4638 267.133 −1.30E+00 −5.81E−01 1 Unchanged Low Q9H832 L12gh5 hypothetical protein FLJ13855 173.4437 307 156.9292 212.3427 −1.44E−01 8.22E−01 1 Unchanged Low Q9UBW8 F18ef1 COP9 constitutive photomorpho

102.8052 111 157.0119 123.4686 6.11E−01 1.05E−01 1 Unchanged Low P14136 E23ab5 glial fibriliary acidic protein 108.166 86.6 157.2761 117.3353 5.40E−01 −3.21E−01 1 Unchanged Low Q9NYF3 F08ef1 chromosome 5 open reading frar 121.4116 94.3 157.5806 124.4392 3.76E−01 −3.64E−01 1 Unchanged Low Q15056 A09gh2 Williams-Beuren syndrome chror 202.4969 124 157.6763 161.3602 −3.61E−01 −7.09E−01 1 Unchanged Low O15534 I16ab8 period homolog 1 (Drosophila) 237.2007 143 157.7195 179.3665 −5.89E−01 −7.28E−01 1 Unchanged Low Q9Y399 O21ef2 mitochondrial ribosomal protein

229.9134 139 157.7339 175.5893 −5.44E−01 −7.25E−01 1 Unchanged Low O14972 A04cd6 Down syndrome critical region g

230.0837 267 157.7386 218.3678 −5.45E−01 2.16E−01 1 Unchanged Low Q14113 M15ab2 AE binding protein 1 124.9796 95.3 157.955 126.0667 3.38E−01 −3.92E−01 1 Unchanged Low O95755 O18cd5 RA836; member RAS oncogene 132.9919 97 158.0474 129.3518 2.49E−01 −4.55E−01 1 Unchanged Low Q9NPC3 I09gh4 enhancer of invasion 10 104.2128 121 158.1023 127.8011 6.01E−01 2.17E−01 1 Unchanged Low Q9Y6E9 N24cd7 sirtuin silent mating type informal 111.8557 153 158.2227 140.9006 5.00E−01 4.48E−01 1 Unchanged Low Q9Y5B8 D17cd8 NME7 92.69165 116 158.2444 122.4719 7.72E−01 3.30E−01 1 Unchanged Low P49642 I21ab6 primase; polypeptide 1 (49 kD) 135.2376 70.2 158.2887 121.2327 2.27E−01 −9.47E−01 1 Unchanged Low O60660 J04ab2 ash2 (absent; small; or homeotic 274.3502 177 158.3372 203.1619 −7.93E−01 −6.34E−01 1 Unchanged Low Q9H251 O08gh7 cadherin related 23 113.1038 184 158.4524 151.9031 4.86E−01 7.03E−01 1 Unchanged Low Q9Y6C2 A22cd7 elastin microfibril interface locate 107.9751 92.2 158.6648 119.6097 5.55E−01 −2.28E−01 1 Unchanged Low O95825 D13cd5 crystallin; zeta (quinone reducta

144.0183 133 158.6719 145.1487 1.40E−01 −1.17E−01 1 Unchanged Low Q9UHG3 J02ef2 prenylcysteine lyase 250.3969 207 158.8419 205.2993 −6.57E−01 −2.77E−01 1 Unchanged Low O00629 J18ab6 karyopherin alpha 4 (importin alp 518.8184 295 158.8458 324.141 −1.71E+00 −8.16E−01 1 Unchanged Low Q15397 B14gh1 KIAA0020 gene product 109.8533 134 158.9595 134.3527 5.33E−01 2.89E−01 1 Unchanged Low Q14999 H01gh1 KIAA0076 gene product 71.35119 173 159.0037 134.6153 1.16E+00 1.28E+00 1 Unchanged Low Q12772 M18cd2 sterol regulatory element binding 158.6108 94.6 159.1986 137.4667 5.34E−03 −7.46E−01 1 Unchanged Low O75150 F09gh1 ring finger protein 40 129.2351 169 159.2038 152.3442 3.01E−01 3.84E−01 1 Unchanged Low O43423 L07gh6 acidic (leucine-rich) nuclear pho

140.3006 143 159.4372 147.5392 1.84E−01 2.63E−02 1 Unchanged Low O43311 D12cd8 muscleblind-like (Drosophila) 165.2243 99.4 159.4681 141.3508 −5.12E−01 −7.34E−01 1 Unchanged Low Q9NYX4 B07ef4 calcyon; D1 dopamine receptor-

207.2791 147 159.5302 171.42 −3.78E−01 −4.91E−01 1 Unchanged Low Q9HD71 G04gh4 hypothetical nuclear factor SBB

123.7874 140 159.5491 141.2517 3.66E−01 1.82E−01 1 Unchanged Low Q9NZH2 N03cd8 replication initiation region prote

225.0949 179 159.6113 187.9443 −4.96E−01 −3.30E−01 1 Unchanged Low Q9NVH1 B05gh3 hypothetical protein FLJ10737 137.4673 217 159.6304 171.2625 2.16E−01 6.57E−01 1 Unchanged Low Q9NVG3 B11gh3 hypothetical protein FLJ10751 96.28296 105 159.6829 120.1783 7.30E−01 1.19E−01 1 Unchanged Low P52179 A21cd4 myomesin 1 (skelemin) (185 kD) 157.0608 94 159.8272 136.9676 2.52E−02 −7.40E−01 1 Unchanged Low O94815 B09cd3 frizzled homolog 1 (Drosophila) 93.97877 101 159.9198 118.2939 7.67E−01 1.04E−01 1 Unchanged Low Q9UBY9 G01ef4 heat shock 27 kD protein family;

98.97552 102 160.1725 120.3216 6.94E−01 4.08E−02 1 Unchanged Low Q9NVX7 G18gh3 hypothetical protein FLJ10450 111.5198 121 160.2507 130.905 5.23E−01 1.17E−01 1 Unchanged Low O95704 A02cd6 FE65-like protein 2 99.35088 115 160.3239 124.7475 6.90E−01 2.06E−01 1 Unchanged Low P19801 A23ab2 amiloride binding protein 1 (amin 164.6296 68.3 160.3477 131.0836 −3.80E−02 −1.27E+00 1 Unchanged Low O43709 L18ef3 Williams Beuren syndrome chror 127.8538 134 160.4415 140.7855 3.28E−01 6.84E−02 1 Unchanged Low Q12839 N24ef1 H326 109.677 116 160.6141 128.8096 5.50E−01 8.26E−02 1 Unchanged Low O43503 D10ab8 RAD51 homolog C (S. cerevisiae 96.34779 97.6 160.6551 118.1934 7.38E−01 1.83E−02 1 Unchanged Low Q07898 J10cd4 CD163 antigen 87.73563 177 160.8614 141.7231 8.75E−01 1.01E+00 1 Unchanged Low O96015 F22cd5 dynein; axonemal; light polypepti 94.54055 251 160.9963 168.8465 7.68E−01 1.41E+00 1 Unchanged Low Q92524 L11ab8 proteasome (prosome; macropal

396.6515 220 161.0391 259.1291 −1.30E+00 −8.52E−01 1 Unchanged Low Q92692 B06ab8 pollovirus receptor-related 2 (her 302.7185 317 161.2569 260.2905 −9.09E−01 6.60E−02 1 Unchanged Low Q9Y6Y8 I16cd7 Sec23-interacting protein p125 104.2429 131 161.2684 132.2965 6.30E−01 3.34E−01 1 Unchanged Low Q9NZ78 J16gh3 uncharcterized bone marrow pn 107.2001 127 161.3587 131.7449 5.90E−01 2.41E−01 1 Unchanged Low Q15120 G15cd1 pyruvate dehydrogenases kinase; 96.64061 107 161.6468 121.6758 7.42E−01 1.43E−01 1 Unchanged Low P35241 F22ab8 radixin 276.6012 213 161.7003 216.9693 −7.74E−01 −3.80E−01 1 Unchanged Low Q9Y326 D23ef2 brain specific protein 359.3582 160 161.7123 227.0406 −1.15E+00 −1.17E+00 1 Unchanged Low Q92600 J03cd5 RCD1 required for cell differentia 115.6633 145 161.7142 140.923 4.84E−01 3.30E−01 1 Unchanged Low O00487 N14cd5 26S proteasome-associated pad

329.3518 275 161.8834 255.4035 −1.02E+00 −2.60E−01 1 Unchanged Low Q9Y689 P21cd7 ADP-ribosylation factor-like 5 137.7737 159 161.8965 152.9706 2.33E−01 2.09E−01 1 Unchanged Low Q9ULB8 P05cd8 CMP-NeuAC: (beta)-N-acetylgala 91.01128 121 161.9148 124.5785 8.31E−01 4.09E−01 1 Unchanged Low O60897 L09cd7 RAB; member of RAS oncogene 89.32474 112 162.0127 120.9939 8.59E−01 3.22E−01 1 Unchanged Low P51809 J05cd2 synaptobrevin-like 1 228.3546 141 162.1052 177.2043 −4.94E−01 −6.94E−01 1 Unchanged Low O75581 A03ab7 low density lipoprotein receptor-r 122.4708 125 162.1159 136.4087 4.05E−01 2.53E−02 1 Unchanged Low O43795 F12ef4 myosin class I; myh-1c 259.4543 282 162.137 234.504 −6.78E−01 1.20E−01 1 Unchanged Low Q14188 H17ef5 transcription factor Dp-2 (E2F dir 107.308 204 162.1489 157.7494 5.96E−01 9.25E−01 1 Unchanged Low P06280 B07ab3 galactosidase; alpha 178.0238 304 162.2871 214.6169 −1.34E−01 7.70E−01 1 Unchanged Low Q14541 O17ab7 hepatocyte nuclear factor 4; gam 549.8997 283 162.4659 331.895 −1.78E+00 −9.57E−01 1 Unchanged Low P57723 E17gh8 poly(rC) binding protein 4 186.2845 231 162.5267 193.1283 −1.97E−01 3.08E−01 1 Unchanged Low Q9NWU3 A24gh3 DEAD/H (Asp-Glu-Ala-Asp/His) t 154.71 104 162.6529 140.5056 7.22E−02 −5.71E−01 1 Unchanged Low Q9NPC5 J16ef8 nudix (nucleoside diphosphate

107.1863 98.4 162.6929 122.7442 6.02E−01 −1.24E−01 1 Unchanged Low Q9Y3C5 B19ef3 ring finger protein 11 160.0631 184 162.7518 162.3366 2.40E−02 3.68E−02 1 Unchanged Low Q9NWX3 B01gh2 chromosome 20 open reading fr

98.58482 95.6 162.7744 118.9844 7.23E−01 −4.44E−02 1 Unchanged Low P52742 I22cd3 zinc finger portein 135 (clone pH 81.4141 121 162.8382 121.6363 1.00E+00 −4.44E−02 1 Unchanged Low Q9Y313 D17ef2 PTD013 protein 90.25232 116 1634053 123.3545 8.56E−01 3.67E−01 1 Unchanged Low Q9P2W9 B11ef4 syntaxin 18 128.6426 188 163.4277 160.0555 3.45E−01 5.48E−01 1 Unchanged Low P14778 F09ab6 interleukin 1 receptor; type I 264.5401 539 163.4432 322.4754 −6.95E−01 1.03E+00 1 Unchanged Low Q15464 I12ef5 SHB (Src homology 2 domain co

284.291 301 163.5379 249.6096 −7.98E−01 8.24E−02 1 Unchanged Low O15444 H07cd2 small inducible cytokine subfamily 244.6426 97.1 163.6053 168.4558 −5.80E−01 −1.33E+00 1 Unchanged Low P49796 P14ef4 regulator of G-protein signalling:

220.2769 99.3 163.6222 161.0774 −4.29E−01 −1.15E+00 1 Unchanged Low Q9NUS7 B04gh3 hypothetical protein FLJ11164 81.76063 114 163.6422 119.7258 1.00E+00 4.77E−01 1 Unchanged Low P48651 L11ef3 phosphatidylserine synthase 1 211.8695 139 163.6792 171.5708 −3.72E−01 −6.06E−01 1 Unchanged Low Q07706 F15cd4 tetracycline transporter-like prote

143.0791 144 163.7206 150.2019 1.94E−01 7.31E−01 1 Unchanged Low O75143 B11gh1 KIAA0652 gene product 106.5331 155 163.7687 141.6405 6.20E−01 5.37E−01 1 Unchanged Low O75039 L19gh1 KIAA0451 gene product 174.142 135 163.8572 157.7714 −8.78E−02 −3.64E−01 1 Unchanged Low P02261 M10gh6 H2A histone family; member N 93.48591 273 163.8621 176.9259 8.10E−01 1.55E+00 1 Unchanged Low Q9H9A0 L20gh5 hypothetical protein FLJ12895 86.42599 130 164.3655 126.7707 9.27E−01 5.84E−01 1 Unchanged Low Q9NV35 J21gh3 hypothetical protein FLJ10958 99.15342 154 164.4852 139.1489 7.30E−01 6.33E−01 1 Unchanged Low Q9P1G8 C05gh4 WW domain-containing adapter

119.4436 182 164.5311 155.3256 4.62E−01 6.08E−01 1 Unchanged Low P26368 D11cd7 U2 small nuclear ribonucleoprote

217.0564 107 164.8861 163.126 −3.97E−01 −1.01E+00 1 Unchanged Low Q9BSZ7 E11gh8 DEAD/H (Asp-Glu-Ala-Asp/His) t 130.7858 111 164.9084 135.6059 3.34E−01 −2.35E−01 1 Unchanged Low Q9Y391 G23ef2 androgen-regulated short-chain

222.3497 128 164.9823 171.7067 −4.31E−01 −7.99E−01 1 Unchanged Low Q9NYR5 E05ef3 HSPC126 protein 99.37243 110 165.2098 124.8579 7.33E−01 1.46E−01 1 Unchanged Low P05165 N12ab7 propionyl Coenzyme A carboxyla

100.892 120 165.6902 128.9755 7.16E−01 2.54E−01 1 Unchanged Low Q9NPF4 O21gh3 O-slaloglycoprotein endopeptida

103.8223 112 165.9716 127.3658 6.77E−01 1.13E−01 1 Unchanged Low P16106 D01cd3 H3 histone family; member K 99.19006 130 166.1216 131.6683 7.44E−01 3.87E−01 1 Unchanged Low P35249 O03ef5 replication factor C (activator 1)

105.2406 98.7 166.2092 123.3812 6.59E−01 −9.27E−02 1 Unchanged Low P28702 P18gh1 retinoid X receptor; beta 74.914 142 166.2214 127.7227 1.15E+00 9.23E−01 1 Unchanged Low P49674 K14ab4 casein kinase 1: epsilon 99.33956 145 166.3564 136.8564 7.44E−01 5.44E−01 1 Unchanged Low Q9NXW2 I03gh2 DnaJ (Hsp40) homolog; subfamily 247.7907 235 166.4412 216.5041 −5.74E−01 −7.47E−02 1 Unchanged Low O14672 I01ab2 a disintegin and metalloprateina 378.0042 226 166.5417 258.8185 −1.18E+00 −7.43E−01 1 Unchanged Low Q9Y5B9 I20cd7 chromatin-specific transcription

163.0543 188 166.6045 172.4726 3.11E−02 2.04E−01 1 Unchanged Low Q9H9J2 H22gh5 mitochondrial ribosomal protein

206.428 256 166.8142 209.7386 −3.07E−01 3.10E−01 1 Unchanged Low P23759 G06ab8 paired box gene 7 92.41833 200 166.8514 153.0178 8.52E−01 1.11E+00 1 Unchanged Low Q16643 L05ab4 drebrin 1 265.008 152 166.9734 194.7352 −6.66E−01 −8.00E−01 1 Unchanged Low P48454 I21cd1 protein phosphatase 3 (formerly

105.9496 169 167.0428 147.2674 6.57E−01 6.72E−01 1 Unchanged Low Q9Y508 F21ef4 zinc finger protein 313 331.595 395 167.2366 297.9139 −9.88E−01 2.52E−01 1 Unchanged Low P19474 G09cd2 Siogren syndrome antigen A1 (5

301.1776 183 167.414 217.1349 −8.47E−01 −7.20E−01 1 Unchanged Low P46109 N13ab5 v-crk sarcoma virus CT10 oncog

151.2065 141 167.7716 153.202 1.50E−01 −1.05E−01 1 Unchanged Low P54855 B19cd4 UDP glycosyltransferase 2 family 137.8939 127 167.8346 144.2152 2.83E−01 −1.20E−01 1 Unchanged Low Q14242 H14cd1 selectin P ligand 112.9679 130 167.9184 136.8261 5.72E−01 1.98E−01 1 Unchanged Low Q9BSS1 P17gh8 hypothetical protein FLJ14525 86.75908 113 167.974 122.482 9.53E−01 3.78E−01 1 Unchanged Low Q9Y3B2 L23ef1 homolog of yeast exosomal core 152.0751 140 167.9915 153.2264 1.44E−01 −1.23E−01 1 Unchanged Low P31391 N03cd1 somatostatin receptor 4 147.3942 92.5 168.0254 135.9754 1.89E−01 −6.72E−01 1 Unchanged Low O60623 O03ab4 diptheria toxin resistance protein 210.9658 170 168.0762 183.0009 −3.28E−01 −3.12E−01 1 Unchanged Low Q99959 L24ab8 plakophilin 2 362.9423 211 168.1655 247.4823 −1.11E+00 −7.80E−01 1 Unchanged Low B21gh7 leukocyte immunoglobullin-like re

139.2571 234 168.1829 180.4876 2.72E−01 7.49E−01 1 Unchanged Low Q01658 P18ab5 down-regulator of transcription 1

205.2249 122 168.2606 165.0596 −2.87E−01 −7.54E−01 1 Unchanged Low Q9HCS4 P10gh7 HMG-box transcription factor TCI 76.48423 156 168.2926 133.5936 1.14E+00 1.03E+00 1 Unchanged Low Q9P035 N20ef2 butyrate-induced transcript 1 102.716 142 168.3034 137.5999 7.12E−01 4.65E−01 1 Unchanged Low Q9C0K7 P24gh3 amyotrophic lateral sclerosis 2 (

102.352 108 168.4355 126.1345 7.19E−01 7.24E−02 1 Unchanged Low Q9NYF4 I13ef3 chromosome 5 open reading frar 89.72908 137 168.4424 131.7509 9.09E−01 6.11E−01 1 Unchanged Low P30042 M19cd4 chromosome 21 open reading fra

98.84241 97.5 168.5171 121.6076 7.70E−01 −2.03E−02 1 Unchanged Low O75325 K16cd6 glioma amplified on chromosome 116.3239 83.3 168.5172 122.705 5.35E−01 −4.82E−01 1 Unchanged Low Q9Y670 N01ef2 transient receptor potential calio

96.41826 90.8 168.5297 118.5764 8.06E−01 −8.69E−02 1 Unchanged Low Q9UPRB I14ef8 KIAA1084 protein 101.3235 111 168.5336 126.797 7.34E−01 1.26E−01 1 Unchanged Low Q9Y2X7 I21ef4 G protein-coupled receptor kinas 160.7403 167 168.7352 165.5706 7.00E−02 5.72E−02 1 Unchanged Low P47872 D24cd1 secretin receptor 174.6672 209 168.738 184.1802 −4.98E−02 2.60E−01 1 Unchanged Low O43353 C17cd4 receptor-interacting serine-thre

272.5279 388 168.7722 276.5684 −6.91E−01 5.11E−01 1 Unchanged Low P32321 P14ab5 dCMP deaminase 218.5685 60.1 168.8404 149.1554 −3.72E−01 −1.86E+00 1 Unchanged Low O43612 J16ab4 hypocrelin (orexin) neuropeptide 66.45691 194 168.9064 143.2577 1.35E+00 1.55E+00 1 Unchanged Low Q92874 M15ab4 deoxyribonuclease I-like 2 218.1787 146 168.9596 177.8201 −3.69E−01 −5.76E−01 1 Unchanged Low Q9UI90 I15ef8 PRO0038 protein 89.17218 389 168.9849 215.61 9.22E−01 2.12E+00 1 Unchanged Low P30519 N05ab6 heme oxygenase (decycling) 2 586.3897 387 169.1269 380.9032 −1.79E+00 −5.99E−01 1 Unchanged Low Q9NVE7 D03gh3 hypothetical protein FLJ10782 141.6695 148 169.2644 152.9283 2.57E−01 6.16E−02 1 Unchanged Low Q9P010 A14ef8 HSPC154 protein 227.9143 246 169.4393 214.317 −4.28E−01 1.08E−01 1 Unchanged Low Q9UH59 M04cd8 bromodomain-containing 7 147.6635 103 169.5045 139.9456 1.99E−01 −5.24E−01 1 Unchanged Low Q9UM82 E01cd6 spermatogenesis associated 2 230.7114 221 169.6678 207.1298 −4.43E−01 −6.20E−02 1 Unchanged Low Q9P2Y4 N14ef1 zinc finger protein 219 105.6753 175 169.7666 150.1216 6.84E−01 7.27E−01 1 Unchanged Low Q9GZS3 H19gh7 recombination protein REC14 124.7245 162 169.9984 152.3724 4.47E−01 3.81E−01 1 Unchanged Low P07686 J17ab3 hexosaminidase B (beta polypep 217.0423 135 170.0092 174.0094 −3.52E−01 −6.85E−01 1 Unchanged Low Q9NZV6 L06ef2 selenoprotein X; 1 241.3633 202 170.0232 204.3052 −5.05E−01 −2.60E−01 1 Unchanged Low O14678 E17cd1 ATP-binding cassette; sub-family 77.65216 127 170.0525 124.9148 1.13E+00 7.10E−01 1 Unchanged Low P29972 O04ab2 aquaporin 1 (channel-forming in

309.1218 134 170.2078 204.2885 −8.61E−01 −1.21E+00 1 Unchanged Low O95373 D03cd6 RAN binding protein 7 247.4368 113 170.45 177.0459 −5.38E−01 −1.13E+00 1 Unchanged Low Q15436 O12cd6 Sec23 homolog A (S. cerevisiae) 90.05071 100 170.9386 120.3545 9.25E−01 1.52E−01 1 Unchanged Low Q9BQ67 K23gh6 glutamate rich WD repeat protein 140.3198 112 170.966 141.0924 2.85E−01 −3.25E−01 1 Unchanged Low P35321 D21gh6 small proline-rich protein 1A 62.28271 237 171.0104 156.8515 1.46E+00 1.93E+00 1 Unchanged Low Q9UPQB I10ef8 KIAA1094 protein 76.76245 123 171.0467 123.4833 1.16E+00 6.76E−01 1 Unchanged Low O43292 A19cd4 GPAA1P anchor attachment prot 95.36294 92.4 171.0704 119.6038 8.43E−01 −4.59E−02 1 Unchanged Low Q9UBM3 G02cd1 proteasome (prosome; macropai

287.6026 204 171.1554 221.0285 −7.49E−01 −4.93E−01 1 Unchanged Low P19338 M20ab7 nucleolin 148.8642 87.6 171.2094 135.8947 2.02E−01 −7.65E−01 1 Unchanged Low Q9NPE6 E17gh1 sperm associated antigen 4 111.172 135 171.4356 139.3341 6.25E−01 2.84E−01 1 Unchanged Low O00442 J12cd3 RTC domain containing 1 274.6701 279 171.531 241.6967 −6.79E−01 2.20E−02 1 Unchanged Low P28356 D09ef1 homeo box D9 84.5638 106 171.5949 120.5873 1.02E+00 3.21E−01 1 Unchanged Low P49447 G06ef1 cytochrome b-561 174.7152 167 171.6447 171.1671 −2.56E−02 −6.39E−02 1 Unchanged Low Q9UQA4 P18cd4 nuclear factor (erythroid-derived 227.4253 470 171.8945 289.7702 −4.04E−01 1.05E+00 1 Unchanged Low O15254 D09ab2 acyl-Coenzyme A oxidase 3; pris 192.2301 192 172.0218 185.2853 −1.60E−01 −4.71E−03 1 Unchanged Low Q9NWW6 B11gh2 hypothetical protein FLJ20559 198.7861 220 172.0261 197.0098 −2.09E−01 1.48E−01 1 Unchanged Low O75391 M08cd5 sperm associated antigen 7 154.1159 140 172.0658 155.2376 1.59E−01 −1.43E−01 1 Unchanged Low Q92959 H19cd2 solute carrier family 21 (prostag

86.25485 102 172.112 120.1434 9.97E−01 2.43E−01 1 Unchanged Low O00499 G06ab2 bridging integrator 1 162.8584 111 172.4453 148.8447 8.25E−02 −5.50E−01 1 Unchanged Low Q14197 J05ab6 Immature colon carcinoma trans

90.92583 102 172.5526 121.725 9.24E−01 1.62E−01 1 Unchanged Low Q9NXS9 K15gh2 hypothetical protein FLJ20071 121.4575 103 172.5552 132.3749 5.07E−01 −2.36E−01 1 Unchanged Low O75954 N18cd6 tetraspan transmembrane 4 sup

83.06795 119 172.5557 124.8565 1.05E+00 5.16E−01 1 Unchanged Low Q9UJY9 E17cd8 lifeguard 156.5909 75.6 172.6495 134.9529 1.41E−01 −1.05E+00 1 Unchanged Low P82912 F10gh5 mitochondrial ribosomal protein

105.0578 196 172.7091 158.0886 7.17E−01 9.03E−01 1 Unchanged Low Q12918 J02ab6 killer cell lectin-like receptor sub

205.6225 290 172.8141 222.8453 −2.51E−01 4.97E−01 1 Unchanged Low Q14789 E01ab6 golgi autoantigen; golgin subfam 96.09162 194 173.0059 154.2154 8.48E−01 1.01E+00 1 Unchanged Low Q04206 I23ef6 v-rel reticuloendotheliosis viral

328.9295 242 173.0443 248.1568 −9.27E−01 −4.40E−01 1 Unchanged Low P19838 M15ef5 nuclear factor of kappa light poly 229.2262 277 173.0997 226.323 −4.05E−01 2.71E−01 1 Unchanged Low Q92748 A24cd2 thyroid hormone responsive (SP

101.3906 88.2 173.314 120.9562 7.73E−01 −2.02E−01 1 Unchanged Low O95095 P13ab2 amyloid beta precursor protein (

199.951 201 173.3314 191.35 −2.06E−01 5.88E−03 1 Unchanged Low P52209 K18ab8 phosphogluconate dehydrogena

211.8178 147 173.42 177.5327 −2.89E−01 −5.23E−01 1 Unchanged Low P42566 H10ef5 epidermal growth factor receptor 194.9437 158 173.4643 175.3861 −1.68E−01 −3.05E−01 1 Unchanged Low Q13772 D05gh6 nuclear receptor coactivator 4 273.5167 367 173.5038 271.4641 −6.57E−01 4.26E−01 1 Unchanged Low P43897 D09gh6 Ts translation elongation factor;

325.7575 226 173.8489 241.8156 −9.06E−01 −5.28E−01 1 Unchanged Low P09329 D08ef7 phosphoribosyl pyrophosphate

103.7882 86.2 174.5738 121.5057 7.50E−01 −2.69E−01 1 Unchanged Low O75616 F24cd4 death effector domain-containing 172.0163 176 174.7689 174.3849 2.29E−02 3.61E−02 1 Unchanged Low Q9UHI9 B18ef1 flavohemoprotein b5 + b5R 169.2028 197 174.7919 180.2862 4.69E−02 2.18E−01 1 Unchanged Low Q9H824 J07gh6 F-box only protein 22 89.2751 161 175.62 141.9533 9.76E−01 8.50E−01 1 Unchanged Low Q9UQ43 G07ab3 BAI1-associated protein 2 184.8198 165 175.6399 175.1475 −7.35E−02 −1.64E−01 1 Unchanged Low Q43173 N08ef1 sialyltransferase 8C (alpha2; 3Ga 220.9909 256 175.9869 217.6266 −3.29E−01 2.12E−01 1 Unchanged Low Q9BZZ2 G13gh7 sialoadhesin 147.52 189 175.9952 170.7942 2.55E−01 3.56E−01 1 Unchanged Low Q92611 I16gh1 KIAA0212 gene product 96.3144 94.3 176.0348 122.2106 8.70E−01 −3.08E−02 1 Unchanged Low Q969V6 K14gh7 megakaryoblastic leukemia (tran

135.6533 161 176.0531 157.6423 3.76E−01 2.49E−01 1 Unchanged Low P08107 K14ab7 heat shock 70 kD protein 1B 153.5141 106 176.1145 145.1219 1.98E−01 −5.38E−01 1 Unchanged Low Q9BQ24 E21gh6 hypothetical protein MGC2550 153.9741 255 176.3889 195.2182 1.96E−01 7.29E−01 1 Unchanged Low Q9H7X1 N07gh5 hypothetical protein FLJ14153 155.291 236 176.5938 189.2819 1.85E−01 6.03E−01 1 Unchanged Low Q99616 D09cd2 small inducible cytokine subfamil

130.1641 100 176.5958 135.6192 4.40E−01 −3.79E−01 1 Unchanged Low Q92896 L04cd7 golgi apparatus protein 1 97.73429 90.3 176.622 121.5361 8.54E−01 −1.15E−01 1 Unchanged Low Q14582 J16ef6 Mad4 homolog 210.3185 244 176.6383 210.1876 −2.52E−01 2.12E−01 1 Unchanged Low Q13505 K21ab7 metaxin 1 199.1231 168 176.6745 181.2437 −1.73E−01 −2.46E−01 1 Unchanged Low Q13722 O24cd8 chromosome 3p21.1 gene seque 85.85963 144 176.7101 135.6336 1.04E+00 7.49E−01 1 Unchanged Low P01308 I10ab6 insulin 367.022 113 176.7437 218.8465 −1.05E+00 −1.70E+00 1 Unchanged Low O00405 D19ab8 protein phosphatase 1; regulator 233.0866 306 176.8763 238.6383 −3.98E−01 3.92E−01 1 Unchanged Low P41215 E03ab5 fatty-acid-Coenzyme A ligase; lo

267.9822 199 177.1301 214.8046 −5.97E−01 −4.27E−01 1 Unchanged Low P31314 F04ef6 homeo box 11 (T-cell lymphoma 107.4127 170 177.4236 151.5175 7.24E−01 6.60E−01 1 Unchanged Low O95427 G21cd8 phosphatidylinositol glycan; clas

84.22817 116 177.4629 125.8189 1.08E+00 4.59E−01 1 Unchanged Low Q12981 C24ef6 BCL2/adenovirus E1B 19 kD inte

82.38214 99.8 177.5246 119.9152 1.11E+00 2.77E−01 1 Unchanged Low Q9Y5V1 L10ef1 HSPC042 protein 212.074 184 177.7635 191.3703 −2.55E−01 −2.03E−01 1 Unchanged Low Q9H4B4 O22ab4 cytokine-inducible kinase 161.982 194 177.788 177.8629 1.34E−01 2.59E−01 1 Unchanged Low Q9H6D1 P15gh5 chromosome 20 open reading fra

95.43432 108 177.8526 126.9312 8.98E−01 1.72E−01 1 Unchanged Low O60504 J18cd5 vinexin beta (SH3-containing ad

109.3831 99.8 177.8876 129.0088 7.02E−01 −1.33E−01 1 Unchanged Low Q9UNK0 I02cd5 syntaxin 8 218.2149 171 177.9777 189.0342 −2.94E−01 −3.53E−01 1 Unchanged Low O95657 B24cd4 proline-serine-threonine phosph

369.9485 158 178.0072 235.2956 −1.06E+00 −1.23E+00 1 Unchanged Low P20645 C05ab7 mannose-6-phosphate receptor ( 355.8249 234 178.1318 256.0667 −9.98E−01 −6.03E−01 1 Unchanged Low O14569 B03ab2 putative tumor suppressor 122.4884 79.2 178.136 126.62 5.40E−01 −6.28E−01 1 Unchanged Low O15293 D18cd3 MAP-kinase activating death don 157.092 114 178.1677 149.8523 1.82E−01 −4.59E−01 1 Unchanged Low P00390 E14ef7 glutathione reductase 282.1492 196 178.1741 218.8246 −6.63E−01 −5.24E−01 1 Unchanged Low Q9HBV3 K24gh5 PP3111 protein 229.2714 361 178.4093 256.1517 −3.62E−01 6.54E−01 1 Unchanged Low Q14558 H17ab8 phosphoribosyl pyrophosphate

301.219 227 178.4567 235.5213 −7.55E−01 −4.09E−01 1 Unchanged Low O14710 F01ef5 cell cycle progression 2 protein 261.2178 189 178.7923 209.7103 −5.47E−01 −4.66E−01 1 Unchanged Low Q9UJ70 J10ef3 N-acetylglucosamine kinase 151.2986 276 178.7992 201.9381 2.41E−01 8.66E−01 1 Unchanged Low Q13397 M18cd6 zinc finger protein 238 215.883 285 178.9318 226.5893 −2.71E−01 4.00E−01 1 Unchanged Low Q9NRG4 B21gh4 HSKM-B protein 143.1326 279 178.999 200.3335 3.23E−01 9.62E−01 1 Unchanged Low P51449 B01cd2 RAR-related orphan receptor C 236.6977 97.2 179.0372 170.992 −4.03E−01 −1.28E+00 1 Unchanged Low Q9H768 O21gh7 synaptotagmin-like 2 83.78255 121 179.0813 128.0355 1.10E+00 5.33E−01 1 Unchanged Low Q14332 F22ef5 frizzled homolog 2 (Drosophila) 86.25011 129 179.1323 131.3078 1.05E+00 5.76E−01 1 Unchanged Low Q13207 N13cd2 T-box 2 118.9378 108 179.1858 135.2524 5.91E−01 −1.44E−01 1 Unchanged Low Q9H6B8 B19gh5 hypothetical protein similar to mc 134.338 129 179.5015 147.5119 4.18E−01 −6.19E−02 1 Unchanged Low O00462 J09ab7 mannosidase; beta A; lysosomal 83.23817 107 179.6953 123.2365 1.11E+00 3.59E−01 1 Unchanged Low Q9Y3D8 H14ef2 adrenal gland protein AD-004 178.4931 163 179.7989 173.7578 1.05E−02 −1.31E−01 1 Unchanged Low P17900 F19ab3 GM2 ganglioside activator protein 124.7747 232 179.914 178.9058 5.28E−01 8.95E−01 1 Unchanged Low Q9P0M4 O10cd8 Interleukin 17C 260.8753 223 180.0241 221.2511 −5.35E−01 −2.27E−01 1 Unchanged Low F13gh8 G protein-coupled receptor 54 87.92591 133 180.0735 133.5723 1.03E+00 5.94E−01 1 Unchanged Low Q9NZ92 J02gh3 SWI/SNF related; matrix associa 267.7307 247 180.206 231.4963 −5.71E−01 −1.19E−01 1 Unchanged Low Q9NX94 L18gh6 hypothetical protein FLJ20154 133.6318 165 180.3424 159.7713 4.32E−01 3.07E−01 1 Unchanged Low P04049 G12ef5 v-raf-1 murine leukemia viral onc 225.086 183 180.3925 196.2063 −3.19E−01 −2.98E−01 1 Unchanged Low Q13181 B06cd1 ATP-binding cassette; sub-family 167.9383 127 180.4651 158.5133 1.04E−01 −4.02E−01 1 Unchanged Low P22102 M05ab6 phosphoribosylglycinamide form 295.0489 180 180.5026 218.4202 −7.09E−01 −7.15E−01 1 Unchanged Low Q9NQZ8 A09gh5 endothelial zinc finger protein inc 96.79284 138 180.7283 138.4428 9.01E−01 5.10E−01 1 Unchanged Low Q9UN30 D04cd2 sex comb on midleg-like 1 (Droso 97.47885 86 181.0121 121.4921 8.93E−01 −1.81E−01 1 Unchanged Low P26651 J04ef6 zinc finger protein 36; C3H type; 286.0733 162 181.0638 209.8211 −6.60E−01 −8.17E−01 1 Unchanged Low P18887 O06ef6 X-ray repair complementing defa 85.61601 102 181.0778 122.9254 1.08E+00 2.54E−01 1 Unchanged Low Q9Y2S0 P14ef1 RNA polymerase I 16 kDa subun 182.9338 149 181.2184 170.8985 −1.36E−02 −3.00E−01 1 Unchanged Low P49023 I05ef7 paxillin 313.7788 334 181.2995 276.3491 −7.91E−01 9.00E−02 1 Unchanged Low P49321 O03ab7 nuclear autoantigenic sperm prot 119.903 78.2 181.3524 126.4866 5.97E−01 −6.17E−01 1 Unchanged Low Q13428 M14cd1 Treacher Collins-Franceschetti s 164.3621 123 181.4282 156.2838 1.43E−01 −4.18E−01 1 Unchanged Low Q9HCS6 G07gh4 vacuolar protein sorting 11 (yeas 177.2833 302 181.4601 220.0848 3.36E−02 7.66E−01 1 Unchanged Low P20813 I02gh6 cytochrome P450; subfamily IIB ( 122.3562 162 181.476 155.3947 5.69E−01 4.08E−01 1 Unchanged Low O00459 C05cd1 phosphoinositide-3-kinase; regul 145.3741 160 181.534 162.3275 3.20E−01 1.39E−01 1 Unchanged Low P50151 H24ab4 guanine nucleotide binding prote 186.5329 193 182.0963 187.0796 −3.47E−02 4.62E−02 1 Unchanged Low Q16850 D12ab3 cytochrome P450; 51 (lanosterol 353.9667 116 182.1309 217.3331 −9.59E−01 −1.61E+00 1 Unchanged Low Q9ULW3 J09cd8 TATA-binding protein-binding pro 97.23454 207 182.1565 162.0616 9.06E−01 1.09E+00 1 Unchanged Low Q16378 O20cd7 proline rich 4 (lacrimal) 81.91 152 182.3589 138.8678 1.15E+00 8.95E−01 1 Unchanged Low P41240 J14ab4 c-src tyrosine kinase 175.1285 153 182.4257 170.0806 5.89E−02 −1.98E−01 1 Unchanged Low Q16649 G05cd1 nuclear factor; interleukin 3 regul 353.6698 169 182.4266 235.1072 −9.55E−01 −1.06E+00 1 Unchanged Low Q9Y3M2 J03ef8 chromosome 22 open reading fr

74.27488 194 182.6022 150.2264 1.30E+00 1.38E+00 1 Unchanged Low Q9UK58 M14gh4 cyclin L anla-6a 191.3619 313 182.6351 229.0134 −6.73E−02 7.10E−01 1 Unchanged Low P47874 M23cd1 olfactory marker protein 250.3691 172 182.73 201.6274 −4.54E−01 −5.43E−01 1 Unchanged Low O95620 O03cd7 protein similar to E. coli yhdg and 227.8932 207 183.1055 205.8925 −3.16E−01 −1.14E−01 1 Unchanged Low Q9UHV2 J11cd8 CDK4-binding protein p34SEI1 144.2806 163 183.5211 163.6559 3.47E−01 1.77E−01 1 Unchanged Low P02810 F07gh6 proline-rich protein HaeIII subfan 410.3478 392 183.6977 328.6668 −1.16E+00 −6.62E−02 1 Unchanged Low O94903 K04cd7 proline synthetase co-transcriber 242.2062 146 183.9744 190.7733 −3.97E−01 −7.29E−01 1 Unchanged Low Q9P0W6 I03ef4 lipopolysaccharide specific respc 149.1418 177 184.0725 169.9232 3.04E−01 2.43E−01 1 Unchanged Low Q9H8X4 O15gh5 stromal membrane-associated pr 358.1542 342 184.0879 294.6026 −9.60E−01 −6.84E−02 1 Unchanged Low P02786 D24ef5 transferrin receptor (p90; CD71) 320.8365 257 184.2545 254.0696 −8.00E−01 −3.19E−01 1 Unchanged Low E15ef1 immunoglobulin heavy constant

386.489 176 184.3533 249.0303 −1.07E+00 −1.13E+00 1 Unchanged Low Q99717 J01ab7 MAD; mothers against decapents 227.5817 153 184.3978 188.4757 −3.04E−01 −5.69E−01 1 Unchanged Low Q15036 B23gh1 sorting nexin 17. 303.8909 411 184.4831 299.6453 −7.20E−01 4.34E−01 1 Unchanged Low P31751 A08ab2 v-akt murine thymoma viral onco

253.7531 253 184.8245 230.4512 −4.57E−01 −5.57E−03 1 Unchanged Low P11177 G21ab8 pyruvate dehydrogenase (lipoam 229.1486 150 185.0719 188.1769 −3.08E−01 −6.08E−01 1 Unchanged Low Q9UEQ6 F22ab2 arrestin; beta 2 190.7331 128 185.1221 167.9086 −4.31E−02 −5.77E−01 1 Unchanged Low Q16531 J11ab5 damage-specific DNA binding pr

205.1934 229 185.1363 206.5357 −1.48E−01 1.60E−01 1 Unchanged Low P28698 G24cd3 zinc finger protein 42 (myeloid-sp 76.12612 105 185.3347 122.3029 1.28E+00 4.70E−01 1 Unchanged Low P41968 N12ef4 melanocortin 3 receptor 225.3987 287 185.5363 232.6783 −2.81E−01 3.49E−01 1 Unchanged Low P54920 E03cd4 N-ethylmalelmide-sensitive factor 306.753 267 185.697 252.9933 −7.24E−01 −2.03E−01 1 Unchanged Low Q99487 C19ab8 platelet-activating factor acetylhy 228.4138 241 185.7091 218.5222 −2.99E−01 8.00E−02 1 Unchanged Low Q9H0C8 N15gh7 integrin-linked kinase-associated 120.8459 109 185.7532 138.517 6.20E−01 −1.49E−01 1 Unchanged Low P17252 F17ab8 protein kinase C; alpha 108.3851 74 185.8466 122.7553 7.78E−01 −5.50E−01 1 Unchanged Low P06493 B01ef5 cell division cycle 2; G1 to S and 108.1696 76.2 185.8754 123.4207 7.81E−01 −5.05E−01 1 Unchanged Low O00139 C14ab7 kinesin heavy chain member 2 140.4141 205 185.9437 177.1988 4.05E−01 5.48E−01 1 Unchanged Low P54259 N05ef6 dentatorubral-pallidoluysian atro

165.5295 152 186.0962 167.773 1.69E−01 −1.26E−01 1 Unchanged Low Q99757 G10cd8 thioredoxin 2 309.0415 163 186.106 219.4587 −7.32E−01 −9.21E−01 1 Unchanged Low Q9NW68 B12gh2 hypothetical protien FLJ10276 107.4044 242 186.1575 178.6551 7.93E−01 1.17E+00 1 Unchanged Low P16106 O16gh6 H3 histone family; member J 137.9914 135 186.2589 152.9203 4.33E−01 −3.69E−02 1 Unchanged Low P40692 M06ef6 mutL homolog 1; colon cancer; n 98.77988 108 186.2872 131.0441 9.15E−01 1.30E−01 1 Unchanged Low Q99798 E01ab2 aconilase 2; mitochondrial 615.211 291 186.5524 364.1757 −1.72E+00 −1.08E+00 1 Unchanged Low P53618 A11ef3 coatomer protein complex; subur 238.4951 102 186.6268 175.716 −3.54E−01 −1.23E+00 1 Unchanged Low Q9UJ69 N24gh2 Toll-interacting protein 211.4055 259 186.6408 219.0188 −1.80E−01 2.93E−01 1 Unchanged Low Q9NRM2 P22ef8 zinc finger protein 277 232.9567 227 186.8854 215.6334 −3.18E−01 −3.70E−02 1 Unchanged Low Q92879 B06cd6 CUG triplet repeat; RNA binding 217.3752 198 187.122 200.6744 −2.16E−01 −1.38E−01 1 Unchanged Low O75399 H22gh1 deformed epidermal autoregulator 189.8387 266 187.2872 214.4669 −1.95E−02 4.88E−01 1 Unchanged Low Q9BZE4 I17cd8 G protein-binding protein CRFG 151.2547 214 187.3094 184.3092 3.08E−01 5.03E−01 1 Unchanged Low Q9NXB2 G08gh2 hypothetical protein FLJ20343 259.0672 285 187.4246 243.8822 −4.67E−01 1.38E−01 1 Unchanged Low O95424 M06ef4 MYLE protein 103.2077 184 187.5574 158.2861 8.62E−01 8.35E−01 1 Unchanged Low P54577 D14cd3 tyrosyl-tRNA synthetase 145.5748 108 187.5756 146.9084 3.66E−01 −4.36E−01 1 Unchanged Low O43692 N03ef7 protease inhibitor 15 102.5299 163 187.7565 150.9471 8.73E−01 6.65E−01 1 Unchanged Low O60507 J03cd3 tyrosylprotein sulfotransferase 1 190.271 136 188.0843 171.4862 −1.67E−02 −4.83E−01 1 Unchanged Low Q9BYS9 B15gh5 MMS19-like (MET18 homolog; S. 99.29429 117 188.1006 134.7877 9.22E−01 2.36E−01 1 Unchanged Low P32780 G11ab6 general transcription factor IIH; p 258.9396 180 188.3175 209.0492 −4.59E−01 −5.25E−01 1 Unchanged Low Q14004 D07ef5 cell division cycle 2-like 5 (cholin 92.56943 158 188.3656 146.1954 1.02E+00 7.68E−01 1 Unchanged Low Q15910 L08ab5 enhancer of zeste homolog 2 (Dr 213.1801 306 188.8314 235.9636 −1.75E−01 5.21E−01 1 Unchanged Low P47974 H22ab4 zinc finger protein 36; C3H type-I 187.7102 163 188.8801 179.8162 8.96E−03 −2.05E−01 1 Unchanged Low Q13177 E20ab8 p21 (CDKN1A)-activated kinase. 367.7706 232 188.9048 262.9597 −9.61E−01 −6.63E−01 1 Unchanged Low P16gh8 baculoviral IAP repeat-containing 251.3679 126 189.0052 188.6409 −4.11E−01 −1.00E+00 1 Unchanged Low P98172 J01ef7 ephrin-B1 122.8828 109 189.5198 140.4039 6.25E−01 −1.75E−01 1 Unchanged Low Q9BQB1 N04gh6 hypothetical protein FLJ10342 113.908 172 189.7648 158.4309 7.36E−01 5.91E−01 1 Unchanged Low O75472 H11cd5 DnaJ (Hsp40) homolog; subfamil 227.1041 204 189.9354 206.8756 −2.58E−01 −1.58E−01 1 Unchanged Low O75608 K06cd6 lysophospholipase I 357.6112 374 190.1833 307.2824 −9.11E−01 6.48E−02 1 Unchanged Low O00193 E14ef3 small acidic protein 223.9793 284 190.2397 232.7223 −2.36E−01 3.42E−01 1 Unchanged Low Q14452 B08ab5 glucocorticoid receptor DNA binc

158.8451 147 190.439 164.6255 2.80E−01 −9.75E−02 1 Unchanged Low P55268 P18ef6 laminin; beta 2 (laminin S) 125.0717 152 190.5787 155.8763 6.08E−01 2.81E−01 1 Unchanged Low Q9P006 A20ef8 mitochondrial ribosomal protein

114.6952 151 190.6578 152.156 7.33E−01 3.98E−01 1 Unchanged Low Q9Y385 P07ef1 CGI-111 protein 158.6983 176 190.6804 175.2567 2.65E−01 1.52E−01 1 Unchanged Low Q9NQ34 A10gh4 chromosome 11 open reading fra

144.3438 161 190.6944 165.3815 4.02E−01 1.59E−01 1 Unchanged Low Q9NWY4 O14gh2 hypothetical protein FLJ20534 70.02507 110 191.0561 123.5579 1.45E+00 6.46E−01 1 Unchanged Low Q9UBS8 P17ab2 ring finger protein 14 227.9827 247 191.1542 221.9109 −2.54E−01 1.13E−01 1 Unchanged Low Q9UBS4 J06ef2 DnaJ (Hsp40) homolog; subfamil

181.8446 175 191.2168 182.7428 7.25E−02 −5.40E−02 1 Unchanged Low Q12797 J22ab2 aspartate beta-hydroxylase 101.2251 86.5 191.3988 126.3618 9.19E−01 −2.27E−01 1 Unchanged Low Q9H4I9 P10gh8 hypothetical gene supported by

167.5049 219 191.4831 192.7801 1.93E−01 3.89E−01 1 Unchanged Low O14907 E24ef8 Tax interaction protein 1 351.7729 403 191.7684 315.6313 −8.75E−01 1.97E−01 1 Unchanged Low Q14673 B09gh1 Bcl-2-associated transcription fa

97.16912 117 191.9499 135.533 9.82E−01 2.74E−01 1 Unchanged Low Q9NWB7 P01gh2 estrogen-related receptor beta III 567.7076 84.6 192.0982 281.455 −1.56E+00 −2.75E+00 1 Unchanged Low Q9BVH4 G21gh6 hypothetical protein MGC3196 164.8572 169 192.4133 175.4765 2.23E−01 3.72E−02 1 Unchanged Low P22897 I17ab7 mannose receptor; C type 1 77.30638 100 192.4612 123.4215 1.32E+00 3.78E−01 1 Unchanged Low P19012 L04ab6 keratin 15 146.5632 130 192.6097 156.5003 3.94E−01 −1.69E−01 1 Unchanged Low Q14738 C16cd1 protein phosphatase 2; regulator 224.4642 183 192.7984 200.124 −2.19E−01 −2.94E−01 1 Unchanged Low O95152 F04cd4 vesicle trafficking protein 197.6319 196 192.9314 195.3686 −3.47E−02 −1.53E−02 1 Unchanged Low P78426 A09cd3 NK6 transcription factor homolog 198.5291 353 193.0203 248.2544 −4.06E−02 8.31E−01 1 Unchanged Low Q14790 P14ab3 caspase 8; apoptosis-related cys 124.8603 284 193.1013 200.6718 6.29E−01 1.19E+00 1 Unchanged Low P07711 N13ab4 cathepsin L 137.16 121 193.1454 150.5861 4.94E−01 −1.75E−01 1 Unchanged Low P32942 B02ab6 Intercellular adhesion molecule 3 140.3673 140 193.1656 157.6897 4.61E−01 −8.57E−03 1 Unchanged Low L18ab2 ATPase; Na+/K+ transporting; al

188.9371 131 194.2503 171.3764 4.00E−02 −5.29E−01 1 Unchanged Low Q9NWS0 F13gh2 hypothetical protein FLJ20643 81.29108 107 194.4652 127.6547 1.26E+00 3.99E−01 1 Unchanged Low Q9NWZ5 O06gh2 uridine kinase-like 1 176.188 358 194.4782 242.9739 1.42E−01 1.02E+00 1 Unchanged Low O75792 D15cd6 ribonuclease HI; large subunit 100.3515 99.6 194.705 131.5441 9.56E−01 −1.12E−02 1 Unchanged Low P05141 I04ab2 solute carrier family 25 (mitocho

454.9832 311 194.7577 320.3918 −1.22E+00 −5.47E−01 1 Unchanged Low Q9NX38 K22gh2 hypothetical protein FLJ20457 140.7383 161 195.2668 165.7012 4.72E−01 1.95E−01 1 Unchanged Low Q9Y682 A18cd8 sec22 homolog 193.7656 271 195.3918 220.1941 1.21E−02 4.86E−01 1 Unchanged Low P78381 C02cd4 solute carrier family 35 (UDP-gal

276.1892 207 195.6585 226.4009 −4.97E−01 −4.14E−01 1 Unchanged Low Q9UMP5 B23ef3 replication initiation region prote

270.4297 179 195.6957 214.9641 −4.67E−01 −5.97E−01 1 Unchanged Low Q9P0Q0 C15ef3 hypothetical protein HSPC228 129.6054 241 195.7376 188.838 5.95E−01 8.96E−01 1 Unchanged Low Q9UBQ3 M12cd7 polyamine-modulated factor 1 189.4397 172 195.7465 185.7473 4.72E−02 −1.39E−01 1 Unchanged Low P27540 D22ab2 aryl hydrocarbon receptor nuclea

239.4814 258 195.776 231.071 −2.91E−01 1.07E−01 1 Unchanged Low Q9Y2W1 F03cd5 thyroid hormone receptor-associ

160.2008 248 195.7775 201.3236 2.89E−01 6.30E−01 1 Unchanged Low P82267 E15ab4 adaptor-related protein complex 198.6022 231 195.7793 208.571 −2.07E−02 2.20E−01 1 Unchanged Low P00918 C16ab3 carbonic anhydrase II 283.4506 172 195.9099 216.9569 −5.33E−01 −7.25E−01 1 Unchanged Low Q9Y663 E07cd6 heparan sulfate (glucosamine) 3-

259.052 99.8 196.1045 184.9847 −4.02E−01 −1.38E+00 1 Unchanged Low Q9NX40 K18gh2 ovarian carcinoma immunoreacti

119.6155 247 196.1836 187.7106 7.14E−01 1.05E+00 1 Unchanged Low P50222 L09ab7 mesenchyme homeo box 2 (grow

165.3048 223 196.5502 195.0839 2.50E−01 4.34E−01 1 Unchanged Low Q13610 C16cd7 nuclear phosphoprotein similar t

160.8948 331 196.7055 229.4375 2.90E−01 1.04E+00 1 Unchanged Low P49591 B12cd2 seryl-tRNA synthetase 152.5268 69.6 196.7944 139.6467 3.68E−01 −1.13E+00 1 Unchanged Low P04554 C19gh5 protamine 3 314.8934 296 196.9835 269.3189 −6.77E−01 −8.89E−02 1 Unchanged Low P02538 N12ef6 keratin 6A 227.8925 277 197.1759 233.9139 −2.09E−01 2.80E−01 1 Unchanged Low Q13637 G23cd7 RAB32; member RAS oncogene 392.0158 269 197.2609 286.1382 −9.91E−01 −5.43E−01 1 Unchanged Low P39086 J02ab3 glutamate receptor; ionotropic; k

184.3318 210 197.334 197.2285 9.83E−02 1.88E−01 1 Unchanged Low Q9H8F9 H20gh5 hypothetical protein 24432 287.08 202 197.402 228.8927 −5.40E−01 −5.06E−01 1 Unchanged Low Q99460 L13ab8 proteasome (prosome; macropa

298.3527 228 197.4025 241.22 −5.96E−01 −3.89E−01 1 Unchanged Low Q9UKP6 D20gh1 G protein-coupled receptor 14 213.3717 142 197.5131 184.3366 −1.11E−01 −5.86E−01 1 Unchanged Low Q16589 A04ef5 cyclin G2 99.61434 214 197.5658 170.3526 9.88E−01 1.10E+00 1 Unchanged Low O95316 M03cd5 ribosomal protein S6 kinase; 90 k 144.8234 145 197.5662 162.324 4.48E−01 −2.40E−03 1 Unchanged Low O14545 A09cd7 FLN29 gene product 238.4292 288 197.8936 241.5146 −2.69E−01 2.74E−01 1 Unchanged Low Q9Y249 P03cd6 homologous to yeast nitrogon pe

191.1146 224 198.1049 204.4863 5.18E−02 2.31E−01 1 Unchanged Low Q92794 K12cd4 zinc finger protein 220 134.123 179 198.312 170.3523 5.64E−01 4.13E−01 1 Unchanged Low P36894 A12ab3 bone morphogenetic protein rece

149.2953 236 198.4963 194.5315 4.11E−01 6.59E−01 1 Unchanged Low P79525 L21ab7 MHC class I polypeptide-related 120.8289 125 198.5782 148.0291 7.17E−01 4.53E−02 1 Unchanged Low O14947 K04ab6 laminin; beta 3 (nicein (125 kD);

360.8887 284 199.2636 281.2972 −8.57E−01 −3.47E−01 1 Unchanged Low Q12899 K16cd3 tripartite motif-containing 26 188.6935 250 199.2998 212.5994 7.89E−02 4.05E−01 1 Unchanged Low M24gh8 zinc finger protein 289; ID1 regul

91.37228 137 199.4969 142.4645 1.13E+00 5.79E−01 1 Unchanged Low Q9UIJ5 A18ef2 zinc finger; DHHC domain contai

436.5048 452 199.696 362.7132 −1.13E+00 5.01E−02 1 Unchanged Low P46821 J11ab7 microtubule-associated protein 1 121.2356 136 199.8286 152.4972 7.21E−01 1.70E−01 1 Unchanged Low O60906 P04cd1 sphingomyelin phosphodiesteras 282.5771 281 199.835 254.5351 −5.00E−01 −7.08E−03 1 Unchanged Low P04040 O18ab5 catalase 160.7098 239 199.9283 199.8034 3.15E−01 5.71E−01 1 Unchanged Low O60709 B16cd5 dynamin 1-like 85.33527 220 199.9492 168.4792 1.23E+00 1.37E+00 1 Unchanged Low Q14714 A02cd4 sarcospan (Kras oncogene-asso

378.724 148 200.1413 242.1486 −9.20E−01 −1.36E+00 1 Unchanged Low P39687 F01cd4 acidic (leucine-rich) nuclear pho

226.8272 108 200.186 178.3873 −1.80E−01 −1.07E+00 1 Unchanged Low O75341 K16cd4 BRCA1 associated protein 151.895 209 200.2666 187.1088 3.99E−01 4.62E−01 1 Unchanged Low Q9NUN1 D16gh3 hypothetical protein FLJ11259 152.5767 196 200.5435 182.989 3.94E−01 3.60E−01 1 Unchanged Low Q9UHR5 L22ef7 transcriptional regulator protein 225.1172 345 200.7483 256.9591 −1.65E−01 6.16E−01 1 Unchanged Low Q9UMX3 D15gh8 BCL2-related ovarian killer 185.2616 176 200.9857 187.4707 1.18E−01 −7.26E−02 1 Unchanged Low Q02297 J05ef6 neuregulin 1 89.51288 234 201.3025 175.0464 1.17E+00 1.39E+00 1 Unchanged Low Q9BQ83 A21gh6 hypothetical protein MGC5178 302.7768 398 201.3498 300.7124 −5.89E−01 3.95E−01 1 Unchanged Low O43491 C22ab4 erythrocyte membrane protein b

265.5557 144 201.5208 203.6633 −3.98E−01 −8.84E−01 1 Unchanged Low Q92922 N16cd1 SWI/SNF related; matrix associa

251.3134 195 201.571 216.0309 −3.18E−01 −3.64E−01 1 Unchanged Low Q16099 J11ef3 glutamate receptor; ionotropic; k

200.0311 288 201.66 229.9201 1.17E−02 5.26E−01 1 Unchanged Low O95328 B06gh4 hypothetical protein 626 253.2751 240 201.6989 231.7737 −3.29E−01 −7.56E−02 1 Unchanged Low Q06265 C15cd1 polymyositis/scleroderma autoan 167.3169 182 202.2097 183.9827 2.73E−01 1.25E−01 1 Unchanged Low Q01780 K12gh6 polymyositis/scleroderma autoan 196.9508 270 202.2308 223.1866 3.82E−02 4.57E−01 1 Unchanged Low Q9NPF9 G07ef3 HeLa cyclin-dependent kinase 2 251.6953 170 202.5242 207.9337 −3.14E−01 −5.70E−01 1 Unchanged Low Q9P1U0 B03ef4 zinc ribbon domain containing; 1 110.7474 151 202.7351 154.8483 8.72E−01 4.48E−01 1 Unchanged Low Q13480 C02ab5 GRB2-associated binding protein 171.5634 150 203.065 174.7367 2.43E−01 −1.98E−01 1 Unchanged Low O95205 O05gh1 C3H-type zinc finger protein; sim

138.7838 267 203.3797 202.2261 5.72E−01 9.62E−01 1 Unchanged Low O76091 I11cd1 nitrilase 1 194.24 179 203.4317 192.2638 6.67E−02 −1.17E−01 1 Unchanged Low Q9Y364 F21ef2 DKFZP434J154 protein 208.15 322 203.5516 244.4561 −3.22E−02 6.28E−01 1 Unchanged Low P51116 I14cd5 fragile X mental retardation; auto 215.9784 213 203.6388 210.8166 −8.49E−02 −2.12E−02 1 Unchanged Low P49915 H19cd4 guanine monphosphate syntheta

175.5001 115 203.6534 164.6237 2.15E−01 −6.13E−01 1 Unchanged Low Q9UHR3 O04cd8 nasopharyngeal carcinoma susc

120.0173 196 203.8212 173.3257 7.64E−01 7.09E−01 1 Unchanged Low Q15007 O10cd5 Wllms' tumour 1-associating prot

237.1077 258 204.228 233.0967 −2.15E−01 1.22E−01 1 Unchanged Low P24941 B03ef5 cyclin-dependent kinase 2 98.60804 214 204.3554 172.2468 1.05E+00 1.12E+00 1 Unchanged Low P53634 L01ef7 cathepsin C 97.3314 77.9 204.771 126.6548 1.07E+00 −3.22E−01 1 Unchanged Low Q13123 K03ef7 IK cytokine; down-regulator of H

108.6134 153 204.9565 155.5636 9.16E−01 4.95E−01 1 Unchanged Low Q9NUT6 P21gh3 hypothetical protein FLJ11151 285.3106 565 205.0219 351.7208 −4.77E−01 9.85E−01 1 Unchanged Low Q9Y279 B23cd7 Ig superfamily protein 356.8489 226 205.0366 262.6019 −7.99E−01 −6.59E−01 1 Unchanged Low O75319 H07cd3 dual specificity phosphatase 11

250.2151 205 205.1456 220.2678 −2.87E−01 −2.84E−01 1 Unchanged Low Q9NYH9 L08ef3 hepatocellular carcinoma-associa

287.2586 283 205.223 258.6032 −4.85E−01 −1.99E−02 1 Unchanged Low Q9UNF0 M20cd7 protein kinase C and casein kina

438.5503 349 205.53 331.0599 −1.09E+00 −3.29E−01 1 Unchanged Low O60437 D03ab8 periplakin 443.9882 301 205.5879 316.8358 −1.11E+00 −5.61E−01 1 Unchanged Low Q9NZN8 N22cd8 CCR4-NOT transcription comple

189.665 224 205.673 206.5153 1.17E−01 2.41E−01 1 Unchanged Low Q14232 A18ab4 eukaryotic translation initiation fa

273.7271 210 205.7436 229.9659 −4.12E−01 −3.79E−01 1 Unchanged Low O00142 C03ef5 thymidine kinase 2; mitochondria 124.7128 147 205.9951 159.1674 7.24E−01 2.35E−01 1 Unchanged Low O60443 N15ab5 deafness; autosomal dominant 5 122.4035 264 208.3187 197.4327 7.53E−01 1.11E+00 1 Unchanged Low O95406 J20cd5 cornichon-like 181.7181 138 206.4442 175.4375 1.84E−01 −3.95E−01 1 Unchanged Low Q12841 E24cd7 follistatin-like 1 80.93058 97.7 206.5097 128.3877 1.35E+00 2.72E−01 1 Unchanged Low O15217 B04ab5 glutathione S-transferase A4 78.38055 91.3 206.6118 125.424 1.40E+00 2.20E−01 1 Unchanged Low P10645 E01ab4 chromogranin A (parathyroid sec 115.7467 283 206.8714 201.8922 8.38E−01 1.29E+00 1 Unchanged Low Q9HA68 D09gh5 G protein beta subunit-like 198.1992 192 206.9573 199.1923 6.24E−02 −4.27E−02 1 Unchanged Low Q9Y439 B06ef8 PRP31 pre-mRNA processing fa

175.7234 310 207.0904 230.9065 2.37E−01 8.19E−01 1 Unchanged Low Q9Y386 G08ef2 CGI-78 protein 325.6509 246 207.7702 259.7061 −6.48E−01 −4.06E−01 1 Unchanged Low P53990 D21gh1 KIAA0174 gene product 230.1187 401 207.9831 279.676 −1.46E−01 8.01E−01 1 Unchanged Low O95865 O11ef3 dimethylarginine dimethylaminoh 125.0105 157 208.0048 163.3476 7.35E−01 3.29E−01 1 Unchanged Low B21ef1 immunoglobulin lambda-like poly 142.7367 230 208.1338 193.5142 5.44E−01 6.86E−01 1 Unchanged Low Q15834 I17cd7 hepatitis delta antigen-interacting 320.7647 226 208.1753 251.6031 −6.24E−01 −5.06E−01 1 Unchanged Low P18846 H05ab4 activating transcription factor 1 470.9776 206 208.3404 295.2222 −1.18E+00 −1.19E+00 1 Unchanged Low Q14349 A23cd7 HLA-B associated transcript 8 138.8938 175 208.5984 174.3142 5.87E−01 3.37E−01 1 Unchanged Low Q9NVM5 M08gh3 hypothetical protein FLJ10637 98.19923 115 209.0315 140.794 1.09E+00 2.30E−01 1 Unchanged Low P12955 N18ab7 peptidase D 133.8157 192 209.0325 178.2362 6.43E−01 5.20E−01 1 Unchanged Low Q99700 D14cd1 spinocerebellar ataxia 2 (olivopo

191.0044 240 209.0555 213.1956 1.30E−01 3.27E−01 1 Unchanged Low Q9UJA2 E21gh3 chromosome 20 open reading fra

134.2553 316 209.227 219.8275 6.40E−01 1.23E+00 1 Unchanged Low Q02246 J21ef6 contactin 2 (axonal) 108.0043 68.8 209.3915 128.7469 9.55E−01 −6.50E−01 1 Unchanged Low P48553 E06cd2 transmembrane protein 1 148.0375 238 209.4168 198.4177 5.00E−01 6.84E−01 1 Unchanged Low Q99639 K03cd2 suppressor of Ty 5 homolog (S.

225.1962 296 209.795 243.5051 −1.02E−01 3.92E−01 1 Unchanged Low Q9NQX5 N02gh4 neural proliferation; differentiatio

188.0695 206 209.8245 201.225 1.58E−01 1.30E−01 1 Unchanged Low Q99799 O08cd6 nuclear RNA export factor 1 205.4132 175 209.9237 196.7655 3.13E−02 −2.32E−01 1 Unchanged Low Q9BZV1 J05gh7 UBX domain-containing 1 127.7069 236 209.9733 191.2074 7.17E−01 8.86E−01 1 Unchanged Low Q03113 M19ab5 guanine nucleotide binding prote

140.2412 112 209.9975 154.1344 5.82E−01 −3.22E−01 1 Unchanged Low P01130 B21ab6 low density lipoprotein receptor (

301.1179 394 210.369 301.7776 −5.17E−01 3.87E−01 1 Unchanged Low Q9UHN6 L11cd8 transmembrane protein 2 182.3012 130 210.5088 174.2344 2.08E−01 −4.89E−01 1 Unchanged Low Q99738 A03cd3 pinin; desmosome associated pr

200.7164 204 210.6944 205.0214 7.00E−02 2.10E−02 1 Unchanged Low Q9Y576 N03ef2 ankyrin repeat and SOCS box-cc 121.1139 76.2 210.8606 136.0527 8.00E−01 −6.69E−01 1 Unchanged Low P02304 B03gh6 H4 histone; family 2 81.15302 191 210.8651 161.1406 1.38E+00 1.24E+00 1 Unchanged Low P01118 I08ab7 v-KI-ras2 Kirsten rat sarcoma 2 v

209.4177 239 211.0234 219.9522 1.10E−02 1.93E−01 1 Unchanged Low P15924 K13ef7 desmoplakin (DPI; DPII) 249.9083 263 211.0334 241.3819 −2.44E−01 7.48E−02 1 Unchanged Low O43597 A19cd6 sprouty homolog 2 (Drosophila) 119.5051 155 211.0573 161.8627 8.21E−01 3.75E−01 1 Unchanged Low P09622 I06ab3 dihydrolipoamide dehydrogenas

346.3029 232 211.1679 263.2128 −7.14E−01 −5.77E−01 1 Unchanged Low Q08257 G16ef7 crystallin; zeta (quinone reducta

514.6998 301 211.6448 345.4839 −1.28E+00 −7.73E−01 1 Unchanged Low Q9UHY8 J09cd7 fasciculation and elongation pro

86.8735 95.1 211.8371 131.2705 1.29E+00 1.31E−01 1 Unchanged Low P10646 P23cd2 tissue factor pathway inhibitor (li

596.8869 458 212.0146 422.403 −1.49E+00 −3.81E−01 1 Unchanged Low Q92685 L08cd5 Not56 (D. melanogaster)-like pro 195.2017 217 212.2397 208.1394 1.21E−01 1.53E−01 1 Unchanged Low P34949 I13ab7 mannose phosphate isomerase 102.2281 135 212.3424 149.8251 1.05E+00 4.00E−01 1 Unchanged Low Q9NPE9 M21ef8 HSPC055 protein 91.56792 157 212.3544 153.7649 1.21E+00 7.81E−01 1 Unchanged Low Q99853 J24ef7 forkhead box B1 141.4272 105 212.4773 153.0918 5.87E−01 −4.25E−01 1 Unchanged Low Q9HD41 C24gh4 CHMP1.5 protein 280.2988 230 212.8608 241.047 −3.97E−01 −2.85E−01 1 Unchanged Low Q16625 A10ab8 occludin 859.5688 338 212.9222 470.2634 −2.01E+00 −1.35E+00 1 Unchanged Low P45973 L18ef6 chromobox homolog 5 (HP1 alph

164.9514 124 213.1315 167.3186 3.70E−01 −4.13E−01 1 Unchanged Low Q9NVI9 O12gh3 hypothetical protein FLJ10707 136.0971 136 213.1484 161.8885 6.47E−01 3.42E−03 1 Unchanged Low P37173 O09ef7 transforming growth factor; beta

112.4415 208 213.3211 178.0564 9.24E−01 8.90E−01 1 Unchanged Low Q9UKF7 O21cd8 retinal degeneration B beta 333.6061 287 213.5389 277.9863 −6.44E−01 −2.18E−01 1 Unchanged Low P16870 J23ef7 carboxypeptidase E 81.85341 137 213.5973 144.0377 1.38E+00 7.40E−01 1 Unchanged Low P00374 D16ab3 dihydrofolate reductase 148.8142 59.6 213.6217 140.6638 5.22E−01 −1.32E+00 1 Unchanged Low P19957 M04ab8 protease inhibitor 3; skin-dervied 202.9357 582 213.9068 333.0661 7.60E−02 1.52E+00 1 Unchanged Low O75962 J24cd2 triple functional domain (PTPRF 233.7849 197 213.9409 215.0154 −1.28E−01 −2.45E−01 1 Unchanged Low P16050 C24ab2 arachidonate 15-lipoxygenase 288.5504 87.3 213.9824 196.6194 −4.31E−01 −1.72E+00 1 Unchanged Low Q9Y3D2 N14cd7 pilln-like transcription factor 200.9397 224 214.0069 213.0068 9.09E−02 1.57E−01 1 Unchanged Low O00505 J16ab6 karyopherin alpha 3 (impartin alp

358.8945 313 214.0819 295.4165 −7.45E−01 −1.96E−01 1 Unchanged Low Q9NZD8 N15ef1 acid cluster protein 33 222.816 223 214.2958 220.0079 −5.62E−02 6.21E−04 1 Unchanged Low P46937 G10cd6 Yes-associated protein 1; 65 kD 219.0427 268 214.3846 233.924 −3.10E−02 2.93E−01 1 Unchanged Low P53384 O05ab7 nucleotide binding protein 1 (Min 272.4995 223 214.5051 236.5867 −3.45E−01 −2.91E−01 1 Unchanged Low Q9UI28 K10ef4 AD-003 protein 120.4834 147 214.7067 160.6424 8.34E−01 2.84E−01 1 Unchanged Low Q14851 O20ab8 plastin 1 (I isoform) 517.7448 303 214.7993 345.2493 −1.27E+00 −7.72E−01 1 Unchanged Low P10914 K01ef6 Interferon regulatory factor 1 310.699 395 214.9514 306.8604 −5.32E−01 3.46E−01 1 Unchanged Low P212B1 A03ab3 ATPase; H+ transporting; lysoso

299.07 638 215.0012 383.914 −4.76E−01 1.09E+00 1 Unchanged Low P53701 G19ab6 holocytochrome c synthase (cyto

251.8825 415 215.1177 293.8906 −2.28E−01 7.19E−01 1 Unchanged Low Q9Y2B1 C18ef3 transmembrane protein 5 103.4737 123 215.2492 147.2535 1.06E+00 2.50E−01 1 Unchanged Low Q14166 D23ef8 KIAA0153 protein 332.5834 276 215.4465 274.7657 −8.26E−01 −2.68E−01 1 Unchanged Low Q15738 B09ef4 NAD(P) dependent steroid dehyd

253.061 171 215.5558 213.0647 −2.31E−01 −5.69E−01 1 Unchanged Low Q16586 I06cd1 sarcoglycan; alpha (50 kD dystro

358.221 129 215.8058 234.3861 −7.31E−01 −1.47E+00 1 Unchanged Low Q9Y6J8 L05ef2 map kinase phosphatase-like pr

275.0054 326 215.9987 272.4953 −3.48E−01 2.48E−01 1 Unchanged Low Q9H5F2 P17gh5 hypothetical protein FLJ23499 204.1242 332 216.1178 250.8425 8.24E−02 7.03E−01 1 Unchanged Low Q05655 E02cd1 protein kinase C; delta 419.7056 297 216.1184 310.8344 −9.58E−01 −5.00E−01 1 Unchanged Low Q9NXU7 M03gh3 hypothetical protein FLJ20048 240.4802 235 216.1338 230.6008 −1.54E−01 −3.21E−02 1 Unchanged Low O15498 P21cd6 SNARE protein Ykt6 188.9561 242 216.7243 215.7355 1.98E−01 3.54E−01 1 Unchanged Low Q92664 F07ab4 general transcription factor IIIA 318.1862 193 216.7575 242.5829 −5.54E−01 −7.23E−01 1 Unchanged Low Q9Y223 N03cd5 UDP-N-acetylglucosamine-2-epi

207.311 295 217.1156 239.9817 8.67E−02 5.11E−01 1 Unchanged Low O95816 E21ab3 BCL2-associated athanogene 2 84.7224 94.2 217.4827 132.1461 1.36E+00 1.53E−01 1 Unchanged Low Q9H0K5 A21gh8 hypothetical protein DKFZp434H 193.1934 324 217.6924 244.8706 1.72E−01 7.45E−01 1 Unchanged Low Q9BTJ1 C03ef2 ribosomal protein S27-like 132.1497 411 218.2702 253.7125 7.24E−01 1.64E+00 1 Unchanged Low Q9NRR5 J23gh4 chromosome 1 open reading fra

138.2192 201 218.4149 185.8791 6.60E−01 5.40E−01 1 Unchanged Low Q9Y5L3 A13ab4 ectonucleoside triphosphate dip

235.2745 316 218.4547 256.4569 −1.07E−01 4.24E−01 1- Unchanged Low O75351 K06cd5 suppressor of K+ transport defec 274.5936 311 218.6389 267.9692 −3.29E−01 1.78E−01 1 Unchanged Low O75443 F07cd2 tectorin alpha 183.4591 150 218.7282 184.2202 2.54E−01 −2.86E−01 1 Unchanged Low Q9H7X4 K04gh7 KIAA1085 protein 268.2576 372 218.7527 286.2489 −2.94E−01 4.71E−01 1 Unchanged Low O00255 K22ab6 multiple endocrine neoplasia I 134.7209 117 218.9335 156.9374 7.01E−01 −2.02E−01 1 Unchanged Low Q9BV94 D05gh3 chromosome 20 open reading fra

319.259 316 219.2324 284.912 −5.42E−01 −1.37E−02 1 Unchanged Low O14813 D10ab2 aristaless homeobox (Drosophila 226.3067 320 219.2567 255.131 −4.57E−02 4.99E−01 1 Unchanged Low P35269 D15ab4 general transcription factor IIF; p 243.8395 213 219.8975 225.4377 −1.49E−01 −1.98E−01 1 Unchanged Low Q12891 E08ef5 hyaluronoglucosaminidase 2 331.3833 311 220.4462 287.6363 −5.88E−01 −9.12E−02 1 Unchanged Low O15162 L08gh1 phospholipid scramblase 1 440.6448 597 220.6688 419.5068 −9.98E−01 4.39E−01 1 Unchanged Low Q14469 O08ab7 hairy homolog (Drosophila) 151.2148 251 221.0242 207.739 5.48E−01 7.31E−01 1 Unchanged Low P06241 P13ab4 FYN oncogene related to SRC; F 106.4214 82.5 221.2951 136.7385 1.06E+00 −3.67E−01 1 Unchanged Low Q9BVG9 P17gh7 phosphatidylserine synthase 2 225.5812 200 221.5588 215.8454 −2.60E−02 −1.71E−01 1 Unchanged Low Q9P0P9 K12ef2 hypothetical protein LOC51249 290.4444 434 222.6323 315.5648 −3.84E−01 5.78E−01 1 Unchanged Low Q9UMF9 L14cd3 eukaryotic translation initiation fa 207.6515 242 222.6344 224.2505 1.01E−01 2.24E−01 1 Unchanged Low Q03527 L07ab8 proteasome (prosome: macropai

441.6371 284 222.6794 316.1666 −9.88E−01 −6.36E−01 1 Unchanged Low P31153 J15ab7 methionine adenosyltransferase 245.2111 134 222.7802 200.5541 −1.38E−01 −8.75E−01 1 Unchanged Low Q04741 D21ef1 empty spiracles homolog 1 (Dros 240.3769 189 222.791 217.4148 −1.10E−01 −3.46E−01 1 Unchanged Low Q13153 L22ef5 p21/Cdc42/Rac1-activated kinase 243.198 277 222.8583 247.6258 −1.26E−01 1.87E−01 1 Unchanged Low Q9Y388 H15ef2 CGI-79 protein 100.7214 181 223.2467 168.2598 1.15E+00 8.44E−01 1 Unchanged Low Q9HC14 K17gh5 mitochondrial ribosomal protein

158.7783 200 223.2594 193.9429 4.92E−01 3.31E−01 1 Unchanged Low P30281 O08ef5 cyclin D3 107.4859 167 223.2751 166.0499 1.05E+00 6.39E−01 1 Unchanged Low Q9UFK2 P05ef8 DKFZP564K1964 protein 133.0476 210 223.4229 188.8934 7.48E−01 6.60E−01 1 Unchanged Low Q13011 O23ab4 enoyl Coenzyme A hydratase 1;

337.9818 273 223.7187 278.2904 −5.95E−01 −3.07E−01 1 Unchanged Low P09601 E20ef7 heme oxygenase (decycling) 1 186.4519 425 223.7447 278.3661 2.63E−01 1.19E+00 1 Unchanged Low Q9BVZ8 P23gh8 hypothetical protein FLJ14936 126.689 127 224.0692 159.346 8.23E−01 6.71E−03 1 Unchanged Low Q13889 A11ab5 general transcription factor IIH: p 112.1935 202 224.1653 179.5227 9.99E−01 8.50E−01 1 Unchanged Low P49703 P23ab2 ADP-ribosylation factor 4-like 125.6732 91.2 224.1896 147.0234 8.35E−01 −4.62E−01 1 Unchanged Low Q9GZU7 G11gh4 nuclear LIM interactor-interacting 305.5546 150 224.2596 226.5474 −4.46E−01 −1.03E+00 1 Unchanged Low P10253 M22ab3 glucosidase; alpha; acid (Pompe 187.3998 156 224.2782 189.0733 2.59E−01 −2.69E−01 1 Unchanged Low Q9Y3V5 B18ef8 hypothetical protein DKFZP586F 303.8477 426 224.4103 318.1897 −4.37E−01 4.89E−01 1 Unchanged Low O14773 P17ef7 ceroid-lipofuscinosis; neuronal 2: 169.6468 214 224.4535 202.7117 4.04E−01 3.35E−01 1 Unchanged Low P22061 G13cd1 protein-L-isoaspartate (D-aspart

118.1783 163 224.5569 168.6387 9.26E−01 4.66E−01 1 Unchanged Low P14868 K21ab4 aspartyl-IRNA synthetase 117.1946 78.1 225.0996 140.1468 9.42E−01 −5.85E−01 1 Unchanged Low O14938 D16ef6 nuclear factor I/X (CCAAT-bindin 94.58773 84.9 225.3458 134.9545 1.25E+00 −1.55E−01 1 Unchanged Low O75968 P21ef3 pannexin 1 215.9189 216 225.5368 219.072 6.29E−02 −1.06E−03 1 Unchanged Low Q9H779 C15gh6 hypothetical protein MGC2821 138.4597 313 225.8086 225.7323 7.06E−01 1.18E+00 1 Unchanged Low Q9BX72 C02gh8 IFP38 168.9682 172 225.8249 188.9468 4.18E−01 2.61E−02 1 Unchanged Low O43563 G24cd1 solute carrier family 22 (organic

133.7352 149 225.8428 169.4168 7.56E−01 1.53E−01 1 Unchanged Low O15142 D17ab2 ARP2 actin-related protein 2 ho

250.3086 215 226.0552 230.3093 −1.47E−01 −2.22E−01 1 Unchanged Low Q9UJ41 K17ef4 putative Rab5 GDP/GTP exchan

121.9098 165 226.5205 171.2118 8.94E−01 4.38E−01 1 Unchanged Low P05231 F21ef7 interleukin 6 (interferon; beta 2) 240.2349 673 226.529 379.972 −8.48E−02 1.49E+00 1 Unchanged Low Q9Y2H0 G24ef8 KIAA0964 protein 279.6086 310 226.545 271.9604 −3.04E−01 1.48E−01 1 Unchanged Low Q9UJT9 E15cd8 F-box and leucine-rich repeat por

287.9128 294 226.762 269.5315 −3.44E−01 2.98E−02 1 Unchanged Low Q9Y306 O23ef2 pelota homolog (Drosophila) 146.8037 190 226.8083 187.7391 6.28E−01 3.69E−01 1 Unchanged Low Q9Y6A6 N04ef3 transcription factor (p38 interacti

174.5425 171 226.9539 190.8287 3.79E−01 −2.97E−02 1 Unchanged Low O75300 K18cd2 ribosome binding protein 1 homo 98.67954 73.7 227.0651 133.1515 1.20E+00 −4.21E−01 1 Unchanged Low P51798 L03ef1 chloride channel 7 278.4282 282 228.319 263.0106 −2.86E−01 1.98E−02 1 Unchanged Low Q14839 C21ab4 chromodomain helicase DNA bin 104.8847 161 228.322 164.8091 1.12E+00 6.20E−01 1 Unchanged Low O60299 O18gh1 KIAA0552 gene product 132.5981 337 228.426 232.6614 7.85E−01 1.35E+00 1 Unchanged Low Q9Y6F1 H03ab2 ADP-ribosyltransferase (NAD+;

248.9844 399 228.5355 292.1577 −1.24E−01 6.80E−01 1 Unchanged Low O15212 E04ef3 HLA class II region expressed ge

250.113 292 228.5629 256.7661 −1.30E−01 2.22E−01 1 Unchanged Low Q9Y2W2 J14ef2 WW domain binding protein 11 335.0512 304 228.6314 289.1386 −5.51E−01 −1.42E−01 1 Unchanged Low Q9UKN5 O03cd8 PR domain containing 4 252.6208 80.6 228.639 187.2825 −1.44E−01 −1.65E+00 1 Unchanged Low Q00978 C24cd6 interferon-stimilated transcription 303.7171 404 228.7768 312.2774 −4.09E−01 4.13E−01 1 Unchanged Low Q9UHY0 L08ef1 HP1-BP74 295.9512 267 228.8435 263.8122 −3.71E−01 −1.50E−01 1 Unchanged Low Q9Y248 L13ef2 HSPC037 protein 92.39515 70.3 229.0541 130.5748 1.31E+00 −3.95E−01 1 Unchanged Low O96019 E21ab2 BAF53 228.9673 345 229.5696 267.9206 3.79E−03 5.92E−01 1 Unchanged Low P10276 K19ab8 retinoic acid receptor: alpha 250.0312 122 229.7466 200.7048 −1.22E−01 −1.03E+00 1 Unchanged Low Q9BUC7 P22gh8 hypothetical protein MGC4172 136.4413 398 229.8471 254.8265 7.52E−01 1.55E+00 1 Unchanged Low Q9HAC1 D01gh5 praja 1 143.4188 97.5 230.0154 156.9785 6.81E−01 −5.57E−01 1 Unchanged Low Q93078 M18gh6 H2B histone family; member H 179.9656 203 230.2553 204.3058 3.56E−01 1.72E−01 1 Unchanged Low P08572 N22ef8 collagen; type IV; alpha 2 70.14126 87.3 230.3868 129.2665 1.72E+00 3.15E−01 1 Unchanged Low P15056 G10ef5 v-raf murine sarcoma viral oncog 194.1803 174 231.0687 199.7155 2.51E−01 −1.59E−01 1 Unchanged Low Q15543 J15cd2 TAF13 RNA polymerase II; TAT

222.3129 262 231.2695 238.5733 5.70E−02 2.38E−01 1 Unchanged Low O14901 J05cd3 TGFB inducible early growth res

277.9069 277 231.5621 262.1749 −2.63E−01 −4.43E−03 1 Unchanged Low N10gh8 diphosphate dimethylallyl diphos 313.8915 257 231.841 267.6704 −4.37E−01 −2.87E−01 1 Unchanged Low P51965 O13cd3 ubiquitin-conjugating enzyme E2 254.2693 673 232.1178 386.4499 −1.32E−01 1.40E+00 1 Unchanged Low Q9Y3R2 G04cd8 trabsportin-SR 338.45 219 232.2301 263.1005 −5.43E−01 −6.31E−01 1 Unchanged Low O94829 G10gh1 importin 13 160.6646 247 232.3109 213.3188 5.30E−01 6.17E−01 1 Unchanged Low Q92859 M13ab8 neogenin homolog 1 (chicken) 153.0455 249 232.6926 211.5326 6.04E−01 7.01E−01 1 Unchanged Low Q12846 O02cd2 syntaxin 4A (placental) 323.5547 93.2 232.9973 216.5887 −4.74E−01 −1.80E+00 1 Unchanged Low P01286 G15ef1 growth harmone releasing hormo

237.6384 263 233.028 244.6261 −2.83E−02 1.47E−01 1 Unchanged Low Q9UH92 L01cd8 transcription factor-like 4 172.7135 195 233.1639 200.1328 4.33E−01 1.72E−01 1 Unchanged Low O75323 P09ab5 glioblastoma amplified sequence 178.3893 168 233.5843 193.2783 3.89E−01 −8.78E−02 1 Unchanged Low Q9UQ33 P07ef2 microtubule-associated protein;

101.7866 134 234.2195 156.5563 1.20E+00 3.93E−01 1 Unchanged Low Q9Y3A7 A17ef2 CGI-101 protein 402.1639 210 234.3057 282.2981 −7.79E−01 −9.34E−01 1 Unchanged Low Q9Y2Z0 A17cd7 suppressor of G2 allele of SKP1: 184.6693 256 234.3223 224.9662 3.44E−01 4.71E−01 1 Unchanged Low P56211 F16ab2 cyclic AMP phosphoprotein; 19 k 276.9734 386 234.3401 299.2676 −2.41E−01 4.81E−01 1 Unchanged Low P21127 O13ef1 cell division cycle 2-like 2 159.1108 304 234.454 232.4012 5.59E−01 9.32E−01 1 Unchanged Low Q07866 B23ab7 kinesin 2 (60-70 kD) 254.5932 408 234.5156 299.1796 −1.19E−01 6.82E−01 1 Unchanged Low Q9BTI3 H11ef8 KIAA1068 protein 228.7025 230 234.5211 231.0835 3.62E−02 8.33E−03 1 Unchanged Low Q9H2J4 E11gh6 hypothetical protein MGC3062 238.7573 256 235.0353 243.2412 −2.27E−02 1.00E−01 1 Unchanged Low Q9NXE5 E10gh2 hypothetical protein FLJ20296 193.8379 399 235.1468 275.9024 2.79E−01 1.04E+00 1 Unchanged Low Q92572 E17ab4 adaptor-related protein complex: 86.23952 209 235.2813 176.703 1.45E+00 1.27E+00 1 Unchanged Low Q9NXT6 K05gh2 FtsJ homolog 3 (E. coli) 254.7485 277 235.4026 255.685 −1.14E−01 1.20E−01 1 Unchanged Low O15321 F05cd6 transmembrane 9 superfamily m

295.1129 227 235.695 252.5647 −3.24E−01 −3.79E−01 1 Unchanged Low O15383 F07cd6 HIV-1 Tat interactive protein 2; 3

402.8554 444 235.7849 360.7235 −7.73E−01 1.39E−01 1 Unchanged Low O60403 B06cd8 olfactory receptor; family 10; sub

237.7465 262 235.906 245.2774 −1.12E−02 1.41E−01 1 Unchanged Low P49354 K24ab4 famesyltransferase; CAAX box;

173.9344 193 235.9155 201.1077 4.40E−01 1.54E−01 1 Unchanged Low P48039 B07ef6 melatonin receptor 1A 305.0267 208 236.1249 249.7986 −3.69E−01 −5.51E−01 1 Unchanged Low O43562 C08ab8 solute carrier family 22 (organic

115.4101 125 236.1587 158.9844 1.03E+00 1.20E−01 1 Unchanged Low Q9HC89 N24ef8 calpain 10 212.0136 242 236.247 230.2337 1.56E−01 1.93E−01 1 Unchanged Low P00790 M13ef1 pepsinogen 5; group I (pepsinog

256.009 266 236.6918 253.0491 −1.13E−01 5.77E−02 1 Unchanged Low Q9NVP1 G01cd6 DEAD/H (Asp-Glu-Ala-Asp/His)

78.40555 89 236.7778 134.724 1.59E+00 1.83E−01 1 Unchanged Low Q9UBN1 F23ef3 calcium channel; voltage-depend 269.9719 360 237.0557 289.0967 −1.88E−01 4.16E−01 1 Unchanged Low P35659 M22cd3 DEK oncogene (DNA binding) 80.02159 77.8 237.1934 131.6712 1.57E+00 −4.06E−02 1 Unchanged Low P54252 N09ef6 Machado-Joseph disease (spino

156.7549 274 237.2775 222.5126 5.98E−01 8.03E−01 1 Unchanged Low Q14152 L12cd3 eukaryotic translation initiation fa

364.5131 268 237.302 289.959 −6.19E−01 −4.43E−01 1 Unchanged Low Q9Y314 E16ef2 eNOS interacting protein 123.3313 219 237.3058 193.3594 9.44E−01 8.31E−01 1 Unchanged Low Q9NRC7 E23ef3 sirtuin silent mating type informal 136.0486 328 237.5194 233.7238 8.04E−01 1.27E+00 1 Unchanged Low P02533 N02ef6 keratin 14 (epidermolysis bullosa 203.4102 190 237.6951 210.4458 2.25E−01 −9.66E−02 1 Unchanged Low O60907 J19cd2 transducin (beta)-like 1 X-linked 175.9553 171 237.7396 194.8701 4.34E−01 −4.19E−02 1 Unchanged Low P43155 B16ab3 carnitine acetyltransferase 288.355 190 237.6908 238.6829 −2.78E−01 −6.03E−01 1 Unchanged Low Q15077 H08ab8 pyrimidinergic receptor P2Y: G-p 389.9746 248 238.1475 292.1056 −7.12E−01 −6.52E−01 1 Unchanged Low Q12840 I06ab7 kinesin family member 5A 238.3605 282 238.2407 252.8959 −7.25E−04 2.43E−01 1 Unchanged Low P26599 A05cd3 polypyrimidine tract binding prot

160.4912 345 238.4 247.8557 5.71E−01 1.10E+00 1 Unchanged Low Q9Y316 M11ef2 C21orf19-like protein 450.6398 327 238.5981 338.8101 −9.17E−01 −4.62E−01 1 Unchanged Low P24394 O18ab6 interleukin 4 receptor 309.5199 330 238.6201 292.7071 −3.75E−01 9.24E−02 1 Unchanged Low P32418 J22gh1 solute carrier family 8 (sodium/c

171.4835 134 238.7225 181.3894 4.77E−01 −3.56E−01 1 Unchanged Low P42694 N01ef3 helicase with zinc finger domain 165.7017 146 238.7561 183.6122 5.27E−01 −1.79E−01 1 Unchanged Low O60755 L09cd3 galanin receptor 3 162.6185 268 238.7669 223.2368 5.54E−01 7.22E−01 1 Unchanged Low Q16204 A18cd4 DNA segment; single copy; prob

192.0586 225 238.8166 218.6477 3.14E−01 2.29E−01 1 Unchanged Low Q12980 N15cd7 Conserved gene telomeric to alpl

183.7714 174 238.9231 198.8702 3.79E−01 −7.95E−02 1 Unchanged Low P08559 N16ab7 pyruvate dehydrogenase (lipoam 375.1479 206 239.4879 273.612 −6.48E−01 −8.63E−01 1 Unchanged Low Q9Y2U9 K02ef3 host cell factor homolog 127.5142 154 239.623 173.6438 9.10E−01 2.70E−01 1 Unchanged Low Q9Y2T2 P17cd7 adaptor-related protein complex: 336.9686 395 239.6299 323.8714 −4.92E−01 2.29E−01 1 Unchanged Low Q13105 K10cd3 zinc finger protein 151 (pHZ-67) 177.9188 243 240.018 220.1539 4.32E−01 4.47E−01 1 Unchanged Low Q9H1J1 J12gh5 similar to yeast Upf3; variant A 154.12 183 241.0316 192.8261 6.45E−01 2.50E−01 1 Unchanged Low Q08752 E01cd1 peptidylprolyl isomerase D (cycic

446.371 203 241.0389 296.8872 −8.89E−01 −1.13E+00 1 Unchanged Low P38159 F14ab7 RNA binding motif protein; X ch

342.4693 176 241.0429 253.2584 −5.07E−01 −9.58E−01 1 Unchanged Low Q9Y337 A12cd8 kallikrein 5 215.5515 312 241.2144 256.4089 1.62E−01 5.36E−01 1 Unchanged Low P25445 A02ef6 tumor necrosis factor receptor su

102.3524 215 241.2257 186.0304 1.24E+00 1.07E+00 1 Unchanged Low Q9BZH1 P02gh5 membrane-spanning 4-domains; 350.8825 212 241.5154 268.2725 −5.39E−01 −7.24E−01 1 Unchanged Low O43633 O12ef4 putative breast adenocarcinoma 308.4601 232 241.573 260.7188 −3.53E−01 −4.10E−01 1 Unchanged Low Q99536 B03cd6 vesicle amine transport protein 1 222.8504 400 241.6698 288.1564 1.17E−01 8.44E−01 1 Unchanged Low P24557 N11cd1 thromboxane A synthase 1 (plate

326.4482 236 241.6841 268.1689 −4.34E−01 −4.66E−01 1 Unchanged Low O75369 G16ab4 filamin B; beta (actin binding prol

331.6975 459 241.7672 344.1714 −4.56E−01 4.69E−01 1 Unchanged Low P50453 H10ab8 serine (or cysteine) proteinase in

439.8605 370 242.4005 350.7941 −8.60E−01 −2.49E−01 1 Unchanged Low P35680 O18cd1 transcription factor 2; hepatic; LF 235.5021 174 242.5943 217.2497 4.28E−02 −4.40E−01 1 Unchanged Low Q03924 I01gh7 zinc finger protein 117 (HPF9) 257.8571 301 242.7729 267.2646 −8.70E−02 2.24E−01 1 Unchanged Low Q9NRQ5 F17gh4 FN5 protein 361.924 325 242.8257 309.8867 −5.76E−01 −1.56E−01 1 Unchanged Low Q99867 G12gh7 tubulin; beta polypeptide 4; mem 376.7361 247 243.6773 289.1694 −6.29E−01 −6.08E−01 1 Unchanged Low Q9H682 B19gh7 A20-binding inhibitor of NF-kapp

205.6095 365 243.7949 271.5091 2.46E−01 8.28E−01 1 Unchanged Low O00148 N12cd5 DEAD/H (Asp-Glu-Ala-Asp/His)

259.196 140 244.0023 214.3036 −8.71E−02 −8.92E−01 1 Unchanged Low F11cd8 TCF3 (E2A) fusion partner (in ch 170.7519 295 244.0153 236.7141 5.15E−01 7.91E−01 1 Unchanged Low Q9UG51 N05ef3 anaphase-promoting complex su 274.4079 331 244.0324 283.0875 −1.69E−01 2.70E−01 1 Unchanged Low O75175 F12cd8 CCR4-NOT transcription comple

230.1579 253 244.0384 242.329 8.45E−02 1.35E−01 1 Unchanged Low Q9GZQ8 C05gh2 microtubule-associated proteins 261.5987 395 244.0725 300.1702 −1.00E−01 5.94E−01 1 Unchanged Low P19438 A04ef6 tumor necrosis factor receptor su

233.3188 197 244.3384 224.9565 6.66E−02 −2.43E−01 1 Unchanged Low Q9NRR8 O04gh4 small protein effector 1 of Cdc42 338.2133 329 244.5729 303.9389 −4.68E−01 −3.97E−02 1 Unchanged Low O95162 N10ef8 peroxisomal short-chain alcohol

154.9486 108 244.9155 169.1352 6.60E−01 −5.27E−01 1 Unchanged Low O95279 J22cd3 potassium channel; subfamily K; 274.3417 127 244.9972 215.5542 −1.63E−01 −1.11E+00 1 Unchanged Low Q9NTW4 N21ef8 DKFZP564A2416 protein 403.4188 219 245.1953 289.1446 −7.18E−01 −8.83E−01 1 Unchanged Low Q9NWM9 H21gh2 hypothetical protein FLJ20730 121.538 207 245.69 191.4607 1.02E+00 7.69E−01 1 Unchanged Low P40121 P23ab5 capping protein (actin filament);

452.2006 414 245.8846 370.7982 −8.79E−01 −1.26E−01 1 Unchanged Low Q92466 I04ab3 damage-specific DNA binding pr

99.17314 220 246.0478 188.2839 1.31E+00 1.15E+00 1 Unchanged Low O43365 K05gh7 homeo box A3 132.7369 196 246.2071 191.5647 8.91E−01 5.60E−01 1 Unchanged Low Q9NVJ7 O02gh3 DEAD/H (Asp-Glu-Ala-Asp/His)

336.1927 284 246.3831 288.7892 −4.48E−01 −2.44E−01 1 Unchanged Low Q9NVY5 H08ef7 serotogically defined colon canc

182.4596 178 246.7633 202.4155 4.36E−01 −3.55E−02 1 Unchanged Low Q9BY40 G12gh8 CDA11 protein 141.0763 131 246.8975 173.0132 8.07E−01 −1.06E−01 1 Unchanged Low Q9NZE2 O06ef2 hypothetical protein LOC51321 76.41026 135 247.0025 152.875 1.69E+00 8.23E−01 1 Unchanged Low P29275 K11ab2 adenosine A2b receptor 354.5115 191 247.0615 264.0659 −5.21E−01 −8.95E−01 1 Unchanged Low Q9NZE0 P22ef1 WW domain-containing adapter

82.72809 71.1 247.6094 133.8159 1.58E+00 −2.18E−01 1 Unchanged Low Q03111 N03ab7 myeloid/lymphoid or mixed-linea

225.1377 162 247.8275 211.7891 1.39E−01 −4.71E−01 1 Unchanged Low Q08499 G21ef6 phosphodiesterase 4D; cAMP-sp 125.5177 92.9 248.1727 155.5405 9.83E−01 −4.34E−01 1 Unchanged Low Q15628 A20ef6 TNFRSF1A-associated via death 214.1641 250 248.2613 237.3623 2.13E−01 2.21E−01 1 Unchanged Low Q9Y657 C07cd7 spindlin 217.9487 202 248.4185 222.9201 1.89E−01 −1.07E−01 1 Unchanged Low Q9UHQ1 I09cd8 nuclear prelamin A recognition f

312.9614 303 248.5926 288.0624 −3.32E−01 −4.84E−02 1 Unchanged Low P17980 H24ef6 proteasome (prosome; macropai

331.1488 193 248.6286 257.496 −4.13E−01 −7.81E−01 1 Unchanged Low P45877 I19ab8 peptidylprolyl isomerase C (cycl

165.0716 169 248.9851 194.3167 5.93E−01 3.30E−02 1 Unchanged Low O95340 A23cd5 3′-phosphoadenosine 5′-phosph

110.9876 88.6 249.0622 149.5355 1.17E+00 −3.26E−01 1 Unchanged Low Q9H9Z7 F18gh5 hypothetical protein FLJ12448 158.5794 279 249.1478 228.8009 6.52E−01 8.13E−01 1 Unchanged Low O15172 E11cd4 phosphoserine phosphatase-like 321.9068 291 249.3629 287.4495 −3.68E−01 −1.45−01 1 Unchanged Low P01298 F05ab8 pancreatic polypeptide 544.0034 194 249.376 329.1527 −1.13+00 −1.49E+00 1 Unchanged Low Q13395 J17cd2 TAR (HIV) RNA binding protein 1 260.7056 234 249.3777 248.0711 −6.41E−02 −1.55E−01 1 Unchanged Low O15551 G23ab4 claudin 3 279.9519 250 249.4618 259.744 −1.66E−01 −1.64E−01 1 Unchanged Low P55060 G20ef6 CSE1 chromosome segregation 322.1588 276 249.5903 282.6907 −3.68E−01 −2.21E−01 1 Unchanged Low O43288 E13ab3 UDP-Gal: betaGlcNac beta 1; 4-

316.581 468 249.8072 344.9578 −3.42E−01 5.65E−01 1 Unchanged Low P04424 J10ab2 argininosuccinate lyase 594.9833 269 250.046 371.2798 −1.25E+00 −1.15E+00 1 Unchanged Low Q9NWR5 C10gh3 hypothetical protein FLJ20657 171.9643 252 250.1961 244.6498 5.41E−01 5.50E−01 1 Unchanged Low Q98UN8 M21gh6 hypothetical protein MGC3067 165.6904 175 250.2847 197.0059 5.95E−01 7.92E−02 1 Unchanged Low P49760 G01ab4 CDC-like kinase 2 69.23701 97.1 250.3266 138.8925 1.85E+00 4.88E−01 1 Unchanged Low Q9UEG3 E01gh7 myotubularin related protein 3 367.623 236 250.553 284.5589 −5.53E−01 −6.42E−01 1 Unchanged Low Q9P0Y6 N07ef1 chromosome 3 open reading frar 268.1158 256 250.6098 258.2636 −9.74E−02 −6.63E−02 1 Unchanged Low Q92535 M06ab8 phosphatidylinositol glycan; clas

218.2502 172 250.9192 213.6071 2.01E−01 −3.46E−01 1 Unchanged Low Q00577 A24gh7 purine-rich element binding prot

839.6 273 251.0214 454.6488 −1.74E+00 −1.62E+00 1 Unchanged Low O75717 L21ab2 AND-1 protein 225.9974 250 251.1522 242.2724 1.52E−01 1.44E−01 1 Unchanged Low P04278 L09cd1 sex hormone-binding globulin 215.6067 196 251.1944 221.0173 2.20E−01 −1.36E−01 1 Unchanged Low P51124 G19ab5 granzyme M (lymphocyte met-as

108.9072 114 251.2498 158.1827 1.21E+00 7.09E−02 1 Unchanged Low P15259 P04ab7 phosphoglycerate mutase 2 (mu

333.2442 363 251.6606 315.8301 −4.05E−01 1.22E−01 1 Unchanged Low Q12893 O13cd7 PL6 protien 174.3077 280 252.0241 235.3565 5.32E−01 6.82E−01 1 Unchanged Low P57738 A11gh2 T-cell leukemia transiocation aite 166.5683 232 252.2165 217.0429 5.99E−01 4.80E−01 1 Unchanged Low P24863 O22ef5 cyclin C 668.8634 523 252.3632 481.4089 −1.41E+00 −3.55E−01 1 Unchanged Low Q9Y370 H03ef2 CGI-60 protein 153.6349 157 252.5036 187.603 7.17E−01 2.82E−02 1 Unchanged Low Q9HD89 E04gh4 found in inflammatory zone 3 189.8748 182 252.7224 208.2163 4.13E−01 −6.07E−02 1 Unchanged Low O14807 N04cd7 muscle RAS oncogene homolog 105.1243 181 252.8147 179.5238 1.27E+00 7.81E−01 1 Unchanged Low Q13435 I07cd7 splicing factor 3b; subunit 2; 145

270.3354 268 252.8473 263.6077 −9.65E−02 −1.45E−02 1 Unchanged Low Q9UMY4 F19cd8 sorting nexin 12 178.8659 227 253.0138 219.6698 5.00E−01 3.45E−01 1 Unchanged Low O43929 C04ab8 origin recognition complex; subu

267.5605 354 253.265 291.5955 −7.92E−02 4.04E−01 1 Unchanged Low Q9BZQ1 H14gh7 chromosome 1 open reading frar 219.6632 362 253.5183 278.4192 2.07E−01 7.21E−01 1 Unchanged Low P55042 K03ef5 Ras-related associated with diab 300.5794 514 253.5279 355.8906 −2.46E−01 7.73E−01 1 Unchanged Low Q92870 k18ef1 amyloid beta (A4) precursor prot

76.07104 77.9 253.5714 135.8422 1.74E+00 3.40E−02 1 Unchanged Low P33778 C19gh7 H2B histone family; member F 169.4431 391 253.9554 271.5522 5.84E−01 1.21E+00 1 Unchanged Low Q9ULZ3 K22cd8 apoptosis-associated speck-like 255.9554 517 254.0856 342.2046 −1.06E−02 1.01E+00 1 Unchanged Low Q13485 A20ef5 MAD; mothers against decapent

163.1373 181 254.1546 199.4935 6.40E−01 1.51E−01 1 Unchanged Low Q9H6B4 C24gh5 zinc finger protein 335 326.6826 261 254.3385 280.5396 −3.61E−01 −3.26E−01 1 Unchanged Low Q9H7F8 O06gh7 hypothetical protein FLJ20958 190.1073 258 254.7198 234.2579 4.22E−01 4.40E−01 1 Unchanged Low Q92508 B17gh1 KIAA0233 gene product 241.1859 216 255.0491 237.2652 8.06E−02 −1.62E−01 1 Unchanged Low Q9UM47 C15ab8 Notch homolog 3 (Drosophila) 64.97745 132 255.0839 150.552 1.97E+00 1.02E+00 1 Unchanged Low P18084 E17ef7 integrin; beta 5 259.2818 129 255.1335 214.6124 −2.33E−02 −1.00E+00 1 Unchanged Low Q99462 K22gh6 ubiquitin-conjugating enzyme E2 207.6691 179 255.2632 213.9424 2.98E−01 −2.15E−01 1 Unchanged Low O75619 J10ef7 RNA helicase-related protein 198.1059 335 255.6713 262.7733 3.68E−01 7.56E−01 1 Unchanged Low Q92733 K07cd1 papillary renal cell carcinoma (tr

200.3207 260 256.1407 238.8334 3.55E−01 3.76E−01 1 Unchanged Low Q15796 H21ab7 MAD; mothers against decapent

376.8422 446 256.2171 359.5423 −5.57E−01 2.42E−01 1 Unchanged Low P15291 E07ab3 UDP-Gal: betaGlcNAc beta 1; 4-

411.9325 403 256.9006 357.1444 −6.81E−01 −3.31E−02 1 Unchanged Low Q99417 I07cd8 c-myc binding protein 264.1386 256 256.9088 259.037 −4.00E−02 −4.48E−02 1 Unchanged Low P05732 D09ab4 creatine kinase; muscle 202.527 127 257.2272 195.4365 3.45E−01 −6.78E−01 1 Unchanged Low P50570 K13ab5 dynamin 2 248.1389 228 257.2474 244.4335 5.20E−01 −1.23E−01 1 Unchanged Low Q9Y5A9 F20ef2 high-glucose-regulated protein 8 359.385 371 257.3917 329.2557 −4.82E−01 4.59E−02 1 Unchanged Low Q92841 B17cd6 DEAD/H (Asp-Glu-Ala-Asp/His) t 229.8916 270 257.9255 252.4572 1.66E−01 2.30E−01 1 Unchanged Low P51808 B22cd2

-complex-associated-testis-exp

182.2992 245 257.9487 228.2619 5.01E−01 4.24E−01 1 Unchanged Low O95758 H23cd5 ROD1 regulator of differentiation 411.9888 462 258.1758 377.5392 −6.74E−01 1.67E−01 1 Unchanged Low P32970 I15ef5 tumor necrosis factor (ligand) su

443.4158 456 258.4229 386.0177 −7.79E−01 4.11E−02 1 Unchanged Low O75689 K21cd7 centaurin; alpha 1 191.7263 327 258.6362 259.1653 4.32E−01 7.71E−01 1 Unchanged Low P55072 O06cd4 valosin-containing protein 466.7034 363 258.8411 362.8018 −8.50E−01 −3.63E−01 1 Unchanged Low P47813 A16ab4 eukaryotic transtation initiation fa 486.6493 337 259.0481 360.7943 −9.10E−01 −5.31E−01 1 Unchanged Low Q15532 J03cd2 synovial sarcoma translocation;

190.8535 212 259.1488 220.5805 4.41E−01 1.50E−01 1 Unchanged Low Q15813 M19cd2 tubulin-specific chaperone

151.2337 166 259.2747 192.1296 7.78E−01 1.33E−01 1 Unchanged Low P14373 B08cd2 ret finger protein 282.5757 270 259.3599 270.5765 −1.24E−01 −6.68E−02 1 Unchanged Low O14980 G02cd3 exportin 1 (CRM1 homolog; yeas 239.4965 207 259.7187 235.5264 1.17E−01 −2.08E−01 1 Unchanged Low P07942 P20ef6 laminin; beta 1 71.03574 92.4 259.7579 141.0764 1.87E+00 3.80E−01 1 Unchanged Low P53041 C20cd1 protein phosphatase 5; catalytic

272.5094 196 259.8138 242.7533 −6.88E−02 −4.76E−01 1 Unchanged Low Q07820 E12ef6 myetoid cell leukemia sequence 362.5007 243 260.0329 288.4688 −4.79E−01 −5.78E−01 1 Unchanged Low P53816 E04cd7 HRAS-like suppressor 3 606.0957 558 260.1565 474.8201 −1.22E+00 −1.19E−01 1 Unchanged Low Q9P1C8 E09gh4 hypothetical protien PRO2577 238.9909 205 260.3147 234.8631 1.23E−01 −2.19E−01 1 Unchanged Low P51968 O21cd3 ubiquitin-conjugating enzyme E2 148.3528 243 260.3185 217.1092 8.11E−01 7.10E−01 1 Unchanged Low Q99739 M03cd7 plm-2 oncogene 178.694 274 260.4482 237.5556 5.44E−01 6.14E−01 1 Unchanged Low P35913 N14ab7 phosphodiesterase 6B; cGMP-s

199.3654 173 260.5708 210.8879 3.86E−01 −2.07E−01 1 Unchanged Low P52756 J24cd5 RNA binding motif protein 5 280.6537 230 261.0637 257.2441 −1.04E−01 −2.87E−01 1 Unchanged Low Q9NXX5 K17gh3 hypothetical protein FLJ20004 130.163 197 261.2642 196.0576 1.01E+00 5.96E−01 1 Unchanged Low Q14498 O06cd5 RNA-binding region (RNP1; RR

196.0463 216 261.5829 224.4664 4.16E−01 1.38E−01 1 Unchanged Low P28069 A03ab8 POU domain; class 1; transcripti

261.1822 206 261.7763 243.064 3.28E−03 −3.41E−01 1 Unchanged Low P51397 E20ab5 death-associated protein 348.1009 312 261.9342 307.4499 −4.10E−01 −1.57E−01 1 Unchanged Low Q9NUI8 C24gh7 putative methyltransferase 157.3551 329 262.0287 249.4637 7.36E−01 1.06E+00 1 Unchanged Low O00322 M09cd7 uroplakin 1A 223.5286 295 262.0828 260.1175 2.30E−01 3.99E−01 1 Unchanged Low P78368 I09ab4 casein kinase 1; gamma 2 211.1048 272 262.1137 248.257 3.12E−01 3.63E−01 1 Unchanged Low Q01081 I22cd4 U2(RNU2) small nuclear RNA au 138.1533 91.3 262.1811 163.878 9.24E−01 −5.98E−01 1 Unchanged Low O43193 J15ab5 G protein-coupled receptor 38 69.57316 208 262.301 179.1305 1.91E+00 1.56E+00 1 Unchanged Low Q9Y3B0 M03ef2 CGI-105 protein 174.5026 177 262.5458 204.6742 5.89E−01 2.03E−02 1 Unchanged Low Q9NV80 H05gh3 WD repeat domain 12 178.5139 279 262.6286 239.9609 5.57E−01 6.43E−01 1 Unchanged Low Q9Y473 O18cd4 zinc finger protein 175 141.3794 275 263.1099 226.3406 8.96E−01 9.57E−01 1 Unchanged Low Q9Y548 L20gh2 hypothetical protein DJ167A19.1 233.5442 240 263.4412 245.7773 1.74E−01 4.14E−02 1 Unchanged Low Q13952 N15ef6 nuclear transcription factor Y; ga 241.7469 354 263.6055 286.4173 1.25E−01 5.50E−01 1 Unchanged Low P18815 K17cd3 RD RNA-binding protein 237.0199 242 263.7642 247.7362 1.54E−01 3.25E−02 1 Unchanged Low P33241 B23ef1 lymphocyte-specific protein 1 94.80267 131 264.242 163.4955 1.48E+00 4.71E−01 1 Unchanged Low O15116 C01ef4 Lsm1 protein 344.8146 479 264.6979 362.8572 −3.81E−01 4.74E−01 1 Unchanged Low P50897 A11ab8 palmitoyl-protein thioesterase 1 ( 126.6311 142 264.8236 177.9418 1.06E+00 1.69E−01 1 Unchanged Low F20gh8 MADP-1 protein 134.6124 228 264.9564 209.3298 9.77E−01 7.63E−01 1 Unchanged Low Q9Y3A5 G12ef2 CGI-97 protein 469.4567 544 265.0744 426.2946 −8.25E−01 2.14E−01 1 Unchanged Low Q9BVT1 G03gh6 leukocyte receptor cluster (LRC) 282.5457 328 265.5443 291.9599 −8.95E−02 2.14E−01 1 Unchanged Low Q9UM44 E10cd7 HERV-H LTR-associating 2 180.7238 119 265.5625 188.5666 5.55E−01 −5.98E−01 1 Unchanged Low Q9UGC7 A05gh3 similar to prokaryotic-type Class I 289.9756 362 265.7778 306.0797 −1.26E−01 3.22E−01 1 Unchanged Low P49146 G01ab8 neuropeptide Y receptor Y2 222.0084 57.8 265.9266 181.9126 2.60E−01 −1.94E+00 1 Unchanged Low P54687 I03ab3 branched chain aminotransferas

103.4218 93.8 266.0547 154.4299 1.36E+00 −1.41E−01 1 Unchanged Low O60884 O09cd6 DnaJ (Hsp40) homolog; subfamil

330.3137 367 266.0819 321.0577 −3.12E−01 1.51E−01 1 Unchanged Low Q9NVC6 J01cd7 cofactor required for Sp1 transcri 183.0562 150 266.1556 199.8392 5.40E−01 −2.84E−01 1 Unchanged Low O43399 G06cd2 tumor protein D52-like 2 283.4636 348 266.2168 299.1558 −9.06E−02 2.95E−01 1 Unchanged Low O75880 K22cd2 SCO cytochrome oxidase deficie 156.7184 117 266.2419 179.8238 7.65E−01 −4.28E−01 1 Unchanged Low P49406 F01gh1 mitochondrial ribosomal protein

577.0339 353 266.3918 398.6973 −1.12E+00 −7.10E−01 1 Unchanged Low Q9NYK5 E15gh2 mitochondrial ribosomal protein

473.2712 449 266.7642 396.3322 −8.27E−01 −7.61E−02 1 Unchanged Low O15428 P18cd2 protein (peptidyl-prolyl cls/trans

185.1313 249 267.1449 233.6377 5.29E−01 4.25E−01 1 Unchanged Low O14842 K04ab5 G protein-coupled receptor 40 222.6002 170 267.4241 219.8563 2.65E−01 −3.93E−01 1 Unchanged Low O15262 I06cd6 ring finger protein 3 243.845 401 267.4275 304.1323 1.33E−01 7.18E−01 1 Unchanged Low Q9NP61 J01ef3 ADP-ribosylation factor GTPase

344.6989 175 267.443 262.4544 −3.66E−01 −9.76E−01 1 Unchanged Low O15491 P22cd5 WD-repeat protein 254.6168 355 267.6951 292.4461 7.23E−02 4.80E−01 1 Unchanged Low O75390 P01ab5 citrate synthase 656.561 312 268.0488 412.1526 −1.29E+00 −1.07E+00 1 Unchanged Low P57088 I12gh3 hypothetical protein FLJ10525 377.5067 349 268.1833 331.588 −4.93E−01 −1.13E−01 1 Unchanged Low Q9NRY6 K06gh4 phospholipid scramblase 3 272.0774 334 268.2248 291.4542 −2.06E−02 2.96E−01 1 Unchanged Low O15403 E05cd5 solute carrier family 16 (monocar 384.2992 73.5 268.3423 242.0422 −5.18E−01 −2.39E+00 1 Unchanged Low Q9BPZ5 K09gh6 hypothetical protein MGC3123 127.3745 286 268.7928 227.363 1.08E+00 1.17E+00 1 Unchanged Low P10301 P01cd2 related RAS viral (r-ras) oncog

314.4978 204 268.8367 262.4726 −2.26E−01 −6.24E−01 1 Unchanged Low A20gh7 HLA-B associated transcript 4 168.0802 234 269.0656 223.8166 6.79E−01 4.79E−01 1 Unchanged Low Q9P018 A08ef8 HSPC142 protein 196.1899 346 269.5447 270.6564 4.58E−01 8.20E−01 1 Unchanged Low Q9Y4H2 L10cd3 Insulin receptor substrate 2 297.029 329 270.4962 298.8227 −1.35E−01 1.47E−01 1 Unchanged Low Q9UJX3 F04ef2 anaphase-promoting complex su 210.2906 204 270.642 228.4449 3.64E−01 −4.10E−02 1 Unchanged Low Q9H5X0 O01gh6 hypothetical protein MGC2941 333.5834 308 270.759 304.1289 −3.01E−01 −1.15E−01 1 Unchanged Low Q92820 H23cd4 gamma-glutamyl hydrolase (conj

78.13783 101 271.925 150.359 1.80E+00 3.70E−01 1 Unchanged Low Q9UKK3 K15ab2 ADP-ribosyltransferase (NAD+;

337.297 450 271.9944 352.9975 −3.10E−01 4.15E−01 1 Unchanged Low Q9NWC8 N13gh2 hypothetical protein FLJ10120 315.7654 301 272.0013 296.1206 −2.15E−01 −7.10E−02 1 Unchanged Low O14965 I07cd2 serine/threonine kinase 6 139.2727 101 272.158 170.6789 9.67E−01 −4.69E−01 1 Unchanged Low P50613 B11ef5 cyclin-dependent kinase 7 (MO1

286.8535 423 272.2018 327.4234 −7.56E−02 5.61E−01 1 Unchanged Low Q9H1C4 H08gh7 unc-93 homolog B1 (C. elegans) 348.8713 501 272.3385 374.1085 −3.57E−01 5.22E−01 1 Unchanged Low P21851 E13ab4 adaptor-related protein complex

338.7753 373 272.4617 328.1045 −3.14E−01 1.39E−01 1 Unchanged Low Q9UGJ0 B14ef2 protein kinase; AMP-activated; g

425.3015 543 272.5312 413.4782 −6.42E−01 3.51E−01 1 Unchanged Low P04035 D17ab6 3-hydroxy-3-methylglutaryl-Coen 242.9132 169 273.2324 228.5315 1.70E−01 −5.20E−01 1 Unchanged Low Q9UKY7 K03gh3 hypothetical protein H41 643.0085 272 273.736 396.2551 −1.23E+00 −1.24E+00 1 Unchanged Low O95478 B18gh1 hypothetical protein YR-29 248.2059 221 273.8047 247.5607 1.42E−01 1.70E−01 1 Unchanged Low Q9Y3W9 B16ef8 sentrin/SUMO-specific protease

220.4064 333 274.1753 275.7642 3.15E−01 5.94E−01 1 Unchanged Low Q9Y325 A20ef2 CGI-36 protein 346.618 338 274.2434 319.4542 −3.38E−01 −3.85E−02 1 Unchanged Low Q92854 B09cd6 sema domain; immunoglobulin d

342.6474 183 274.4146 266.8232 −3.20E−01 −9.02E−01 1 Unchanged Low P16106 O08gh6 H3 histone family; member C 105.4744 221 274.8424 200.5879 1.38E+00 1.07E+00 1 Unchanged Low O43143 M05ab4 DEAD/H (Asp-Glu-Ala-Asp/His)

412.7015 349 274.9731 345.6042 −5.86E−01 −2.41E−01 1 Unchanged Low Q13547 L12ef6 histone deacetylase 1 375.5725 372 275.2293 340.9663 −4.48E−01 −1.34E−02 1 Unchanged Low Q9H6F9 D11gh5 hypothetical protein FLJ22313 306.5811 290 275.269 290.6336 −1.55E−01 −8.00E−02 1 Unchanged Low O9NX18 M08gh2 hypothetical protein FLJ20487 311.71 394 275.6418 327.1007 −1.77E−01 3.38E−01 1 Unchanged Low O94764 P03cd5 RAN binding protein 9 256.3223 268 275.8144 266.5947 1.06E−01 6.24E−02 1 Unchanged Low P82909 N18gh8 mitochondrial ribosomal protein

261.4618 343 275.8463 293.6016 7.73E−02 3.94E−01 1 Unchanged Low Q9UI07 D18ef8 likely ortholog of mouse heal sh

199.8914 199 276.061 225.0966 4.66E−01 −4.00E−03 1 Unchanged Low P20337 M01ef5 RAB3B; member RAS oncogene 214.8304 126 276.148 205.8132 3.62E−01 −7.65E−01 1 Unchanged Low Q07960 B22ab2 Rho GTPase activating protein

219.98 218 276.184 237.9303 3.28E−01 −1.55E−02 1 Unchanged Low P49448 P03cd7 Glutamate dehydrogenase-2 344.3683 229 276.2751 283.2713 −3.18E−01 −5.88E−01 1 Unchanged Low Q9NX48 K08gh2 hypothetical protein FLJ20442 493.7568 601 276.8343 457.1855 −8.35E−01 2.83E−01 1 Unchanged Low Q9NV56 J03gh3 chromosome 20 open reading fr

138.9543 104 277.4945 173.6478 9.98E−01 −4.11E−01 1 Unchanged Low O00154 L21cd7 brain acyl-CoA hydrolase 173.5669 189 277.5737 213.4547 6.77E−01 1.25E−01 1 Unchanged Low Q9UI70 B04ef1 nucleolar protein ANKT 307.7657 349 277.6076 311.4328 −1.49E−01 1.81E−01 1 Unchanged Low P26045 N17ab8 protein tyrosine phosphatase; no 412.292 315 277.6603 334.8518 −5.70E−01 −3.90E−01 1 Unchanged Low Q9Y2A8 C24ef3 CD209 antigen-like 72.21222 91.3 277.8103 147.0989 1.94E+00 3.38E−01 1 Unchanged Low Q9BZ89 F08gh7 phospholipase A2; group XII 175.384 216 277.9804 223.0558 6.64E−01 2.99E−01 1 Unchanged Low P35052 J24ab4 glypican 1 214.4355 173 278.2085 221.7567 3.76E−01 −3.13E−01 1 Unchanged Low Q9H0S9 K21gh7 nuclear receptor binding factor-2 80.19669 155 278.4321 171.2074 1.80E+00 9.51E−01 1 Unchanged Low Q15654 I07ef7 thyroid hormone receptor interac

264.295 238 278.8016 260.4802 7.71E−02 −1.49E−01 1 Unchanged Low P51946 I09ab7 manage a trois 1 (CAK assembly 239.1769 272 278.9368 263.2799 2.22E−01 1.84E−01 1 Unchanged Low Q13133 B20cd5 nuclear receptor subfamily 1; gro

276.5554 260 279.1408 272.0232 1.34E−02 −8.70E−02 1 Unchanged Low Q9P0J9 H22gh3 goliath protein 337.3229 215 279.5646 277.1331 −2.71E−01 −6.53E−01 1 Unchanged Low Q15546 G23cd8 monocyte to macrophage differe

136.5038 94 279.6415 170.0401 1.03E+00 −5.39E−01 1 Unchanged Low P28325 E09ab5 cystatin D 371.6792 309 279.7092 320.2206 −4.10E−01 −2.65E−01 1 Unchanged Low O94985 O04ef8 calsyntenin 1 137.0471 205 279.921 207.2587 1.03E+00 5.80E−01 1 Unchanged Low P48634 M03cd4 HLA-B associated transcript 2 266.8369 179 280.5497 241.9692 7.23E−02 −5.80E−01 1 Unchanged Low Q9BRL6 O15gh7 Splicing factor; arginine/serine-

220.3804 304 280.5881 268.4079 3.48E−01 4.65E−01 1 Unchanged Low O94851 E06gh1 KIAA0750 gene product 108.6672 172 280.9738 187.2889 1.37E+00 6.64E−01 1 Unchanged Low Q9NW56 E20gh3 hypothetical protein FLJ10305 240.4538 314 281.002 278.4551 2.25E−01 3.85E−01 1 Unchanged Low Q9H6X6 P19gh5 CasL interacting molecule 183.3739 302 281.185 255.4932 6.17E−01 7.19E−01 1 Unchanged Low P41217 N13ab7 antigen identified by monoclonal 325.1642 166 281.3505 257.5072 −2.09E−01 −9.70E−01 1 Unchanged Low P31512 P04ab4 flavin containing monooxygenas

192.4074 276 281.6555 249.9252 5.50E−01 5.19E−01 1 Unchanged Low Q15425 H05cd2 SA hypertention-associated hor

186.2766 151 281.9205 206.4709 5.98E−01 −3.01E−01 1 Unchanged Low P40306 L05ab8 proteasome (prosome; macropai

408.3043 513 281.9429 400.975 −5.34E−01 3.28E−01 1 Unchanged Low Q9NWZ8 O02gh2 hypothetical protein FLJ20514 287.569 146 281.9498 238.3826 −2.65E−02 −9.82E−01 1 Unchanged Low P57073 E22ef8 SRY (sex determining region Y)

202.5886 268 281.9705 251.002 4.77E−01 4.06E−01 1 Unchanged Low Q9Y450 H22cd6 HBS1-like (S. cerevisiae) 230.8266 312 282.4288 274.9973 2.91E−01 4.34E−01 1 Unchanged Low P04062 O08ab3 glucosidase; beta; acid (includes 295.5318 389 282.6453 322.2918 −6.43E−02 3.95E−01 1 Unchanged Low O75065 E22gh1 phosphodiesterase 4D interactin

168.0201 154 282.6456 201.6823 7.50E−01 −1.22E−01 1 Unchanged Low Q9ULX2 F09ef3 NIMA (never in mitosis gene a)

288.5578 208 283.1715 259.9871 −2.72E−02 −4.71E−01 1 Unchanged Low Q99871 C06ef4 three prime repair exonuclease 2 205.6083 225 283.2504 237.9088 4.62E−01 1.29E−01 1 Unchanged Low Q93065 I15cd6 PER811 family member in MHC

295.7132 457 283.4269 345.3524 −6.12E−02 6.28E−01 1 Unchanged Low O43837 B12ab7 isocitrate dehydrogenase 3 (NA

348.9961 296 283.6422 310.0846 −2.99E−01 −2.30E−01 1 Unchanged Low Q9H9L3 L06gh7 hypothetical protein FLJ12671 209.5906 279 283.6912 257.4051 4.37E−01 4.12E−01 1 Unchanged Low Q13740 A18ab2 activated leucocyte cell adhesio

231.4555 253 283.7582 256.0277 2.94E−01 1.28E−01 1 Unchanged Low Q12888 L09cd2 tumor protein p53 binding protei

132.9276 223 283.8572 213.3434 1.09E+00 7.48E−01 1 Unchanged Low P78318 J13ab6 immunoglobulin (CD79A) binding 423.8715 512 283.9511 406.4772 −5.78E−01 2.71E−01 1 Unchanged Low P48436 K24cd1 SRY (sex determining region Y)-

345.2087 197 284.0786 275.3736 −2.81E−01 −8.10E−01 1 Unchanged Low P18065 B19ef1 insulin-like growth factor binding 286.6516 283 284.2331 264.4952 −1.22E−02 −2.05E−02 1 Unchanged Low Q9ULW6 F22cd8 nucleosome assembly protein 1-

223.0694 148 284.717 218.587 3.52E−01 −5.92E−01 1 Unchanged Low O95154 N03cd7 aldo-keto reductase family 7; me

299.9079 298 284.8919 294.419 −7.41E−02 −7.00E−03 1 Unchanged Low O95169 P14ab8 NADH dehydrogenase (ubiquino

374.2624 199 285.0096 286.0758 −3.93E−01 −9.12E−01 1 Unchanged Low Q99982 C24ef4 XIAP associated factor-1 63.10609 116 285.0252 154.8111 2.18E+00 8.82E−01 1 Unchanged Low Q99470 F14cd2 stromal cell-derived factor 2 230.3684 316 285.1394 277.1416 3.08E−01 4.56E−01 1 Unchanged Low P16104 N19ab5 H2A histone family; member X 234.8351 195 285.2056 238.3532 2.80E−01 −2.68E−01 1 Unchanged Low Q9UG25 B04ef6 SOCS box-containing WD prote

213.293 398 285.5392 298.9147 4.21E−01 9.00E−01 1 Unchanged Low Q13158 C21cd4 Fas (TNFRSF6)-associated via d 263.0157 281 285.9553 276.784 1.21E−01 9.74E−02 1 Unchanged Low Q9NW32 D10gh2 hypothetical protein FLJ10346 235.0532 386 286.3524 302.6214 2.85E−01 7.17E−01 1 Unchanged Low O95153 M05cd5 peripheral benzodiazepine recep 155.1824 231 287.1271 224.5106 8.88E−01 5.75E−01 1 Unchanged Low Q9BQ73 H06gh7 hypothetical protein FKSG28 212.0736 297 267.201 265.3817 4.37E−01 4.85E−01 1 Unchanged Low Q15426 C02ef7 protein tyrosine phosphatase; re

296.9619 441 287.2583 341.7927 −4.79E−02 5.71E−01 1 Unchanged Low Q92858 L12ab2 atonal homolog 1 (Drosophlia) 611.3779 278 287.2641 392.3029 −1.09E+00 −1.14E+00 1 Unchanged Low Q16849 P15ab8 protein tyrosine phosphatase; re

145.9896 55.6 287.3262 162.9842 9.77E−01 −1.39E+00 1 Unchanged Low P11279 D07ab7 lysosomal-associated membrane 369.9925 310 287.3935 322.5735 −3.64E−01 −2.54E−01 1 Unchanged Low Q96II1 I16gh7 hypothetical protein MGC14961 103.7251 80.7 287.4071 157.2667 1.47E+00 −3.63E−01 1 Unchanged Low P78504 O20ab2 jagged 1 (Alagille syndrome) 255.0945 347 287.4633 296.4108 1.72E−01 4.43E−01 1 Unchanged Low O75937 G06ef3 DnaJ (Hsp40) homolog; subfami

294.9992 264 287.503 282.0586 −3.71E−02 −1.62E−01 1 Unchanged Low O60575 O16ef4 serine protease inhibitor; Kazal

142.2326 152 287.9 194.1988 1.02E+00 1.00E−01 1 Unchanged Low Q9NYP7 K05gh5 homolog of yeast long chain poly 299.2029 187 288.1627 257.9759 −5.42E−02 −6.81E−01 1 Unchanged Low O95436 H01cd6 solute carrier family 34 (sodium

238.6021 425 288.3247 317.3784 2.73E−01 8.34E−01 1 Unchanged Low O95324 B15ab2 ATP-binding cassette; sub-family 267.704 275 288.4558 277.0901 1.08E−01 3.94E−02 1 Unchanged Low Q9UQF6 B08ef3 ribosomal protein L36 519.2003 425 288.5855 410.9115 −8.47E−01 −2.89E−01 1 Unchanged Low P13010 K12ef6 X-ray repair complementing defe 174.6996 256 288.9405 239.6403 7.26E−01 5.51E−01 1 Unchanged Low Q9UJZ1 P03cd8 stomatin (EPB72)-like 2 490.6115 272 289.2003 350.5499 −7.63E−01 −8.52E−01 1 Unchanged Low P50281 I18ab7 matrix metalloproteinase 14 (mer 126.7204 196 289.8803 204.0657 1.19E+00 6.26E−01 1 Unchanged Low P15927 B08cd1 replication protein A2 (32 kD) 100.0172 194 290.3306 194.7022 1.54E+00 9.54E−01 1 Unchanged Low O75496 B02ef1 germinin 466.4376 454 290.7216 403.7854 −6.82E−01 −3.84E−02 1 Unchanged Low Q9P1E3 C23gh4 presenillns associated rhomboid- 232.5496 263 291.2445 262.3787 3.25E−01 1.79E−01 1 Unchanged Low P40189 B14ab6 interleukin 6 signal transducer (g 330.8834 315 291.3287 312.5572 −1.84E−01 −6.89E−02 1 Unchanged Low Q9Y259 H03ab4 choline kinase-like 328.1801 375 291.3288 331.557 −1.72E−01 1.93E−01 1 Unchanged Low O00633 C12ef5 phosphatase and tensin homolog 199.7323 189 291.6118 226.7943 5.46E−01 −7.94E−02 1 Unchanged Low Q13432 H13cd5 unc-119 homolog (C. elegans) 127.1818 268 291.793 229.0999 1.20E+00 1.08E+00 1 Unchanged Low Q9Y677 E03ef2 COP9 constitutive photomorpho

186.9367 204 291.9539 227.7917 6.43E−01 1.29E−01 1 Unchanged Low Q9BW24 D03ef8 KIAA0676 protein 170.3265 240 292.9836 234.5628 7.83E−01 4.97E−01 1 Unchanged Low Q9NSD9 B12cd5 phenylalanyl-tRNA synthetase b

226.6641 219 293.111 246.1288 3.71E−01 −5.22E−02 1 Unchanged Low Q9NWQ0 C16gh3 hypothetical protein FLJ20695 497.4612 656 293.1504 482.328 −7.63E−01 4.00E−01 1 Unchanged Low Q9NWT6 C02gh3 hypoxia-inducible factor 1; alpha 521.7793 276 293.7543 363.8746 −8.29E−01 −9.18E−01 1 Unchanged Low Q9UPN3 J12ef7 microtubule-actin crosslinking fa

578.3578 563 294.1533 478.6344 −9.75E−01 −3.78E−02 1 Unchanged Low Q96HW0 A06gh7 zinc finger protein 38 (KOX 25) 126.7599 355 294.3016 258.7634 1.22E+00 1.49E+00 1 Unchanged Low Q14257 F18ab8 reticulocalbin 2; EF-hand calciu

237.969 217 295.1469 249.8842 3.11E−01 −1.36E−01 1 Unchanged Low Q9NRJ5 J05gh4 poly(A) polymerase beta (testis s

379.2857 276 295.7341 316.91 −3.59E−01 −4.60E−01 1 Unchanged Low P23280 P02ab3 carbonic anhydrase VI 137.6155 102 296.1358 178.6789 1.11E+00 −4.28E−01 1 Unchanged Low Q14677 I02gh1 KIAA0171 gene product 330.738 204 296.1674 277.0019 −1.59E−01 −6.96E−01 1 Unchanged Low Q9Y394 H17ef2 CGI-86 protein 471.0368 358 296.7589 375.1673 −6.67E−01 −3.97E−01 1 Unchanged Low Q9UKX5 L18cd7 integrin; alpha 11 99.18133 126 297.0397 173.978 1.58E+00 3.42E−01 1 Unchanged Low Q92539 G02gh1 lipin 2 260.7493 235 297.1151 264.3623 1.88E−01 −1.49E−01 1 Unchanged Low Q9NW01 G10gh3 hypothetical protein FLJ10402 165.6121 135 297.1276 199.1936 8.43E−01 −2.97E−01 1 Unchanged Low Q9NUW5 N21gh3 hypothetical protein FLJ11099 228.3252 247 297.5163 257.4882 3.82E−01 1.11E−01 1 Unchanged Low Q9BYC4 C13gh8 mitochondrial ribosomal protein

478.9122 408 297.754 394.9285 −6.86E−01 −2.31E−01 1 Unchanged Low P02545 F01ab7 lamin A/C 707.7874 294 297.9921 433.306 −1.25E+00 −1.27E+00 1 Unchanged Low O60585 A17cd6 serine/arginine repetitive matrix

318.399 331 298.2057 315.9302 −9.45E−02 5.68E−02 1 Unchanged Low P23458 L12ef5 Janus kinase 1 (a protein tyrosin 385.7348 441 298.2124 375.1408 −3.71E−01 1.95E−01 1 Unchanged Low Q9BY13 O06gh8 hook3 protein 435.0319 471 298.2969 401.4116 −5.44E−01 1.14E−01 1 Unchanged Low Q9UBC2 C05gh5 epidermal growth factor receptor 171.9695 271 298.6179 247.3586 7.96E−01 6.59E−01 1 Unchanged Low O76022 A14cd7 E1B-55 kDa-associated protein 5 256.9682 243 298.7615 266.0871 2.17E−01 −8.34E−02 1 Unchanged Low P33993 K04ef6 MCM7 minichromosoma mainten 239.0601 165 298.875 234.4011 3.22E−01 −5.33E−01 1 Unchanged Low Q92963 F02cd2 Ric-like: expressed in many tissu 447.2008 499 299.9377 415.4004 −5.76E−01 1.58E−01 1 Unchanged Low Q9HAF1 P09gh5 hypothetical protein FLJ11730 270.4702 414 300.0397 328.0993 1.50E−01 8.13E−01 1 Unchanged Low Q9NZ36 P02gh4 uncharacterized hypothalamus p 505.7323 333 300.1219 379.485 −7.53E−01 −6.05E−01 1 Unchanged Low Q9BQQ3 C09gh8 golgi phosphoprotein 5 208.3671 343 300.1696 283.9342 5.27E−01 7.20E−01 1 Unchanged Low O95214 P09ef3 leptin receptor overlapping trans

292.4076 419 300.357 337.2896 3.87E−02 5.19E−01 1 Unchanged Low Q9Y294 A21ef8 DKFZP547E2110 protein 168.5906 243 301.1573 237.0749 8.54E−01 5.47E−01 1 Unchanged Low O95810 O01cd4 serum deprivation response (phc 279.903 272 301.2133 284.3868 1.06E−01 −4.11E−02 1 Unchanged Low P30670 L21ab4 guanine nucleotide binding prote 470.8713 466 301.8899 412.8188 −6.41E−01 −1.59E−02 1 Unchanged Low P51946 O14ef5 cyclin H 180.4218 244 301.9337 242.2819 7.43E−01 4.38E−01 1 Unchanged Low Q15290 G18cd1 retinoblastoma binding protein 6 298.4739 346 302.0906 315.4543 1.74E−02 2.12E−01 1 Unchanged Low Q9NX11 A03gh3 hypothetical protein FLJ20498 165.3845 190 302.1175 219.2418 8.69E−01 2.02E−01 1 Unchanged Low Q9P0S3 A23ef2 hypothetical protein LOC51240 187.2653 229 302.318 239.5316 6.91E−01 2.90E−01 1 Unchanged Low P04554 H11ab8 protamine 2 393.1528 362 302.3989 352.4183 −3.79E−01 −1.20E−01 1 Unchanged Low O15243 O05ef4 leptin receptor gene-related prot

329.3033 391 302.5417 340.9139 −1.22E−01 2.47E−01 1 Unchanged Low O43717 G03cd7 tumor differentially expressed 1 284.4846 364 302.9444 317.004 9.07E−02 3.54E−01 1 Unchanged Low O95876 J10ef1 hypothetical protein LOC51057 172.7128 226 302.9853 233.8891 8.11E−01 3.88E−01 1 Unchanged Low Q9H8D5 N17gh5 tumor endothelial marker 6 247.105 190 303.4837 246.7925 2.96E−01 −3.81E−01 1 Unchanged Low Q9Y3B6 D24ef1 CGI-112 protein 493.6755 288 303.7855 361.6747 −7.01E−01 −7.80E−01 1 Unchanged Low Q9P0S7 E13ef2 hypothetical protein LOC51238 143.0704 139 303.896 195.3392 1.09E+00 −4.11E−02 1 Unchanged Low O60630 D22ab4 deltex homolog 1(Drosophilia) 310.6617 221 303.9702 278.4627 −3.14E−02 −4.93E−01 1 Unchanged Low O95285 O07gh1 macrophage erythroblast attache 332.2343 413 304.0714 349.7511 −1.28E−01 3.14E−01 1 Unchanged Low Q08945 G17cd2 structure specific recognition pro

335.05 229 304.6617 289.639 −1.37E−01 −5.48E−01 1 Unchanged Low O43583 D08cd3 density-regulated protein 203.0088 253 304.7034 253.5145 5.86E−01 3.17E−01 1 Unchanged Low O95149 D04cd5 RNA; U transporter 1 186.979 254 304.889 248.5641 7.05E−01 4.41E−01 1 Unchanged Low Q9HAS8 N10gh4 elaC homolog 2 (E. coli) 243.3076 331 304.8937 293.0254 3.26E−01 4.44E−01 1 Unchanged Low Q9BQ39 A23gh6 nucleolar protein GU2 234.3353 160 305.2734 233.2592 3.82E−01 −5.49E−01 1 Unchanged Low O15304 C06ef6 CD27-binding (Slva) protein 88.75727 153 305.4708 182.3257 1.78E+00 7.83E−01 1 Unchanged Low Q15394 I08gh1 basic leucine-zipper protein BZA 347.7168 384 305.6252 345.6465 −1.66−01 1.42E−01 1 Unchanged Low Q9NZA3 N09ef1 CDA14 235.1955 312 305.7623 284.2776 3.79E−01 4.07E−01 1 Unchanged Low P26022 P23ab8 pentaxin-related gene; rapidly ln

97.61703 61.3 305.8598 154.9189 1.65E+00 −6.72E−01 1 Unchanged Low Q00536 L24ef5 PCTAIRE protein kinase 1 290.1914 359 306.0473 318.5577 7.68E−02 3.09E−01 1 Unchanged Low Q9UMW5 E19ef2 cerebral cell adhesion molecule 52.28353 234 306.6326 197.6582 2.55E+00 2.16E+00 1 Unchanged Low O95353 J17cd6 Cdc42 effector protein 3 95.65314 208 306.7186 203.4709 1.68E+00 1.12E+00 1 Unchanged Low O95808 B03ef2 arsenate resistance protein ARS

187.799 225 307.4311 240.0311 7.11E−01 2.60E−01 1 Unchanged Low Q9BXJ8 O17gh8 transmembrane protein induced I 411.8484 646 308.2116 455.5065 −4.18E−01 6.50E−01 1 Unchanged Low P36776 A06cd5 protease; serine; 15 390.4608 365 308.5755 354.6324 −3.40E−01 −9.78E−02 1 Unchanged Low Q9BUR9 M19gh6 hypothetical protein MGC4614 250.3191 338 308.7431 299.1204 3.03E−01 4.35E−01 1 Unchanged Low Q9Y3R1 F23cd6 Rab acceptor 1 (prenylated) 158.9446 207 308.7948 224.7776 9.58E−01 3.78E−01 1 Unchanged Low Q92997 Do3ef7 dishevelled; dsh homolog 3 (Dro

240.0941 305 309.2314 284.6254 3.65E−01 3.43E−01 1 Unchanged Low O14682 N17cd3 ectodermal-neural cortex (with B

326.0664 189 309.539 274.7193 −7.50E−02 −7.90E−01 1 Unchanged Low Q9Y255 I08cd8 px19-like protein 533.9688 455 309.7497 432.9739 −7.86E−01 −2.30E−01 1 Unchanged Low Q16664 O17ef4 protein \A\** 354.4762 286 310.2736 316.9703 −1.92E−01 −3.09E−01 1 Unchanged Low P31943 O04ab7 heterogeneous nuclear ribonucle 690.0051 250 310.5901 416.9005 −1.15E+00 −1.46E+00 1 Unchanged Low P49848 J09cd2 TAF6 RNA polymerase II; TATA 151.1422 133 310.9274 198.2917 1.04E+00 −1.87E−01 1 Unchanged Low Q04984 P19ab8 heat shock 10 kD protein 1 (chap

338.1568 327 311.1011 325.4422 −1.20E−01 −4.81E−02 1 Unchanged Low P20719 N08ef4 homeo box A5 271.4135 326 311.2742 302.8287 1.98E−01 2.63E−01 1 Unchanged Low Q9H5Y0 D21gh7 hypothetical protein FLJ22795 325.1674 305 311.3753 313.8457 −6.25E−02 −9.24E−02 1 Unchanged Low P19021 G15ab8 peptidylglycine alpha-amidating

219.5791 273 311.913 268.0943 5.06E−01 3.13E−01 1 Unchanged Low Q92544 B13gh1 KIAA0255 gene product 270.8313 307 312.0297 296.5662 2.04E−01 1.80E−01 1 Unchanged Low Q12907 G07cd7 chromosome 5 open reading frar

313.0938 222 312.5092 282.474 −2.70E−03 −4.97E−01 1 Unchanged Low Q9BW91 C03gh6 nudix (nucleoside diphosphate lli

346.395 314 312.5575 324.483 −1.48E−01 −1.39E−01 1 Unchanged Low P53365 M23cd8 partner of RAC1 (arfaptin 2) 293.2566 349 312.9335 318.382 9.37E−02 2.51E−01 1 Unchanged Low P35869 O17ab2 aryl hydrocarbon receptor 249.5731 417 313.1153 326.5306 3.27E−01 7.40E−01 1 Unchanged Low Q13145 I19cd8 putative transmembrane protein 490.8698 608 313.616 470.7589 −6.46E−01 3.08E−01 1 Unchanged Low O14747 A18e86 death-associated protein 6 348.2382 450 313.7398 370.593 −1.51E−01 3.69E−01 1 Unchanged Low Q9GZT5 H03gh7 wingless-type MMTV integration 362.0025 327 313.9764 334.369 −2.05E−01 −1.46E−01 1 Unchanged Low P08174 M19ef1 decay accelerating factor for corr

705.5781 457 314.0939 492.3204 −1.17E+00 −6.26E−01 1 Unchanged Low Q9H689 K01gh4 hypothetical protein RG083M05

241.9641 291 314.1855 282.3328 3.77E−01 2.65E−01 1 Unchanged Low Q9P0T7 K05ef2 hypothetical protein LOC51235 266.1575 324 314.3982 301.4061 2.40E−01 2.82E−01 1 Unchanged Low Q9H2V7 I12gh8 spinster-like protein 275.9977 394 314.4425 328.1261 1.88E−01 5.13E−01 1 Unchanged Low Q9NWT0 D23gh2 hypothetical protein FLJ20625 420.628 488 314.6523 407.636 −4.19E−01 2.13E−01 1 Unchanged Low Q9Y6X2 E22cd6 protein inhibitor of activated STA 149.0425 237 315.009 233.7882 1.08E+00 6.71E−01 1 Unchanged Low Q9P1P1 F10ef8 clone FLB1727 (LOC51215) 419.9659 330 315.0092 355.1102 −4.15E−01 −3.46E−01 1 Unchanged Low P23919 H04cd7 deoxythymidylate kinase (thymid

123.4582 84.1 315.562 174.3854 1.35E+00 −5.53E−01 1 Unchanged Low P37140 D09ab8 protein phosphatase 1; catalytic

355.0781 503 315.7751 391.3748 −1.69E−01 5.03E−01 1 Unchanged Low Q9NW54 B22gh2 homolog of rat nadrin 432.3799 670 315.8314 472.8474 −4.53E−01 6.33E−01 1 Unchanged Low Q9UMS0 C05ef4 HIRA interacting protein 5 504.0153 382 315.8386 400.6081 −6.74E−01 −4.00E−01 1 Unchanged Low P14207 E23ef1 folate receptor 2 (fetal) 235.5291 154 316.0649 235.1893 4.24E−01 −6.13E−01 1 Unchanged Low Q9UHC7 L05ef4 makorin; ring finger protein; 1 243.752 243 316.3297 267.5313 3.76E−01 −7.36E−03 1 Unchanged Low O75844 K23cd6 zinc metalloproteinase (STE24 h 338.221 174 316.3789 276.2357 −9.63E−02 −9.58E−01 1 Unchanged Low P18gh8 LIM homeobox protein 4 87.11814 84.8 316.6454 162.8523 1.86E+00 −3.90E−02 1 Unchanged Low P16587 P19ab2 ADP-ribosylation factor 3 444.3724 348 317.1873 369.9292 −4.86E−01 −3.52E−01 1 Unchanged Low Q9NVY2 F18gh2 hypothetical protein FLJ10439 420.4716 399 317.2936 378.7795 −4.06E−01 −7.72E−02 1 Unchanged Low Q9Y3I1 J09ef4 F-box only protein 7 368.7457 422 317.6515 369.3121 −2.15E−01 1.93E−01 1 Unchanged Low Q9H320 P21cd8 variable charge; X chromosome 147.0814 348 318.4769 271.2531 1.11E+00 1.24E+00 1 Unchanged Low P49903 J11ef4 selenium donor protein 329.031 446 318.9322 364.5082 −4.50E−02 4.37E−01 1 Unchanged Low O00506 B05cd6 serine/threonine kinase 25 (STE

273.696 275 319.3179 289.4017 2.22E−01 7.86E−03 1 Unchanged Low O00273 F14ab5 DNA fragmentation factor; 45 kD 328.993 401 319.634 350.0198 −4.16E−02 2.87E−01 1 Unchanged Low Q08170 H11cd2 splicing factor; arginine/seriene-ri

231.1994 193 319.7733 247.9554 4.68E−01 −2.61E−01 1 Unchanged Low Q9Y3B8 N15ef8 small fragment nuclease 120.8094 282 320.0578 240.8904 1.41E+00 1.22E+00 1 Unchanged Low Q9P0N0 E11ef2 mitochondrial ribosomal protein

377.6692 391 320.1382 362.9626 −2.38E−01 5.03E−02 1 Unchanged Low Q9BRI3 D11gh8 hypothetical protein MGC11303

373.5695 391 320.4318 361.6895 −2.21E+00 8.60E−02 1 Unchanged Low Q9Y319 D19ef2 CGI-30 protein 107.1253 123 320.4576 183.4471 1.58E+00 1.97E−01 1 Unchanged Low Q16514 M17gh1 TAF12 RNA polymerase II; TAT

116.3618 304 320.8611 246.9777 1.46E+00 1.38E+00 1 Unchanged Low P13489 D13ef7 ribonuclease/angiogenin inhibito

224.1663 232 321.0895 259.1076 5.18E−01 5.00E−02 1 Unchanged Low Q99987 P08ef5 vaccinia related kinase 2 205.9202 194 321.2364 240.3908 6.42E−01 −8.59E−02 1 Unchanged Low P56181 H21ef1 NADH dehydrogenase (ubiquino

435.0715 319 321.3696 358.4382 −4.37E−01 −4.48E−01 1 Unchanged Low P51148 N18ab8 RAB5C; member RAS oncogene 329.7976 358 321.5906 336.6203 −3.64E−02 1.20E−01 1 Unchanged Low Q9HD34 E12gh4 CGI-203 protein 257.866 249 322.345 276.3612 3.22E−01 −5.12E−02 1 Unchanged Low Q9HAN2 F02gh6 purnilio homolog 2 (Drosophila) 291.9641 326 322.4096 313.4126 1.43E−01 1.58E−01 1 Unchanged Low P08107 K13ef5 heat shock 70 kD protein 1A 535.4871 382 322.6223 413.3803 −7.31E−01 −4.87E−01 1 Unchanged Low O60499 N18cd3 syntaxin 10 189.7411 304 322.7738 272.2579 7.66E−01 6.81E−01 1 Unchanged Low Q9HBL3 M19gh4 N-terminal kinase-like 165.2938 224 323.2472 237.4707 9.68E−01 4.38E−01 1 Unchanged Low Q9BSJB D22gh6 KIAA0747 protein 549.1645 575 323.5208 482.4222 −7.63E−01 8.53E−02 1 Unchanged Low O60838 G09gh7 SAC2 suppressor of actin multati

216.0571 254 324.4643 264.8237 5.87E−01 2.33E−01 1 Unchanged Low Q98TM6 M11gh8 hypothetical protein MGC3195 371.9412 334 324.5103 343.6429 −1.97E−01 −1.53E−01 1 Unchanged Low Q9H4L0 K06gh5 leucine zipper protein FKSG14 47.34403 70.6 324.6661 147.5387 2.78E+00 5.77E−01 1 Unchanged Low P50402 I14ab3 emerin (Emery-Dreifuss muscula 321.3743 304 324.6751 316.6654 1.47E−02 −8.04E−02 1 Unchanged Low Q9NZP7 G05ef3 calcium binding protein Cab45 p

336.1107 239 324.6956 299.844 −4.98E−02 −4.94E−01 1 Unchanged Low P49116 G22cd2 nuclear receptor subfamily 2; gro

295.9342 224 325.1253 281.6482 1.36E−01 −4.03E−01 1 Unchanged Low P11234 D14ab8 v-ral simian leukemia viral oncog

565.699 444 325.5924 444.9874 −7.97E−01 −3.51E−01 1 Unchanged Low P15408 D21ab5 FOS-like antigen 2 265.6989 437 325.8448 342.8236 2.94E−01 7.18E−01 1 Unchanged Low Q9P1Q8 N05cd8 RAB3A interacting protein (rabin

357.6493 253 326.2784 312.2142 −1.33E−01 −5.03E−01 1 Unchanged Low P39060 P16ef6 collagen; type XVIII; alpha 1 151.6584 212 326.8288 230.0488 1.11E+00 4.81E−01 1 Unchanged Low Q9Y2N3 N05gh1 KIAA0618 gene product 378.8717 252 326.8347 319.0933 −2.13E−01 −5.91E−01 1 Unchanged Low P02749 M22ab2 apolipoprotein H (beta-2-glycopn

408.7454 226 327.1228 320.758 −3.21E−01 −8.52E−01 1 Unchanged Low Q9P189 L20gh3 hypothetical protein PRO1855 392.3328 358 327.1908 359.0226 −2.62E−01 −1.34E−01 1 Unchanged Low O43822 B19ab4 chromosome 21 open reading fr

249.9987 297 327.8679 291.7148 3.91E−01 2.50E−01 1 Unchanged Low Q9UNZ2 N15ef2 likely ortholog of rat p47 413.5167 519 327.9429 420.0854 −3.35E−01 3.27E−01 1 Unchanged Low Q9Y4G5 B22cd8 dynein; cytoplasmic; heavy poly

376.6624 426 327.9518 376.7971 −2.00E−01 1.77E−01 1 Unchanged Low Q13310 C13cd4 poly(A) binding protein; cytoplas

316.8746 338 328.1257 327.507 5.03E−02 9.11E−02 1 Unchanged Low P45974 O14cd3 ubiquitin specific protease 5 (Iso

268.1073 316 328.1257 304.4284 2.95E−01 2.39E−01 1 Unchanged Low P55317 A04ab7 hepatocyte nuclear factor 3; alph 273.7527 306 328.8562 302.8162 2.65E−01 1.60E−01 1 Unchanged Low O43364 H08cd8 homeo box A2 511.053 468 329.1292 435.9554 −6.35E−01 −1.28E−01 1 Unchanged Low P55345 H15ab6 HMT1 hnRNP methyltransferase 384.8758 307 329.5023 333.8774 −1.47E−01 −2.48E−01 1 Unchanged Low P48230 O22cd2 transmembrane 4 superfamily m

565.1635 417 330.825 437.5376 −7.73E−01 −4.40E−01 1 Unchanged Low Q9BUY3 C21gh5 sorting nexin 6 166.5144 297 330.8949 264.7192 9.91E−01 8.34E−01 1 Unchanged Low O00115 B01ef6 deoxyribonuclease II; lysosomal 275.2503 372 331.0554 326.0947 2.66E−01 4.34E−01 1 Unchanged Low O43318 M11cd2 mitogen-activated protein kinase 186.7739 247 331.1308 254.8269 8.26E−01 4.01E−01 1 Unchanged Low O95572 B08gh1 mitofusin 2 252.7846 277 331.4516 287.175 3.91E−01 1.33E−01 1 Unchanged Low P35080 K12ab8 profilin 2 111.4363 85.9 332.2299 176.518 1.58E+00 −3.76E−01 1 Unchanged Low Q9NW29 E24gh3 hypothetical protein FLJ10350 219.5611 173 332.8499 241.9521 6.00E−01 −3.40E−01 1 Unchanged Low Q9NZE9 O07ef2 BRAF35/HDAC2 complex (80 kD 219.3916 348 332.8813 299.9861 6.01E−01 6.64E−01 1 Unchanged Low Q9BYV2 C E05gh8 ring finger protein 30 500.2246 338 333.9675 390.6398 −5.83E−01 −5.66E−01 1 Unchanged Low Q9UJX4 F02ef2 anaphase promoting complex sul

237.1218 269 334.5884 280.1684 4.97E−01 1.81E−01 1 Unchanged Low O00302 B19cd6 calcium homeostasis endoplasm

327.1489 382 334.7371 347.7981 3.31E−02 2.22E−01 1 Unchanged Low Q92886 K23cd1 neurogenin 1 290.2357 283 335.1054 302.7027 2.07E−01 −3.76E−02 1 Unchanged Low O14929 P07cd3 histone acetyltransferase 1 344.9153 130 335.4301 270.1111 −4.02E−02 −1.41E+00 1 Unchanged Low Q9NVK7 M18gh3 chromosome 19 open reading fre 281.2043 287 335.4383 301.1995 2.54E−01 2.92E−02 1 Unchanged Low Q9UBN0 P09ef4 proline rich 3 309.9093 344 335.4526 329.7234 1.14E−01 1.50E−01 1 Unchanged Low O43611 E14cd3 cytoplasmic linker 2 180.9108 220 336.1459 245.5832 8.94E−01 2.80E−01 1 Unchanged Low O94777 G23cd4 doiichyl-phosphate mannosyltran 294.1356 244 336.7183 291.5641 1.95E−01 −2.71E−01 1 Unchanged Low Q14669 K05gh1 thyroid hormone receptor interac 486.9829 397 337.0199 406.8782 −5.31E−01 −2.96E−01 1 Unchanged Low Q9NUR0 B20gh3 hypothetical protein FLJ11196 63.09205 107 337.0769 168.9127 2.42E+00 7.56E−01 1 Unchanged Low Q16822 L08ab8 phosphoenolpyruvate carboxykin 262.4601 156 337.1655 251.8272 3.61E−01 −7.52E−01 1 Unchanged Low Q9Y640 A14cd8 stromal cell derived factor recept 215.2348 220 337.2906 257.3848 6.48E−01 2.92E−02 1 Unchanged Low P48595 C01cd1 serine (or cysteine) proteinase in 62.04001 410 337.3872 269.7194 2.44E+00 2.72E+00 1 Unchanged Low P26639 M15cd2 threonyl-tRNA synthetase 355.1309 422 337.8401 371.5003 −7.20E−02 2.47E−01 1 Unchanged Low P29597 O03cd3 tyrosine kinase 2 209.3427 258 338.1471 268.5377 6.92E−01 3.02E−01 1 Unchanged Low O60671 B02ab8 RAD1 homolog (S. pombe) 188.2718 104 339.1461 210.3983 8.49E−01 −8.59E−01 1 Unchanged Low Q9NW97 P17gh2 hypothetical protein FLJ10199 262.3124 536 339.3086 379.0815 3.71E−01 1.03E+00 1 Unchanged Low Q9P027 O23ef8 HSPC133 protein 616.0461 363 339.3102 439.5495 −8.60E−01 −7.62E−01 1 Unchanged Low O95772 E20gh8 hypothetical protein MGC3251 195.9084 227 339.3844 254.0574 7.93E−01 2.12E−01 1 Unchanged Low Q9NR28 N13gh4 second mitochondria-derived act 271.4457 543 339.8107 384.7351 3.24E−01 1.00E+00 1 Unchanged Low P11413 F15ab3 glucose-6-phosphate dehydroge

258.0938 135 340.0217 244.4906 3.98E−01 −9.31E−01 1 Unchanged Low Q99567 A04ab8 nucleoporin 88 kD 464.4826 320 340.5878 375.0149 −4.48E−01 −5.38E−01 1 Unchanged Low Q96ZR9 F22gh7 ring finger protein 27 206.7918 398 340.7239 315.1764 7.20E−01 9.45E−01 1 Unchanged Low O43632 L22cd6 gamma-tubulin complex protein 2 328.0052 322 341.4805 330.4468 5.81E−02 −2.73E−02 1 Unchanged Low Q9Y305 I05cd8 Mitochondrial Acyl-CoA Thioeste 447.9229 475 341.5085 421.5064 −3.91E−01 8.49E−02 1 Unchanged Low P17096 L14ef6 high-mobility group (nonhistone

393.4158 266 341.5301 333.78 −2.04E−01 −5.62E−01 1 Unchanged Low P28677 E10cd3 visinin-like 1 235.283 241 341.6123 272.797 5.38E−01 3.76E−02 1 Unchanged Low Q9UBX5 K04cd6 fibulin 5 79.52593 108 341.7638 176.4964 2.10E+00 4.44E−01 1 Unchanged Low Q9Y304 E12ef2 ovarian cancer overexpressed 1 326.0044 238 341.8947 301.8585 6.87E−02 −4.56E−01 1 Unchanged Low O15379 L16ef6 histone deacetylase 3 198.0005 380 342.3529 306.8418 7.90E−01 9.41E−01 1 Unchanged Low Q02790 H16ab5 FK506 binding protein 4 (59 kD) 323.5993 240 343.4254 302.2597 8.58E−02 −4.33E−01 1 Unchanged Low Q9H240 K12ef5 Notch homolog 2 (Drosophila) 270.5904 566 343.4339 393.3189 3.44E−01 1.06E+00 1 Unchanged Lo O76095 P22cd8 Jumping translocation breakpoint 252.8696 227 343.482 274.4316 4.42E−01 −1.56E−01 1 Unchanged Low Q9Y5Q8 P07cd7 general transcription factor IIIC;

545.6403 324 343.9958 404.6602 −6.66E−01 −7.50E−01 1 Unchanged Low Q9NNW5 H06ef8 WD repeat domain 6 254.1607 369 344.0253 322.3381 4.37E−01 5.37E−01 1 Unchanged Low P01121 C09ef6 ras homolog gene family; memb

241.7544 304 344.0732 296.4811 5.09E−01 3.29E−01 1 Unchanged Low Q9H0V7 K18gh8 hypothetical protein DKFZp564O 568.248 304 344.2985 405.6684 −7.23E−01 −9.00E−01 1 Unchanged Low O60664 P02cd5 cargo selection protein (mannos

520.0919 232 344.5523 365.5782 −5.94E−01 −1.16E+00 1 Unchanged Low P56554 O15cd3 ubiquitin-conjugating enzyme E2 374.4383 417 345.0269 378.959 −1.18E−01 1.57E−01 1 Unchanged Low O00330 O06cd3 Pyruvate dehydrogenase comple 345.9372 430 345.2213 373.6892 −2.99E−03 3.14E−01 1 Unchanged Low O60784 N17cd5 target of myb1 (chicken) 364.3098 317 345.2431 342.086 −7.76E−02 −2.02E−01 1 Unchanged Low Q9NQZ0 H03ef4 CMP-N-acetylneuraminic acid sy 788.5176 339 345.3498 491.0715 −1.19E+00 −1.22E+00 1 Unchanged Low P52790 A04ab5 hexokinase 3 (white cell) 260.6034 430 345.4621 345.2169 4.07E−01 7.21E−01 1 Unchanged Low P52815 B10cd1 mitochondrial ribosomal protein

234.3191 277 345.7776 285.7775 5.61E−01 2.43E−01 1 Unchanged Low O14983 O10ef1 ATPase; Ca++ transporting; card 167.4066 223 346.1734 245.4613 1.05E+00 4.12E−01 1 Unchanged Low P04259 D01ab7 keratin 6B 534.1837 405 347.6543 428.9832 −6.20E−01 −3.99E−01 1 Unchanged Low P16455 M04ef6 O-6-methylguanine-DNA methylt

299.0887 307 348.0545 318.0812 2.19E−01 3.81E−02 1 Unchanged Low Q9Y5L9 N04cd6 Snf2-related CBP activator prote

285.2875 187 348.0925 273.2945 2.87E−01 −6.13E−01 1 Unchanged Low P41214 A16gh1 ligatin 237.0742 307 348.5538 297.4677 5.56E−01 3.72E−01 1 Unchanged Low Q9H6U4 P13gh5 hypothetical protein FLJ21865 419.2747 175 348.8375 314.4039 −2.65E−01 −1.26E+00 1 Unchanged Low Q15393 L10ef7 splicing factor 3b; subunit 3; 130

242.1115 239 349.6571 277.0735 5.30E−01 −1.59E−02 1 Unchanged Low P55055 C04gh1 nuclear receptor subfamily 1; gro 325.6291 368 349.8393. 347.7942 1.03E−01 1.76E−01 1 Unchanged Low P51805 M03ef4 SEX gene 303.0664 383 350.6414 345.4093 2.10E−01 3.36E−01 1 Unchanged Low O75815 G23ab3 breast cancer anti-estrogen resis 249.1903 293 350.9571 297.768 4.94E−01 2.34E−01 1 Unchanged Low Q9Y2Y9 F19ef2 Kruppel-like factor 13 241.1753 366 351.0501 319.2905 5.42E−01 6.00E−01 1 Unchanged Low Q99633 D04cd3 pre-mRNA processing factor 1B 405.046 348 351.3478 366.1886 −2.05E−01 −2.18E−01 1 Unchanged Low P05155 C08ab3 serine (or cysteine) proteinase in 303.3386 334 351.5074 329.7432 2.13E−01 1.41E−01 1 Unchanged Low Q9UN50 O16cd7 EAP30 subunit of ELL complex 321.9045 326 351.5535 333.1657 1.27E−01 1.84E−02 1 Unchanged Low Q14011 E11ab4 cold inducible RNA binding prote 292.5107 412 351.6685 352.0144 2.66E−01 4.94E−01 1 Unchanged Low O75807 M02ef3 protein phosphatase 1; regulator 371.7509 652 352.5048 458.6852 −7.67E−02 8.10E−01 1 Unchanged Low Q14457 K19ab3 beciin 1 (coiled-coil); myosin-like 368.4142 678 352.9542 466.4393 −6.18E−02 8.80E−01 1 Unchanged Low Q02818 J06ef6 nucleobindin 1 330.8747 213 353.1168 298.8382 9.39E−02 −6.39E−01 1 Unchanged Low O15235 L10gh1 mitochondrial ribosomal protein

355.1234 467 353.2438 391.6738 −7.66E−03 3.94E−01 1 Unchanged Low Q9Y3E0 A02ef2 CGI-141 protein 152.8668 320 353.6986 275.4907 1.21E+00 1.07E+00 1 Unchanged Low Q9NQZ5 H19gh4 START domain containing 7 277.2941 280 353.7264 303.5369 3.51E−01 1.19E−02 1 Unchanged Low Q9UHW4 D24ef8 protein x 0001 266.9848 291 353.7644 303.9535 4.06E−01 1.25E−01 1 Unchanged Low P82914 P04gh7 mitochondrial ribosomal protein

444.1517 417 354.4965 405.0567 −3.25E−01 −9.27E−02 1 Unchanged Low P25787 L11ef7 proteasome (prosome; macropal

432.9379 526 355.1116 437.9448 −2.86E−01 2.80E−01 1 Unchanged Low P26447 D02cd1 S100 calcium binding protein A4 198.7401 273 355.1396 275.5734 8.38E−01 4.57E−01 1 Unchanged Low Q9Y605 P02gh8 T-cell activation protein 411.1148 356 355.1531 373.9359 −2.11E−01 −2.10E−01 1 Unchanged Low Q14776 K14cd4 leucine-zipper-like transcriptiona 202.0365 273 355.4522 276.788 8.15E−01 4.34E−01 1 Unchanged Low P30837 C02ab2 aldehyde dehydrogenase 1 famil 631.0407 451 355.7998 479.1158 −8.27E−01 −4.86E−01 1 Unchanged Low P09668 L03ef7 cathepsin H 460.8488 564 356.7735 460.5856 −3.69E−01 2.92E−01 1 Unchanged Low Q02313 J02gh8 Krueppel-related zinc finger prot

402.289 391 356.9162 383.4797 −1.73E−01 −4.02E−02 1 Unchanged Low Q13148 H11cd7 TAR DNA binding protein 322.5816 353 357.1404 344.328 1.47E−01 1.31E−01 1 Unchanged Low Q16645 K24ab5 FK506 binding protein 1B (12.6

216.7704 488 357.2698 353.4204 7.21E−01 1.17E+00 1 Unchanged Low N02gh8 protein phosphatase 1; regulator 77.52993 71.1 357.2714 168.643 2.20E+00 −1.24E−01 1 Unchanged Low P57739 F18gh1 claudin 2 188.162 238 357.443 261.2968 9.26E−01 3.41E−01 1 Unchanged Low O60568 F13cd4 procollagen-lysine; 2-oxoglutarat 332.5306 269 357.5594 319.8117 1.05E−01 −3.04E−01 1 Unchanged Low Q9HAU4 N11gh5 E3 ublquitin ligase SMURF2 425.5948 665 357.6911 482.7167 −2.51E−01 6.44E−01 1 Unchanged Low P49914 J01cd6 5; 10-methenyltetrahydrofolate sy 340.2344 238 358.0826 312.027 7.38E−02 −5.17E−01 1 Unchanged Low O60510 E11cd8 atrophin-1 interacting protein 1;

171.9425 265 358.342 265.2168 1.06E+00 6.26E−01 1 Unchanged Low Q98X68 L15gh8 histidine triad nucleotide binding 207.0703 360 358.5328 308.6409 7.92E−01 7.99E−01 1 Unchanged Low P29084 B02ab5 general transcription factor IIE; p 261.3572 225 358.621 281.687 4.57E−01 −2.17E−01 1 Unchanged Low P09526 C05ef6 RAP1B; member of RAS oncoge

320.4156 355 359.0861 344.9493 1.64E−01 1.49E−01 1 Unchanged Low O15471 P01ef4 leukocyte immunogiobuiln-like re 219.8277 260 359.2909 279.8225 7.09E−01 2.44E−01 1 Unchanged Low Q9UEE9 K03ab3 craniofacial development protein 124.0304 245 359.5047 242.684 1.54E+00 9.79E−01 1 Unchanged Low Q15011 L03ef3 homocysteine-inducible; endopia 352.4459 183 359.7095 298.5074 2.94E−02 −9.43E−01 1 Unchanged Low Q9BWG8 A13gh6 hypothetical protein MGC2491 170.1162 203 360.534 244.6389 1.08E+00 2.57E−01 1 Unchanged Low Q9Y397 A04ef2 zinc finger; DHHC domain contai 431.1743 495 360.6182 428.8727 −2.58E−01 1.99E−01 1 Unchanged Low Q14596 H17ab7 membrane component; chromos

303.2476 402 361.5265 355.7499 2.54E−01 4.08E−01 1 Unchanged Low P23497 C13cd2 nuclear antigen Sp100 331.8296 491 361.9825 394.8464 1.25E−01 5.64E−01 1 Unchanged Low Q16633 A24cd1 POU domain; class 2; associatin

103.1231 99.3 382.0007 188.1549 1.81E+00 −5.39E−02 1 Unchanged Low Q99961 J12cd1 SH3-domain GRB2-like 1 231.086 247 362.8536 280.235 6.51E−01 9.47E−02 1 Unchanged Low Q07021 N20ab3 complement component 1; q sub

471.8742 202 363.3385 345.9018 −3.77E−01 −1.22E+00 1 Unchanged Low Q16513 E04cd1 protein kinase C-like 2 546.0111 561 364.4852 490.5792 −5.83E−01 3.97E−02 1 Unchanged Low Q9H070 H10cd8 adaptor-related protein complex: 353.2901 278 364.7541 331.9695 4.61E−02 −3.46E−01 1 Unchanged Low Q13227 A16ab5 G protein pathway suppressor 2 557.5311 352 364.8449 424.6909 −6.12E−01 −6.65E−01 1 Unchanged Low P20339 M03ef5 RAB5A; member RAS oncogene 404.6579 664 365.7139 478.1731 −1.46E−01 7.15E−01 1 Unchanged Low Q9NXX4 G15gh2 hypothetical protein FLJ20005 155.2731 248 365.9622 255.5867 1.24E+00 6.61E−01 1 Unchanged Low Q92900 N17cd1 regulator of nonsense transcripts 328.2926 316 366.2931 336.7297 1.58E−01 −5.69E−02 1 Unchanged Low Q9H2K4 I05gh3 chromosome 11 open reading fra 198.6548 155 366.4866 240.051 8.83E−01 −3.58E−01 1 Unchanged Low O14917 E17ef4 protocadherin 17 250.3859 311 366.6879 309.398 5.50E−01 3.13E−01 1 Unchanged Low Q9NZ88 J06gh3 chromosome 6 open reading frar 199.6701 362 367.2681 309.7781 8.79E−01 8.60E−01 1 Unchanged Low Q9BYC8 C15gh8 mitochondrial ribosomal protein 1 257.9414 429 367.9727 351.4981 5.13E−01 7.33E−01 1 Unchanged Low Q15311 C21cd7 ralA binding protein 1 295.4648 411 368.6028 358.3107 3.19E−01 4.76E−01 1 Unchanged Low Q9NWE9 E02gh3 hypothetical protein FLJ10074 455.3747 383 369.4489 402.6031 −3.02E−01 −2.50E−01 1 Unchanged Low O95571 G22ef3 protein expressed in thyroid 398.0124 507 369.925 425.0962 −1.06E−01 3.50E−01 1 Unchanged Low P36941 A09ab7 hymphotoxin beta receptor (TNFF 403.0565 454 370.0343 409.094 −1.23E−01 1.72E−01 1 Unchanged Low P49790 F11cd5 nucleoporin 153 kD 264.6175 316 370.2793 317.116 4.85E−01 2.58E−01 1 Unchanged Low Q99607 C06ab4 E74-like factor 4 (ets domain trar 267.135 268 371.3515 302.1703 4.75E−01 4.79E−03 1 Unchanged Low Q9UIV1 H05cd8 CCR4-NOT transcription comple; 201.0959 465 371.6771 345.9619 8.86E−01 1.21E+00 1 Unchanged Low Q9Y3E4 O13ef2 CGI-146 protein 107.5317 262 371.8333 247.1535 1.79E+00 1.29E+00 1 Unchanged Low P19367 D17ab3 hexokinase 1 512.0647 215 371.9817 366.4437 −4.61E−01 −1.25E+00 1 Unchanged Low Q14250 J15cd5 enigma (LIM domain protein) 229.1944 218 371.9927 272.9152 6.99E−01 −7.52E−02 1 Unchanged Low Q9UL33 B20ef2 unknown 343.1533 636 372.4427 450.4535 1.18E−01 8.90E−01 1 Unchanged Low Q15019 H03ef5 neural precursor cell expressed; 489.0601 274 372.9279 378.666 −3.91E−01 −8.36E−01 1 Unchanged Low Q13084 H05cd6 melanoma-associated antigen re 421.8259 278 373.0512 357.6504 −1.77E−01 −6.01E−01 1 Unchanged Low Q9UMR2 O18cd7 DEAD/H (Asp-Glu-Ala-Asp/His) t 383.654 423 373.0622 393.1434 −4.04E−02 1.40E−01 1 Unchanged Low P55855 H06cd2 SMT3 suppressor of mif two 3 ho 454.9011 444 373.596 424.0867 −2.84E−01 −3.58E−02 1 Unchanged Low Q13155 G20cd4 JTV1 gene 322.6641 409 373.7416 368.4293 2.12E−01 3.42E−01 1 Unchanged Low P78371 H11cd6 chaperonin containing TCP1; sut 480.5464 430 374.014 428.2475 −3.62E−01 −1.60E−01 1 Unchanged Low P08173 P17ab3 cholinergic receptor; muscarinic 444.2461 514 374.4117 444.3189 −2.47E−01 2.11E−01 1 Unchanged Low O60478 E02cd2 transmembrane 7 superfamily m

274.7639 438 374.61 362.4989 4.47E−01 6.73E−01 1 Unchanged Low O60429 D16gh4 hypothetical protein FLJ12886 142.8322 257 375.0573 258.282 1.39E+00 8.47E−01 1 Unchanged Low O75935 O04cd7 dynaclin 3 (p22) 408.9698 432 375.1224 405.4281 −1.25E−01 7.97E−02 1 Unchanged Low Q13147 J05ab2 abl-interactor 2 299.098 249 375.379 307.9098 3.28E−01 −2.63E−01 1 Unchanged Low Q9NPH4 E14gh3 LUC7-like (S. cerevislae) 207.38 302 376.3768 295.4166 8.60E−01 5.45E−01 1 Unchanged Low Q9UJ96 C13cd8 potassium voltage-gated channe 582.717 448 376.4373 468.9343 −6.30E−01 −3.80E−01 1 Unchanged Low P17081 C13ef6 likely ortholog of mouse TC10-al

293.1604 417 376.4996 362.2816 3.61E−01 5.09E−01 1 Unchanged Low P11166 J05ef5 solute carrier family 2 (facilltated 351.7333 393 376.564 373.8343 9.84E−02 1.61E−01 1 Unchanged Low Q14820 D12ef6 splicing factor 1 382.846 408 376.7779 389.2167 −2.30E−02 9.19E−02 1 Unchanged Low Q92935 I06ab5 exostoses (multiple)-like 1 659.9005 276 376.8548 437.6869 −8.08E−01 −1.26E+00 1 Unchanged Low P31749 E20ef6 v-akt murine thymorna viral onco

385.4669 303 376.9169 355.1851 −3.24E−02 −3.46E−01 1 Unchanged Low Q13454 L05cd7 Putative prostate cancer tumor s

326.9146 363 377.0852 355.5691 2.06E−01 1.50E−01 1 Unchanged Low P35520 C24ab3 cystathionine-beta-synthase 70.85109 68.1 377.1148 172.0203 2.41E+00 −5.72E−02 1 Unchanged Low P53602 M01ab7 mevalonate (diphospho) decarbc 682.0309 178 378.114 412.6357 −8.51E−01 −1.94E−00 1 Unchanged Low Q9H7G3 C04gh6 mitochondrial ribosomal protein

333.6677 207 378.1396 306.3867 1.81E−01 −6.86E−01 1 Unchanged Low Q13123 C06ab7 IK cytokine; down-regulator of HI 257.7332 439 378.1806 358.3456 5.53E−01 7.69E−01 1 Unchanged Low O14744 G14cd6 SKB1 homolog (S. pombe) 348.0026 410 378.4165 378.8177 1.21E−01 2.37E−01 1 Unchanged Low Q9Y566 D16ef8 SH3 and multiple ankyrin repeat 209.2687 281 379.5197 290.0718 8.59E−01 4.27E−01 1 Unchanged Low Q9BUJ9 A03gh7 Mov10; Moloney leukemia virus 385.0517 472 380.308 412.4352 −1.79E−02 2.94E−01 1 Unchanged Low P51790 I02ab5 chloride channel 3 330.2251 237 380.3105 315.7621 2.04E−01 −4.80E−01 1 Unchanged Low O14547 J09cd6 PRP8 pre-mRNA processing fact 239.0005 256 380.5886 291.9777 6.71E−01 1.01E−01 1 Unchanged Low Q99753 A05cd7 cisplatin resistance associated 257.1873 397 380.7894 345.0384 5.66E−01 6.27E−01 1 Unchanged Low Q9NQC8 H15gh4 hypothetical protein LOC58912 185.2607 276 381.0416 280.7773 1.04E−00 5.75E−01 1 Unchanged Low O43919 M01ef6 linker for activation of T cells 206.6586 105 381.2059 230.823 8.83E−01 −9.82E−01 1 Unchanged Low P78345 F15cd6 ribonuclease P (38 kD) 321.791 530 381.5687 411.2575 2.46E−01 7.21E−01 1 Unchanged Low P54257 A03ef5 huntingtin-associated protein 1(

450.2874 322 382.6029 384.9948 −2.35E−01 −4.83E−01 1 Unchanged Low Q9Y3F4 G18cd7 unr-interacting protein 390.9437 335 382.6142 369.3734 −3.11E−02 −2.25E−01 1 Unchanged Low P29536 F14cd7 lelomodin 1 (smooth muscle) 343.3731 209 382.9438 311.936 1.57E−01 −7.13E−01 1 Unchanged Low O75925 K03cd4 protein inhibitor of activated STA 423.9992 606 383.7943 471.2944 −1.44E−01 5.15E−01 1 Unchanged Low Q9UMX5 J23ef4 secreted protein of unknown fun

344.8668 306 384.5676 345.2233 1.57E−01 −1.71E−01 1 Unchanged Low Q9UMZ9 N02cd7 interleukin enhancer binding fact 348.7866 278 384.7729 337.1554 1.42E−01 −3.28E−01 1 Unchanged Low Q92905 P03ef6 COP9 constitutive photomorphog 257.5597 392 386.1452 345.1985 5.84E−01 6.06E−01 1 Unchanged Low Q9NSD7 L20ef1 G-protein coupled receptor SALF 734.6282 277 386.7193 466.2798 −9.26E−01 −1.40E+00 1 Unchanged Low Q9P2W3 G01ef3 guanine nucleotide binding prote 70.71144 81.4 386.7442 179.6321 2.45E+00 2.04E−01 1 Unchanged Low Q9BV17 N14gh5 mitochondrial ribosomal protein

367.7177 520 386.9198 424.8293 7.34E−02 4.99E−01 1 Unchanged Low Q9Y4L1 B23cd6 oxygen regulated protein (150 kD 413.0575 372 387.5372 390.9975 −9.20E−02 −1.49E−01 1 Unchanged Low Q02363 F18ab7 inhibitor of DNA binding 2; domin 484.7132 359 388.2552 410.6421 −3.20E−01 −4.33E−01 1 Unchanged Low Q9Y5J8 E06cd8 translocase of inner mitochondris 440.2763 542 388.4554 456.8557 −1.81E−01 2.99E−01 1 Unchanged Low E22ef1 G protein-coupled receptor 26 499.1316 450 389.582 446.2248 −3.57E−01 −1.50E−01 1 Unchanged Low Q99501 N11cd6 growth arrest-specific 2 like 1 359.8065 540 389.6398 429.6515 1.15E−01 5.84E−01 1 Unchanged Low Q00613 M17ef5 heat shock transcription factor 1 363.3847 375 389.8695 376.2292 1.01E−01 4.71E−02 1 Unchanged Low Q9H5Z1 H16gh4 DEAD/H (Asp-Glu-Ala-Asp/His) t

136.5899 124 389.9835 217.0007 1.51E+00 −1.35E−02 1 Unchanged Low P09661 P24cd1 small nuclear ribonucleoprotein

441.1409 115 390.2085 315.5701 −1.77E−01 −1.94E+00 1 Unchanged Low P54709 P05ef5 ATPase; Na+/K+ transporting; b

425.6647 432 391.8135 416.5779 −1.20E−01 2.22E−02 1 Unchanged Low P13164 M06ef5 interferon induced transmembrar

45.13817 256 392.1204 231.1336 3.12E+00 2.50E+00 1 Unchanged Low Q9Y6E2 A23ef8 HSPC028 protein 329.8857 363 392.2431 361.6248 2.50E−01 1.37E−01 1 Unchanged Low Q9NVG2 B13gh3 vacuolar protein sorting 35 (yea

359.0233 557 392.2574 436.0959 1.28E−01 6.34E−01 1 Unchanged Low P27448 E10ef5 MAP/microtubule affinity-regula

397.7845 369 392.3918 386.4633 −1.97E−02 −1.08E−01 1 Unchanged Low O15438 P18cd3 ATP-binding cassette; sub-family 618.0409 488 392.8159 499.6643 −6.54E−01 −3.40E−01 1 Unchanged Low Q9UL48 I04ef2 CK2 interacting protein 1; HQ002 176.5553 215 393.4111 261.8209 1.16E+00 2.88E−01 1 Unchanged Low O94763 A11cd4 RPB5-mediating protein 333.6215 533 393.9446 420.3384 2.40E−01 6.77E−01 1 Unchanged Low Q13190 I19cd2 syntaxin 5A 179.6148 235 393.985 269.5995 1.13E+00 3.89E−01 1 Unchanged Low Q13122 D21ef3 EBNA-2 co-activator (100 kD) 381.3069 375 394.5999 383.7948 4.94E−02 −2.22E−02 1 Unchanged Low O75312 L01cd4 zinc finger protein 259 348.7542 422 394.8016 388.3905 1.79E−01 2.74E−01 1 Unchanged Low P37837 D20cd2 transaldolase 1 399.2717 326 395.693 373.7275 −1.30E−02 −2.92E−01 1 Unchanged Low O75762 G19cd6 ankyrin-like with transmembrane 222.8517 364 395.7427 327.3962 8.28E−01 7.06E−01 1 Unchanged Low Q99969 K19ef3 retinoic acid receptor responder

283.5705 257 396.0287 312.0672 4.62E−01 −1.44E−01 1 Unchanged Low Q9UNP2 H15cd2 solute carrier family 1 (neutral an 149.1019 138 396.5014 227.7665 1.41E+00 −1.15E−01 1 Unchanged Low P56524 C23cd6 histone deacetylase 4 328.6037 303 397.1317 342.9334 2.73E−01 −1.17E−01 1 Unchanged Low Q9H644 C19gh6 hypothetical protein MGC5585 140.9811 228 397.2624 255.3931 1.49E+00 6.93E−01 1 Unchanged Low Q13627 O19ab4 dual-specificity tyrosine-(Y)-phos 498.484 327 397.3922 407.7774 −3.27E−01 −6.06E−01 1 Unchanged Low Q03405 O01ef5 plasminogen activator; urokinase 500.1391 396 396.2456 431.3524 −3.29E−01 −3.38E−01 1 Unchanged Low Q9NPQ8 L16gh4 likely ortholog of mouse synemb

372.8251 443 398.4083 404.6217 9.57E−02 2.48E−01 1 Unchanged Low Q15375 A10ab5 EphA7 243.0574 290 396.5414 310.569 7.13E−01 2.55E−01 1 Unchanged Low P05114 G04ab7 high-mobility group (nonhistone

196.8334 278 398.7327 291.2748 1.02E+00 4.99E−01 1 Unchanged Low Q9UKU4 C13ef2 retinal short-chain dehydrogenas 370.8225 497 399.4413 422.4244 1.07E−01 4.23E−01 1 Unchanged Low P08195 E21ab7 solute carrier family 3 (activators 442.5453 345 399.5678 395.768 −1.47E−01 −3.58E−01 1 Unchanged Low Q15545 J11cd2 TAF7 RNA polymerase II; TATA 400.689 526 401.1308 442.5426 1.59E−03 3.92E−01 1 Unchanged Low D24gh8 hypothetical protein FLJ14511 246.3293 225 401.3816 290.8781 7.04E−01 −1.31E−01 1 Unchanged Low Q05397 L20ef5 PTK2 protein tyrosine kinase 2 389.8718 440 401.4713 410.2909 4.23E−02 1.73E−01 1 Unchanged Low Q9Y6G1 C21ef8 PTD011 protein 434.6906 483 401.5119 439.8467 −1.15E−01 1.53E−01 1 Unchanged Low P41212 O23ef5 ets variant gene 6 (TEL oncogen 315.7331 502 401.8428 406.6035 3.48E−01 6.70E−01 1 Unchanged Low O14737 G05cd5 programmed cell death 5 498.729 430 402.3091 443.7457 −3.10E−01 −2.13E−01 1 Unchanged Low Q9UHB9 A10ef3 signal recognition particle 68 kD 212.5357 247 402.3276 287.2236 9.21E−01 2.16E−01 1 Unchanged Low Q96D21 C20ef8 RASD family; member 2 395.909 486 402.4304 427.9499 2.36E−02 2.94E−01 1 Unchanged Low Q9Y4I1 J05ef1 myosin VA (heavy polypeptide 1

371.5954 353 402.453 375.8247 1.15E−01 −7.23E−01 1 Unchanged Low Q9Y5L4 L14ef7 translocase of inner mitochondri

291.7019 369 404.0738 354.9111 4.70E−01 3.39E−01 1 Unchanged Low O75439 N22cd4 peptidase (mitochondiral proces

512.9004 184 404.5715 367.0789 −3.42E−01 −1.48E+00 1 Unchanged Low P55010 K22ab4 eukaryotic translation initiation fa 427.4989 296 405.4996 376.3076 −7.62E−02 −5.31E−01 1 Unchanged Low Q9BY44 G10gh8 CDA02 protein 453.6064 401 405.956 420.1404 −1.60E−01 −1.78E−01 1 Unchanged Low Q13164 B21ef5 mitogen-activated protein kinase 209.1026 256 406.234 290.5304 9.58E−01 2.93E−01 1 Unchanged Low P53667 P08ab6 LIM domain kinase 1 359.4655 392 406.5183 386.0829 1.77E−01 1.26E−01 1 Unchanged Low Q9UNH6 F05ef2 sorting nexin 7 479.6898 396 406.7812 427.3762 −2.38E−01 −2.78E−01 1 Unchanged Low O00258 K17cd4 tryptophan rich basic protein 339.3172 500 407.1504 415.5431 2.63E−01 5.60E−01 1 Unchanged Low Q9Y3I0 I12ef3 hypothetical protein 458.2693 546 407.2408 470.3717 −1.70E−01 2.52E−01 1 Unchanged Low Q9Y368 D13cd8 parvin; beta 114.232 159 407.3882 226.9908 1.83E+00 4.80E−01 1 Unchanged Low P14866 H13ab8 heterogeneous nuclear ribonucle 442.5489 274 407.4025 374.6383 −1.19E−01 −6.92E−01 1 Unchanged Low Q13885 K01cd3 tubulin; beta polypeptide 441.2669 413 407.8683 420.8456 −1.14E−01 −9.41E−02 1 Unchanged Low O43765 J06cd1 small glutamine-rich tetratricope

378.9705 438 408.6453 408.6939 1.09E−01 2.10E−01 1 Unchanged Low O14632 B12ef4 homeodomain interacting protein 394.449 535 408.8773 446.1081 5.18E−02 4.40E−01 1 Unchanged Low P31939 L10ab2 5-aminoimidazole-4-carboxamid

501.3028 386 409.3069 432.286 −2.92E−01 −3.76E−01 1 Unchanged Low P28331 P18ab8 NADH dehydrogenase (ubiquino

490.4347 417 409.3283 438.7901 −2.61E−01 −2.35E−01 1 Unchanged Low P41970 P05ef6 ELK3; ETS-domain protein (SRF 205.9453 359 410.8037 325.3706 9.96E−01 8.03E−01 1 Unchanged Low Q92973 J22ab6 karyopherin (importin) beta 2 393.6551 234 410.9425 346.1733 6.20E−02 −7.51E−01 1 Unchanged Low P36507 J10ef5 mitogen-activated protein kinase 395.22 437 411.4052 414.6953 5.79E−02 1.46E−01 1 Unchanged Low Q16512 F21ab8 protein kinase C-like 1 456.2727 486 411.8245 451.4528 −1.48E−01 9.18E−02 1 Unchanged Low O43447 M08cd6 peptidyl prolyl isomerase H (cyc

179.441 222 411.9165 271.0162 1.20E+00 3.05E−01 1 Unchanged Low P30040 M13ef3 chromosome 12 open reading fr

346.6792 296 412.2064 351.5665 2.50E−01 −2.29E−01 1 Unchanged Low O95399 C19cd7 urotensin 2 452.0721 366 413.1451 410.4914 −1.30E−01 −3.04E−01 1 Unchanged Low M01ab3 UDP-Gal:betaGal beta 1:3-galac 499.9529 290 413.3454 401.0113 −2.74E−01 −7.87E−01 1 Unchanged Low Q12792 N11ab8 protein tyrosine kinase 9 476.3952 364 413.4208 416.007 −2.05E−01 −3.87E−01 1 Unchanged Low Q14318 J02cd7 FK506 binding protein 8 (38 kD) 461.2322 432 413.4238 435.6453 −1.58E−01 −9.35E−02 1 Unchanged Low O75955 N10cd5 fiotillin 1 304.6674 310 415.4364 343.498 4.47E−01 2.68E−02 1 Unchanged Low Q9BVY8 B09gh7 hypothetical protein MGC5499 490.2382 417 416.02 440.9559 −2.37E−01 −2.35E−01 1 Unchanged Low Q16288 O19ef5 neurotrophic tyrosine kinase; rec 126.7467 186 416.4128 243.0358 1.72E+00 5.53E−01 1 Unchanged Low O75380 J20ab8 NADH dehydrogenase (ubiquino

449.5778 413 416.4836 426.4999 −1.10E−01 −1.21E−01 1 Unchanged Low Q9BY51 B15gh8 hypothetical protein GL009 429.1998 354 417.3575 400.0464 −4.04E−02 −2.80E−01 1 Unchanged Low Q9BVK3 E19gh6 hypothetical protein MGC2463 452.5828 387 417.7046 422.5145 −1.47E−01 −2.56E−01 1 Unchanged Low Q9P0N3 A24ef2 hypothetical protein FLJ10597 137.7487 289 417.999 281.424 1.60E+00 1.07E+00 1 Unchanged Low P24534 D03ab4 eukaryotic translation elongation 347.2405 328 418.0152 364.5026 2.68E−01 −8.11E−02 1 Unchanged Low P49336 C01ab4 cyclin-dependent kinase 8 426.3751 281 418.121 375.2575 −2.82E−02 −6.00E−01 1 Unchanged Low P34130 P16cd2 neurotrophin 5 (neurotrophin 4/5

327.4146 223 418.6011 323.0643 3.54E−01 −5.53E−01 1 Unchanged Low O75425 P06gh5 hypothetical protein AF053356_

340.4357 339 419.3637 366.1692 3.01E−01 −7.34E−03 1 Unchanged Low Q15293 F16ab8 reticulocalbin 1; EF-hand calciu

241.6383 250 420.5597 304.1243 7.99E−01 5.01E−02 1 Unchanged Low O95376 D08ab2 ariadne homolog 2 (Drosophila) 254.1122 322 420.8229 332.2465 7.28E−01 3.41E−01 1 Unchanged Low O75489 J16ab8 NADH dehydrogenase (ubiquino

375.7034 327 422.3772 375.1108 1.69E−01 −1.99E−01 1 Unchanged Low P28482 B15ef5 mitogen-activated protein kinase 493.835 452 422.4625 456.1064 −2.25E−01 −1.28E−01 1 Unchanged Low P20823 B09cd1 transcription factor 1; hepatic; LF 322.4782 527 423.4405 424.3654 3.93E−01 7.09E−01 1 Unchanged Low O15250 I04cd4 X-prolyl aminopeptidase (amino

524.8188 542 423.7387 496.7532 −3.09E−01 4.57E−02 1 Unchanged Low P55769 P22ab8 NHP2 non-histone chormosome

137.3557 479 424.0031 346.68 1.63E+00 1.80E+00 1 Unchanged Low O94817 N21ab2 APG12 autophagy 12-like (S. ce

631.6055 402 424.3577 485.9574 −5.74E−01 −8.52E−01 1 Unchanged Low O75352 K08cd5 mannose-P-dolichol utilization d

272.444 523 424.8266 406.7998 6.41E−01 9.41E−01 1 Unchanged Low Q16585 I16cd1 sarcoglycan; beta (43 kD dystrop

256.2113 293 425.1172 324.9166 7.31E−01 1.96E−01 1 Unchanged Low Q9H7X7 B16gh5 hypothetical protein FLJ14117 261.9578 463 425.3725 383.5805 6.99E−01 8.23E−01 1 Unchanged Low O15173 I16cd6 progesterone receptor membrane 295.0481 244 425.8728 321.6602 5.29E−01 −2.74E−01 1 Unchanged Low Q9GZX9 A16gh4 twisted gastrulation 84.61732 147 426.1124 219.3062 2.33E+00 7.99E−01 1 Unchanged Low Q16594 M09cd2 TAF9 RNA polymearase II; TATA 171.3507 520 426.7606 372.6331 1.32E+00 1.60E+00 1 Unchanged Low O00479 O17gh1 high-mobility group (nonhistone

265.695 354 426.7642 348.9168 6.84E−01 4.15E−01 1 Unchanged Low P54760 C22ab5 EphB4 528.7066 413 427.0543 456.4179 −3.08E−01 −3.55E−01 1 Unchanged Low P25490 F06ef6 YY1 transcription factor 481.2844 530 427.184 479.4548 −1.72E−01 1.39E−01 1 Unchanged Low Q9UJY0 B07ef1 putative necleotide binding prote

505.9493 431 427.3544 454.8441 −2.44E−01 −2.31E−01 1 Unchanged Low Q09668 A22ef3 AHNAK nucleoprotein (desmoyol 392.0671 399 427.3828 406.041 1.24E−01 2.41E−02 1 Unchanged Low O15305 P22ab7 phosphomannomutase 2 325.0777 480 428.3778 411.2528 3.98E−01 5.63E−01 1 Unchanged Low O60492 M09ab4 7-dehydrocholestrol reductase 388.5228 213 428.5923 343.3316 1.42E−01 −8.68E−01 1 Unchanged Low Q9UND3 G11cd6 nuclear pore complex interacting 280.8175 312 428.5952 340.6147 6.10E−01 1.54E−01 1 Unchanged Low Q9HB15 M15gh5 potassium channel: subfamily K: 473.5589 408 428.9308 436.9131 −1.43E−01 −2.14E−01 1 Unchanged Low Q9Y3B4 H23ef2 CGI-110 protein 290.9669 331 429.1497 350.4808 5.61E−01 1.87E−01 1 Unchanged Low Q14107 F05ef5 D123 gene product 387.0465 405 429.9331 407.3091 1.52E−01 6.52E−02 1 Unchanged Low P52435 A22cd1 polymerase (RNA) II (DNA direct 527.0446 461 429.9488 472.7272 −2.94E−01 −1.93E−01 1 Unchanged Low Q9Y262 L11ef2 eukaryotic translation initiation fa

591.5767 311 430.6788 444.385 −4.58E−01 −9.28E−01 1 Unchanged Low P10163 L20cd2 proline-rich protein BstNI subfam

521.4154 251 431.1299 401.2036 −2.74E−01 −1.05E+00 1 Unchanged Low P38378 F01cd8 protein transport protein SEC61

635.5838 369 431.9958 478.7225 −5.57E−01 −7.86E−01 1 Unchanged Low P48735 B06ab6 Isocitrate dehydrogenase 2 (NA

600.2178 338 432.1616 456.8577 −4.74E−01 −8.28E−01 1 Unchanged Low Q9NPF5 F02gh4 DNA methyltranferase 1-associ

451.5343 382 432.3473 421.964 −6.26E−02 −2.41E−01 1 Unchanged Low O14616 K22cd4 zinc finger protein-like 1 194.5871 348 432.4885 324.9789 1.15E+00 8.38E−01 1 Unchanged Low Q00839 A12ab7 heterogeneous nuclear ribonucle

416.5145 410 432.5188 419.7665 5.44E−02 −2.18E−02 1 Unchanged Low O95563 J15ef8 DKFZP564B167 protein 390.848 389 432.8082 404.2972 1.47E−01 −5.96E−03 1 Unchanged Low Q92974 I03cd6 rho/rac guanine nucleotide exch

142.3392 124 433.2388 233.2947 1.61E+00 −1.95E−01 1 Unchanged Low Q9UEE5 M07cd5 serine/threonine kinase 17a (apc

397.8599 472 433.4221 434.4129 1.24E−01 2.46E−01 1 Unchanged Low Q9NX81 O19gh3 BTB (POZ) domain containing 2 175.3887 206 433.4811 271.6819 1.31E+00 2.33E−01 1 Unchanged Low Q9NXF9 O01gh3 O-linked mannose beta1; 2-N-ac

477.6375 353 434.2927 421.54 −1.37E−01 −4.38E−01 1 Unchanged Low P98171 F13ef1 Rho GTPase activating protein 4 368.9887 231 435.3585 345.0241 2.39E−01 −6.77E−01 1 Unchanged Low P56192 I14ab7 methionine-tRNA synthetase 263.0076 295 435.694 331.1505 7.29E−01 1.63E−01 1 Unchanged Low O95411 K09cd5 TGFB1-induced anti-apoptotic fa

233.3926 310 436.2684 326.6136 9.02E−01 4.10E−01 1 Unchanged Low P09132 E23cd2 signal recognition particle 19 kD 227.6193 595 436.5994 419.7603 9.38E−01 1.38E+00 1 Unchanged Low Q92537 O24gh1 KIAA0247 gene product 291.1054 232 437.1141 319.914 5.86E−01 −3.30E−01 1 Unchanged Low P49761 G03ab4 CDC-like kinase 3 458.9286 562 437.5601 486.0405 −6.88E−02 2.91E−01 1 Unchanged Low Q9HDC4 O19gh4 junctophilin 3 346.7829 388 439.282 391.3835 3.41E−01 1.62E−01 1 Unchanged Low P98160 A13ef7 heparan sulfate proteoglycan 2 (

505.6962 372 439.9544 439.0897 −2.01E−01 −4.44E−01 1 Unchanged Low Q9NQV6 O22gh4 PR domain containing 10 369.157 514 440.5347 441.3923 2.55E−01 4.79E−01 1 Unchanged Low Q9NRX6 J09gh4 protein x 013 324.5306 345 440.8995 370.1383 4.42E−01 8.82E−02 1 Unchanged Low O76084 A13cd4 catenin (cadherin-associated pro 471.1305 211 441.7617 374.6479 −9.29E−02 −1.16E+00 1 Unchanged Low P23197 E19cd7 chromobox homolog 1 (HP1 beta 480.8183 362 441.9595 428.3076 −1.22E−01 −4.09E−01 1 Unchanged Low Q99439 E10ab6 calponin 2 429.1961 304 442.4148 391.978 4.38E−02 −4.96E−01 1 Unchanged Low Q14656 O04ef6 dystonia 1: torsion (autosomal d

415.3893 533 442.9429 463.6417 9.27E−02 3.59E−01 1 Unchanged Low Q9NPJ3 P04gh4 uncharacterized hypothalamus p 411.0811 430 443.2575 428.1718 1.09E−01 6.55E−02 1 Unchanged Low P41226 B10ef7 ubiquitin-activating enzyme E1-

298.6597 342 443.334 361.2685 5.70E−01 1.95E−01 1 Unchanged Low Q9Y478 C24cd1 protein kinase; AMP-activated; b

306.0158 165 443.5049 304.7576 6.35E−01 −8.93E−01 1 Unchanged Low P06cd8 nodal homolog (mouse) 349.4202 252 443.7188 348.2928 3.45E−01 −4.73E−01 1 Unchanged Low Q12904 O06ef7 small inducible cytokine subfamil

374.6683 459 445.5171 426.5346 2.50E−01 2.94E−01 1 Unchanged Low P20264 C02cd1 POU domain; class 3; transcription 458.6994 302 447.8929 402.9521 −3.44E−02 −6.02E−01 1 Unchanged Low Q15428 B11cd4 splicing factor 3a; subunit 2; 66 k

284.0454 334 448.6652 355.7289 6.60E−01 2.36E−01 1 Unchanged Low P49771 G06ef6 fms-related tyrosine kinase 3 liga

449.6827 417 452.1329 439.4747 7.64E−03 −1.10E−01 1 Unchanged Low P49005 A18cd1 polymerase (DNA directed); delt

363.5225 232 452.6832 349.3417 3.16E−01 −6.49E−01 1 Unchanged Low Q99879 M14gh6 H2B histone family; member E 325.9523 483 452.8012 420.4323 4.74E−01 5.69E−01 1 Unchanged Low P49821 G20cd1 NADH dehydrogenase (ubiqunio

511.5488 392 454.6223 452.5721 −1.70E−01 −3.86E−01 1 Unchanged Low P10644 H22ef5 protein kinase; cAMP-dependent 420.8225 518 454.8256 464.5909 1.12E−01 3.00E−01 1 Unchanged Low Q9Y5J4 L17gh6 pyrroline 5-carboxylate reductase 145.6987 303 455.1667 301.448 1.64E+00 1.06E+00 1 Unchanged Low P31040 K02cd2 succinate dehydrogenase compl

671.3369 351 456.2212 492.7974 −5.57E−01 −9.36E−01 1 Unchanged Low Q9UHA2 F04ef8 synovial sarcoma translocation g 438.6951 480 456.469 458.4094 5.73E−02 1.30E−01 1 Unchanged Low Q9UBF6 C02ef3 ring finger protein 7 315.6541 400 456.9368 390.7186 5.34E−01 3.40E−01 1 Unchanged Low Q9Y5S2 C21cd6 CDC42 binding protein kinase b

386.9683 447 456.9709 430.2759 2.40E−01 2.08E−01 1 Unchanged Low P20809 H07ef7 interleukin 11 399.048 140 458.1544 332.3748 1.99E−01 −1.51E+00 1 Unchanged Low Q13526 F21ef5 protein (peptidyl-prolyl cls/trans

333.4194 460 458.2237 417.3666 4.59E−01 4.66E−01 1 Unchanged Low Q9NWQ9 H01gh2 hypothetical protein FLJ20671 430.7122 577 458.2293 488.6936 8.93E−02 4.22E−01 1 Unchanged Low Q9Y6J0 E05cd8 calcineurin binding protein 1 474.3964 117 458.7489 350.127 −4.84E−02 −2.02E+00 1 Unchanged Low Q9Y4Z6 B13cd7 vacuolar protein sorting 45A (yea

115.1679 276 458.8586 283.3006 1.99E+00 1.26E+00 1 Unchanged Low Q01433 G02ab8 adenosine monophosphate dean 352.5251 390 459.2935 400.6864 3.82E−01 1.47E−01 1 Unchanged Low O43181 M07ab8 NADH dehydrogenase (ubiquino

417.4586 432 460.2425 436.6589 1.41E−01 5.03E−02 1 Unchanged Low Q9NWT5 D15gh2 hypothetical protein FLJ20618 354.3599 523 460.3326 445.8286 3.77E−01 5.61E−01 1 Unchanged Low O75431 P19cd6 metaxin 2 282.4791 443 460.352 395.1258 7.05E−01 6.48E−01 1 Unchanged Low P09543 A18gh7 2′;3′-cyclic nucleotide 3′ phospho

258.2862 510 462.033 409.9513 8.39E−01 9.80E−01 1 Unchanged Low Q9BTE1 B05gh8 dynactin 4 562.6142 460 462.4054 494.9234 −2.83E−01 −2.91E−01 1 Unchanged Low P16152 H14ab5 carbonyl reductase 1 234.3184 240 463.6916 312.8541 9.85E−01 3.30E−02 1 Unchanged Low O15121 D06cd3 degenerative spermatocyte homo

264.7024 270 464.4612 333.1906 8.11E−01 3.08E−02 1 Unchanged Low O60909 E09ab3 UDP-Gal: betaGlcNAc beta 1; 4-

365.8881 379 464.9697 403.197 3.46E−01 4.98E−02 1 Unchanged Low O75223 C11gh6 hypothetical protein MGC3077 493.9011 276 465.7709 411.9427 −8.46E−02 −8.39E−01 1 Unchanged Low Q9BQA1 K03gh6 MEP50 protein 379.1943 303 466.1997 382.8783 2.98E−01 −3.22E−01 1 Unchanged Low O43427 F20cd4 fibroblast growth factor (acidic)

323.6471 325 466.8724 371.8858 5.29E−01 6.63E−03 1 Unchanged Low Q9BWG6 A15gh6 hypothetical protein MGC3180 309.3486 596 468.0924 457.7257 5.98E−01 9.45E−01 1 Unchanged Low Q9Y6R2 M04cd6 chromosome 4 open reading frar 337.7358 352 469.9502 386.6911 4.77E−01 6.13E−02 1 Unchanged Low Q9HBK7 M07gh4 NPD007 protein 367.4893 489 471.1924 442.4205 3.59E−01 4.11E−01 1 Unchanged Low P52758 E04ef7 translational inhibitor protein p14 324.9333 318 471.2741 371.3427 5.36E−01 −3.19E−02 1 Unchanged Low P47897 E19cd1 glutaminyl-tRNA synthetase 400.1718 364 472.5359 412.2837 2.40E−01 −1.36E−01 1 Unchanged Low Q9BWQ6 P20gh5 hypothetical protein MGC3262 288.8083 483 473.0084 415.0843 7.12E−01 7.43E−01 1 Unchanged Low P35325 H22cd5 small proline-rich protein 2B 390.5307 584 474.2762 483.0992 2.80E−01 5.82E−01 1 Unchanged Low Q9HA68 O23gh5 hypothetical protein FLJ12154 556.3676 383 474.593 471.3877 −2.29E−01 −5.38E−01 1 Unchanged Low P49368 P16ab5 deoxyhypusine synthase 458.6886 481 477.1999 472.2313 5.17E−02 6.79E−02 1 Unchanged Low Q9UKZ7 J18ef1 colon carcinoma related protein 505.0182 450 478.4787 477.7496 −7.79E−02 −1.67E−01 1 Unchanged Low P01730 K15ef5 CD4 antigen (p55) 516.4046 432 478.8033 475.788 −1.09E−01 −2.57E−01 1 Unchanged Low P20674 L06cd4 cytochrome c oxidase subunit Va 512.4055 372 480.2708 454.7764 −9.34E−02 −4.63E−01 1 Unchanged Low Q12828 H02ef6 far upstream element (FUSE) bin 462.592 312 480.5079 418.2868 5.48E−02 −5.69E−01 1 Unchanged Low Q9Y6A4 J18ef3 similar to mouse Git3 or D. malar 359.9248 485 480.8661 442.0882 4.18E−01 4.32E−01 1 Unchanged Low O60888 B09ef2 divalent cation tolerant protein C 298.6981 304 481.136 361.3342 6.88E−01 2.62E−02 1 Unchanged Low O75716 F08cd3 serine/threonine kinase 16 384.1875 379 481.1652 408.0382 4.02E−01 5.66E−02 1 Unchanged Low P30711 E18ef7 glutathione S-transferase theta 1 327.8121 533 481.9461 447.6268 5.56E−01 7.02E−01 1 Unchanged Low Q15008 L03gh1 KIAA0107 gene product 475.6485 506 482.3327 488.0851 2.01E−02 9.00E−02 1 Unchanged Low P17174 N07ab4 glutamic-oxaloacetic transamina

412.5293 224 484.4384 373.5229 2.32E−01 −8.84E−01 1 Unchanged Low P13798 K16ab2 N-acylaminoacyl-peptide hydrola 365.1218 351 484.44 400.3314 4.08E−01 −5.51E−02 1 Unchanged Low Q9P2R8 E15ef4 Misshapen/NIK-related kinase 469.5725 511 484.515 488.4865 4.52E−02 1.23E−01 1 Unchanged Low Q9UNT1 E20cd7 RAB; member of RAS oncogene 268.916 347 484.9919 366.9843 8.51E−01 3.68E−01 1 Unchanged Low O75607 L11cd7 nucleophosmin/nucleoplasmin; 3 350.2387 272 485.5671 369.1972 4.71E−01 −3.66E−01 1 Unchanged Low O94925 B20gh1 glutaminase 410.4357 471 486.8946 456.0458 2.46E−01 1.98E−01 1 Unchanged Low O95390 A06ab3 growth differentiation factor 11 264.606 324 489.3912 359.3416 8.87E−01 2.92E−01 1 Unchanged Low O75956 K13cd6 tumor suppressor deleted in oral 524.962 482 489.6212 498.9664 −1.01E−01 −1.22E−01 1 Unchanged Low O95573 I23ab5 fatty-acid-Coenzyme A ligase; lo

354.1387 174 489.6455 339.2885 4.67E−01 −1.02E+00 1 Unchanged Low Q9BXH1 N23gh6 Bcl-2 binding component 31 493.3887 433 492.1083 472.8963 −3.75E−03 −1.88E−01 1 Unchanged Low P13662 L20cd5 nuclear transport factor 2 392.576 479 492.4942 454.7336 3.27E−01 2.67E−01 1 Unchanged Low Q92793 H05ab5 CREB binding protein (Rubinstel 468.559 474 494.3525 478.8243 7.73E−02 1.53E−02 1 Unchanged Low Q9P0H6 K23ef4 AD-012 protein 406.4789 469 495.1858 456.7944 2.85E−01 2.06E−01 1 Unchanged Low Q9P0R3 C05ef3 hypothetical protein HSPC213 339.0916 509 495.2656 447.9021 5.47E−01 5.87E−01 1 Unchanged Low O75094 E11gh1 slit homolog 3 (Drosophila) 345.9855 439 496.3812 426.952 5.21E−01 3.42E−01 1 Unchanged Low Q9P011 P10ef2 non-canonical ubquitin conjugati

460.4398 538 497.256 498.5084 1.11E−01 2.24E−01 1 Unchanged Low Q92504 M12cd4 HLA class II region expressed g

251.7256 339 497.6138 362.6669 9.83E−01 4.28E−01 1 Unchanged Low O95190 L12cd8 omithine decarboxylase antizym

421.0592 441 497.6839 453.1247 2.41E−01 6.55E−02 1 Unchanged Low Q9Y230 N12cd6 RuvB-like 2 (E. coli) 342.0841 300 497.7767 379.9805 5.41E−01 −1.89E−01 1 Unchanged Low Q9BSG0 M16gh8 chromosome 2 open reading trar 324.5321 458 497.8462 426.9191 6.17E−01 4.98E−01 1 Unchanged Low Q9Y368 I17ef2 chromosome 20 open reading tra 278.1968 453 498.3057 409.8539 8.41E−01 7.04E−01 1 Unchanged Low Q14094 O24ef5 cyclin I 407.6242 354 499.6223 420.31 2.94E−01 −2.05E−01 1 Unchanged Low P43403 H04ef5 zeta-chain (TCR) associated pro 396.0583 396 500.6282 430.7684 3.38E−01 −1.60E−03 1 Unchanged Low P52803 H23ef7 ephrin-A5 357.5339 316 501.0718 391.4643 4.87E−01 −1.79E−01 1 Unchanged Low O95402 E18cd5 cofactor required for Sp1 transcri 106.0683 58.7 501.9814 222.265 2.24E+00 −8.52E−01 1 Unchanged Low O00233 L23ab8 proteasome (prosome; macropali 581.8818 399 502.2082 494.287 −2.12E−01 −5.45E−01 1 Unchanged Low Q9H1K6 O18gh7 mesoderm development candidar 432.735 560 502.7516 498.6205 2.16E−01 3.73E−01 1 Unchanged Low Q9BXL6 K15gh6 caspase recruitment domain prot 425.1251 523 502.8514 483.629 2.42E−01 2.99E−01 1 Unchanged Low Q9H173 H03gh5 endoplasmic reticulum chaperon

456.5646 449 503.5156 469.6418 1.41E−01 −2.46E−02 1 Unchanged Low Q9NV83 H03gh3 hypothetical protein FLJ10876 423.9423 497 504.9702 475.4325 2.52E−01 2.30E−01 1 Unchanged Low P11926 A12ab8 omithine decarboxylase 1 591.3922 362 505.3016 486.3355 −2.27E−01 −7.07E−01 1 Unchanged Low Q04743 D23ef1 empty spiracles homolog 2 (Dros 531.3866 311 505.7367 449.3322 −7.14E−02 −7.73E−01 1 Unchanged Low Q98VK2 G11gh6 hypothetical protein MGC2840 sl 388.8682 383 505.9804 425.9595 3.80E−01 −2.18E−02 1 Unchanged Low O43251 I16ef3 RNA binding motif protein 9 346.6445 530 507.0674 461.1452 5.49E−01 6.12E−01 1 Unchanged Low Q99829 L13cd4 copine I 355.3783 268 508.4915 377.1688 5.17E−01 −4.09E−01 1 Unchanged Low O95777 B10ef2 U6 snRNA-associated Sm-like pr 391.981 311 508.8683 403.8183 3.77E−01 −3.36E−01 1 Unchanged Low Q9UN53 C19ef2 calcium binding protein Cab45 pr 327.721 407 509.3316 414.6963 6.36E−01 3.13E−01 1 Unchanged Low P24310 F03ab4 cytochrome c oxidase subunit VII 184.0695 288 509.4504 327.1972 1.47E+00 6.46E−01 1 Unchanged Low Q9H929 N09gh5 hypothetical protein FLJ13055 387.341 500 510.1197 465.7217 3.97E−01 3.67E−01 1 Unchanged Low P10768 K19ef1 esterase D/formylglutathione hyd 596.3068 102 510.5002 402.8142 −2.24E−01 −2.55E+00 1 Unchanged Low O95287 D17cd5 golgi autoantigen; golgin subfam 346.1135 560 510.6433 472.3714 5.61E−01 6.95E−01 1 Unchanged Low Q01105 H18cd1 SET translocation (myeloid leuxe 328.6513 403 511.1477 414.2142 6.37E−01 2.94E−01 1 Unchanged Low Q9UK45 B08ef2 U6 snRNA-associated Sm-like pr 388.4486 551 511.9386 483.7088 3.98E−01 5.04E−01 1 Unchanged Low P35611 I17ab2 adducin 1 (alpha) 435.0349 519 512.6447 488.7819 2.37E−01 2.54E−01 1 Unchanged Low O14681 K22cd5 etoposide-induced mRNA 451.5599 324 516.5292 430.8211 1.94E−01 −4.77E−01 1 Unchanged Low P80303 A05cd1 nucleobindin 2 296.1418 236 516.7037 349.5918 8.03E−01 −3.28E−01 1 Unchanged Low Q9NWC0 N19gh2 F-box only protein 4 434.5394 477 517.7728 476.3476 2.53E−01 1.34E−01 1 Unchanged Low P00367 B06ab5 glutamate dehydrogenase 1 360.6 303 518.2525 394.0342 5.23E−01 −2.50E−01 1 Unchanged Low O00469 I09ab8 procollagen-lysine; 2-oxoglutarat 735.8327 238 518.6446 497.4006 −5.05E−01 −1.63+00 1 Unchanged Low Q9UI04 M18ef4 mitochondrial ribosomal protein I 364.1383 336 520.377 406.7523 5.15E−01 −1.17E−01 1 Unchanged Low P20338 N08ab8 RAB4A; member RAS oncogene 487.9427 457 520.7608 488.5317 9.39E−02 −9.49E−02 1 Unchanged Low Q9HCU8 I19gh4 polymerase (DNA-directed); delt

513.52 431 522.5153 489.0161 2.51E−02 −2.53E−01 1 Unchanged Low P00519 I06ef5 v-abi Abelson murine leukemia v 232.4636 301 522.7624 352.0574 1.17E+00 3.73E−01 1 Unchanged Low Q13880 O02cd5 brain and reproductive organ-ex

572.4849 263 523.9906 453.0588 −1.28E−01 −1.12E+00 1 Unchanged Low P25789 L13ef7 proteasome (prosome; macropali 436.5895 534 526.397 498.9408 2.70E−01 2.90E−01 1 Unchanged Low O43805 J16cd3 Sjogren's syndrome nuclear auto 368.0123 539 526.5215 477.7167 5.17E−01 5.50E−01 1 Unchanged Low O75817 A13cd6 POP7 (processing of precursor; 375.1187 433 526.6432 445.0255 4.89E−01 2.08E−01 1 Unchanged Low Q9UBI1 N11cd7 BUP protein 337.1018 428 526.9646 430.701 6.45E−01 3.45E−01 1 Unchanged Low P03950 G12ab2 angiogenin; ribonuclease; RNase 395.0198 200 527.7882 374.4251 4.18E−01 −9.79E−01 1 Unchanged Low P78423 F20cd1 small inducible cytokine subfamily 201.965 747 530.2357 493.2272 1.39E+00 1.89E+00 1 Unchanged Low Q9P1D0 E07gh4 hypothetical protein PRO2533 58.04051 73.3 531.5331 220.9467 3.20E+00 3.36E−01 1 Unchanged Low P03999 K05ab3 opsin 1 (cone pigments); short-w 116.5093 37.9 532.8048 229.0786 2.19E+00 −1.62E+00 1 Unchanged Low O95793 M22cd2 staufen; RNA binding protein (Dr 417.7687 498 534.8626 483.6536 3.56E−01 2.54E−01 1 Unchanged Low P22750 M05ef2 RAB4B; member RAS oncogene 297.3584 346 538.4665 393.9782 8.57E−01 2.19E−01 1 Unchanged Low B06gh8 ubiquitin UBF-fi 431.0731 472 540.8482 481.1517 3.27E−01 1.29E−01 1 Unchanged Low Q9NRX8 J15gh4 oxidoreductase UCPA 168.7047 523 544.0864 411.9671 1.69E+00 1.63E+00 1 Unchanged Low Q9UHQ3 J20gh4 stromal cell protein 469.8784 214 548.1893 410.1503 2.17E−01 −1.13E+00 1 Unchanged Low Q96S52 J22gh8 phosphatidylinositol glycan; clas

404.9498 287 548.8906 412.8095 4.34E−01 −4.99E−01 1 Unchanged Low Q9H3F6 C24gh8 MSTP028 protein 442.9007 396 549.0707 462.5636 3.10E−01 −1.63E−01 1 Unchanged Low P37198 K03cd8 nucleoporin 62 kD 428.2961 499 550.8083 492.7531 3.63E−01 2.21E−01 1 Unchanged Low Q9H1D4 B05gh4 arginyl aminopeptidase (aminop

430.3273 477 551.8541 486.2744 3.59E−01 1.47E−01 1 Unchanged Low O75350 K04cd5 glycoprotein; synaptic 2 480.7082 436 552.8489 489.9278 2.02E−01 −1.40E−01 1 Unchanged Low Q9P024 D16ef3 Huntingtin Interacting protein K 369.5132 480 553.5493 467.714 5.83E−01 3.78E−01 1 Unchanged Low Q9Y224 H21ef2 CGI-99 protein 449.089 472 554.6607 492.0453 3.05E−01 7.30E−02 1 Unchanged Low Q13361 O12cd3 Microfibril-associated glycoprotel 194.28 354 557.066 368.553 1.52E+00 8.67E−01 1 Unchanged Low Q02535 F01ef1 inhibitor of DNA binding 3; domir 84.05787 174 559.513 272.6788 2.73E+00 1.05E+00 1 Unchanged Low O95864 L24cd4 fatty acid desaturase 2 298.4502 113 559.6571 323.8122 9.07E−01 −1.40E+00 1 Unchanged Low P53621 H16ab4 coatomer protein complex; subur 409.2779 471 560.6313 480.1571 4.54E−01 2.01E−01 1 Unchanged Low P35638 N03ab4 DNA-damage-inducible transcrip 322.5942 318 565.361 401.9484 8.09E−01 −2.12E−02 1 Unchanged Low P22307 D22cd1 sterol carrier protein 2 354.3674 356 569.1558 426.421 6.84E−01 5.58E−03 1 Unchanged Low Q92543 D15gh1 KIAA0254 gene product 328.3511 356 569.5472 417.8592 7.95E−01 1.15E−01 1 Unchanged Low P78330 N06ab8 phosphoserine phosphatase 253.4253 220 569.9825 347.8406 1.17E+00 −2.03E−01 1 Unchanged Low Q9UNX3 G15ef2 ribosomal protein L26-like 1 401.3697 445 572.3441 472.8205 5.12E−01 1.48E−01 1 Unchanged Low P49169 C10ab2 aldehyde dehydrogenase 9 famil 446.252 277 579.314 434.2707 3.76E−01 −6.87E−01 1 Unchanged Low Q9ULX0 H03gh6 inorganic pyrophosphatase 488.3446 402 579.6142 489.9828 2.47E−01 −2.81E−01 1 Unchanged Low O15353 H21cd3 winged-hellx nude 407.9375 497 680.6191 495.2368 5.09E−01 2.85E−01 1 Unchanged Low Q9NRP2 D21gh4 DC13 protein 382.8544 421 581.5421 461.731 6.03E−01 1.36E−01 1 Unchanged Low Q16280 E18ef1 cyclic nucleotide gated channel

464.0608 360 584.8035 469.6748 3.34E−01 −3.66E−01 1 Unchanged Low P04183 C04cd2 thymidine kinase 1; soluble 346.7317 289 588.3101 407.8979 7.63E−01 −2.64E−01 1 Unchanged Low Q12824 O17ef5 SWI/SNF related; matrix associa 218.8831 554 590.2326 454.3734 1.43E+01 1.34E+00 1 Unchanged Low Q99719 B09ab8 peanut-like 1 (Drosophila) 419.5269 410 592.2598 474.0479 4.97E−01 −3.19−02 1 Unchanged Low P46100 H07ab3 alpha thalassemia/mental retard

309.8648 167 594.3041 356.9983 9.40E−01 −8.93E−01 1 Unchanged Low Q16610 O05ab5 extracellular matrix protein 1 238.3172 335 596.1691 389.6774 1.32E+00 4.89E−01 1 Unchanged Low P39656 E23ab6 dolichyl-diphosphoollgosacchari

433.6719 367 598.0668 466.4028 4.64E−01 −2.39E−01 1 Unchanged Low P53814 G07cd3 smoothelin 517.4102 269 598.16 461.5158 2.09E−01 −9.44E−01 1 Unchanged Low Q9P0N4 P24ef1 hypothetical protein LOC51260 609.9142 286 601.9324 499.258 −1.90E−02 −1.09E−01 1 Unchanged Low Q9BXZ1 A02gh7 peptidylprolyl isomerase (cyclopt 465.4301 362 603.8737 477.1895 3.76E−01 −3.62E−01 1 Unchanged Low Q9Y2Q4 H19ef8 HSPC002 protein 337.5615 391 604.9187 444.641 8.42E−01 2.14E−01 1 Unchanged Low O15527 A18ab8 8-oxoguanine DNA glycosylase 330.4852 282 605.3444 406.0683 8.73E−01 −2.27E−1 1 Unchanged Low Q04323 G01ef2 ORF 497.159 255 610.1121 454.2076 2.95E−01 −9.61E−01 1 Unchanged Low P12004 G18ab8 proliferating cell nuclear antigen

332.1465 303 612.821 416.0883 8.84E−01 −1.31E−01 1 Unchanged Low Q99720 M11cd6 sigma receptor (SR31747 binding 363.8609 379 615.0729 452.6158 7.57E−01 5.85E−02 1 Unchanged Low P43307 G13cd2 signal sequence receptor; alpha 226.1566 322 618.9554 389.0352 1.45E+00 5.10E−01 1 Unchanged Low Q9H3Y8 O05gh6 chromosome 20 open reading fra 221.2984 246 619.4944 362.4108 1.49E+00 1.55E−01 1 Unchanged Low Q9NRX2 A08gh5 mitochondrial ribosomal protein

284.6282 305 827.9834 405.9846 1.14E+00 1.01E−01 1 Unchanged Low Q9P2X0 L10gh2 dolichyl-phosphate mannosyltran 285.542 431 638.6696 451.8107 1.16E+00 5.95E−01 1 Unchanged Low Q9Y5Z8 E05cd7 male-specific legthal 3-like 1 (Dro

361.7331 394 639.7431 465.0297 8.23E−01 1.22E−01 1 Unchanged Low P78524 F01cd2 suppression of tumorigenicity 5 343.4117 289 643.333 425.1425 9.06E−01 −2.50E−01 1 Unchanged Low P55145 F02ab2 arginine-rich; mutated in early st

413.1582 420 656.6324 496.4892 6.68E−01 2.26E−01 1 Unchanged Low P33551 O23ab5 CDC28 protein kinase 1 296.3533 355 671.4891 440.861 1.18E+00 2.59E−01 1 Unchanged Low Q9BVQ0 E09gh6 hypothetical protein MGC5363 43.30788 54.5 681.2449 259.6855 3.98E+00 3.32E−01 1 Unchanged Low P34897 D15cd2 serine hydroxymethyltransferase 440.9652 290 685.6584 472.1838 6.37E−01 −6.05E−01 1 Unchanged Low Q9Y5B4 L23ef2 androgen induced protein 268.4081 519 685.9395 491.1814 1.35E+00 9.52E−01 1 Unchanged Low Q9Y2V5 B15ef2 transforming growth factor beta 1 249.1479 327 712.3879 429.636 1.52E+00 3.94E−01 1 Unchanged Low Q13953 B19cd2 solute carrier family 12 (potassiu

342.5865 428 729.2688 499.9658 1.09E+00 3.21E−01 1 Unchanged Low Q92686 I11ef6 neurogranin (protein kinase C su

330.8792 299 736.2348 455.4495 1.15E+00 −1.45E−01 1 Unchanged Low O60565 J05cd8 cysteine knot superfamily 1; BMF 106.6904 151 781.0154 346.3594 2.87E+00 5.05E−01 1 Unchanged Low Q9Y4M4 I21gh3 putative UDP-GalNAc:polypeptid

346.098 251 848.4309 481.2315 1.29E+00 −4.63E−01 1 Unchanged Low P16581 E01ef7 selectin E (endothelial adhesion 109.3094 378 875.1666 454.0605 3.00E+00 1.79E+01 1 Unchanged Low O14733 P02ef5 mitogen-activated protein kinase 98.83312 140 688.014 375.5944 3.17E+00 5.02E−01 1 Unchanged Low Q16623 M24cd2 syntaxin 1A (brain) 403.2337 165 926.5022 498.3425 1.20E+00 −1.29E+00 1 Unchanged Low Q9P1M5 P12gh3 WW domain containing oxidored 38.93 19.3 1292.23 450.1426 5.05E+00 −1.01E+00 2 Unchanged Medium O60613 L18cd4 15 kDa selenoprotein 1220.902 1110 1285.07 1205.045 7.39E−02 −1.38E−01 2 Unchanged Medium Q16698 M07ab4 2:4-dienoyl CoA reductase 1; mit 469.9997 706 615.3087 597.2594 3.89E−01 5.88E−01 2 Unchanged Medium Q9HBA8 D23gh1 24-dihydrocholesterol reductase 768.0888 278 626.0195 557.2677 −2.95E−01 −1.47E+00 2 Unchanged Medium Q9P012 M13ef4 30 kDa protein 546.352 691 614.5795 617.4113 1.70E−01 3.39E−01 2 Unchanged Medium Q9UL53 P24cd7 5′-3′ exoribonuclease 2 648.132 604 430.2235 560.6322 −5.91E−01 −1.03E−01 2 Unchanged Medium P49902 N16cd7 5′-nucleotidase; cytosollc II 1040.523 1220 440.0817 900.9404 −1.24E+00 2.32E−01 2 Unchanged Medium O95336 P09cd7 6-phosphogluconolactonase 524.3104 755 812.5955 697.4428 6.32E−01 5.27E−01 2 Unchanged Medium Q03393 A23ab8 6-pyruvoyltetrahydroptarin synth

358.0591 700 517.4335 525.0184 5.31E−01 9.66E−01 2 Unchanged Medium Q13443 P01ef7 a disintegrin and metalloproteina 1306.754 481 445.3663 744.5037 −1.55E+00 −1.44E+00 2 Unchanged Medium O75173 F15ab2 a disintegrin-like and metalloproteina 786.5151 1080 1254.804 1033.446 6.74E−01 4.29E−01 2 Unchanged Medium P51572 O03gh1 accessory proteins BAP31/BAP2 985.1381 889 656.6554 843.6943 −5.85E−01 −1.48E−01 2 Unchanged Medium P42765 D03ab2 acetyl-Coenzyme A acyltransfera 849.6041 1280 1204.131 1111.329 5.03E−01 5.92E−01 2 Unchanged Medium P24666 E05ab2 acid phosphatase 1; soluble 1642.966 1970 1890.909 1833.204 2.03E−01 2.59E−01 2 Unchanged Medium Q92688 D21cd6 acidic (leucine-rich) nuclear phos

470.8575 289 835.9103 531.9498 8.28E−01 −7.04E−01 2 Unchanged Medium O14639 B21ab2 actin binding LIM protein 1351.973 393 358.779 701.2899 −1.91E+00 −1.78E−00 2 Unchanged Medium O15143 F06ab2 actin related protein ⅔ complex 696.0033 513 349.0474 519.3549 −9.96E−01 −4.40E−01 2 Unchanged Medium O15509 F12ab2 actin related protein ⅔ complex 909.0832 889 807.751 868.6913 −1.71E−01 −3.18E−02 2 Unchanged Medium O15511 F14ab2 actin related protein ⅔ complex 732.1996 619 466.1372 605.8842 −6.51E−01 −2.42E−01 2 Unchanged Medium P12718 A08ab6 actin; gamma 2; smooth muscle; 585.3438 846 2095.96 1175.856 1.84E+00 5.32E−01 2 Unchanged Medium Q9P016 O09ef4 AD-015 protein 947.0386 837 1259.571 1041.448 4.11E−01 −1.79E−01 2 Unchanged Medium O43747 M13ab2 adaptor-related protein complex 1104.332 532 419.4712 685.2957 −1.40E+00 −1.05E+00 2 Unchanged Medium P20172 A11ab6 adaptor-related protein complex: 1266.83 1280 2285.193 1617.354 8.28E−01 −7.63E−03 2 Unchanged Medium O14617 H07ab2 adaptor-related protein complex: 679.4847 495 357.0868 510.4994 −9.28E−01 −4.57E−01 2 Unchanged Medium P07741 M24ab2 adenine phosphoribosyltransfera 1885.065 862 823.8455 1190.468 −1.19E+01 −1.13E−00 2 Unchanged Medium P00568 A02ab2 adenylate kinase 1 2404.119 399 354.3768 1052.361 −2.76E+00 −2.59E+00 2 Unchanged Medium Q9U1J7 I06ef2 adenylate kinase 3 alpha like 758.7288 1050 662.8834 828.3999 −1.95E−01 4.87E−01 2 Unchanged Medium P30566 M07ab2 adenylosuccinate lyase 495.8874 622 518.4238 545.4304 5.90E−01 3.27E−01 2 Unchanged Medium Q16186 M11cd7 adhesion regulating molecule 1 622.3901 610 574.5888 602.2578 −1.15E−01 −2.95E−02 2 Unchanged Medium Q9NVF6 B19gh3 ADP-ribosylation factor 1 GTPas 449.3679 623 676.1878 582.9297 5.90E−01 4.72E−01 2 Unchanged Medium P26438 B04ab2 ADP-ribosylation factor 6 732.1241 818 876.9277 809.1342 2.60E−01 1.61E−01 2 Unchanged Medium P40616 D12ab2 ADP-ribosylation factor-like 1 827.1898 1220 1141.92 1064.016 4.65E−01 5.64E−01 2 Unchanged Medium P36404 D14ab2 ADP-ribosylation factor-like 2 1751.048 1550 1871.661 1723.74 9.61E−02 −1.77E−01 2 Unchanged Medium P56559 D20ab2 ADP-ribosylation factor-like 7 485.4562 598 568.6824 550.5764 2.28E−01 3.00E−01 2 Unchanged Medium P35368 K17ab2 adrenergic; alpha-18: receptor 1433.715 1510 1335.995 1426.069 −1.02E−01 7.34E−02 2 Unchanged Medium P15144 G24ab2 alanyl (membrane) aminopeptida 987.3343 222 480.1162 563.2289 −1.04E+00 −21.5E+00 2 Unchanged Medium P30038 L09ab2 aldehyde dehydrogenase 4 famil

1179.797 598 657.4315 811.7082 −8.44E−01 −9.81E−01 2 Unchanged Medium P14550 L05ab2 aldo-keto reductase family 1: m

555.464 886 609.9901 683.9189 1.35E−01 6.74E−01 2 Unchanged Medium O43488 L07ab2 aldo-keto reductase family 7: m

546.409 525 748.5424 606.6855 4.54E−01 −5.74E−02 2 Unchanged Medium P09972 C16ab2 aldolase C; fructose-bisphospha

878.5714 1050 947.5062 960.156 1.09E−01 2.63E−01 2 Unchanged Medium O43590 G12ef4 alpha-actinin-2-associated LIM p 776.3757 1070 501.1993 783.883 −6.13E−01 4.68E−01 2 Unchanged Medium Q08117 M19ab2 amio-terminal enhancer of split 1779.707 1430 1219.695 1476.318 −5.45E−01 −3.16E−01 2 Unchanged Medium Q13438 G05cd7 amplified in osteosarcoma 658.0513 638 802.3407 699.6136 2.86E−01 −4.36E−02 2 Unchanged Medium O96018 M01gh1 amyloid beta (A4) precursor proti

762.3898 750 1117.682 876.6611 5.52E−01 −2.38E−02 2 Unchanged Medium Q13564 P11ab2 amyloid beta precursor protein bi 587.5144 664 786.6426 679.5497 4.21E−01 1.78E−01 2 Unchanged Medium Q9Y679 B08cd7 ancient ubiquitous protein 1 1191.741 1270 1022.771 1160.442 −2.21E−01 8.81E−02 2 Unchanged Medium Q9UKB4 B12ef2 anglomatin like 2 523.7253 776 568.8766 622.7291 1.19E−01 5.66E−01 2 Unchanged Medium Q13725 H19ab2 anglotensin receptor 1 1495.332 1360 1058.942 1304.886 −4.98E−01 −1.36E−01 2 Unchanged Medium P08133 I20ab2 annexin A6 253.0938 413 879.9474 515.5041 1.80E+00 7.08E−01 2 Unchanged Medium P20073 I22ab2 annexin A7 650.1591 481 420.4945 517.0979 −6.29E−01 −4.36E−01 2 Unchanged Medium P03971 E22ab2 anti-Mullerian hormone 1140.812 948 840.7158 909.9247 −8.32E−01 −2.67E−01 2 Unchanged Medium P30041 O08cd5 anti-oxidant protein 2 (non-seleni 1248.922 1160 3067.945 1824.225 1.30E+00 −1.12E−01 2 Unchanged Medium P27695 K06ef6 APEX nuclease (multifunctional

665.9854 653 835.6897 718.2149 3.27E−01 −2.85E−02 2 Unchanged Medium Q9Y4J7 P01ab2 apoptosis inhibitor 5 1850.534 68.4 147.4186 688.7802 −3.65E+00 −4.76E+00 2 Unchanged Medium Q9Y5L7 L03ef2 apoptosis related protein APR-3 662.9122 583 1426.489 890.7729 1.11E+00 −1.86E−01 2 Unchanged Medium O94778 O14ab2 aquaporin 8 1475.036 1420 1474.307 1455.01 −7.13E−04 −5.92E−02 2 Unchanged Medium O15296 E02ab2 arachidonate 15-lipoxygenase; s

826.8209 607 720.2105 718.1334 −1.99E−01 −4.45E−01 2 Unchanged Medium P48444 O18ab2 archain 1 1291.871 1200 1374.223 1288.649 8.92E−02 −1.07E−01 2 Unchanged Medium P00966 J24ab2 argininosuccinate synthetase 1049.688 1600 949.4889 1199.548 −1.45E−01 6.08E−01 2 Unchanged Medium P42024 D15ab2 ARP1 actin-related protein 1 hon 1054.286 1720 1777.944 1518.804 7.54E−01 7.10E−01 2 Unchanged Medium O43681 J16ab2 arsA arsenite transporter; ATP-bi 540.3448 724 595.3348 620.0089 1.40E−01 4.23E−01 2 Unchanged Medium Q9ULX3 E02ef4 ART-4 protein 728.7274 595 509.3934 611.0757 −5.17E−01 −2.92E−01 2 Unchanged Medium O96030 H16ab2 artemin 881.7849 728 638.2016 749.363 −4.66E−01 −2.76E−01 2 Unchanged Medium P15289 F24ab2 arylsulfatase A 1639.546 1230 1012.121 1294.172 −6.96E−01 −4.14E−01 2 Unchanged Medium P08243 J18ab2 asparagine synthetase 891.3027 643 1540.113 1024.719 7.89E−01 −4.72E−01 2 Unchanged Medium O95630 L17ab2 associated molecule with the SH: 660.3522 872 729.2383 753.7548 1.43E−01 4.01E−01 2 Unchanged Medium O95135 B09ab2 ataxin 2 related protein 902.4529 345 342.3299 530.0852 −1.40E+00 −1.39E+00 2 Unchanged Medium O14530 N15ab2 ATP binding protein associated v 827.4646 1390 766.257 993.482 −1.11E−01 7.45E−01 2 Unchanged Medium P30049 N20ab2 ATP synthase; H+ transporting; r 625.0408 468 441.4691 511.6658 −5.02E−01 −4.16E−01 2 Unchanged Medium Q9UII2 I10ef2 ATPase inhibitor precursor 776.4612 1220 641.2787 878.5341 −2.76E−01 6.49E−01 2 Unchanged Medium Q9Y5K8 F17ef2 ATPase; H+ transporting; lysoso

998.0597 1670 1029.886 1232.91 4.53E−02 7.43E−01 2 Unchanged Medium O75787 P15ab2 ATPase; H+ transporting; lysoso

815.707 945 1081.688 947.5842 4.07E−01 2.13E−01 2 Unchanged Medium P05023 P09ef5 ATPase; Na+/K+ transporting; al

1299.236 517 709.0882 841.8422 −8.74E−01 −1.33E+00 2 Unchanged Medium P45844 P13ef5 ATP-binding cassette; sub-family 863.8068 381 606.1642 616.8957 −5.11E−01 −1.18E+00 2 Unchanged Medium Q9HAP7 M08gh5 baculoviral IAP repeat-containing 1507.175 1740 1945.196 1730.54 3.68E−01 2.07E−01 2 Unchanged Medium O94812 G09ab3 BAI1-associated protein 3 1073.67 983 826.6524 961.2437 −3.77E−01 −1.27E−01 2 Unchanged Medium P35613 B14ef7 basigin (OK blood group) 603.4821 474 865.2409 647.414 5.20E−01 −3.50E−01 2 Unchanged Medium Q9BSR6 A20gh8 BBP-like protein 1 816.219 1320 914.1927 1015.173 1.64E−01 6.88E−01 2 Unchanged Medium O00512 K01ab3 B-cell CLL/lymphoma 9 1357.15 76.7 80.36541 504.741 −4.08E+00 −4.15E+00 2 Unchanged Medium Q12983 E19ab5 BCL2/adenovirus E1B 19 kD inte

763.7046 548 991.4529 767.5569 3.77E−01 −4.80E−01 2 Unchanged Medium Q92934 K24ef1 BCL2-antagonist of cell death 538.8191 727 603.5103 623.2249 1.64E−01 4.33E−01 2 Unchanged Medium Q07817 E10ef8 BCL2-like 1 2062.673 2510 1097.372 1890.905 −9.10E−01 2.85E−01 2 Unchanged Medium O43892 M23ab3 Bicaudal D homolog 1 (Drosophil 654.9397 414 548.7409 539.1375 −2.55E−01 −6.63E−01 2 Unchanged Medium P53004 O19ab3 biliverdin reductase A 490.0724 569 512.2807 523.696 6.39E−02 2.15E−01 2 Unchanged Medium O60629 G21ab3 bladder cancer associated protei

607.9847 1180 1083.411 956.1289 8.33E−01 9.53E−01 2 Unchanged Medium Q9HBX3 N21gh6 brain and nasopharyngeal carcin 1672.876 54 44.02379 590.2997 −5.25E+00 −4.95E+00 2 Unchanged Medium P56945 H23ef3 breast cancer anti-estrogen resis 1334.88 1300 1304.356 1312.13 −3.34E−02 −4.14E−02 2 Unchanged Medium O15255 G21cd6 CAAX box 1 733.6878 577 1202.182 837.48 7.12E−01 −3.48E−01 2 Unchanged Medium P12830 C16ef5 cadherin 1; type 1; E-cadherin (e 1094.64 924 489.5012 835.8959 −1.16E+00 −2.45E−01 2 Unchanged Medium P19022 E03ef7 cadherin 2; type 1; N-cadherin (n 337.5528 540 747.1198 541.7151 1.15E+00 6.79E−01 2 Unchanged Medium P22223 K19ef7 cadherin 3; type 1; P-cadherin (p 896.8467 1200 372.3054 823.6929 −1.27E+00 4.22E−01 2 Unchanged Medium P22676 N07ab5 calbindin 2; (29 kD; calretinin) 1781.134 1500 2116.438 1797.589 2.49E−01 −2.52E−01 2 Unchanged Medium Q99828 O19gh1 calcium and integrin binding 1 (c

1130.551 1320 838.3709 1096.979 −4.31E−01 2.26E−01 2 Unchanged Medium P02593 I18ab4 calmodulin 1 (phosphorylase kin

1076.299 787 983.6302 949.1389 −1.30E−01 −4.51E−01 2 Unchanged Medium Q13942 L01ab5 calmodulin 3 (phosphorylase kin

902.667 464 871.1455 746.0174 −5.13E−02 −9.59E−01 2 Unchanged Medium P27824 I05ef1 calnexin 1492.644 1370 1543.709 1470.4 4.85E−02 −1.19E−01 2 Unchanged Medium P17655 C20ef6 calpain 2; (m/ll) large subunit 671.5939 837 549.4365 685.847 −2.90E−01 3.17E−01 2 Unchanged Medium P04632 C22ef6 calpain; small subunit 1 1565.935 1650 1258.047 1490.643 −3.16E−01 7.36E−02 2 Unchanged Medium Q15417 P17ab5 calponin 3; acidic 911.495 603 737.1204 750.6841 −3.06E−01 −5.95E−01 2 Unchanged Medium Q9UEG5 D17ef8 capicua homolog (Drosophila) 629.0213 486 439.6052 518.1163 −5.17E−01 −3.73E−01 2 Unchanged Medium P52907 O08ab4 capping protein (actin filament) n

848.0436 684 584.7035 705.5063 −5.36E−01 −3.11E−01 2 Unchanged Medium Q9GZX3 N16gh1 carbohydrate (N-acetylglucosami 793.1054 929 751.3352 824.5253 −7.81E−02 2.28E−01 2 Unchanged Medium Q16619 K01ab4 cardiotrophin 1 1478.249 1220 1559.477 1420.784 7.72E−02 −2.72E−01 2 Unchanged Medium Q9UBD9 I24cd8 cardiotrophin-like cytokine; neur

361.4077 893 489.6592 581.3157 4.38E−01 1.30E+00 2 Unchanged Medium Q15699 M16cd4 cartilage paired-class homeoprot 747.0317 596 1109.834 817.569 5.71E−01 −3.26E−01 2 Unchanged Medium P48729 A22ab6 casein kinase 1; alpha 1 690.8551 1150 902.9474 914.9218 3.86E−01 7.36E−01 2 Unchanged Medium P48730 L07ab4 casein kinase 1; delta 951.5238 1160 1111.571 1073.796 2.24E−01 2.84E−01 2 Unchanged Medium P19138 L08ef5 casein kinase 2; alpha 1 polypep 483.6062 597 461.8036 513.9702 −6.66E−02 3.03E−01 2 Unchanged Medium P49662 C12ef6 caspase 4; apoptosis-related cys 2013.957 2460 1017.425 1831.485 −9.85E−01 2.90E−01 2 Unchanged Medium P21964 F19ef6 catechol-O-methyltransferase 697.5886 1170 1268.869 1046.831 8.63E−01 7.51E−01 2 Unchanged Medium P26232 K01ef7 catenin (cadherin-associated pro 797.8639 717 810.257 774.9896 2.22E−02 −1.54E−01 2 Unchanged Medium P35222 G07ef7 catenin (cadherin-associated pro 969.252 1290 1103.619 1121.277 1.87E−01 4.14E−01 2 Unchanged Medium P07339 N23ef7 cathepsin D (lysosomal aspartyl

1253.01 947 1133.879 1111.314 −1.44E−01 −4.04E−01 2 Unchanged Medium Q99967 C18cd6 Cbp/p300-interacting transactivar 1293.915 1600 2245.133 1711.366 7.95E−01 3.02E−01 2 Unchanged Medium P49715 N17ef6 CCAAT/enhancer binding protein 882.9323 884 1045.45 937.3612 2.44E−01 1.26E−03 2 Unchanged Medium P53567 N22ab5 CCAAT/enhancer binding protein 826.9569 1160 1584.869 1191.643 9.38E−01 4.92E−01 2 Unchanged Medium O95627 B21cd8 CCR4-NOT transcription comple

606.4629 851 692.4535 716.7046 1.91E−01 4.89E−01 2 Unchanged Medium Q04900 G02cd4 CD164 antigen; sialomucin 750.3086 570 673.7234 664.5986 −1.55E−01 −3.97E−01 2 Unchanged Medium P07766 P07ab3 CD3E antigen; epsilon polypepti

1808.209 1410 2643.721 1953.844 5.48E−01 −3.59E−01 2 Unchanged Medium P34810 A21ab4 CD68 antigen 2460.227 1100 1293.961 1617.586 −9.27E−01 −1.16E+00 2 Unchanged Medium P18582 B21ab5 CD81 antigen (target of antiprolif 1303.144 938 1598.276 1279.761 2.95E−01 −4.75E−01 2 Unchanged Medium Q16181 F09ef5 CDC10 cell division cycle 10 hon 426.6642 443 751.3623 540.3444 8.16E−01 5.42E−02 2 Unchanged Medium Q16543 H01ef5 CDC37 cell division cycle 37 hon 1085.897 1050 1336.155 1158.574 2.99E−01 −4.35E−02 2 Unchanged Medium O14735 I14cd6 CDP-diacylglycerol-inositol 3-ph 241.7793 1180 311.7422 579.4931 3.67E−01 2.29E+00 2 Unchanged Medium P30260 F13ef5 cell division cycle 27 1060.812 1470 1469.824 1334.733 4.70E−01 4.74E−01 2 Unchanged Medium P49427 B12ef7 cell division cycle 34 762.5808 1300 766.6843 942.0784 7.74E−03 7.66E−01 2 Unchanged Medium P29373 F01ef7 cellular retinoic acid binding prot

1226.236 803 1350.177 1126.373 1.39E−01 −6.11E−01 2 Unchanged Medium P41208 F09ab5 centrin; EF-hand protein; 2 539.1633 672 676.8582 629.3345 3.28E−01 3.18E−01 2 Unchanged Medium O00522 F05ab4 cerebral cavemous malformation 870.4309 631 723.1482 741.4854 −2.67E−01 −4.64E−01 2 Unchanged Medium O15183 B12cd3 CGG triplet repeat binding protei 402.949 610 883.3283 632.0808 1.13E+00 5.98E−01 2 Unchanged Medium Q9Y2Z5 D07ef2 CGI-06 protein 721.6709 674 1177.641 857.6492 7.06E−01 −9.94E−02 2 Unchanged Medium Q9Y3C3 J05ef2 CGI-120 protein 1229.537 1360 2124.304 1572.302 7.89E−01 1.49E−01 2 Unchanged Medium Q9Y3D0 J11ef2 CGI-128 protein 1592.767 2370 2011.685 1992.502 3.37E−01 5.75E−01 2 Unchanged Medium Q9Y3E5 J17ef2 CGI-147 protein 532.425 788 567.0634 629.3057 9.09E−02 5.66E−01 2 Unchanged Medium Q9Y3E8 C08ef2 CGI-150 protein 785.276 924 778.0449 829.1206 −1.33E−02 2.35E−01 2 Unchanged Medium Q9Y320 A19ef2 CGI-31 protein 745.0314 932 703.7829 793.4541 −8.22E−02 3.22E−01 2 Unchanged Medium Q9Y357 P16ef1 CGI-40 protein 817.7272 769 418.6337 668.441 −9.66E−01 −8.87E−02 2 Unchanged Medium Q9Y360 A10ef2 CGI-45 protein 786.0567 914 796.6229 832.2061 1.93E−02 2.17E−01 2 Unchanged Medium Q9Y512 B04ef3 CGI-51 protein 967.3508 859 1045.638 957.4201 1.12E−01 −1.71E−01 2 Unchanged Medium Q9Y390 K21ef2 CGI-81 protein 1391.902 802 1140.01 1111.152 −2.88E−01 −7.96E−01 2 Unchanged Medium P40227 N20ab4 chaperonin containing TCP1; sut 1011.613 436 592.4944 679.9043 −7.72E−01 −1.22E+00 2 Unchanged Medium Q99832 H07cd6 chaperonin containing TCP1; sut 1190.644 1090 1548.874f 1274.983 3.79E−01 −1.33E−01 2 Unchanged Medium Q9UBR5 I23ef4 chemokine-like factor 1 1047.63 1800 1059.437 1303.992 1.62E−02 7.85E−01 2 Unchanged Medium Q9UHN8 N05ef4 chemokine-like factor 1 1568.851 2030 1237.728 1611.343 −3.42E−01 3.70E−01 2 Unchanged Medium P54105 L07ef5 chloride channel; nucleotide-sen: 471.0775 487 640.6855 532.9217 4.44E−01 4.80E−02 2 Unchanged Medium Q14781 F09ef1 chromobox homolog 2(Pc class I 795.873 749 713.815 753.0305 −1.57E−01 −8.68E−02 2 Unchanged Medium Q9BXS4 K12cd5 chromosome 1 open reading frar 874.0189 1370 904.3066 1050.603 4.91E−02 6.52E−01 2 Unchanged Medium Q9NPA0 H07gh4 chromosome 11 hypothetical pro 998.8577 834 858.794 897.3389 −2.18E−01 −2.60E−01 2 Unchanged Medium Q9UKR5 G14cd7 chromosome 14 open reading fra 1181.962 1160 1285.11 1207.747 1.21E−01 −3.18E−02 2 Unchanged Medium P56378 M16cd5 chromosome 14 open reading fra 503.5233 690 890.9975 694.9486 8.23E−01 4.55E−01 2 Unchanged Medium O95433 B22cd7 chromosome 14 open reading fra 656.1775 563 438.9755 552.8428 −5.80E−01 −2.20E−01 2 Unchanged Medium Q9NV31 J23gh3 chromosome 15 open reading fra 853.8367 832 861.2221 848.9729 1.24E−02 −3.76E−02 2 Unchanged Medium Q9NVE2 D09gh3 chromosome 2 open reading frar 648.49 671 468.6352 596.0999 −4.69E−01 4.96E−02 2 Unchanged Medium Q9UI05 L04gh4 chromosome 20 open reading fra 2518.951 2140 1201.051 1952.881 −1.07E+00 −2.36E−01 2 Unchanged Medium Q9P0A7 M09ef8 chromosome 20 open reading fra 581.9098 1080 1200.665 954.524 1.04E+00 8.93E−01 2 Unchanged Medium Q9Y3B1 H22ef1 chromosome 20 open reading fra 1691.864 1230 783.7799 1235.108 −1.11E+00 −4.60E−01 2 Unchanged Medium Q9BQ89 C01gh8 chromosome 20 open reading fra 1460.875 952 1221.732 1211.641 −2.58E−01 −6.17E−01 2 Unchanged Medium Q96C58 J19gh7 chromosome 6 open reading frar 1254.647 1080 480.9999 940.0036 −1.38E+00 −2.10E−01 2 Unchanged Medium Q9Y5Z4 K12ef3 chromosome 6 open reading frar 915.3818 988 372.3119 758.6366 −1.30E+00 1.10E−01 2 Unchanged Medium Q00610 I12cd5 clathrin; heavy polypeptide (Hc) 1639.759 1210 1437.44 1427.503 −1.90E−01 −4.44E−01 2 Unchanged Medium P56749 F04cd7 claudin 12 2262.278 2480 1233.472 1992.755 −8.75E−01 1.34E−01 2 Unchanged Medium O43809 M15cd7 cleavage and polyadenylation sp 640.2301 503 683.3467 608.9825 9.40E−02 −3.47E−01 2 Unchanged Medium O96005 G05ab4 cleft lip and palate associated tra 1353.338 1170 1394.845 1304.597 4.36E−02 −2.15E−01 2 Unchanged Medium Q16740 E20cd4 ClpP caseinolytic protease; ATP- 625.8711 528 475.0848 543.0367 −3.98E−01 −2.45E−01 2 Unchanged Medium P55085 O24ab5 coagulation factor II (thrombin) re 829.7537 979 392.7495 734 −1.08E+00 2.39E−01 2 Unchanged Medium P13726 B05ab4 coagulation factor III (thrombopla 1079.841 880 442.6212 800.9723 −1.29E+00 −2.94E−01 2 Unchanged Medium Q9Y678 D14ef8 coat protein gamma-cop 815.7993 738 1009.756 854.5161 3.08E−01 −1.45E−01 2 Unchanged Medium Q15363 M11ef3 coated vesicle membrane protein 706.3054 804 870.2118 793.6589 3.01E−01 1.88E−01 2 Unchanged Medium O43513 N06cd4 cofactor required for Sp1 transcri 591.8619 481 798.8706 623.9284 4.33E−01 −2.99E−01 2 Unchanged Medium Q9Y281 N18cd8 cofilin 2 (muscle) 671.9394 270 1093.534 678.6369 7.03E−01 −1.31E+00 2 Unchanged Medium P04141 G22gh6 colony stimulating factor 2 (gra

116.2139 1290 165.718 522.783 6.12E−01 3.47E+00 2 Unchanged Medium P02745 L06ef1 complement component 1; q sub

683.4431 1650 798.2366 1042.465 2.24E−01 1.27E+00 2 Unchanged Medium p29279 I16ab4 connective tissue growth factor 596.4123 537 1071.517 734.8489 8.45E−01 −1.52E−01 2 Unchanged Medium O43191 B02cd3 COP9 constitutive photomorphog 855.8616 1030 1302.334 1062.925 6.06E−01 2.68E−01 2 Unchanged Medium Q99627 C01cd7 COP9 homolog 788.2297 968 1195.497 984.0634 6.01E−01 2.97E−01 2 Unchanged Medium O15387 G21cd7 COP9 subunit 6 (MOV34 homolo 590.9973 382 628.5041 533.8251 8.88E−02 −6.30E−01 2 Unchanged Medium Q9ULV4 K18ef3 coronin; actin binding protein; 1C 1594.037 1200 1362.545 1385.839 −2.26E−01 −4.09E−01 2 Unchanged Medium Q9BR76 I14gh7 coronin; actin-binding protein; 1E 708.5653 1080 690.8568 827.7864 −3.65E−02 6.13E−01 2 Unchanged Medium Q41061 B22cd5 COX17 homolog; cytochrome c c 889.1581 1440 745.8658 1026.374 −2.54E−01 7.00E−01 2 Unchanged Medium Q9Y6B2 E02ef8 CREBBP/EP300 inhibitory protei 946.9513 1030 1988.725 1323.308 1.07E+00 1.27E−01 2 Unchanged Medium Q9NY68 C06gh4 CTL2 gene 1381.821 804 788.5002 991.4995 −8.09E−01 −7.81E−01 2 Unchanged Medium P24385 O04ef5 cyclin D1 (PRAD1: parathyroid a

1214.611 2150 1100.478 1486.769 −1.42E−01 8.21E−01 2 Unchanged Medium Q9NXT4 K09gh2 cyclin M2 1560.659 1720 1582.768 1620.99 2.03E−02 1.40E−01 2 Unchanged Medium P01034 I11ab6 cystatin C (amyloid angiopathy a 1067.127 970 1366.396 1134.612 3.57E−01 −1.37E−01 2 Unchanged Medium Q15828 I13ab4 cystatin E/M 967.1669 2790 451.3932 1404.267 −1.10E+00 1.53E+00 2 Unchanged Medium P01036 C02ab6 cyctatin S 1261.605 466 1069.756 932.4892 −2.38E−01 −1.44E+00 2 Unchanged Medium P52943 I05ab4 cysteine-rich protein 2 874.1939 499 1277.819 883.82 5.48E−01 −8.08E−01 2 Unchanged Medium P13498 G18ab3 cytochrome b-245; alpha polyper 708.9954 1050 359.3156 707.7483 −9.81E−01 5.73E−01 2 Unchanged Medium P00167 C04ab6 cytochrome b-5 2187.128 1480 1034.311 1565.893 −1.08E+00 −5.67E−01 2 Unchanged Medium P00001 N24gh6 cytochrome c 547.6708 442 517.6125 502.4788 −8.14E−02 −3.09E−01 2 Unchanged Medium P10606 I24gh6 cytochrome c oxidase subunit Vb 1364.01 2100 2087.456 1851.225 6.14E−01 6.24E−01 2 Unchanged Medium P08574 P10ab5 cytochrome c-1 667.9346 443 441.6771 517.7383 −5.97E−01 −5.93E−01 2 Unchanged Medium Q99426 C17gh1 cytoskeleton-associated protein 560.9411 684 777.3269 673.9633 4.71E−01 2.85E−01 2 Unchanged Medium Q07065 G13cd7 cytoskeleton-associated protein 602.5101 575 1785.415 987.5887 1.57E+00 −6.78E−02 2 Unchanged Medium Q15038 L13ef3 DAZ associated protein 2 808.0755 890 564.7611 754.4305 −5.17E−01 1.40E−01 2 Unchanged Medium Q9H2L4 B18gh8 DC32 408.0427 702 780.2878 630.0414 9.35E−01 7.82E−01 2 Unchanged Medium Q9NPA8 G22gh7 DC6 protein 944.3094 1570 1514.164 1342.189 6.81E−01 7.32E−01 2 Unchanged Medium O60231 H13cd3 DEAD/H (Asp-Glu-Ala-Asp/His) t 753.8815 873 799.6561 808.7915 8.50E−02 2.11E−01 2 Unchanged Medium Q9GZR7 E02gh4 DEAD/H (Asp-Glu-Ala-Asp/His) t 803.42 984 774.3765 854.0965 −5.31E−02 2.93E−01 2 Unchanged Medium P17844 F04ab4 DEAD/H (Asp-Glu-Ala-Asp/His) t 1482.642 1440 1670.104 1530.749 1.72E−01 −4.26E−02 2 Unchanged Medium Q08211 M03ab4 DEAD/H (Asp-Glu-Ala-Asp/His) t 907.5859 658 907.4343 824.2193 −2.41E−04 −4.65E−01 2 Unchanged Medium Q9UJV9 D08ef2 DEAD-box protein abstrakt 976.8378 1230 870.3672 1024.437 −1.66E−01 3.28E−01 2 Unchanged Medium P51398 G18ef6 death associated protein 3 920.3044 981 814.3518 905.1904 −1.76E−01 9.20E−02 2 Unchanged Medium Q13437 G22cd4 Deleted in split-hand/split-foot 1

1565.344 1500 1721.872 1596.672 1.37E−01 −5.88E−02 2 Unchanged Medium O60735 O06cd6 dendritic cell protein 858.6375 502 467.3432 609.2393 −8.78E−01 −7.75E−01 2 Unchanged Medium Q16854 M06ab5 deoxyguanosine kinase 858.1918 885 989.3036 910.8082 2.05E−01 4.43E−02 2 Unchanged Medium Q9Y295 H04ab8 developmentally regulated GTP I 736.3786 634 660.7023 676.9267 −1.56E−01 −2.17E−01 2 Unchanged Medium P00387 F09ab3 diaphorase(NADH) (cytochrome 1402.134 1030 1435.74 1290.593 3.42E−02 −4.40E−01 2 Unchanged Medium Q9UHY9 I08ef2 dicarbonyl/L-xylulose reductase 544.2125 740 938.7807 741.1 7.87E−01 4.44E−01 2 Unchanged Medium P36957 C06ab6 dihydrolipoamide S-succinyltrans 625.9037 713 393.7165 577.6196 −6.69E−01 1.88E−01 2 Unchanged Medium Q99075 M12ef7 diphtheria toxin receptor (heparir 721.8431 638 197.117 518.9525 −1.87E+00 −1.78E−01 2 Unchanged Medium Q9UFN1 H10gh6 DKFZP564B147 protein 966.5927 947 1469.105 1127.658 6.04E−01 −2.91E−02 2 Unchanged Medium O95882 C13ef8 DKFZP564C1940 protein 941.4076 865 804.639 870.3185 −2.26E−01 −1.22E−01 2 Unchanged Medium Q9Y269 C07ef8 DKFZP564M082 protein 675.8991 1110 1208.543 998.4411 8.38E−01 7.17E−01 2 Unchanged Medium Q9NWE3 J11ef8 DKFZP566C243 protein 419.5607 770 625.8483 605.084 5.77E−01 8.76E−01 2 Unchanged Medium Q9H6Y7 H04gh6 DKFZP566H073 protein 1390.389 1480 1191.195 1352.292 −2.23E−01 8.55E−02 2 Unchanged Medium Q9Y3X0 P23ef8 DKFZP586M1019 protein 588.3603 505 672.4872 588.5767 1.93E−01 −2.21E−01 2 Unchanged Medium O60762 G19cd4 dolichyl-phosphate mannosyltran 407.0059 581 605.8353 531.3373 5.74E−01 5.14E−01 2 Unchanged Medium P53805 B11ab5 Down syndrome critical region g

370.0907 663 511.9248 515.0794 4.68E−01 8.42E−01 2 Unchanged Medium Q13597 N13ef3 downregulated in ovarian cancer 594.6931 693 623.702 636.966 6.87E−02 2.20E−01 2 Unchanged Medium Q9C005 J05gh8 dpy-30-like protein 810.4585 1210 1174.001 1064.132 5.35E−01 5.76E−01 2 Unchanged Medium Q13448 J03cd6 DR1-associated protein 1 (negati

1240.359 1140 2382.895 1586.247 9.42E−01 −1.27E−01 2 Unchanged Medium Q9UHF9 K01ef4 dual oxidase 2 1146.14 648 316.6462 703.5318 −1.86E+00 −8.23E−01 2 Unchanged Medium P61452 N22ab4 dual specificity phosphatase 3 (v

649.6813 605 473.5652 576.1845 −4.56E−01 −1.02E−01 2 Unchanged Medium Q14203 A13ab6 dynactin 1 (p150; glued homolog 507.5942 529 623.6948 553.5576 2.97E−01 6.06E−02 2 Unchanged Medium Q13561 D19cd6 dynactin 2 (p50) 1585.567 1380 1173.024 1372.261 −4.16E−01 −1.84E−01 2 Unchanged Medium Q13409 I16ef1 dynein; cytoplasmic; intermediate 793.3207 604 464.9675 620.6506 −7.71E−01 −3.94E−1 2 Unchanged Medium Q09472 C18ab4 E1A binding protein p300 1496.409 2120 1342.944 1651.644 −1.56E−01 5.00E−01 2 Unchanged Medium D20gh8 EAF1 protein 642.1587 652 469.6834 588.0816 −4.51E−01 2.28E−02 2 Unchanged Medium P78365 N19ab4 early development regulator 2 (p

894.3715 1070 761.5923 907.5945 −2.32E−01 2.54E−01 2 Unchanged Medium Q99848 G11cd7 EBNA1 binding protein 2 977.8671 611 818.6583 802.3778 −2.56E−01 −6.79E−01 2 Unchanged Medium Q12805 A21ab6 EGF-containing fibulin-like extra

1002.82 332 458.9563 597.7783 −1.13E+00 −1.60E+00 2 Unchanged Medium Q9Y6I3 D21cd8 EH domain-binding mitotic phosp

736.8984 500 629.1845 621.9752 −2.28E−01 −5.60E−01 2 Unchanged Medium Q15717 C04ab4 ELAV (embryonic lethal; abnorm

850.8493 800 843.4463 831.3485 −1.26E−02 −8.94E−02 2 Unchanged Medium P13804 I24ab3 electron-transfer-flavoprotein; alp

916.8391 545 529.5868 664.3533 −7.96E−01 −7.54E−01 2 Unchanged Medium Q14247 K17ef6 ems1 sequence (mammary tumo

1135.188 1050 1002.084 1063.9 −1.80E−01 −1.06E−01 2 Unchanged Medium P42892 O21ab4 endothelin converting enzyme 1 602.4294 799 809.7071 737.1982 4.27E−01 4.08E−01 2 Unchanged Medium P30084 A17ab6 enoyl Coenzyme A hydratase; sh 802.3114 1210 741.2226 917.9548 −1.14E−01 5.93E−01 2 Unchanged Medium P07099 I20ab3 epoxide hydrolase 1; microsomal 1231.48 1840 1198.169 1424.661 −3.96E−02 5.83E−01 2 Unchanged Medium P29692 H04ab5 eukaryotic translation elongation 1329.758 744 1110.87 1061.631 −2.59E−01 −8.37E−01 2 Unchanged Medium P20042 L05cd4 eukaryotic translation initiation fa 1489.433 603 956.276 1016.24 −6.39E−01 −1.30E+00 2 Unchanged Medium P41091 A20ab4 eukaryotic translation initiation fa 742.5843 474 478.7249 565.2535 −6.33E−01 −6.46E−01 2 Unchanged Medium Q99613 L16cd3 eukaryotic translation initiation fa 1140.022 853 998.7488 997.2011 −1.91E−01 −4.19E−01 2 Unchanged Medium P78344 C02ab4 eukaryotic translation initiation fa 1562.952 1520 1177.845 1419.665 −4.08E−01 −4.19E−02 2 Unchanged Medium P23588 A24ab4 eukaryotic translation initiation fa 1343.019 1010 1125.825 1160.659 −2.54E−01 −4.07E−01 2 Unchanged Medium Q13541 C03ab5 eukaryotic translation initiation fa 1655.926 1060 2293.236 1669.873 4.70E−01 −6.43E−01 2 Unchanged Medium Q13542 A19ab6 eukaryotic translation initiation fa 1620.111 1850 1663.197 1712.605 3.79E−02 1.95E−01 2 Unchanged Medium O60573 G16cd5 eukaryotic translation initiation fa 799.7789 883 819.3679 833.9147 3.49E−02 1.42E−01 2 Unchanged Medium Q16394 K02ab3 exostoses (multiple) 1 513.7526 428 813.2693 584.9471 6.63E−01 −2.64E−01 2 Unchanged Medium P37268 C17ab6 famesyl-diphosphate famesyltra

726.0862 455 649.0518 610.2023 −1.62E−01 −6.73E−01 2 Unchanged Medium P55899 L22ab5 Fc fragment of IgG; receptor; tra

450.8629 771 476.1039 566.0193 7.86E−02 7.74E−01 2 Unchanged Medium Q9UK73 P05ef3 fem-1 homolog b (C. elegans) 548.2677 547 530.801 541.9489 −4.67E−02 −3.93E−03 2 Unchanged Medium P21333 G14ab4 filamin A; alpha (actin binding pr

946.0465 675 1277.458 966.2982 4.33E−01 −4.86E−01 2 Unchanged Medium P26885 P07ab4 FK506 binding protein 2 (13 kD) 814.6357 510 661.4593 662.0387 −3.01E−01 −6.76E−01 2 Unchanged Medium Q13451 F15ab4 FK506 binding protein 5 1366.905 1110 812.8568 1097.248 −7.50E−01 −2.98E−01 2 Unchanged Medium O95633 M01cd6 folllstatin-like 3 (secreted glycop

1312.174 1280 1092.99 1227.557 −2.64E−01 −3.86E−02 2 Unchanged Medium P15407 A20cd4 FOS-like antigen 1 1696.135 1350 1218.491 1421.01 −4.77E−01 −3.31E−01 2 Unchanged Medium Q14192 G02ab4 four and a half LIM domains 2 309.9219 591 1210.635 703.7424 1.97E+00 9.30E−01 2 Unchanged Medium Q9NZA0 N17gh8 fuse-binding protein-interacting

924.2347 911 1110.468 981.791 2.65E−01 −2.13E−02 2 Unchanged Medium P35637 P19ab4 fusion; derived from t(12; 16) mall

866.3996 654 1159.792 893.3381 4.21E−01 −4.06E−01 2 Unchanged Medium E21gh7 FXYD domain-containing ion tra

942.6126 1060 802.8679 935.6666 −2.32E−01 1.71E−01 2 Unchanged Medium Q9Y653 B02cd5 G protein-coupled receptor 56 2010.489 2160 1501.617 1889.081 −4.21E−01 1.00E−01 2 Unchanged Medium Q9H1C0 E18gh4 G protein-coupled receptor 92 712.1007 750 719.7999 727.2869 1.55E−02 7.47E−02 2 Unchanged Medium P15170 L13ab4 G1 to S phase transition 1 2042.425 1410 1109.721 1521.226 −8.80E−01 −5.33E−01 2 Unchanged Medium O95166 D09cd7 GABA(A) receptor-associated pr

1280.495 2210 1227.378 1572.36 −6.11E−02 7.87E−01 2 Unchanged Medium O08765 D21cd7 GABA(A) receptor-associated pr

1241.27 1130 918.8337 1095.839 −4.34E−01 −1.39E−01 2 Unchanged Medium P16278 O05ef1 galactosidase; beta 1 539.4222 800 656.0518 665.3025 2.82E−01 5.69E−01 2 Unchanged Medium P78537 J23ab4 GCN5 general control of amino-

813.3309 637 919.5196 790.0409 1.77E−01 −3.52E−01 2 Unchanged Medium P31150 F14ab4 GDP dissociation inhibitor 1 633.6157 894 640.108 722.7008 1.47E−02 4.97E−01 2 Unchanged Medium P08396 B23ab3 gelsolin (amyloidosis; Finnish typ

330.1567 577 633.2269 513.4286 9.40E−01 8.05E−01 2 Unchanged Medium P52657 E03ab6 general transcription factor IIA; 2 538.6557 685 700.1857 641.1721 3.78E−01 3.46E−01 2 Unchanged Medium Q00403 F08ef6 general transcription factor IIB 500.4565 791 454.8328 582.2035 −1.38E−01 6.61E−01 2 Unchanged Medium P48060 I23cd7 glioma pathogenesis-related pro

676.4844 692 752.7928 707.2232 1.54E−01 3.35E−02 2 Unchanged Medium P06744 B19ab3 glucose phosphate isomerase 900.9772 553 726.4749 726.7688 −3.11E−01 −7.05E−01 2 Unchanged Medium P30101 G13ab5 glucose regulated protein; 58 kD 1708.658 1250 2220.105 1726.668 3.78E−01 −4.50E−01 2 Unchanged Medium O43836 I22ef1 glutamate receptor; ionotropic; N 1729.777 1890 1655.131 1758.853 −6.36E−02 1.29E−01 2 Unchanged Medium P15104 H22ab5 glutamate-ammonia ligase (gluta 1170.59 1040 1180.088 1130.151 1.17E−02 −1.71E−01 2 Unchanged Medium Q06210 A23ab5 glutamine-fructose-6-phosphate

869.494 600 863.157 777.6585 −1.06E−02 −5.34E−01 2 Unchanged Medium Q9Y3D4 M19ef2 glutaredoxin 2 888.5406 894 1099.209 960.4756 3.07E−01 8.32E−03 2 Unchanged Medium Q9Y2Q3 C24ef2 glutathione S-transferase subunit 841.3959 346 414.7892 533.8957 −1.02E+00 −1.28E+00 2 Unchanged Medium P48637 D01ab3 glultathione synthatase 650.8496 429 488.6663 522.9685 −4.13E−01 −6.00E−01 2 Unchanged Medium P78417 E20cd5 glutathione-S-transferase like; g

1983.626 2020 1805.489 1937.888 −1.36E−01 2.95E−02 2 Unchanged Medium P49840 J14ef4 glycogen synthase kinase 3 alph

1057.368 1460 1247.816 1254.087 2.39E−01 4.63E−01 2 Unchanged Medium P13224 F23ab3 glycoprotein lb (platelet): beta pc 487.4684 530 653.4727 557.0977 4.23E−01 1.22E−01 2 Unchanged Medium Q9UBQ7 L08cd7 glyoxylate reductase/hydroxypyn

947.0262 977 997.593 973.9926 7.50E−02 4.55E−02 2 Unchanged Medium Q9P2T1 C02ef2 GMPR2 for guanosine monopho

762.0126 1070 817.0496 882.4154 1.01E−01 4.87E−01 2 Unchanged Medium Q9H4A6 I04gh5 golgi phosphoprotein 3 (coat-pro 1027.603 1210 1209.783 1148.94 2.35E−01 2.35E−01 2 Unchanged Medium P28789 B19ab5 granulin 1611.298 1750 1238.745 1532.188 −3.79E−01 1.16E−01 2 Unchanged Medium Q14393 H10ab3 growth arrest-specific 6 484.489 563 739.1661 595.5619 6.09E−01 2.17E−01 2 Unchanged Medium P29354 H06ef5 growth factor receptor-bound pro 721.5894 854 663.0587 746.3732 −1.22E−01 2.44E−01 2 Unchanged Medium Q14451 D20ab4 growth factor receptor-bound pro 712.3296 846 636.8962 731.6029 −1.61E−01 2.47E−01 2 Unchanged Medium Q9Y6G2 E04ef8 growth hormone inducible trans

1289.256 1020 974.263 1093.42 −4.04E−1 −3.43E−01 2 Unchanged Medium P04899 J09ab4 guanine nucleolide binding prote

860.9208 1390 1748.649 1334.01 1.02E+00 6.94E−01 2 Unchanged Medium P11016 M13ef5 guanine nucleotide binding prote

758.629 773 836.6295 789.4586 1.41E−01 2.73E−02 2 Unchanged Medium Q13905 G09ab6 guanine nucleotide-releasing fac 410.0949 569 535.1889 504.61 3.84E−01 4.71E−01 2 Unchanged Medium Q16774 L16ab3 guanylate kinase 1 968.5867 1340 975.8911 1095.967 1.08E−02 4.72E−01 2 Unchanged Medium Q9Y649 K16ef4 GW128 protein 1663.305 2420 1834.174 1971.464 1.41E−01 5.39E−01 2 Unchanged Medium P07305 G13ab5 H1 histone family; member 0 1780.353 1870 1746.555 1797.448 −2.77E−02 6.73E−02 2 Unchanged Medium O75367 M14cd5 H2A histone family; member Y 1065.311 837 455.5967 786.0181 −1.23E+00 −3.48E−01 2 Unchanged Medium P17317 C24ab6 H2A histone family; member Z 591.0013 461 1570.489 874.2269 1.41E+00 −3.58E−01 2 Unchanged Medium P02278 M16gh6 H2B histone family; member G 586.8773 852 684.6287 707.973 2.22E−01 5.38E−01 2 Unchanged Medium Q9NS37 A03gh5 HCF-binding transcription factor 857.3143 717 601.7268 725.1835 −5.11E−01 −2.59E−01 2 Unchanged Medium O96004 E02cd5 heart and neural crest derivatives 705.5163 612 621.033 646.3401 −1.84E−01 −2.04E−01 2 Unchanged Medium P10809 M11ef5 heat shock 60 kD protein 1 (chap

1693.23 1020 1276.41 1330.235 −4.08E−01 −7.30E−01 2 Unchanged Medium P34932 I11ef1 heat shock 70 kD protein 4 1402.505 1610 1042.113 1352.283 −4.28E−01 2.01E−01 2 Unchanged Medium P07900 G18ef7 heat shock 90 kD protein 1; alpha 2405.793 1430 1512.258 1783.374 −6.70E−01 −7.48E−01 2 Unchanged Medium P08238 B20ab7 heat shock 90 kD protein 1; beta 2781.462 1950 979.1145 1903.993 −1.51E+00 −5.11E−01 2 Unchanged Medium O75506 H17ab6 heat shock factor binding protein 1132.126 1300 1081.748 1171.256 −6.57E−02 1.99E−01 2 Unchanged Medium Q9UHG4 K18ef4 heme-regulated initiation factor 2 413.2841 659 576.3971 549.5035 4.80E−01 6.73E−01 2 Unchanged Medium P09105 J21ab4 hemoglobin; theta 1 702.445 484 769.2336 651.9692 1.31E−01 −5.37E−01 2 Unchanged Medium O43504 D23cd6 hepatitis B virus x interacting pro 1008.655 1340 949.0116 1097.672 −8.79E−02 4.05E−01 2 Unchanged Medium Q9H2I6 N10gh5 hepatitis C virus core-binding pro 676.7297 620 473.9328 590.1783 −5.14E−01 −1.27E−01 2 Unchanged Medium P51858 K16ef7 hepatoma-derived growth factor

894.1008 1170 490.7458 850.7213 −8.65E−01 3.85E−01 2 Unchanged Medium Q04150 A08ab7 heterogeneous nuclear ribonucle 943.3857 870 1065.597 959.787 1.76E−01 −1.16E−01 2 Unchanged Medium Q13151 E15cd7 heterogeneous nuclear ribonucle 906.986 944 1143.552 998.1703 3.34E−01 5.77E−02 2 Unchanged Medium P22626 N09ab6 heterogeneous nuclear ribonucle 1021.87 1010 1584.855 1206.298 6.33E−01 −1.38E−02 2 Unchanged Medium P07910 A10ab7 heterogeneous nuclear ribonucle 747.5309 718 1059.349 841.6601 5.03E−01 −5.79E−02 2 Unchanged Medium O14979 L09cd5 heterogeneous nuclear ribonucle 1057.699 1990 1646.172 1563.717 6.38E−01 9.10E−01 2 Unchanged Medium P52597 G06ab7 heterogeneous nuclear ribonucle 1902.939 1280 1517.274 1567.536 −3.27E−01 −5.69E−01 2 Unchanged Medium Q07244 N13ab6 heterogeneous nuclear ribonucle 847.6967 667 684.4978 733.1055 −3.09E−01 −3.46E−01 2 Unchanged Medium Q15584 P03ab7 heterogeneous nuclear ribonucle 725.3651 569 858.2829 717.4409 2.43E−01 −3.51E−01 2 Unchanged Medium P12081 J12ab4 histidyl-iRNA synthetase 555.5578 565 424.3904 514.8575 −3.89E−01 2.34E−02 2 Unchanged Medium Q9UBN7 E11cd6 histone deacetylase 6 685.5336 407 695.1552 595.8457 2.01E−02 −7.53E−01 2 Unchanged Medium Q13838 M07cd4 HLA-B associated transcript 1 681.4666 604 921.7532 735.5784 4.36E−01 −1.75E−01 2 Unchanged Medium Q99873 H02ef7 HMT1 hnRNP methyltranferase- 890.1184 836 1209.872 978.6584 4.43E−01 −9.05E−02 2 Unchanged Medium Q9H063 M14gh8 homolog of yeast MAF1 744.9951 921 1013.86 893.139 4.45E−01 3.05E−01 2 Unchanged Medium P51610 L21ab5 host cell factor C1 (VP16-access 583.7478 580 735.1691 632.9786 3.33E−01 −9.25E−03 2 Unchanged Medium O00165 I04cd6 HS1 binding protein 1482.068 1490 2425.818 1800.489 7.11E−01 1.12E−02 2 Unchanged Medium Q9Y2Q5 P24ef7 HSPC003 protein 620.7783 1010 825.6574 752.165 1.13E−02 7.02E−01 2 Unchanged Medium Q9Y2R0 A05ef8 HSPC009 protein 1507.005 1720 1784.568 1668.909 2.44E−01 1.87E−01 2 Unchanged Medium Q9Y2T0 A17ef8 HSPC022 protein 453.0964 733 326.4215 504.1821 −4.73E−01 6.94E−01 2 Unchanged Medium Q9UNZ5 C17ef8 HSPC023 protein 825.3888 1310 1347.488 1159.538 7.07E−01 6.62E−01 2 Unchanged Medium Q9P032 O19ef8 HSPC125 protein 558.8905 602 843.0953 668.1435 5.93E−01 1.08E−01 2 Unchanged Medium Q9P019 A06ef8 HSPC141 protein 717.9096 1700 1519.292 1312.254 1.08E+00 1.24E+00 2 Unchanged Medium Q9P004 A24ef8 HSPC160 protein 1182.006 1070 545.8523 932.7666 −1.11E+00 −1.43E−01 2 Unchanged Medium Q9P003 C04ef8 HSPC163 protein 801.5204 1410 1148.378 1118.827 5.19E−01 8.11E−01 2 Unchanged Medium Q9P000 C06ef8 HSPC166 protein 508.2074 921 523.3806 650.7428 4.24E−02 8.57E−01 2 Unchanged Medium Q9Y684 N09ef2 HSPCO34 protein 569.9533 628 797.4819 665.044 4.85E−01 1.39E−01 2 Unchanged Medium Q9NRG2 D01gh4 HTGN29 protein 1276.132 1470 1639.451 1462.8 3.61E−01 2.07E−01 2 Unchanged Medium Q16775 G15ab6 hydroxyacyl glutathione hydrolas 511.3412 676 407.0538 531.4885 −3.29E−01 4.03E−01 2 Unchanged Medium P40939 D07ab3 hydroxacyl-Coenzyme A dehydr 1814.498 1770 1617.578 1733.575 −1.66E−01 −3.69E−02 2 Unchanged Medium P55084 D09ab3 hydroxacyl-Coenzyme A dehydr 539.2691 890 1218.105 882.3271 1.18E+00 7.22E−01 2 Unchanged Medium Q14526 B13ab5 hypermethylated in cancer 1 918.3678 904 1008.759 943.6552 1.35E−01 −2.30E−02 2 Unchanged Medium Q9UBS2 A15ef1 hyperpolarization activated cyclic 676.9289 688 520.6835 628.6277 −3.79E−01 2.40E−02 2 Unchanged Medium Q96EW8 P08gh8 hypothetical gene ZD52F10 727.4433 605 223.8014 518.5858 −1.70E+00 −2.67E−01 2 Unchanged Medium Q9Y2S6 D01ef2 hypothtetical protein 1188.199 1490 1593.015 1423.596 4.23E−01 3.26E−01 2 Unchanged Medium Q9UKZ1 I23gh3 hypothetical protein C40 657.2427 614 506.0272 592.3978 −3.77E−01 −9.84E−02 2 Unchanged Medium Q9UJJ9 D21gh8 hypothetical protein CAB56184 432.491 695 601.25 576.3525 4.75E−01 6.85E−01 2 Unchanged Medium O95891 D08ef8 hypothetical protein CL25022 1675.198 2070 1477.523 1741.841 −1.81E−01 3.07E−01 2 Unchanged Medium Q9UJI9 F08gh6 hypothetical protein DJ328E19.C 1119.481 935 1005.691 1019.924 −1.55E−01 −2.60E−01 2 Unchanged Medium Q9H0U3 K20gh8 hypothetical protein DKFZp564K 1287.049 1080 1145.302 1169.228 −1.68E−01 −2.59E−01 2 Unchanged Medium Q9NWD8 N05gh2 hypothetical protein FLJ10099 754.9838 758 710.8818 741.1753 −8.68E−02 5.11E−03 2 Unchanged Medium Q9NW90 P21gh2 hypothetical protein FLJ10211 492.5962 551 601.7235 548.3816 2.89E−01 1.61E−01 2 Unchanged Medium Q9NW61 B18gh2 hypothetical protein FLJ10297 772.0358 844 620.8513 745.7235 −3.14E−01 1.29E−01 2 Unchanged Medium Q9NW16 G04gh3 hypothetical protein FLJ10374 756.2846 543 467.9722 589.0741 −6.93E−01 −4.78E−01 2 Unchanged Medium Q9NVZ3 G14gh3 hypothetical protein FLJ10420 437.615 702 362.923 500.7932 −2.70E−01 6.81E−01 2 Unchanged Medium Q9NVC3 D23gh3 hypothetical protein FLJ10815 1402.842 928 598.595 976.6359 −1.23E+00 −5.95E−01 2 Unchanged Medium Q9H9K7 B10gh5 hypothetical protein FLJ12681 446.1454 657 593.5606 565.6072 4.12E−01 5.59E−01 2 Unchanged Medium Q9H8H4 H06gh5 hypothetical protein FLJ12800 1058.023 775 1421.894 1084.852 4.26E−01 −4.50E−01 2 Unchanged Medium Q9P0R5 L02ef1 hypothetical protein FLJ14868 702.1841 684 1117.168 834.4521 6.70E−01 −3.78E−02 2 Unchanged Medium Q9NXQ4 M07gh3 hypothetical protein FLJ20113 1503.987 1520 1545.141 1521.653 3.89E−02 1.13E−02 2 Unchanged Medium Q9NXI2 M21gh3 hypothetical protein FLJ20234 643.4985 877 178.0291 566.3149 −1.85E+00 4.47E−01 2 Unchanged Medium Q9NXD5 E18gh2 hypothetical protein FLJ20309 617.1482 1420 758.0334 932.5386 2.97E−01 1.20E+00 2 Unchanged Medium Q9NX64 I16gh2 hypothetical protein FLJ20419 938.8958 825 981.6359 915.2399 6.42E−02 −1.86E−01 2 Unchanged Medium Q9NWX1 A20gh3 hypothetical protein FLJ20552 1366.306 1800 1533.352 1565.249 1.66E−01 3.95E−01 2 Unchanged Medium Q9NWT8 D11gh2 hypothetical protein FLJ20608 980.6383 915 907.2393 934.2965 −1.12E−01 −9.99E−02 2 Unchanged Medium Q9NWM3 C20gh3 hypothetical protein FLJ20739 381.202 593 689.893 554.671 8.56E−01 6.37E−01 2 Unchanged Medium Q9H7C7 D05gh5 hypothetical protein FLJ21044 si 551.5395 708 585.1487 615.0164 8.53E−02 3.61E−01 2 Unchanged Medium Q9H6R6 J23gh5 hypothetical protein FLJ21952 425.3152 396 679.1125 500.0538 6.75E−01 −1.04E−01 2 Unchanged Medium Q9H673 F11gh5 hypothetical protein FLJ22548 si 1394.825 1220 530.5646 1047.134 −1.39E+00 −1.98E−01 2 Unchanged Medium O95476 H15efB hypothetical protein HSA011916 1310.097 1040 1485.684 1279.962 1.81E−01 −3.27E−01 2 Unchanged Medium Q9Y244 B23ef2 hypothetical protein HSPC014 1668.101 1530 1243.802 1481.658 −4.23E−01 −1.22E−01 2 Unchanged Medium Q9P022 P04ef2 hypothetical protein HSPC138 666.1765 521 643.5979 610.0993 −4.97E−02 −3.56E−01 2 Unchanged Medium Q9P013 P06ef2 hypothetical protein HSPC148 916.5214 1450 1133.279 1167.03 3.06E−01 6.63E−01 2 Unchanged Medium Q9P009 P14ef2 hypothetical protein HSPC155 1031.658 1330 662.2481 1008.218 −6.40E−01 3.67E−01 2 Unchanged Medium Q9P0S9 A19ef3 hypothetical protein HSPC194 1336.172 1570 1957.055 1622.151 5.51E−01 2.36E−01 2 Unchanged Medium Q9NPI0 A23ef3 hypothetical protein HSPC196 280.0356 644 672.086 532.0086 1.26E+00 1.20E+00 2 Unchanged Medium Q95887 C18ef2 hypothetical protein LOC51061 777.5591 709 551.8354 679.3596 −4.95E−01 −1.34E−01 2 Unchanged Medium Q9P0T9 K02ef2 hypothetical protein LOC51234 1224.056 1290 1457.544 1322.295 2.52E−01 7.04E−02 2 Unchanged Medium Q9P0Q1 K10ef2 hypothetical protein LOC51248 376.8259 933 1014.441 774.623 1.43E+00 1.31E+00 2 Unchanged Medium Q9P0P0 K20ef2 hypothetical protein LOC51255 1301.286 2190 1904.375 1798.292 5.49E−01 7.50E−01 2 Unchanged Medium Q9P0N9 K22ef2 hypothetical protein LOC51256 540.326 374 604.1319 506.0883 1.61E−01 −5.32E−01 2 Unchanged Medium Q9NZD9 M23ef2 hypothetical protein LOC51323 600.1582 715 506.8479 607.2015 −2.44E−01 2.52E−01 2 Unchanged Medium O75207 M02gh4 hypothetical protein LOC57019 663.8685 644 680.7704 663.0017 3.63E−02 −4.30E−02 2 Unchanged Medium Q9BWL0 L24gh7 hypothetical protein MGC: 5244; 569.8856 436 732.9891 579.5932 3.63E−01 −3.87E−01 2 Unchanged Medium Q9BW61 C09gh6 hypothetical protein MGC2594 1446.395 2460 1354.586 1754.667 −9.46E−02 7.68E−01 2 Unchanged Medium Q9BQ49 K05gh6 hypothetical protein MGC2747 527.9287 679 677.2851 628.1009 3.59E−01 3.63E−01 2 Unchanged Medium Q9BQD3 E17gh6 hypothetical protein MGC2479 841.5499 889 899.9017 876.8925 9.67E−02 7.95E−02 2 Unchanged Medium Q9BQ61 A09gh6 hypothetical protein MGC2803 1234.395 2170 1980.421 1794.728 6.82E−01 8.13E−01 2 Unchanged Medium Q9BTV4 O23gh6 hypothetical protein MGC3222 561.6572 502 583.5781 548.9637 5.52E−02 −1.63E−01 2 Unchanged Medium Q9BVX2 C17gh6 hypothetical protein MGC5576 747.2479 762 604.3725 704.7101 −3.06E−01 2.91E−02 2 Unchanged Medium Q9H773 I17gh6 hypothetical protein MGC5627 799.182 819 584.0079 734.1306 −4.53E−01 3.57E−02 2 Unchanged Medium Q9BPX5 L02gh7 hypothetical protein similar aci 583.4076 424 632.4101 546.6359 1.16E−01 −4.60E−01 2 Unchanged Medium Q9UJX8 B09ef3 hypothetical protein estradiol-inc 1184.334 948 1116.899 1083.179 −8.46E−02 −3.21E−01 2 Unchanged Medium P00492 P12cd6 hypoxanthine phosphoribosyltrar 1210.895 233 566.0945 669.9473 −1.10E+00 −2.38E+00 2 Unchanged Medium P22304 I04ab6 iduronate 2-sulfatase (Hunter syr 1197.3 1320 1095.895 1205.085 −1.28E−01 1.43E−01 2 Unchanged Medium Q03827 F02ef6 immediate early protein 850.6538 537 536.2705 574.4895 −2.79E−01 −2.78E−01 2 Unchanged Medium P12268 F11ab6 IMP (inosine monophosphate) de 1254.916 567 1293.693 1038.44 4.39E−02 −1.15E+00 2 Unchanged Medium Q9Y6K9 P03cd3 inhibitor of kappa light polypeptic 822.3859 788 807.6888 805.9933 −2.60E−02 −6.78E−02 2 Unchanged Medium Q14573 F04ab6 inositol 1;4;5-triphosphate recepl 555.9397 646 627.6143 609.9521 1.75E−01 2.17E−01 2 Unchanged Medium O15357 L09ab6 inositol polyphosphate phosphat

997.7512 1150 1290.473 1146.828 3.71E−01 2.08E−01 2 Unchanged Medium O15503 B05ab7 insulin induced gene 1 472.0202 428 615.7553 505.2037 3.84E−01 −1.42E−01 2 Unchanged Medium P52945 L13gh8 insulin upstream factor 1 1437.285 3700 746.514 1961.135 −9.45E−01 1.36E+00 2 Unchanged Medium P51460 B07ab7 insulin-like 3 (Leydig cell) 1227.459 1290 1040.851 1184.891 −2.38E−01 6.76E−02 2 Unchanged Medium P46977 D20ab6 integral membrane protein 1 1693.474 1790 2514.977 1998.711 5.71E−01 7.81E−02 2 Unchanged Medium Q13418 H08ef5 integrin-linked kinase 1340.442 962 1599.336 1300.502 2.55E−01 −4.79E−01 2 Unchanged Medium P48551 O21ef7 interferon (alpha; beta and omeg 605.1613 669 389.178 554.33 −6.37E−01 1.44E−01 2 Unchanged Medium P15260 A02ef7 interferon gamma receptor 1 1165.784 2600 1179.083 1648.504 1.64E−02 1.16E+00 2 Unchanged Medium P38484 D12ef5 interferon gamma receptor 2 (Int

593.8133 773 550.2878 638.9669 −1.10E−01 3.80E−01 2 Unchanged Medium O14896 K05ef6 interferon regulatory factor 6 495.9782 951 406.9438 617.9736 −2.85E−01 9.39E−01 2 Unchanged Medium G13ef5 interferon-gamma receptor (IFNG 616.4461 474 457.8757 515.9592 −4.29E−01 −3.80E−01 2 Unchanged Medium Q14116 L03ab6 interleukin 18 (Interferon-gamma 1525.444 1610 556.9614 1230.533 −1.45E+00 7.71E−02 2 Unchanged Medium O75874 H11ab7 isocitrate dehydrogenase 1 (NA

660.9773 496 904.897 687.2716 4.53E−01 −4.14E−01 2 Unchanged Medium P51553 I21gh1 isocitrate dehydrogenase 3 (NA

815.5318 899 784.1063 832.7908 −5.67E−02 1.40E−01 2 Unchanged Medium P41252 P23ab6 isoleucine-IRNA synthetase 643.6728 316 992.267 650.6946 6.24E−01 −1.03E+00 2 Unchanged Medium Q9UE89 J07ef7 jagged 2 657.9935 460 696.5019 604.7722 6.21E−01 −5.17E−01 2 Unchanged Medium P52292 J14ab6 karyopherin alpha 2 (RAG cohor

1105.911 1270 1670.406 1350.126 5.95E−01 2.04E−01 2 Unchanged Medium P24390 E07cd7 KDEL (Lys-Asp-Glu-Leu) endopl

1556.771 1210 1411.383 1392.342 −1.41E−01 −3.65E−01 2 Unchanged Medium P08779 D03ab7 keratin 16 (focal non-epidermalyl 815.5106 786 663.0228 754.7055 −2.99E−01 −5.39E−02 2 Unchanged Medium Q04695 O24ab6 keratin 17 580.3123 1180 1056.274 937.9159 8.64E−01 1.02E+00 2 Unchanged Medium Q07666 B04cd6 KH domain containing: RNA bind 1212.816 780 1103.092 1031.926 −1.37E−01 −6.37E−01 2 Unchanged Medium Q14165 O16gh1 KIAA0152 gene product 285.0232 348 1374.81 669.3755 2.27E+00 2.89E−01 2 Unchanged Medium Q12765 F03gh1 KIAA0193 gene product 951.658 1000 981.6527 979.0013 4.48E−02 7.68E−02 2 Unchanged Medium O43310 F11gh1 KIAA0427 gene product 482.1741 589 556.0999 542.3144 2.06E−01 2.88E−01 2 Unchanged Medium O43167 J03gh1 KIAA0441 gene product 1398.244 982 1102.589 1160.899 −3.43E−01 −5.10E−01 2 Unchanged Medium Q9H7D5 I18gh7 KIAA1191 protien 886.4026 1930 1061.302 1291.483 2.60E−01 1.12E+00 2 Unchanged Medium Q9HD96 L03cd8 LAG1 longevity assurance homol 1319.272 798 1016.572 1044.592 −3.76E−01 −7.25E−01 2 Unchanged Medium O00182 P04ab6 lectin; galactoside-binding: solub 760.6622 1300 527.6081 864.4149 −5.28E−01 7.79E−01 2 Unchanged Medium Q99538 B04ef7 legumain 464.5 517 1105.037 695.3901 1.25E+00 1.53E−01 2 Unchanged Medium O95751 G01cd8 leucine zipper; down-regulated ir 874.8344 274 970.9239 706.7407 1.50E−01 −1.67E+00 2 Unchanged Medium O15468 P03ef4 leukocyte immunoglobulin-like re 828.8073 939 1120.204 962.0679 4.38E−01 1.84E−01 2 Unchanged Medium Q9UBB4 I06cd8 like mouse brain protein E46 877.3997 623 692.5911 731.0054 −3.41E−01 −4.94E−01 2 Unchanged Medium Q9UFW4 N17ef8 likely ortholog of rat golgi stackin 1680.361 1700 2121.05 1834.238 3.36E−01 1.79E−02 2 Unchanged Medium Q14847 P09ab7 LIM and SH3 protein 1 664.6143 758 895.1972 772.769 4.30E−01 1.91E−01 2 Unchanged Medium O00158 M09ef3 LIM domain only 4 457.4088 299 1353.355 703.0924 1.56E+00 −6.16E−01 2 Unchanged Medium Q9HAP6 M16gh5 Lin-7b protein: likely ortholog of

2114.229 1550 2175.236 1945.862 4.10E−02 −4.50E−01 2 Unchanged Medium P38571 K08ab6 lipase A; lysosmal acid; cholest, 604.0401 587 512.8879 568.1283 −2.36E−01 −4.02E−02 2 Unchanged Medium Q99732 I18cd5 LPS-induced TNF-alpha factor 680.3876 893 449.4711 674.31 −5.98E−01 3.92E−01 2 Unchanged Medium Q9Y4Z1 O21ef4 Lsm3 protein 1841.224 1300 1596.905 1511.517 −3.95E−02 −3.40E−01 2 Unchanged Medium O75896 D05cd7 lung cancer candidate 690.6061 772 601.3296 688.0098 −2.00E−01 1.61E−01 2 Unchanged Medium Q06843 O07ef6 lymphotoxin beta (TNF superfam 405.7368 1040 298.9254 582.7217 −4.41E−01 1.36E+00 2 Unchanged Medium O95372 J04ef7 lysopholipase II 480.0562 737 752.7079 656.485 6.49E−01 6.18E−01 2 Unchanged Medium P13473 N06ab6 lysosomal-associated membrane 952.6393 2000 1277.773 1408.92 4.24E−01 1.07E+00 2 Unchanged Medium Q08397 F09ab7 lysyl oxidase-like 1 1391.453 1630 2243.025 1753.531 6.89E−01 2.25E−01 2 Unchanged Medium Q15046 B17ab7 lysyl-tRNA synthetase 900.8177 556 539.813 665.5485 −7.39E−01 −6.96E−01 2 Unchanged Medium Q13312 D17cd3 MAD1 mitotic arrest deficient-like 807.7627 503 574.4266 628.231 −4.92E−01 −6.85E−01 2 Unchanged Medium Q09160 A05ab6 majar histocompatibility complex; 1524.076 2710 1290.783 1841.106 −2.40E−01 8.30E−01 2 Unchanged Medium P40925 J23ab7 malate dehydrogenase 1; NAD (

1144.218 788 1089.134 1007.157 −7.12E−02 −5.38E−01 2 Unchanged Medium P40926 L01ab7 malate dehydrogenase 2; NAD (

1525.837 1020 1212.544 1251.158 −3.32E−01 −5.88E−01 2 Unchanged Medium Q16826 J15ef3 male-enhanced antigen 1253.21 1530 1827.301 1536.52 5.44E−01 2.87E−01 2 Unchanged Medium Q9NQG1 C06gh5 mannosidase; beta A; lysosomal

533.2883 800 736.627 689.9075 4.66E−01 5.85E−01 2 Unchanged Medium P26572 G11ab7 mannosyl (alpha-1;3-)-glycoprote 619.6733 369 887.6535 625.3732 5.18E−01 −7.49E−01 2 Unchanged Medium Q10469 G15ab7 mannosyl (alpha-1:6-)glycoprote 600.1049 583 636.621 606.4146 8.52E−02 −4.29E−02 2 Unchanged Medium P41223 L09cd4 maternal G10 transcript 372.2443 563 575.7695 503.5179 6.29E−01 5.96E−01 2 Unchanged Medium Q9Y5V3 G13cd6 melanoma antigen: family D; 1 397.4495 952 1674.881 1008.268 2.08E+00 1.26E+00 2 Unchanged Medium P43121 I22ef5 malanoma cell adhesion molecu

886.0756 795 432.1718 704.4837 −1.04E+00 −1.56E−01 2 Unchanged Medium Q92494 D11ef1 membrane cofactor protein (CD4 973.362 1050 834.044 952.9144 −2.23E−01 1.11E−01 2 Unchanged Medium Q14444 H15ab7 membrane component; chromos 549.4803 666 464.8174 560.0583 −2.41E−01 2.77E−01 2 Unchanged Medium Q9NPE2 O12ef2 mesenchymal stem cell protein C 749.8938 932 1085.26 922.5469 5.33E−01 3.14E−01 2 Unchanged Medium Q92571 G07ab7 mesoderm specific transcript hon 617.581 446 537.1735 533.4868 −2.01E−01 −4.71E−01 2 Unchanged Medium O95204 N11ef3 metalloprotease 1 (pitrilysin fam

735.157 349 478.8153 520.899 −6.19E−01 −1.08E+00 2 Unchanged Medium P80297 H20ab7 metallothionein 1L 589.6327 502 656.4441 582.747 1.55E−01 −2.32E−01 2 Unchanged Medium Q99735 C18ef7 microsomal glutathione S-transfe 527.4698 686 373.9779 529.1741 −4.96E−01 3.79E−01 2 Unchanged Medium Q98XW5 D13gh8 microtubule-associated protein 1 247.2817 692 887.6299 609.0447 1.84E+00 1.49E−00 2 Unchanged Medium Q9Y6C9 M14ef3 mitochondrial carrier homolog 2 1874.893 1910 1893.062 1892.145 1.39E−02 2.56E−02 2 Unchanged Medium Q9Y3B7 E07ef2 mitochondrial ribosomal protein 1 401.0368 421 732.113 517.9208 8.68E−01 6.88E−02 2 Unchanged Medium Q9P015 A12ef8 mitochondrial ribosomal protein 1 553.658 760 589.0617 634.2498 8.94E−02 4.57E−01 2 Unchanged Medium Q9NX20 M06gh2 mitochondrial ribosomal protein 1 642.9143 496 701.1442 613.4293 1.25E−01 −3.74E−01 2 Unchanged Medium Q9H0U6 O13ef8 mitochondrial ribosomal protein 1 741.5383 1000 826.8816 856.3674 1.57E−01 4.32E−01 2 Unchanged Medium Q9NZE8 O04ef2 mitochondrial ribosomal protein 1 914.9722 910 956.7888 927.2731 6.45E−02 −7.77E−03 2 Unchanged Medium Q9P0P3 K18ef2 mitochondrial ribosomal protein 1 1217.101 891 1196.143 1101.306 −2.51E−02 −4.50E−01 2 Unchanged Medium Q9Y317 M15ef2 mitochondrial ribosomal protein 1 799.6979 1020 1372.352 1063.499 7.79E−01 3.49E−01 2 Unchanged Medium Q9Y6G3 C19ef8 mitochondrial ribosomal protein 1 571.7264 810 689.3229 690.2211 2.70E−01 5.02E−01 2 Unchanged Medium Q9BYC7 K12gh8 mitochondrial ribosomal protein

490.5463 685 619.0928 591.6118 3.36E−01 4.39E−01 2 Unchanged Medium Q9Y3D3 B12ef1 mitochondrial ribosomal protein

966.7611 1020 1006.958 997.1495 5.88E−02 7.41E−02 2 Unchanged Medium Q9Y676 C15ef8 mitochondrial ribosomal protein

683.2889 580 761.9887 674.9976 1.57E−01 −2.37E−01 2 Unchanged Medium Q9Y3D5 G19ef2 mitochondrial ribosomal protein

696.3306 1080 825.557 865.8021 2.46E−01 6.27E−01 2 Unchanged Medium P82921 O11gh7 mitochondrial ribosomal protein

748.082 1190 1115.5 1019.33 5.76E−01 6.75E−01 2 Unchanged Medium P82850 D07gh4 mitochondrial ribosomal protein

554.1784 515 470.683 513.1921 −2.36E−01 −1.07E−01 2 Unchanged Medium Q9Y2Q9 A03ef8 mitochondrial ribosomal protein

1439.076 1420 1329.749 1395.534 −1.14E−01 −2.15E−02 2 Unchanged Medium Q9NP92 F02ef3 mitochondrial ribosomal protein

669.1652 532 817.3223 606.105 −1.16E−01 −3.31E−01 2 Unchanged Medium Q02750 J08ef5 mitogen-activated protein kinase 615.689 701 453.8702 590.1129 −4.40E−01 1.87E−01 2 Unchanged Medium Q02779 K09ab7 mitogen-activated protein kinase 597.1743 423 509.6637 510.095 −2.29E−01 −4.96E−01 2 Unchanged Medium Q12851 N10ab8 mitogen-activated protein kinase 988.0971 1020 976.7391 994.1804 −1.67E−02 4.26E−02 2 Unchanged Medium P49137 J06ef5 mitogen-activated protein kinase 942.7459 1000 1068.579 1004.624 1.81E−01 8.87E−02 2 Unchanged Medium Q9BYG3 O02gh8 MKI67 (FHA domain) Interacting 791.8688 407 307.4404 502.0002 −1.36E+00 −9.61E−01 2 Unchanged Medium Q15014 C17cd8 MORF-related gene X 1146.48 1030 1262.273 1144.777 1.39E−01 −1.61E−01 2 Unchanged Medium F22ef4 mRNA; clone: PO2ST9 1052.442 1040 905.2614 999.5166 −2.17E−01 −1.60E−02 2 Unchanged Medium Q15773 M18ef5 myeloid leukemia factor 2 577.4585 467 766.6809 603.749 4.09E−01 −3.06E−01 2 Unchanged Medium P35579 O01ef1 myosin; heavy polypeptide 9; no

1426.003 1150 1203.964 1261.007 −2.44E−01 −3.07E−01 2 Unchanged Medium Q9Y6D2 C21ef2 N-acetyltransferase 5 (ARD1 ho

531.5485 708 274.9715 504.9319 −9.51E−01 4.14E−01 2 Unchanged Medium P41227 G13gh1 N-acetyltransferase; homolog of 800.6676 905 818.2554 841.2057 3.13E−02 1.76E−01 2 Unchanged Medium Q13510 H20ab2 N-acylsphingosine amidohydrola 752.1534 1680 677.5006 1028.456 −1.51E−01 1.14E+00 2 Unchanged Medium O43678 O09ab7 NADH dehydrogenase (ubiquino

1366.754 1930 2137.906 1810.699 6.45E−01 4.96E−01 2 Unchanged Medium O95167 E24ab7 NADH dehydrogenase (ubiquino

1431.655 1770 1506.934 1570.238 7.39E−02 3.08E−01 2 Unchanged Medium P56556 O11ab7 NADH dehydrogenase (ubiquino

1650.612 916 795.8725 1120.973 −1.05E+00 −8.49E−01 2 Unchanged Medium O95182 K06ab7 NADH dehydrogenase (ubiquino

750.0893 777 725.1711 750.6457 −4.87E−02 5.03E−02 2 Unchanged Medium P51970 L04cd8 NADH dehydrogenase (ubiquino

554.1995 728 1021.163 767.6928 8.82E−01 3.93E−01 2 Unchanged Medium O96000 J10ab8 NADH dehydrogenase (ubiquino

1110.197 1440 1111.615 1219.156 1.84E−03 3.71E−01 2 Unchanged Medium O95178 J06ab8 NADH dehydrogenase (ubiquino

925.3926 768 815.266 836.3224 −1.83E−01 −2.68E−01 2 Unchanged Medium O95139 M03ab8 NADH dehydrogenase (ubiquino

1392.873 1480 2182.279 1678.472 6.34E−01 8.78E−02 2 Unchanged Medium P17568 H02ab8 NADH dehydrogenase (ubiquino

787.0681 587 591.1924 648.3703 −4.13E−01 −4.74E−01 2 Unchanged Medium Q9Y6M9 P16ab8 NADH dehydrogenase (ubiquino

1299.803 1450 746.8017 1164.524 −7.99E−01 1.55E−01 2 Unchanged Medium O43677 M05ab8 NADH dehydrogenase (ubiquino

586.5059 601 532.551 573.2205 −1.39E−01 3.43E−02 2 Unchanged Medium O00217 M09ab8 NADH dehydrogenase (ubiquino

1383.411 1130 1194.001 1234.615 −2.12E−01 −2.96E−01 2 Unchanged Medium P19404 M07ef1 NADH dehydrogenase (ubiquino

1151.224 443 356.308 650.0945 −1.69E+00 −1.38E+00 2 Unchanged Medium O76008 A12cd6 Nef-associated factor 1 720.2744 951 424.04 698.4474 −7.64E−01 4.01E−01 2 Unchanged Medium Q9UPY4 K22ef3 nesca protein 425.9149 469 621.9336 505.6782 5.46E−01 1.40E−01 2 Unchanged Medium L19gh8 neurabin II 1241.544 862 1023.077 1042.081 −2.79E−01 −5.27E−01 2 Unchanged Medium Q99742 O07ab8 neuronal PAS domain protein 1 1076.259 405 606.3589 695.8521 −8.28E−01 −1.41E+00 2 Unchanged Medium O60448 P20ef3 neuronal thread protein 1831.592 1660 1490.624 1662.051 −2.97E−01 −1.38E−01 2 Unchanged Medium Q9UNW9 O05ab8 neuro-oncological ventral antiger 1049.959 1050 1219.792 1106.982 2.16E−01 1.70E−03 2 Unchanged Medium Q9UGL9 C09gh3 NICE-1 protein 1026.838 1360 381.058 923.3423 −1.43E+00 4.08E−01 2 Unchanged Medium Q9UGL6 M09ef4 NICE-5 protein 912.7542 1390 955.016 1086.502 6.53E−02 6.09E−01 2 Unchanged Medium Q92982 I09ef7 ninjurin 1 458.23 689 412.0181 519.6952 −1.53E−01 5.88E−01 2 Unchanged Medium Q9BPW8 N19cd3 nipsnap homolog 1 (C. elegans) 829.4266 529 562.9689 640.3075 −5.59E−01 −6.50E−01 2 Unchanged Medium Q9NQR4 B13gh4 Nit protein 2 S19.1587 868 665.8632 684.4701 3.59E−01 7.42E−01 2 Unchanged Medium Q9UF10 L08ef2 non-canonical ubquitin conjugati

1336.406 2000 1488.008 1608.811 1.55E−01 5.83E−01 2 Unchanged Medium Q9Y385 H11ef2 non-canonical ubquitin conjugati

625.6356 808 669.812 701.1992 9.84E−02 3.69E−01 2 Unchanged Medium Q15233 O02ef1 non-POU domain containing; oct. 1083.363 1210 1234.216 1174.503 1.88E−01 1.55E−01 2 Unchanged Medium Q13137 A03cd6 nuclear domain 10 protein 910.7725 914 944.6079 923.1712 5.26E−02 5.31E−03 2 Unchanged Medium Q16236 M03cd1 nuclear factor (erythroid-derived 1233.751 1180 1043.638 1153.088 −2.41E−01 −6.20E−02 2 Unchanged Medium P08651 B07ef1 nuclear factor I/C (CCAAT-bindin 726.0476 624 659.6305 669.8575 −1.38E−01 −2.19E−01 2 Unchanged Medium O95134 P10cd3 nuclear localization signal delete 465.2933 522 536.7333 508.0938 2.06E−01 1.67E−01 2 Unchanged Medium Q15772 N19ab2 nuclear protein; marker for differ

1473.704 923 1157.202 1184.738 −3.49E−01 −6.75E−01 2 Unchanged Medium Q9UHY1 L15cd8 nuclear receptor binding protein 515.949 948 619.7512 694.4539 2.64E−01 8.77E−01 2 Unchanged Medium Q9UPC9 H23ab2 nuclear receptor coactivator 3 822.7768 1190 932.9058 982.77 1.81E−01 5.36E−01 2 Unchanged Medium Q15325 N22cd2 nuclease sensitive element bind

1644.614 1720 2064.24 1808.771 3.28E−01 6.25E−02 2 Unchanged Medium O00567 D05cd6 nucleolar protein 5A (56 kD with

659.4335 608 623.2536 630.2325 −8.14E−02 −1.17E−01 2 Unchanged Medium Q9NX24 A10gh3 nucleolar protein family A; memb 466.2539 625 594.8443 581.9547 3.51E−01 4.22E−01 2 Unchanged Medium P06748 K06gh6 nucleophosmin (nucleolar phosp

1605.368 1080 1136.972 1275.358 −4.98E−01 −5.67E−01 2 Unchanged Medium P50583 B01ab2 nudlx (nucleoside diphosphate

1590.763 211 251.3768 684.354 −2.66E+00 −2.91E+00 2 Unchanged Medium Q9UHM6 N20gh8 opsin 4 (malanopsin) 1076.73 1200 1643.887 1305.239 6.10E−01 1.50E−01 2 Unchanged Medium Q9Y218 P22gh1 optinueurin 1014.697 1980 912.1917 1302.823 −1.54E−01 9.66E−01 2 Unchanged Medium Q16612 O01cd5 P311 protein 322.7444 349 2231.846 967.7934 2.79E+00 1.12E−01 2 Unchanged Medium P55771 J21cd7 paired box gene 9 692.506 380 573.135 548.4374 −2.73E−01 −8.67E−01 2 Unchanged Medium Q9UKJ1 N21cd8 paired immunoglobulin-like rece

674.1862 450 558.3225 560.9087 −2.72E−01 −5.83E−01 2 Unchanged Medium Q15165 P24ab7 paraoxonase 2 338.5244 891 583.7771 604.4337 7.86E−01 1.40E+00 2 Unchanged Medium Q07002 P06ef5 PCTAIRE protein kinase 3 836.5659 916 632.7298 795.1858 −4.03E−01 1.31E−01 2 Unchanged Medium Q9Y3C6 J07ef2 peptidylprolyl isomerase (cyclop

548.5938 731 526.6097 602.0621 −5.90E−02 4.14E−01 2 Unchanged Medium P30405 F14cd5 peptidylprolyl isomerase F (cyclo 843.1834 925 467.6738 745.2396 −8.50E−01 1.33E−01 2 Unchanged Medium O43924 G24ab8 phosphodiesterase 6D; cGMP-s

373.1208 630 699.1887 567.4949 9.06E−01 7.56E−01 2 Unchanged Medium P17858 K10ab8 phosphofructokinase; liver 950.5746 525 774.727 750.1835 −2.95E−01 −8.56E−01 2 Unchanged Medium Q01813 C17ef1 phosphofructokinase; platelet 573.5211 646 555.9236 591.6879 −4.50E−02 1.71E−01 2 Unchanged Medium Q00511 N20cd3 phosphoprotein enriched in astrc 1330.005 1500 2288.098 1704.656 7.83E−01 1.70E−01 2 Unchanged Medium P11216 B16ab8 phosphorylase; glycogen; brain 516.7884 495 988.163 666.5476 9.35E−01 −6.30E−02 2 Unchanged Medium P00749 P19ef7 plasminogen activator; urokinase 1096.052 3440 1051.513 1861.568 −5.98E−02 1.65E+00 2 Unchanged Medium P13797 C13cd1 plastin 3 (T isoform) 990.1173 804 1393.037 1062.438 4.93E−01 −3.00E−01 2 Unchanged Medium Q15102 E16ab8 platelet-activating factor acetylhy 469.9778 674 468.9765 537.6672 −3.08E−03 5.20E−01 2 Unchanged Medium P01127 A08ef5 platelet-derived growth factor bel 500.6466 674 456.4576 543.5869 −1.33E−01 4.28E−01 2 Unchanged Medium Q15795 C19ef6 pleckstrin homology; Sec7 and

578.295 740 518.8327 612.22 −1.57E−01 3.55E−01 2 Unchanged Medium O43660 O18ab8 pleiotropic regulator 1 (PRL 1hor

743.7263 933 804.3456 827.0995 1.13E−01 3.27E−01 2 Unchanged Medium Q15155 G12ef3 pM5 protein 664.2511 423 490.295 525.8869 −4.38E−01 −6.51E−01 2 Unchanged Medium Q9H361 L04gh7 poly(A) binding protein; cytoplas

759.4566 491 710.9543 653.8288 −9.52E−02 −8.29E−01 2 Unchanged Medium Q15366 A11cd1 poly(rC) binding protein 2 1951.241 1490 2128.585 1857.745 1.26E−01 −3.86E−01 2 Unchanged Medium P19388 B15ab8 polymerase (RNA) II (DNA direct 552.3545 529 698.4965 593.4201 3.39E−01 −6.12E−02 2 Unchanged Medium P52434 F05gh6 polymerase (RNA) II (DNA direct 949.7064 1480 1210.411 1211.761 3.50E−01 6.35E−01 2 Unchanged Medium P36954 A20cd1 polymerase (RNA) II (DNA direct 1603.557 1820 1413.573 1613.004 −1.82E−01 1.84E−01 2 Unchanged Medium P53803 C17cd1 polymerase (RNA) II (DNA direct 437.9544 893 528.0144 619.6184 2.70E−01 1.03E+00 2 Unchanged Medium Q9UQQ3 J08cd6 POP4 (processing of precursor; 480.5848 645 551.3661 558.9966 1.98E−01 4.25E−01 2 Unchanged Medium Q13670 B07ab8 postmelotic segregation increase 812.7865 779 532.0548 708.0473 −6.11E−01 −6.07E−02 2 Unchanged Medium Q9P0J7 L07gh4 potassium channel modulatory fa 1401.591 1720 1192.204 1438.482 −2.33E−01 2.97E−01 2 Unchanged Medium O60925 K02ab8 prefoldin 1 1631.996 1720 1860.632 1737.289 1.89E−01 7.51E−02 2 Unchanged Medium Q9UHV9 J15ef4 prefoldin 2 514.4897 882 833.1525 743.3158 6.95E−01 7.78E−01 2 Unchanged Medium Q13519 J07ef6 prepronociceptin 564.2079 464 887.4522 638.4071 6.53E−01 −2.83E−01 2 Unchanged Medium P04156 A13ab8 prion protein (p27-30) Creutzfel

797.9495 631 701.8217 710.1438 −1.85E−01 −3.39E−01 2 Unchanged Medium Q9UI73 K03ef8 PRO0246 protein 430.412 535 546.8599 504.0018 3.45E−01 3.13E−01 2 Unchanged Medium Q9P0T3 D14ef1 proapoptotic caspase adaptor p

1261.463 1650 2553.652 1820.221 1.02E+00 3.83E−01 2 Unchanged Medium Q02809 P20ab7 procollagen-lysine; 2-oxoglutarat 503.7557 477 1993.232 991.2271 1.98E+00 −7.97E−02 2 Unchanged Medium P07237 G13ab8 procollagen-proline; 2-oxoglutar

633.8309 406 575.6635 538.3489 −1.39E−01 −6.44E−01 2 Unchanged Medium P09466 E12ab8 progestagen-associated endome 367.0939 625 708.8717 567.0247 9.49E−01 7.68E−01 2 Unchanged Medium Q16342 G22ef6 programmed cell death 2 735.0961 759 490.3938 661.3332 −5.84E−01 4.52E−02 2 Unchanged Medium O75340 I02cd8 programmed cell death 6 1055.888 1090 1358.597 1167.782 3.62E−01 4.70E−02 2 Unchanged Medium P35232 C22ef5 porhibitin 2045.693 1810 1600.236 1818.121 −3.54E−01 −1.78E−01 2 Unchanged Medium Q9UQ80 O03cd1 proliferation-associated 2G4; 38

1902.387 1390 2003.135 1763.59 7.44E−02 −4.58E−01 2 Unchanged Medium Q12796 E05ab3 proline rich 2 1927.78 1530 1475.973 1643.691 −3.85E−01 −3.36E−01 2 Unchanged Medium Q15188 P20cd2 proline-rich protein BstNI subfa

997.5582 1290 1404.4 1232.034 4.93E−01 3.76E−01 2 Unchanged Medium P35998 L09ab8 proteasome (prosome; macropa

1010.463 1200 1059.594 1090.401 6.65E−02 2.49E−01 2 Unchanged Medium P47210 N16cd2 proteasome (prosome; macropa

1037.339 1150 1193 1127.919 2.02E−01 1.53E−01 2 Unchanged Medium O00495 N03ab8 proteasome (prosome; macropa

1043.875 498 563.7775 701.7628 −8.89E−01 −1.07E+00 2 Unchanged Medium O75831 N07ab8 proteasome (prosome; macropa

763.7632 622 506.8297 630.7237 −5.92E−01 −2.97E−01 2 Unchanged Medium Q13200 L15ab8 proteasome (prosome; macropa

644.3008 594 331.4288 523.3702 −9.59E−01 −1.16E−01 2 Unchanged Medium O43242 L17ab8 proteasome (prosome; macropa

2159.327 1230 1637.67 1675.386 −3.99E−01 −8.13E−01 2 Unchanged Medium P55036 N18cd2 proteasome (prosome; macropa

460.8093 724 588.5346 591.0419 3.53E−01 6.51E−01 2 Unchanged Medium P48556 L21ab8 proteasome (prosome; macropa

1240.243 1030 1685.116 1317.42 4.42E−01 −2.72E−01 2 Unchanged Medium Q92530 G07cd6 proteasome (prosome; macropa

1804.777 1570 1800.731 1724.253 −3.24E−03 −2.04E−01 2 Unchanged Medium P28066 J13ab8 proteasome (prosome; macropa

766.589 767 775.2704 769.7417 1.62E−02 1.46E−03 2 Unchanged Medium O14818 J15ab8 proteasome (prosome; macropa

1242.517 1540 1139.994 1308.162 −1.24E−01 3.12E−01 2 Unchanged Medium P49721 J19ab8 proteasome (prosome; macropa

1832.921 2110 1617.062 1853.89 −1.81E−01 2.04E−01 2 Unchanged Medium P28062 H18ab8 proteasome (prosome; macropa

797.3912 905 505.3638 735.864 −6.58E−01 1.82E−01 2 Unchanged Medium P28065 B06ef7 proteasome (prosome; macropa

771.1998 1630 1002.72 1133.626 3.79E−01 1.08E+00 2 Unchanged Medium P10619 A07ab8 protective protein for beta-galac

1539.157 907 980.3046 1142.279 −6.51E−01 −7.62E−01 2 Unchanged Medium Q9UNN8 F03cd6 protein C receptor, endothelial (E 892.1589 702 488.5084 694.2014 −8.69E−01 −3.46E−01 2 Unchanged Medium Q15084 H02cd5 protein disulfide isomerase-relat

1081.309 407 859.0228 782.4339 −3.32E−01 −1.41E+00 2 Unchanged Medium Q9Y2B9 C22cd7 protein kinase (cAMP-dependent 650.9588 1040 754.6101 814.4047 2.13E−01 6.73E−01 2 Unchanged Medium Q13517 A09ef5 protein kinase C binding protein 380.9448 587 630.5497 532.9442 7.27E−01 6.25E−01 2 Unchanged Medium P54619 F15ab8 protein kinase; AMP-activated; g

482.8359 572 841.1746 632.0976 8.01E−01 2.45E−01 2 Unchanged Medium P17612 F13ab8 protein kinase; cAMP-dependent 643.0385 629 901.5293 724.5168 4.87E−01 −3.19E−02 2 Unchanged Medium P09131 F10gh1 Protein P3 529.0069 607 617.0621 584.2407 2.22E−01 1.98E−01 2 Unchanged Medium O60927 P02gh1 protein phosphatase 1; regulator 1728.646 1760 1404.955 1630.486 −2.99E−01 2.42E−02 2 Unchanged Medium P41236 C08cd1 protein phosphatase 1; regulator 532.1136 621 583.7663 576.9436 1.34E−01 2.23E−01 2 Unchanged Medium Q15435 D15ab8 protein phosphatase 1; regulator 634.9759 963 753.9046 784.0242 2.48E−01 6.01E−01 2 Unchanged Medium P05323 E13ef6 protein phosphatase 2 (formerly

1058.276 1120 796.6526 992.192 −4.10E−01 8.39E−02 2 Unchanged Medium Q15257 G01ef5 protein phosphatase 2A; regulator 925.4458 905 1160.437 996.8116 3.26E−01 −3.29E−02 2 Unchanged Medium P33172 F01ab8 protein phosphatase 4 (formerly

1791.171 1220 1064.665 1357.256 −7.51E−01 −5.59E−01 2 Unchanged Medium O00743 F03ab8 protein phosphatase 6; catalytic

998.7 1070 738.4815 936.2693 −4.35E−01 1.02E−01 2 Unchanged Medium P38391 E21cd7 protein translocation complex be

1049.306 1050 1428.451 1175.447 4.45E−01 −9.93E−04 2 Unchanged Medium P78324 M17cd4 protein tyrosine phosphatase; no 639.2381 741 591.4877 657.1953 −1.12E−01 2.13E−01 2 Unchanged Medium Q13332 P21ab8 protein tyrosine phosphatase; re

1882.284 1880 2019.865 1928.827 1.02E−01 1.57E−03 2 Unchanged Medium Q9HAD6 C08gh6 protocadherin 16 dachsous-like ( 987.2552 906 1070.494 981.1143 1.46E−01 −9.50E−02 2 Unchanged Medium O43445 E11cd5 PRP4 pre-mRNA processing fact 777.1081 549 569.3749 631.8368 −4.49E−01 −5.01E−01 2 Unchanged Medium Q9Y6B3 L19ef2 PTD013 protein 652.1251 701 1031.739 794.9108 6.62E−01 1.04E−01 2 Unchanged Medium Q9HAN1 P19gh6 pumillo homolog 1 (Drosophila) 842.4925 1170 1047.18 1019.233 3.14E−01 4.71E−01 2 Unchanged Medium Q9NQA4 C23ef4 putative acid-sensing Ion channe 742.723 762 678.3813 727.7123 −1.31E−01 3.70E−02 2 Unchanged Medium O43598 J05cd6 putative c-Myc-responsive 473.6498 621 459.383 517.9666 −4.41E−02 3.90E−01 2 Unchanged Medium O43257 M12cd6 putative cyclin G1 interacting pro 1118.374 1190 1238.925 1183.655 1.48E−01 9.40E−02 2 Unchanged Medium Q9NY06 M07ef4 putative integral membrane trans 966.4384 544 569.8565 693.4947 −7.62E−01 −8.29E−01 2 Unchanged Medium P17152 H21cd4 putative receptor protein 399.9305 650 591.3162 547.029 5.64E−01 7.00E−01 2 Unchanged Medium Q9Y6I9 B13ef2 putative secreted protein 373.307 485 742.537 533.7168 9.92E−01 3.79E−01 2 Unchanged Medium P54886 B12ab8 pyrroline-5-carboxylate syntheta

406.7128 302 905.8993 538.0842 1.16E+00 −4.31E−01 2 Unchanged Medium Q13876 B03ef7 quiescin Q6 745.299 585 842.2489 718.0657 1.45E−01 −3.50E−01 2 Unchanged Medium O14679 K24ef5 quinone oxidoreductase homolo

710.5753 1160 651.2257 839.1208 −1.26E−01 7.02E−01 2 Unchanged Medium P53611 N16ab8 Rab geranylgeranyltransferase; t 758.1496 727 938.6179 807.7755 3.08E−01 −8.14E−02 2 Unchanged Medium P47224 D06ab8 RAB interacting factor 645.5902 859 577.3956 693.8748 −1.61E−01 4.11E−01 2 Unchanged Medium Q15907 H04cd4 RAB11B; member RAS oncogen

926.8757 1030 1224.758 1060.693 4.02E−01 1.53E−01 2 Unchanged Medium P51153 D04ab8 RAB13; member RAS oncogene 619.0867 935 1131.86 895.2783 8.70E−01 5.95E−01 2 Unchanged Medium P35287 J24ef2 RAB14; member RAS oncogene 543.7425 584 586.1635 571.2023 1.08E−01 1.02E−01 2 Unchanged Medium Q9NP72 P02ef8 RAB18; member RAS oncogene 459.4786 794 634.6616 629.3713 4.66E−01 7.89E−01 2 Unchanged Medium P11476 H22ab8 RAB1A; member RAS oncogene 1039.455 767 993.588 933.4801 −6.51E−02 −4.38E−01 2 Unchanged Medium Q9H0U4 L08gh7 RAB1B; member RAS oncogene 526.9882 691 696.5292 638.0939 4.02E−01 3.90E−01 2 Unchanged Medium P08886 B22ab8 RAB2; member RAS oncogene f

1483.703 1900 2195.304 1858.384 5.65E−01 3.54E−01 2 Unchanged Medium O95716 P04cd4 RAB3D; member RAS oncogene 908.9015 638 556.2242 701.181 −7.08E−01 −5.10E−01 2 Unchanged Medium P35239 D02ab8 RAB5B; member RAS oncogene 598.5113 708 393.3892 566.5496 −6.05E−01 2.42E−01 2 Unchanged Medium P20340 C07ef6 RAB6A; member RAS oncogene 503.1507 655 416.7552 524.9788 −2.72E−01 3.81E−01 2 Unchanged Medium P43487 D16ab8 RAN binding protein 1 1438.305 1180 1786.177 1468.585 3.13E−01 −2.84E−01 2 Unchanged Medium Q9UI26 B20ef1 Ran binding protein 11 1505.224 1180 1273.677 1319.368 −2.41E−01 −3.52E−01 2 Unchanged Medium P47736 D18ab8 RAP1; GTPase activating protei

875.8692 414 461.3322 583.6391 −9.25E−01 −1.08E+00 2 Unchanged Medium Q15382 F17cd2 Ras homolog enriched in brain 2 1435.587 2190 1635.792 1754.23 1.88E−01 6.10E−01 2 Unchanged Medium P52199 B18ab2 ras homolog gene family; memb

534.6169 1520 399.0517 816.6152 −4.22E−01 1.50E+00 2 Unchanged Medium P35238 B20ab2 ras homolog gene family; memb

1022.646 872 1019.472 971.4616 −4.48E−03 −2.29E−01 2 Unchanged Medium Q14644 J08ef7 RAS p21 protein activator (GTPa 615.946 623 627.059 622.1475 2.58E−02 1.74E−02 2 Unchanged Medium Q15404 A10cd8 Ras suppressor protein 1 1543.953 1920 2317.155 1925.544 5.86E−01 3.11E−01 2 Unchanged Medium Q13283 H14cd5 Ras-GTPase-activating protein S 846.7267 789 571.1476 735.5498 −5.68E−01 −1.02E−01 2 Unchanged Medium Q9NVQ9 M05gh1 Rec8p; a meiotic recombination

1334.371 1200 1325.85 1286.027 −9.24E−03 −1.56E−01 2 Unchanged Medium O60895 K17cd6 receptor (calcitonin) activity modi 572.8174 519 899.2606 663.6562 6.51E−01 −1.43E−01 2 Unchanged Medium P35244 I22ef6 replication protein A3 (14 kD) 544.0212 502 924.5385 656.7974 7.65E−01 −1.16E−01 2 Unchanged Medium Q99623 D03cd7 repressor of estrogen receptor a

1139.283 689 1233.151 1020.486 1.14E−01 −7.25E−01 2 Unchanged Medium Q9UMQ4 C01gh1 ret proto-oncogene (multiple end 769.2484 602 803.931 725.1999 6.36E−02 −3.53E−01 2 Unchanged Medium Q9NQC3 M19cd7 reticulon 4 1459.586 586 927.9776 991.1835 −6.53E−01 −1.32E+00 2 Unchanged Medium P47804 P03cd1 retinal G protein coupled recepto 403.1219 497 627.4176 509.1489 6.38E−01 3.02E−01 2 Unchanged Medium Q16576 P07ef8 retinoblastoma binding protein 7 1539.006 1410 798.8744 1250.347 −9.46E−01 −1.23E−01 2 Unchanged Medium O95357 D02cd4 retinoic acid induced 3 678.1926 713 206.6352 532.4837 −1.71E+00 7.14E−02 2 Unchanged Medium Q15299 D20ef1 retinoic acid receptor-beta assoc 1060.232 979 1013.444 1017.603 −6.51E−02 −1.15E−01 2 Unchanged Medium Q9UMY1 P05ef2 retinoic acid repressible protein 610.5279 726 588.2413 641.044 −5.86E−02 2.51E−01 2 Unchanged Medium Q13017 M15ef6 Rho GTPase activating protein 5 560.443 807 514.6138 627.5049 −1.23E−01 5.27E−01 2 Unchanged Medium O43182 B24ab2 Rho GTPase activating protein 6 1257.146 806 895.7191 988.3979 −4.89E−01 −6.41E−01 2 Unchanged Medium O60274 F04gh6 Rho-specific guanine nucleotide 651.9484 577 366.4761 531.8448 −8.31E−01 −1.76E−01 2 Unchanged Medium P07998 P21cd1 ribonuclease; RNase A family; 1 1294.476 3040 1592.811 1976.991 2.99E−01 1.23E+00 2 Unchanged Medium P04843 B12cd1 ribophorin I 1493.814 1360 2248.214 1700.316 5.90E−01 −1.37E−01 2 Unchanged Medium P04844 B14cd1 ribophorin II 1574.181 1170 1880.047 1540.461 2.56E−01 −4.32E−01 2 Unchanged Medium P26373 D11cd1 ribosomal protein L13 2091.256 1200 1924.546 1739.922 −1.20E−01 −7.97E−01 2 Unchanged Medium P40429 H12ef1 ribosomal protein L13a 1928.024 2060 1091.46 1694.794 −8.21E−01 9.89E−02 2 Unchanged Medium P39019 J05cd1 ribosomal protein S19 1794.644 1480 2253.771 1841.785 3.29E−01 −2.81E−01 2 Unchanged Medium P78317 B04cd1 ring finger protein 4 756.2395 661 668.8027 695.4611 −1.77E−01 −1.93E−01 2 Unchanged Medium Q99942 F04cd2 ring finger protein 5 1016.837 949 1126.187 1030.595 1.47E−01 −1.00E−01 2 Unchanged Medium O43148 A15cd4 RNA (guanine-7-) methyltransfer

572.6495 730 390.498 564.3647 −5.52E−01 3.50E−01 2 Unchanged Medium O02916 F06ab8 RNA binding motif protein 4 533.7121 628 430.5298 530.87 −3.10E−01 2.36E−01 2 Unchanged Medium Q9Y580 J10gh6 RNA binding motif protein 7 368.8423 710 558.043 545.5838 5.97E−01 9.45E−01 2 Unchanged Medium Q14621 H07cd7 RNA binding protein (autoantige

499.5699 737 506.822 581.142 2.08E−02 5.61E−01 2 Unchanged Medium Q93062 K17cd7 RNA binding protein gene with r

845.0994 659 640.4514 714.6837 −4.00E−01 −3.60E−01 2 Unchanged Medium Q99497 B15cd7 RNA-binding protein regulatory s 1914.86 1400 2563.974 1958.111 4.21E−01 −4.56E−01 2 Unchanged Medium Q99584 L17cd2 S100 calcium binding protein A1

492.6196 421 675.1457 529.713 4.55E−01 −2.25E−01 2 Unchanged Medium P23526 A06ef1 S-adenosylhomocysteine hydorl

550.6181 603 478.692 544.258 −2.02E−01 1.32E−01 2 Unchanged Medium O43865 H21ab2 S-adenosylhomocysteine hydorl

1460.581 526 466.4887 817.8431 −1.65E+00 −1.47E+00 2 Unchanged Medium O14828 D02cd5 secretory carrier membrane prot

661.3976 460 481.9262 534.3923 −4.57E−01 −5.24E−01 2 Unchanged Medium O75326 L05cd3 sema domain; immunoglobulin d

795.0564 768 943.1132 835.2276 2.46E−01 −5.09E−02 2 Unchanged Medium O43278 I16cd2 serine protease inhibitor; Kunitz I 1295.263 1260 641.0775 1066.162 −1.01E+00 −3.74E−02 2 Unchanged Medium O00271 C05ef5 serine protease inhibitor; Kunitz I 1379.545 1740 876.4128 1332.552 −6.55E−01 3.36E−01 2 Unchanged Medium Q9UEW8 N22ef5 serine threonine kinase 39 (STE

1230.117 1030 841.1872 1032.185 −5.48E−01 −2.63E−01 2 Unchanged Medium Q13043 P15cd2 serine/threonine kinase 4 750.7132 838 756.1662 781.5546 1.04E−02 1.58E−01 2 Unchanged Medium Q9Y282 F01ef2 serologically defined breast canc 1279.414 1160 1907.544 1448.986 5.76E−01 −1.41E−01 2 Unchanged Medium P35542 A02gh1 serum amyloid A4; constitutive 754.5041 1310 811.5701 959.3499 1.05E−01 7.98E−01 2 Unchanged Medium O75790 I22cd6 seven transmembrane domain pr

761.3872 778 799.0998 779.5745 6.97E−02 3.16E−02 2 Unchanged Medium Q9P0V3 H17ef3 SH3-domain binding protein 4 1204.005 1710 1539.363 1483.624 3.54E−01 5.04E−01 2 Unchanged Medium Q99519 C13ab8 stalidase 1 (lysosomal stalidase) 712.4593 680 498.7449 630.4426 −5.15E−01 −6.70E−02 2 Unchanged Medium Q92185 J20cd1 stalytransferase 8A (alpha-N-ac

622.4236 478 462.7941 520.9105 −4.28E−01 −3.82E−01 2 Unchanged Medium Q9Y6A9 C05ef8 signal peptidase 12 kDa 449.125 742 887.4615 692.8575 9.83E−01 7.24E−01 2 Unchanged Medium P21378 I04ef3 signal peptidase complex (18 kD) 630.5817 515 732.1592 626.0198 2.16E−01 −2.91E−01 2 Unchanged Medium O15302 P10ab3 signal recognition particle 72 kD 1040.23 818 841.5078 899.9534 −3.06E−01 −3.47E−01 2 Unchanged Medium O76094 J02cd2 signal recognition particle 72 kD 1473.56 965 1422.2 1286.822 −5.12E−02 −6.11E−01 2 Unchanged Medium Q9UNL2 J10cd2 signal sequence receptor; gamm 1150.724 450 1654.744 1085.128 5.24E−01 −1.35E+00 2 Unchanged Medium P40763 K09ef5 signal transducer and activator o 671.5038 545 348.0347 521.4351 −9.48E−01 −3.02E−01 2 Unchanged Medium Q92783 M24cd3 signal transducing adaptor moie

827.9851 1020 725.7017 857.8322 −1.90E−01 3.01E−01 2 Unchanged Medium Q9H723 N01gh5 similar to rat nuclear ubiquitous

749.7661 530 1258.65 846.2392 7.47E−01 −5.00E−01 2 Unchanged Medium O15258 A04cd7 similar to S. cerevisiae RER1 710.8499 635 933.6382 759.8427 3.93E−01 −1.63E−01 2 Unchanged Medium O14834 A11cd7 similar to S. pombe dim1+ 701.2292 753 903.8926 786.0877 3.66E−01 1.03E−01 2 Unchanged Medium O43617 H05ef3 similar to yeast BET3 (S. cerevis 1759.348 1750 1443.578 1650.871 −2.85E−01 −7.94E−03 2 Unchanged Medium Q04837 G11cd2 single-standed DNA binding pro 1264.277 894 1034.75 1064.292 −2.89E−01 −5.00E−01 2 Unchanged Medium P05455 E19gh1 sjogren syndrome antigen B (aut

850.9691 744 930.6428 841.9268 1.29E−01 −1.93E−01 2 Unchanged Medium P43331 K08cd2 small nuclear ribonucleoprotein

916.3597 1260 1042.335 1073.82 1.86E−01 4.63E−01 2 Unchanged Medium P09012 M12cd2 small nuclear ribonucleoprotein

546.0261 310 685.6636 514.5708 3.23E−01 −8.22E−01 2 Unchanged Medium P08579 A03cd2 small nuclear ribonucleoprotein

502.6355 570 669.9879 581.0279 4.15E−01 1.83E−01 2 Unchanged Medium P09234 A05cd2 small nuclear ribonucleoprotein

1054.327 1450 1302.742 1269.64 3.05E−01 4.62E−01 2 Unchanged Medium P08578 A07cd2 small nuclear ribonucleoprotein

1901.214 1740 1818.557 1819.876 −6.41E−02 −1.28E−01 2 Unchanged Medium Q15357 A11cd2 small nuclear ribonucleoprotein

382.4892 734 593.847 570.2015 6.35E−01 9.41E−01 2 Unchanged Medium P14678 C23cd3 small nuclear ribonucleoprotein

2036.574 1280 1737.398 1686.175 −2.29E−01 −6.65E−01 2 Unchanged Medium Q13487 P08cd1 small nuclear RNA activating co

517.5819 684 648.0121 616.6789 3.24E−01 4.03E−01 2 Unchanged Medium P35326 E17cd3 small proline-rich protein 2A 290.6174 1030 839.3072 721.2318 1.53E+00 1.83E+00 2 Unchanged Medium P55854 H04cd2 SMT3 suppressor of mif tow 3 ho 791.7437 658 962.4453 804.107 2.82E−01 −2.67E−01 2 Unchanged Medium P14648 P19cd5 SNRPN upstream reading frame 1581.907 2270 1670.964 1839.36 7.90E−02 5.18E−01 2 Unchanged Medium P55011 L17cd1 solute carrier family 12 (sodium

591.8676 740 517.2382 616.497 −1.94E−01 3.23E−01 2 Unchanged Medium O95258 P15cd4 solute carrier family 25 (mitochor 476.3075 518 577.8319 523.9535 2.79E−01 1.20E−01 2 Unchanged Medium O15431 A21ab5 solute carrier family 31 (copper t

1227.872 1010 1769.026 1336.855 5.27E−01 −2.77E−01 2 Unchanged Medium P04920 L04cd1 solute carrier family 4; anion exc

1614.362 1560 1704.134 1624.765 7.81E−02 −5.33E−02 2 Unchanged Medium Q01650 J11ef5 solute carrier family 7 (cationic a

832.6996 632 1032.106 832.1088 3.10E−01 −3.99E−01 2 Unchanged Medium Q07890 H23cd2 son of sevenless homolog 2 (Dro 476.9505 568 680.8529 575.1528 5.14E−01 2.51E−01 2 Unchanged Medium O60749 A19cd2 sorting nexin 2 364.9343 931 769.5782 688.5915 1.08E+00 1.35E+00 2 Unchanged Medium O60493 A09cd4 sorting nexin 3 1008.916 1350 1180.469 1180.399 2.27E−01 4.22E−01 2 Unchanged Medium Q9Y5X3 G06ef4 sorting nexin 5 676.0975 647 688.5568 670.591 2.63E−02 −6.32E−02 2 Unchanged Medium Q01082 E09cd2 spectrin; beta; non-erythrocytic 1 571.4909 679 387.0403 545.8922 −5.62E−01 2.49E−01 2 Unchanged Medium P52788 M10cd2 spermine synthase 895.1994 854 770.002 839.7693 −2.17E−01 −6.78E−02 2 Unchanged Medium P17947 C19cd2 spleen focus forming virus (SFF

1307.418 1150 1646.278 1366.573 3.32E−01 −1.90E−01 2 Unchanged Medium Q14818 D10ef6 splicing factor 1 547.0998 499 782.2929 609.3662 5.16E−01 −1.34E−01 2 Unchanged Medium Q15427 K11cd6 splicing factor 3b; subunit 4; 49k

441.2394 612 540.0723 530.9445 2.92E−01 4.71E−01 2 Unchanged Medium Q15815 M06cd2 splicing factor; arginine/serine-ri

738.2591 553 551.9082 614.261 −4.20E−01 −4.18E−01 2 Unchanged Medium Q01130 H22cd1 splicing factor; arginine/serine-ri

553.5808 527 488.5465 522.9409 −1.80E−01 −7.18E−02 2 Unchanged Medium P23152 H24cd1 splicing factor; arginine/serine-ri

1547.474 1460 1428.273 1480.13 −1.16E−01 −7.94E−02 2 Unchanged Medium Q13503 L22cd4 SRB7 suppressor of RNA polym

712.8859 574 725.0591 670.5377 2.44E−02 −3.13E−01 2 Unchanged Medium Q9P2R9 C23ef2 SRp25 nuclear protein 495.796 558 515.095 522.8318 5.51E−02 1.69E−01 2 Unchanged Medium Q9H6I2 F07gh5 SRY (sex determining region Y)-

774.5162 970 714.8666 819.674 −1.16E−01 3.24E−01 2 Unchanged Medium Q9BT81 I13gh8 SRY (sex determining region Y)-

497.0608 530 550.1706 525.7297 1.46E−01 9.25E−02 2 Unchanged Medium O60526 M03cd6 STIP1 homology and U-Box cont

706.6078 538 543.7559 596.1019 −3.78E−01 −3.93E−01 2 Unchanged Medium Q9Y6X1 A21ef4 stress-associated endoplasmic

1683.36 1220 2201.647 1700.636 3.87E−01 −4.68E−01 2 Unchanged Medium P31948 M15ef3 stress-induced-phosphoprotein 1 438.1143 549 517.5834 500.9139 2.47E−01 3.32E−01 2 Unchanged Medium P21912 E09gh1 succinate dehydrogenase compl

701.7228 902 751.7357 785.3111 9.93E−02 3.63E−01 2 Unchanged Medium O14521 H04cd1 succinate dehydrogenase compl

628.8405 505 672.375 601.9355 9.66E−02 −3.18E−01 2 Unchanged Medium P53597 I09gh1 succinate-CoA ligase; GDP-form

704.4006 491 553.293 582.7447 −3.48E−01 −5.22E−01 2 Unchanged Medium O95605 P15cd5 SUMO-1 activating enzyme subu

776.4199 499 433.2742 569.4163 −8.42E−01 −6.39E−01 2 Unchanged Medium Q16550 K01cd2 suppressor of Ty 4 homolog 1 (S 813.5735 1440 991.3588 1081.744 2.85E−01 8.24E−01 2 Unchanged Medium Q15526 K07cd2 surfelt 1 468.3614 522 583.8097 524.7026 3.18E−01 1.56E−01 2 Unchanged Medium O43539 P02cd1 SWI/SNF related; matrix associa

1047.14 1280 1212.614 1178.519 2.12E−01 2.85E−01 2 Unchanged Medium Q9UPX1 D23cd7 synaptopodin 683.4973 536 421.1841 546.8885 −6.98E−01 −3.51E−01 2 Unchanged Medium O95721 O09cd5 synaptosomal-associated protein 830.7721 1030 686.6755 849.1506 −2.75E−01 3.10E−01 2 Unchanged Medium O43391 H09cd2 syndecan binding protein (synter 625.6962 640 379.1899 548.1569 −7.23E−01 3.17E−02 2 Unchanged Medium Q15833 J04cd2 syntaxin binding protein 2 661.0175 556 840.6951 686.0183 3.47E−01 −2.49E−01 2 Unchanged Medium Q92804 O20cd3 TAF15 RNA polymerase II; TAT

873.5584 605 1063.778 847.4936 2.84E−01 −5.30E−01 2 Unchanged Medium Q9Y490 B04cd2 talin 1 1342.238 1170 2365.625 1625.187 8.18E−01 −2.01E−01 2 Unchanged Medium O94797 H20ef7 Tara-like protein 899.0807 448 496.1404 614.3777 −8.58E−01 −1.01E+00 2 Unchanged Medium Q13311 C05cd6 Tax1 (human T-cell leukemia vir

899.9979 1190 926.2314 1004.505 4.15E−02 4.00E−01 2 Unchanged Medium Q16650 F08cd6 T-box; brain; 1 1407.309 1750 1777.889 1645.184 3.37E−01 3.15E−01 2 Unchanged Medium P51864 O04ef7 teratocarcinoma-derived growth I 2037.212 1590 1447.46 1690.282 −4.93E−01 −3.61E−01 2 Unchanged Medium P55061 O19cd2 testis enhanced gene transcript ( 1540.968 1330 1972.323 1615.143 3.56E−01 −2.10E−01 2 Unchanged Medium Q15569 P21cd2 testis-specific kinase 1 837.6269 796 708.1178 780.661 −2.42E−01 −7.31E−02 2 Unchanged Medium O60636 F08cd5 tetraspan 2 468.1664 702 375.3225 515.2157 −3.19E−01 5.85E−01 2 Unchanged Medium O60637 F06cd5 tetraspan 3 1025.362 742 545.9662 770.9441 −9.09E−01 −4.68E−01 2 Unchanged Medium O95857 F13ef3 tetraspan NET-6 protein 702.1579 676 359.1921 578.9636 −9.67E−01 −5.58E−02 2 Unchanged Medium Q99614 M03cd3 tetratricopeptide repeat domain 1 706.3536 891 635.5379 744.2616 −1.52E−01 3.35E−01 2 Unchanged Medium Q13118 L05cd2 TGFB inducible early growth res

445.9691 601 679.2931 575.4732 6.07E−01 4.31E−01 2 Unchanged Medium Q15583 A16cd2 TGFB-induced factor (TALE fami

885.9 1290 1140.439 1105.268 3.64E−01 5.42E−01 2 Unchanged Medium Q9H3N1 N03gh7 thioredoxin domain-containing 409.6333 426 686.7997 507.428 7.46E−01 5.60E−02 2 Unchanged Medium O43396 O17cd5 thioredoxin-like; 32 kD 1821.595 1710 1548.596 1693.179 −2.34E−01 −9.18E−02 2 Unchanged Medium P04216 B02cd2 Thy-1 cell surface antigen 169.8064 298 4157.367 1541.609 4.61E+00 8.10E−01 2 Unchanged Medium P12956 K10ef6 thyroid autoantigen 70 kD (Ku an

1172.56 1490 1395.803 1353.001 2.51E−01 3.46E−01 2 Unchanged Medium P16035 P11ef7 tissue inhibitor of metalloprotein

360.2533 354 913.1351 542.4517 1.34E+00 −2.54E−02 2 Unchanged Medium Q9H2X8 I08gh8 TLH29 protein precursor 710.2447 1000 1386.102 1033.648 9.65E−01 5.00E−01 2 Unchanged Medium Q13077 L11cd2 TNF receptor-associated factor 1 1265.054 1270 756.401 1097.404 −7.42E−01 6.49E−03 2 Unchanged Medium Q9NZ34 P08gh4 TPA regulated locus 1074.319 1090 1284.44 1148.575 2.58E−01 1.69E−02 2 Unchanged Medium Q15369 D18ef6 transcription elongation factor B

771.5598 1100 693.1767 854.8396 −1.55E−01 5.11E−01 2 Unchanged Medium Q15906 P11ef6 transcription factor-like 1 436.5561 510 878.9083 608.5936 1.01E+00 2.25E−01 2 Unchanged Medium P50616 H08cd5 transducer of ERBB2; 1 888.8059 874 518.1816 760.3803 −7.78E−01 −2.40E−02 2 Unchanged Medium Q13595 N04ef7 transformer-2 alpha (htra-2 alph

247.4437 612 698.379 519.219 1.50E+00 1.31E+00 2 Unchanged Medium P37802 F05cd3 transgelin 2 1986.716 2240 1173.434 1798.473 −7.60E−01 1.70E−01 2 Unchanged Medium Q9Y5Z9 D01cd8 transitional epithelia response pr

1324.284 875 1126.793 1108.824 −2.33E−01 −5.97E−01 2 Unchanged Medium Q99595 K10cd6 translocase of inner mitochondri

450.6578 665 448.5161 521.2602 −6.87E−03 5.60E−01 2 Unchanged Medium O60830 A09cd6 translocase of inner mitochondri

1646.564 1590 1992.925 1744.175 2.75E−01 −4.77E−02 2 Unchanged Medium O14925 I24cd6 translocase of inner mitochondri

745.8102 813 653.4301 737.451 −1.91E−01 1.25E−01 2 Unchanged Medium Q9Y5J9 E08cd8 translocase of inner mitochondri

1641.377 1550 1653.524 1615.991 1.06E−02 −7.98E−02 2 Unchanged Medium Q15629 G18ef3 translocating chain-associating n

1003.031 1060 624.4499 897.0752 −6.84E−01 8.48E−02 2 Unchanged Medium Q99442 C10cd2 translocation protein 1 526.8783 772 1065.397 788.001 1.02E+00 5.51E−01 2 Unchanged Medium Q99805 A18cd5 transmembrane 9 superfamily m

1023.368 1260 957.2601 1081.028 −9.63E−02 3.03E−01 2 Unchanged Medium Q9Y2B0 C20ef3 transmembrane protein 4 681.3857 1320 985.8397 995.6424 5.33E−01 9.54E−01 2 Unchanged Medium P49755 J05ef4 transmembrane trafficking protei

1311.203 469 700.7243 827.066 −9.04E−01 −1.48E+00 2 Unchanged Medium F03gh4 transmembrane; prostate androg 1287.98 841 662.4165 930.4505 −9.59E−01 −6.15E−01 2 Unchanged Medium Q03519 B07cd1 transporter 2; ATP-binding casse

851.2148 573 680.8519 701.534 −3.22E−01 −5.72E−01 2 Unchanged Medium Q9NWF9 P02gh2 TRIAD3 protein 665.9772 444 688.6646 599.4053 4.83E−02 −5.86E−01 2 Unchanged Medium Q15656 O07ef7 TRK-fused gene 1878.254 1640 1858.307 1792.501 −1.54E−02 −1.95E−01 2 Unchanged Medium Q92734 J17cd7 TRK-fused gene 1450.307 1810 1609.067 1624.429 1.50E−01 3.23E−01 2 Unchanged Medium Q12815 A21ef7 trophinin associated protein (last 821.5601 1100 722.8644 879.96 −1.65E−01 4.15E−01 2 Unchanged Medium P09493 O02cd1 tropomyosin 1 (alpha) 988.1694 429 1004.982 807.373 2.43E−02 −1.20E+00 2 Unchanged Medium P49411 M11cd3 Tu translation elongation factor;

525.8572 555 476.4592 519.255 −1.42E−01 7.90E−02 2 Unchanged Medium P05217 F03gh6 tubulin; beta; 2 1203.686 705 920.1831 942.8088 −3.87E−01 −7.73E−01 2 Unchanged Medium P23258 K03cd3 tubulin; gamma 1 1733.971 1220 2149.365 1702.331 3.10E−01 −5.03E−01 2 Unchanged Medium Q9UBN6 A16ef6 tumor necrosis factor receptor su 470.7412 751 531.524 584.4772 1.75E−01 6.74E−01 2 Unchanged Medium Q13829 L22ef4 tumor necrosis factor; alpha-indu

849.276 792 552.7776 731.2933 −6.20E−01 −1.01E−01 2 Unchanged Medium O00496 K21cd3 tumor suppressing subtransferab 628.3509 554 800.8751 661.0848 3.50E−01 −1.62E−01 2 Unchanged Medium Q99816 G04cd4 tumor susceptibility gene 101 723.8133 766 627.1295 705.4904 −2.07E−01 8.08E−02 2 Unchanged Medium P16422 C03ab7 tumor-associated calcium signal 1448.512 791 373.663 870.9367 −1.95E+00 −8.73E−01 2 Unchanged Medium Q9NP84 K03ef2 type I transmembrane protein Fn 691.89 498 560.2824 583.2792 −3.04E−01 −4.75E−01 2 Unchanged Medium Q9UJ47 O09cd8 type I transmembrane receptor (

792.9873 819 809.9056 807.3703 3.05E−02 4.69E−02 2 Unchanged Medium P31946 K21ef6 tyrosine 3-monooxygenase/tryp

1220.989 955 724.9898 966.9847 −7.52E−01 −3.55E−01 2 Unchanged Medium P35214 J19ef4 tyrosine 3-monooxygenase/tryp

881.0131 989 682.5327 850.9964 −3.68E−01 1.67E−01 2 Unchanged Medium P27348 G15cd7 tyrosine 3-monooxygenase/tryp

2196.334 1540 1104.855 1615.078 −9.91E−01 −5.08E−01 2 Unchanged Medium O60704 J01cd3 tyrosylprotein sulfotransferase 2 658.3761 299 686.1339 547.7036 5.96E−02 −1.14E+00 2 Unchanged Medium Q9Y4Z0 G09cd8 U6 snRNA-associated Sm-like pr 837.5087 689 914.9547 813.8478 1.28E−01 −2.81E−01 2 Unchanged Medium P14927 G06cd4 ubiquinol-cytochrome c reductas

995.1237 817 954.3085 922.1475 −6.04E−02 −2.85E−01 2 Unchanged Medium Q9UI02 P18ef7 ubiquinol-cytochrome c reductas

953.6884 1460 1546.568 1320.75 6.97E−01 6.16E−01 2 Unchanged Medium P31930 A22cd3 ubiquinol-cytochrome c reductas

846.6396 849 686.9864 794.0747 −3.01E−01 3.33E−03 2 Unchanged Medium P22695 A24cd3 ubiquinol-cytochrome c reductas

468.5936 636 581.791 562.0633 3.12E−01 4.40E−01 2 Unchanged Medium P07919 E08cd4 ubiquinol-cytochrome c reductas

1328.532 1810 1005.378 1382.391 −4.02E−01 4.49E−01 2 Unchanged Medium P47985 E06cd4 ubiquinol-cytochrome c reductas

1519.763 1270 1127.575 1306.086 −4.31E−01 −2.58E−01 2 Unchanged Medium Q9NZ09 N17ef1 ubiquitin associated protein 1588.177 1820 1392.592 1598.619 −1.90E−01 1.93E−01 2 Unchanged Medium Q9UNP0 F09gh6 ubiquitin specific protease 15 525.3364 492 597.7817 538.3523 1.86E−01 −9.48E−02 2 Unchanged Medium Q9UHP3 L21cd8 ubiquitin specific protease 25 554.0657 724 561.5817 613.0845 1.94E−02 3.85E−01 2 Unchanged Medium P22314 O07cd3 ubiquitin-activating enzyme E1 (

1857.238 1640 1863.316 1788.503 4.71E−03 −1.75E−01 2 Unchanged Medium Q13404 O23cd3 ubiquitin-conjugating enzyme E2 1073.414 1210 1128.962 1138.559 7.28E−02 1.77E−01 2 Unchanged Medium P51669 D05cd4 ubiquitin-conjugating enzyme E2 1266.25 1300 1173.73 1247.427 −1.09E−01 4.05E−02 2 Unchanged Medium P47986 O11cd3 ubiquitin-conjugating enzyme E2 616.3689 520 567.7317 567.8765 −1.19E−01 −2.47E−01 2 Unchanged Medium O14933 H14cd4 ubiquitin-conjugating enzyme E2 717.4244 893 596.6415 735.6835 −2.66E−01 3.16E−01 2 Unchanged Medium Q16781 D07cd4 ubiquitin-conjugating enzyme E2 923.6537 816 533.7389 757.984 −7.91E−01 −1.78E−01 2 Unchanged Medium Q93068 A02cd3 ubiquitin-like 1 (sentrin) 1376.087 1530 1294.307 1399.48 −8.84E−02 1.51E−01 2 Unchanged Medium Q15386 I10gh1 ubiquitin-protein isopeptide ligas

531.8659 630 628.2454 596.8686 2.40E−01 2.45E−01 2 Unchanged Medium Q9UBK9 I15cd4 ubiquitously-expressed transcrip

936.2619 1060 1384.764 1125.743 5.65E−01 1.74E−01 2 Unchanged Medium O60512 E11ab3 UDP-Gal:betaGlcNAc beta 1:4-

436.7634 610 542.39 529.5839 3.12E−01 4.81E−01 2 Unchanged Medium P78383 P20cd5 UDP-galactose transporter relat

1570.135 1700 2180.117 1818.963 4.74E−01 1.15E−01 2 Unchanged Medium Q16851 I24cd4 UDP-glucose pyrophosphorylase 1324.08 1260 1318.78 1302.468 −5.79E−03 −6.64E−02 2 Unchanged Medium Q9NZ45 L02gh3 uncharacterized hematopoietic s

652.0685 670 696.5692 672.9895 9.52E−02 3.98E−02 2 Unchanged Medium Q9NZ32 L20gh4 uncharacterized hypothalamus p 1035.575 1250 1354.231 1214.412 3.87E−01 2.75E−01 2 Unchanged Medium Q9NZ29 L16gh4 uncharacterized hypothalamus p 659.53 992 1118.776 923.516 7.62E−01 5.89E−01 2 Unchanged Medium Q15853 C02cd3 upstream transcription factor 2; c 601.6839 635 698.0128 644.9023 2.14E−01 7.78E−02 2 Unchanged Medium Q92528 D02ef7 uridine monophosphate kinase 560.3976 685 623.5243 623.0076 1.54E−01 2.90E−01 2 Unchanged Medium P15692 M04ef7 vascular endotheliai growth facto 460.9257 539 857.3853 619.202 8.95E−01 2.27E−01 2 Unchanged Medium P50552 C08cd3 vasodilator-stimulated phosphop

468.4573 648 392.5569 502.9122 −2.55E−01 4.67E−01 2 Unchanged Medium O60763 H16cd3 vesicle docking protein p115 639.538 543 745.4806 642.7624 2.21E−01 −2.35E−01 2 Unchanged Medium Q15836 A15ef5 vesicle-associated membrane pn 804.2648 1370 1060.211 1076.578 3.99E−01 7.63E−01 2 Unchanged Medium Q9UEU0 O22cd6 vesicle-associated soluble NSF

468.6024 697 698.3534 621.1953 5.76E−01 5.72E−01 2 Unchanged Medium P14921 E24ef5 v-ets erythroblastosis virus E26

913.893 765 291.1538 656.6528 −1.65E+00 −2.57E−01 2 Unchanged Medium P18206 C14cd3 vinculin 580.3315 857 865.7505 767.5496 5.77E−01 5.62E−01 2 Unchanged Medium P00540 G08ef5 v-mos Moloney murine sarcoma 1115.145 728 663.6747 835.5051 −7.49E−01 −6.16E−01 2 Unchanged Medium P01106 E18ef5 v-myc myelocytomatosis viral on

537.8131 601 405.1047 514.7639 −4.09E−01 1.61E−01 2 Unchanged Medium P21796 C16cd3 voltage-dependent anion channe 483.8969 510 584.201 525.9036 2.72E−01 7.47E−02 2 Unchanged Medium Q15765 C12cd3 von Hippel-Lindau binding prote

689.743 705 891.2621 762.0788 3.70E−01 3.20E−02 2 Unchanged Medium P10398 D01ab4 v-raf murine sarcoma 3611 viral

1061.812 639 532.2153 744.4583 −9.96E−01 −7.32E−01 2 Unchanged Medium P11233 A19ef6 v-ral simian leukemia viral oncog 848.7099 1060 1081.428 995.8044 3.50E−01 3.17E−01 2 Unchanged Medium Q9Y6W5 A22gh1 WAS protein family; member 2 1283.077 1630 1493.145 1468.514 2.18E−01 3.45E−01 2 Unchanged Medium Q9UPY6 L06cd6 WAS protein family; member 3 1503.584 1210 2151.643 1623.108 5.17E−01 −3.09E−01 2 Unchanged Medium O75083 D15cd5 WD repeat domain 1 892.4425 977 983.3448 944.1492 1.10E−01 1.30E−01 2 Unchanged Medium O76071 A24cd5 WD40 protein Clao1 609.8821 898 730.5311 746.1814 2.60E−01 5.58E−01 2 Unchanged Medium Q9HCN4 H11gh6 XPA binding protein 1; putative

1199.21 1070 507.3277 923.9753 −1.24E+00 −1.71E−01 2 Unchanged Medium Q9UM05 N17ef3 yeast Sec31p homolog 1887.447 1590 1542.778 1672.59 −2.91E−01 −2.50E−01 2 Unchanged Medium Q9UQR1 P06gh1 zinc finger protein 148 (pHZ-52) 513.8639 737 563.7625 604.9201 1.34E−01 5.21E−01 2 Unchanged Medium Q14119 G21ef5 zinc finger protein 161 1199.558 1760 1197.34 1387.253 −2.67E−03 5.57E−01 2 Unchanged Medium Q9NW07 F06gh2 zinc finger protein 358 402.8342 575 684.7069 554.3431 7.65E−01 5.15E−01 2 Unchanged Medium P20694 D04ef6 zinc finger protein 9 (a cellular re 1042.65 1010 856.5924 969.9823 −2.84E−01 −4.49E−02 2 Unchanged Medium 

1. A method for expanding mammalian acinar cells, comprising culturing said cells in a cell culture system comprising a cell culture medium and a cell attachment surface, under conditions wherein said acinar cells undergo a 3-4 fold expansion together with transdifferentiation into a modified cell phenotype (IP cells) showing characteristics of acinar cells and liver cells.
 2. The method of claim 1, wherein said cells having a modified phenotype express cytokeratin 18 (CK18), CK8, CK19, CK7, HNF1, alpha-1 antitrypsin, pi-glutathione s transferase (pi-GST), liver-specific bHLH transcription factor, Thy-1, C/EBP-alpha and C/EBP-beta, and express little if any carbonic anhydrase, cystic fibrosis transmembrane conductance regulator (CFTR), elastase and amylase.
 3. The method of claim 1, wherein said culture medium comprises insulin, transferrin, selenium and epidermal growth factor (EGF) in a base medium suitable for maintaining epithelial cells.
 4. The method of claim 1, wherein said culture medium comprises serum.
 5. The method of claim 4, wherein said culture medium comprises up to 15% serum.
 6. The method of claim 1, wherein said culture medium is serum-free.
 7. The method of claim 1, wherein said cell culture medium comprises an effective amount of at least one soluble active factor that promotes growth expansion and transdifferentiation of acinar cells to IP cells.
 8. The method of claim 7, wherein said culture medium comprises an effective amount of at least one factor selected from the group consisting of heat inactivated bovine serum albumin (BSA) and the soluble active factors hepatocyte growth factor (HGF), insulin-like growth factor-1 (IGF-1), transforming growth factor alpha (TGF-α), betacellulin, gastrin I and prolactin.
 9. The method of claim 7, wherein said culture medium comprises an effective amount of at least one soluble active factor selected from the group consisting of HGF, betacellulin and prolactin.
 10. The method of claim 1, wherein said cell attachment surface comprises one or more extracellular matrix molecules.
 11. The method of claim 10, wherein said cell attachment surface comprises one or more extracellular matrix molecules selected from the group consisting of Collagen I, Collagen VI, Collagen IV, Vitronectin and Fibronectin.
 12. The method of claim 1, wherein the cells are seeded at a density of 10³-10⁵ cells/cm².
 13. The method of claim 1, wherein the cells are cultured for a period of 4-8 days.
 14. The method of claim 1, wherein the acinar cells are human acinar cells.
 15. The method of claim 1 wherein the acinar cells undergo transdifferentiation from an amylase+ acinar phenotype to an amylase+/CK19+ mixed acinar/liver-specific phenotype.
 16. A culture medium comprising a base medium suitable for maintaining mammalian epithelial cells that includes insulin, transferrin, selenium and EGF, wherein cultivation of human acinar cells in said medium under suitable conditions for 4-8 days results in expansion of said cells by 3-4 fold and transdifferentiation into a modified cell phenotype showing characteristics of acinar and liver cells.
 17. The culture medium of claim 16, wherein the base medium comprises DMEM, Hams F12, MEM, M-199, or RPMI, or a combination thereof.
 18. The culture medium of claim 17, wherein the base medium comprises 4 mM glutamine and a 1:1 mixture of DMEM and Hams
 12. 19. The culture medium of claim 16, which additionally comprises serum.
 20. The culture medium of claim 19, which additionally comprises up to 15% serum.
 21. The culture medium of claim 16, which is serum-free.
 22. The cell culture medium of claim 16, which comprises about 0.1-10 μg/ml insulin, about 0.5-10 μg/ml transferrin, about 0.25 -5.0 ng/ml selenium, and about 1-20 ng/l EGF.
 23. The cell culture medium of claim 16, which additionally comprises an effective amount of at least one soluble active factor that promotes expansion and transdifferentiation of acinar cells into IP cells.
 24. The cell culture medium of claim 16, which additionally comprises an effective amount of at least one factor selected from the group consisting of heat-inactivated BSA and the soluble active factors albumin, HGF, IGF-1, TGF-α, betacellulin, gastrin I and prolactin.
 25. The cell culture medium of claim 24, wherein the concentration of BSA is 0.1 -2%, the concentration of HGF is 1-20 ng/ml, the concentration of IGF-1 is 0.5-50 ng/ml, the concentration of TGF-α is 1-10 ng/ml, the concentration of betacellulin is 0.0005-0.1 ug/ml, the concentration of gastrin I is 1-100 pg/ml, and the concentration of prolactin is 1-10 ng/ml.
 26. The cell culture medium of claim 24, which comprises an effective amount of at least one soluble active factor selected from the group consisting of HGF, betacellulin and prolactin.
 27. A cell culture system, which comprises the cell culture medium of claim 16 and a cell attachment surface.
 28. The cell culture system of claim 27, wherein the cell attachment surface comprises a composition selected from the group consisting of collagen I, collagen VI, collagen IV, vitronectin and fibronectin.
 29. An isolated mammalian cell having a phenotype comprising both acinar and liver-associated markers.
 30. The isolated cell of claim 29 that expresses least one marker selected from the group consisting of CK18, CK8, CK19, CK7, HNF1, alpha-1 antitrypsin, pi-glutathione s transferase (pi-GST), liver-specific bHLH transcription factor, Thy-1, C/EBP-alpha and C/EBP-beta; and that expresses little or none of the following markers: carbonic anhydrase, cystic fibrosis transmembrane conductance regulator (CFTR), elastase and amylase.
 31. The isolated cell of claim 29 that expresses CK18, CK8, CK19, CK7, HNF1, alpha-1 antitrypsin, pi-glutathione s transferase (pi-GST), liver-specific bHLH transcription factor, Thy-1, C/EBP-alpha and C/EBP-beta.
 32. The isolated cell of claim 29 that is derived from a primary culture of pancreatic acinar cells.
 33. The isolated cell of claim 29 that is human.
 34. The isolated cell of claim 29 having an expression profile after 8 days ex vivo as shown in Table
 6. 35. An isolated cell prepared by the method of claim
 1. 36. A kit suitable for expanding mammalian acinar cells, comprising a) a base medium suitable for the cultivation of mammalian epithelial cells, b) a collagen I coated culture substrate, and, separately packaged, c) a serum-free medium supplement containing one or more component selected from the group consisting of BSA, HGF, EGF, TGFA, betacellulin, gastrin I and IGF-1.
 37. The kit of claim 36, wherein the serum-free medium supplement contains components in as suitable ratio for producing a medium containing 0.1-2% BSA, 1-20 ng/ml HGF, 1-20 ng/ml EGF, 1-10 ng/ml TGFA, 0.0005-0.10 ug/ml betacellulin, 1.0-100 pg/mL gastrin1, and 0.5-50 ng/mL IGF1, by the addition of a predetermined amount of base medium.
 38. The kit of claim 36 wherein the cell culture substrate is on the surface of a flask, bottle, petri dish, plate or well, or is part of a scaffold, suitable for cell culture.
 39. A method for transforming IP cells that express markers of acinar cells and liver-associated genes into insulin-producing cells in vitro, comprising culturing said IP cells in a cell culture medium comprising an effective amount of at least one differentiation promoting factor selected from the group consisting of Activin A, acidic FGF, basic FGF, C-Natriuretic Peptide (CNP), Calcitonin Gene Related Peptide, Cholera Toxin B Subunit, Dexamethasone, Gastrin-Releasing Peptide, Glucagon-like Peptide-1 (GLP-1), Glucose, IGF1, IGF2, Insulin, Laminin, LIF, Met-Enkephalin, PDGFAA+PDGFBB, Prolactin, Sonic Hedgehog, Substance P, TGF-alpha, Trolox (alpha-tocopherol derivative), and VEGF, such that the IP cells are transformed into insulin-producing cells.
 40. The method of claim 39, wherein the IP cells are derived from a culture of pancreatic acinar cells.
 41. The method of claim 40, wherein the cells are human.
 42. The method of claim 39, further comprising contacting said cells with a substrate that is coated with one or more extracellular matrix molecules.
 43. The method of claim 42, wherein the extracellular matrix molecules are collagen I, collagen VI, collagen IV, vitronectin, and/or fibronectin.
 44. The method of claim 42, wherein the substrate is on the surface of a flask, petri dish, plate, well or roller bottle, or is part of a scaffold.
 45. The method of claim 39, wherein the medium is serum-free.
 46. The method of claim 39, wherein the medium comprises serum.
 47. The method of claim 46, wherein the medium comprises BSA, insulin, transferrin, selenium and epidermal growth factor (EGF).
 48. The method of claim 39, wherein the cells are seeded on the substrate at a density of 5×10³ to 20×10⁵ cells/cm².
 49. An isolated insulin-producing cell generated by the method of claim
 39. 50. An insulin-producing cell, prepared by differentiating a mammalian acinar cell in vitro, wherein said insulin-producing cell has an expression profile after 16 days ex vivo as shown in Table
 6. 51. A serum-free medium comprising at least one active factor selected from the group consisting of Activin A, acidic FGF, basic FGF, C-Natriuretic Peptide (CNP), Calcitonin Gene Related Peptide, Cholera Toxin B Subunit, Dexamethasone, Gastrin-Releasing Peptide, Glucagon-like Peptide-1 (GLP-1), Glucose, IGF1, IGF2, Insulin, Laminin, LIF, Met-Enkephalin, PDGFAA+PDGFBB, Prolactin, Sonic Hedgehog, Substance P, TGF-alpha, Trolox (alpha-tocopherol derivative), and VEGF, wherein said medium facilitates differentiation of IP cells into insulin-producing cells.
 52. A serum-free medium comprising a 1:1 mixture of DMEM and Hams F12 plus the components listed in Table
 2. 53. A kit suitable for differentiating IP cells to insulin-producing cells, comprising a) a base medium suitable for the cultivation of mammalian epithelial cells; b) a collagen I coated culture substrate, and, separately packaged, c) a serum-free medium supplement containing BSA, Activin A, acidic FGF, basic FGF, C-Natriuretic Peptide (CNP), Calcitonin Gene Related Peptide, Cholera Toxin B Subunit, Dexamethasone, Gastrin-Releasing Peptide, Glucagon-like Peptide-1 (GLP-1), Glucose, IGF1, IGF2, Insulin, Laminin, LIF, Met-Enkephalin, PDGFAA+PDGFBB, Prolactin, Sonic Hedgehog, Substance P, TGF-alpha, Trolox (alpha-tocopherol derivative), or VEGF, or two or more of these components in combination, in suitable amounts to yield final concentrations in the completed medium as indicated in Table 1 herein.
 54. The kit of claim 53, wherein the cell culture substrate is contained on the surface of a flask, bottle, petri dish, plate or well suitable for cell culture.
 55. A method for obtaining insulin-producing cells through culture and manipulation of pancreatic acinar cells in vitro comprising the steps of i) culturing pancreatic acinar cells in a cell culture system comprising a culture medium and a cell attachment surface, under conditions wherein said acinar cells undergo a 3-4 fold expansion together with transdifferentiation into partially differentiated IP cells that express cytokeratin 18 (CK18), CK8, CK19, CK7, HNF1, alpha-1 antitrypsin, pi-glutathione s transferase (pi-GST), liver-specific bHLH transcription factor, Thy-1, C/EBP-alpha and C/EBP-beta; and that express little if any of carbonic anhydrase, cystic fibrosis transmembrane conductance regulator (CFTR), elastase and amylase; and ii) culturing said IP cells in a cell culture system comprising a cell culture medium and a substrate, said culture medium comprising an effective amount of at least one differentiation promoting factor selected from the group consisting of Activin A, acidic FGF, basic FGF, C-Natriuretic Peptide (CNP), Calcitonin Gene Related Peptide, Cholera Toxin B Subunit, Dexamethasone, Gastrin-Releasing Peptide, Glucagon-like Peptide-1 (GLP-1), Glucose, IGF1, IGF2, Insulin, Laminin, LIF, Met-Enkephalin, PDGFAA+PDGFBB, Prolactin, Sonic Hedgehog, Substance P, TGF-alpha, Trolox (alpha-tocopherol derivative), and VEGF; such that the IP cells are transformed into insulin-producing cells.
 56. The method of claim 55, wherein said insulin-producing cells release c-peptide and/or insulin in response to exposure to glucose.
 57. The method of claim 55, wherein the medium of step i) comprises an HGF receptor activator and an EGF receptor activator.
 58. The method of claim 55, wherein the medium of step ii) comprises an effective amount of at least one soluble active factor selected from the group consisting of C-Natriuretic Peptide (CNP), Calcitonin Gene Related Peptide, Cholera Toxin B Subunit, Dexamethasone, Gastrin-Releasing Peptide, Laminin, Met-Enkephalin, PDGFAA+PDGFBB, Sonic Hedgehog, and Substance P.
 59. A method of obtaining insulin-producing cells, said method comprising culturing primary pancreatic cells in a two phase culture system whereby, in the first phase, the cells are cultured on a surface comprising an effective amount of at least one ECM in a medium comprising at least one active soluble factor selected from the group consisting of HGF, TGFα, EGF, IGF1, betacellulin, prolactin and gastrin 1 for 4-10 days; and in a second phase, the cells are cultured on a surface comprising at least one ECM in a medium comprising an effective amount of at least one differentiation promoting factor selected from the group consisting of Activin A, CGRP alpha, C naturiuretic peptide (CNP), Cholera Toxin B Subunit, Dexamethasone, aFGF, Glucagon-Like Peptide-1 (GLP-1), Glucose, Insulin, LIF, PDGFAA, PDGFBB, TGF-alpha, Prolactin, Trolox (Vitamin E), Gastrin Releasing Peptide (GRP), IGF-1, IGF-2, Laminin, Met-Enkephalin, Sonic hedgehog, Substance P, bFGF, and VEGF for 3-14 days to obtain insulin producing cells.
 60. A primary culture of insulin-producing cells derived from glandular epithelial cells that expressed at least one marker selected from the group consisting of: cytokeratin 18 (CK18), CK8, CK19, CK7, HNF1, alpha-1 antitrypsin, pi-glutathione s transferase (pi-GST), liver-specific bHLH transcription factor, Thy-1, C/EBP-alpha and C/EBP-beta; and that expressed little if any of the markers carbonic anhydrase, cystic fibrosis transmembrane conductance regulator (CFTR), elastase and amylase, said insulin-producing cells having the characteristics of forming three-dimensional cell clusters that contain proinsulin and/or insulin and/or c-peptide.
 61. The culture of claim 60 wherein the glandular epithelial cells are pancreatic cells.
 62. The culture of claim 60 wherein the culture releases insulin and/or c-peptide in response to a glucose challenge.
 63. The culture of claim 60, wherein the glandular epithelial cells are human. 